Citrus Sinensis ID: 008634
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M0X5 | 675 | Cysteine-rich receptor-li | yes | no | 0.761 | 0.629 | 0.438 | 1e-95 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.822 | 0.689 | 0.410 | 6e-91 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.833 | 0.720 | 0.402 | 9e-90 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.793 | 0.662 | 0.401 | 7e-89 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.783 | 0.696 | 0.389 | 9e-85 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.797 | 0.658 | 0.399 | 2e-84 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.775 | 0.657 | 0.404 | 6e-84 | |
| Q9ZP16 | 667 | Cysteine-rich receptor-li | no | no | 0.745 | 0.623 | 0.380 | 4e-82 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.738 | 0.611 | 0.386 | 4e-81 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 0.799 | 0.659 | 0.391 | 4e-80 |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 351 bits (900), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 210/479 (43%), Positives = 271/479 (56%), Gaps = 54/479 (11%)
Query: 105 AGKSLYYNASEGEFPDS--VYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWY 162
A SL+ NA+ GE DS VYG++LC+ +VS + C++C+ A N LQ+C K A IWY
Sbjct: 63 AYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWY 122
Query: 163 QVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFN--------DVIAMPSLS 214
ECMVR+S+ S I+ N N+T++ FN DV +LS
Sbjct: 123 D--ECMVRYSNQS--IVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALS 178
Query: 215 SFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFP 274
S + AT++ N + + + QC P L+ DC CL I ++ RC D +G GR++ P
Sbjct: 179 SRKFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDR-SVG-GRVIAP 236
Query: 275 SCIMGFELYRY---------------SKVPAVGALAPSSAPGGKRGRAISIAIGTTLSAL 319
SC +ELY + S V A PS GK I AI +S +
Sbjct: 237 SCSFRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVS-V 295
Query: 320 IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFP 379
V+L G+ W RR + S E + L +G S E
Sbjct: 296 CVLLLGAMCWLLARRR-----NNKLSAETEDLDEDG-----------------ITSTETL 333
Query: 380 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN 439
F ATN FS+ NKLG GGFG VYKG L G+ +A+KRLS+ S QG +EFKNEV+
Sbjct: 334 QFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVD 393
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
++AKLQH+NL +LLG CL+G+E +L+YE++PNKSLD LFD + LDW+RR II GI
Sbjct: 394 VVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGI 453
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
ARGILYLH DSRL IIHRDLKASNILLD DM+PKISDFG+ARIFG +Q QANT I GT
Sbjct: 454 ARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGT 512
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 6e-91, Method: Compositional matrix adjust.
Identities = 205/499 (41%), Positives = 282/499 (56%), Gaps = 40/499 (8%)
Query: 78 CAVSNNTASN-TFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQ 135
C+++ +SN T+++NL L + A S + NA+ G+ PD V GL+LC+ NVS +
Sbjct: 33 CSITTTYSSNSTYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGNVSPE 92
Query: 136 SCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNTY 194
C++CI +VN L +C +EA +Y+ +CM+R+S+ + S ++T + M QN
Sbjct: 93 VCRSCIALSVNESLSRCPNEREAVFYYE--QCMLRYSNRNILSTLNTDGGVFM---QNAR 147
Query: 195 NVTKSLAQSFNDVIAMP--------SLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDC 246
N F D++ P + S R A + +++ + L QC P L+ DC
Sbjct: 148 NPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTPDLTEQDC 207
Query: 247 RDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPGGKRGR 306
DCL +I Q +D G GR PSC ++ Y + VG SS GK G
Sbjct: 208 LDCLQQSIN--QVTYDKIG---GRTFLPSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGGN 262
Query: 307 A-ISIAIGTTLSALIVVLFGSFLWYRRRRHARDQ------EEKRNSQEVQFLHWEGRIRN 359
+ + + ++ +LF +F RR + + + KR EV E
Sbjct: 263 SSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKVKRKETEVT----EPPAET 318
Query: 360 HYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIA 419
+I G Q F + + AT+ F NKLGQGGFG VYKGT G +A
Sbjct: 319 TDGDDITTAGSLQ--------FDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQVA 370
Query: 420 VKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF 479
VKRLS+ SGQG +EF+NEV ++AKLQH+NLV+LLG CLEG+E +L+YE++PNKSLD LF
Sbjct: 371 VKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFLF 430
Query: 480 DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
D T QLDW RR II GIARGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+
Sbjct: 431 DPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGM 490
Query: 540 ARIFGGNQNQANTNIIAGT 558
ARIFG +Q +ANT + GT
Sbjct: 491 ARIFGMDQTEANTRRVVGT 509
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 331 bits (849), Expect = 9e-90, Method: Compositional matrix adjust.
Identities = 206/512 (40%), Positives = 294/512 (57%), Gaps = 47/512 (9%)
Query: 59 SIVSSVMSQYFAEEDMVLSCAVSNNTASN-TFTSNLNILFNQKLHSEAGKSL--YYNASE 115
SI +S + ++ + +C+V+ +SN T+++NL L + A + A+
Sbjct: 15 SITASAQNTFY----LYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNASSYSTGFQTATA 70
Query: 116 GEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS 175
G+ PD V GL+LC+ +VS + C++C+ AVN L +C KE +Y+ +C++R+S+ +
Sbjct: 71 GQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYE--QCLLRYSNRN 128
Query: 176 -SSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMP-------SLSSFRN-ATKRTNIS 226
+ ++T + M+ +N +V + F D++ P + SF+ A ++ +++
Sbjct: 129 IVATLNTDGGMFMQSARNPLSVKQ---DQFRDLVLTPMNLAAVEAARSFKKWAVRKIDLN 185
Query: 227 NIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYS 286
L +C P L DC DCL I Q +D G GRIL PSC ++ Y +
Sbjct: 186 ASQSLYGMVRCTPDLREQDCLDCLKIGIN--QVTYDKIG---GRILLPSCASRYDNYAFY 240
Query: 287 KVPAVGALAPSSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQ 346
VG SS GK G + I I + ++ L ++ R ++ R EK
Sbjct: 241 NESNVGTPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLNEKEPVA 300
Query: 347 EVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGP 406
E +G +I G Q F + ATN F NKLGQGGFG
Sbjct: 301 E------DGN-------DITTAGSLQ--------FDFKAIEAATNCFLPINKLGQGGFGE 339
Query: 407 VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466
VYKGTL+ G +AVKRLS+TSGQG +EF+NEV ++AKLQH+NLV+LLG CLEG+E +L+Y
Sbjct: 340 VYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVY 399
Query: 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526
E++PNKSLD LFD+T ++LDW RR II GIARGILYLH+DSRL IIHRDLKA NILL
Sbjct: 400 EFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILL 459
Query: 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
DDDMNPKI+DFG+ARIFG +Q +A T + GT
Sbjct: 460 DDDMNPKIADFGMARIFGMDQTEAMTRRVVGT 491
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 7e-89, Method: Compositional matrix adjust.
Identities = 202/503 (40%), Positives = 277/503 (55%), Gaps = 60/503 (11%)
Query: 80 VSNNTASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQ 138
+N T+++T+ +NL L A S + NA+ G+ PD V GL+ C+ +VS + C+
Sbjct: 47 TANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGDVSTEVCR 106
Query: 139 NCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTK 198
C+ AVN L +C KEA ++Y EC++R+S+ + I+ T I NT NVT
Sbjct: 107 RCVSFAVNDTLTRCPNQKEATLYYD--ECVLRYSNQN--ILSTLITTGGVILVNTRNVTS 162
Query: 199 SLAQSFNDVIAMPSL---------SSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
+ +D++ +P+L SS + T++ N + + QC P L+ DC C
Sbjct: 163 NQLDLLSDLV-LPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQDCSRC 221
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL-------------AP 296
L I I P RI+ PSC +E+Y + AV P
Sbjct: 222 LQLVINQI-----PTDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVSAPP 276
Query: 297 SSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGR 356
S G + + + A+++ + G RR R
Sbjct: 277 RSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRAR---------------------- 314
Query: 357 IRNHYAYNILRGGK-QQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADG 415
+++Y + G A+S + R AT+ F + NK+GQGGFG VYKGTL+DG
Sbjct: 315 -KSYYTPSAFAGDDITTADSLQLDY---RTIQTATDDFVESNKIGQGGFGEVYKGTLSDG 370
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475
+AVKRLS++SGQG EFKNEV L+AKLQH+NLVRLLG CL+G+E +L+YEY+PNKSLD
Sbjct: 371 TEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLD 430
Query: 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535
LFD + QLDW RR II G+ARGILYLH+DSRL IIHRDLKASNILLD DMNPKI+
Sbjct: 431 YFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIA 490
Query: 536 DFGLARIFGGNQNQANTNIIAGT 558
DFG+ARIFG +Q + NT+ I GT
Sbjct: 491 DFGMARIFGLDQTEENTSRIVGT 513
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 315 bits (806), Expect = 9e-85, Method: Compositional matrix adjust.
Identities = 192/493 (38%), Positives = 268/493 (54%), Gaps = 56/493 (11%)
Query: 89 FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
+ +NL L + A S + +A G+ PD V GL+LC+ +VS C+NC+ ++N
Sbjct: 43 YLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDVSPAVCRNCVAFSIND 102
Query: 148 VLQKCSGTKEAFIWYQVQECMVRFSDHS--SSIMDTSAPLCM----KIFQNTYNVTKSLA 201
L +C +++ +Y ECM+R+SD + S++ A + M I QN N K
Sbjct: 103 TLVQCPSERKSVFYY--DECMLRYSDQNILSTLAYDGAWIRMNGNISIDQNQMNRFKDFV 160
Query: 202 QSFNDVIAMPSLSSFRN-ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRC 260
S + A+ + SS R T + + + L QC P L+ DC CL ++I+ +
Sbjct: 161 SSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDLTRQDCFSCLESSIKLM--- 217
Query: 261 FDPPGMGFGRILFPSCIMGFELYRYSKVPAV--------------GALAPSSAPGGK-RG 305
P GR L+ SC +EL+ + V + S PG
Sbjct: 218 --PLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPLVTSPSLPGKSWNS 275
Query: 306 RAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNI 365
+ +AI T+ ++L + + +R +++ D + ++
Sbjct: 276 NVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNAPAFDGDDI----------------- 318
Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR 425
+ E R+ ATN FS+ NK+GQGGFG VYKGT ++G +AVKRLS+
Sbjct: 319 ---------TTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSK 369
Query: 426 TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSV 485
+SGQG EFKNEV ++AKLQH+NLVRLLG + G E +L+YEYMPNKSLD LFD +
Sbjct: 370 SSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQN 429
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
QLDW RR +I GIARGILYLH+DSRL IIHRDLKASNILLD DMNPK++DFGLARIFG
Sbjct: 430 QLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGM 489
Query: 546 NQNQANTNIIAGT 558
+Q Q NT+ I GT
Sbjct: 490 DQTQENTSRIVGT 502
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 313 bits (803), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 199/498 (39%), Positives = 279/498 (56%), Gaps = 53/498 (10%)
Query: 84 TASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIV 142
++++T+++NL L + A S + N G+ PD V GL+LC+ ++S + C NC+
Sbjct: 51 SSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVA 110
Query: 143 AAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS-SSIMDTSAPLCMK------IFQNTYN 195
+VN L +C +EA +Y+ EC++R+S + S + L M+ QN +
Sbjct: 111 FSVNESLTRCPNQREAVFYYE--ECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRD 168
Query: 196 VTKSLAQS-FNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTI 254
L QS N + SS + +T +T ++++ L QC P L+ DC CL ++I
Sbjct: 169 QFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSI 228
Query: 255 RWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGA-----LAPSSAPG-------G 302
+ F +G R +PSC +ELY + A+G L P S P G
Sbjct: 229 NRMMPLFR---IG-ARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPG 284
Query: 303 KRGRAISIAIGTTLSAL--IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNH 360
K G + + + + A+ + L G +R + D ++ EV
Sbjct: 285 KSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTA---SASEV------------ 329
Query: 361 YAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAV 420
G A + L R ATN F++ NK+G+GGFG VYKGT ++GK +AV
Sbjct: 330 --------GDDMATADSLQL-DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAV 380
Query: 421 KRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480
KRLS+ S QG EFK EV ++AKLQH+NLVRLLG L+G+E +L+YEYMPNKSLD LFD
Sbjct: 381 KRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFD 440
Query: 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
T+ QLDW +R +II GIARGILYLH+DSRL IIHRDLKASNILLD D+NPKI+DFG+A
Sbjct: 441 PTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMA 500
Query: 541 RIFGGNQNQANTNIIAGT 558
RIFG +Q Q NT+ I GT
Sbjct: 501 RIFGLDQTQDNTSRIVGT 518
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 6e-84, Method: Compositional matrix adjust.
Identities = 201/497 (40%), Positives = 271/497 (54%), Gaps = 64/497 (12%)
Query: 89 FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
+ SNL L + A SL ++ ++G+ D V+GLYLCK ++S +SC+ C++ A
Sbjct: 46 YFSNLQTLLTSLSSNNAYFSLGSHSLTKGQNSDMVFGLYLCKGDLSPESCRECVIFAAKD 105
Query: 148 VLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDV 207
+C G KE I Y ECM+ +SD + MDT + + NT VT + FND
Sbjct: 106 TRSRCPGGKEFLIQYD--ECMLGYSDRNI-FMDTVTTTTIITW-NTQKVTADQSDRFNDA 161
Query: 208 I---------AMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQ 258
+ + +S + A K+++ S+ L QCIP L+ +DC CL +I+ +
Sbjct: 162 VLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIPDLTSEDCVMCLQQSIKELY 221
Query: 259 RCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL--------------APSSAPGGKR 304
F+ G GR L PSC +E+Y + K G + PS PG +
Sbjct: 222 --FNKVG---GRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSAPPLPLVSTPSFPPGKGK 276
Query: 305 GRAISIAIGTTL---SALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHY 361
+ I S LI V SF +R + D E+ +
Sbjct: 277 NSTVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYDTPEEDD----------------- 319
Query: 362 AYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVK 421
I G Q F ++ AT+ FS NKLGQGGFG VYKGTL +G +AVK
Sbjct: 320 ---ITTAGSLQ--------FDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVK 368
Query: 422 RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
RLS+TSGQG +EFKNEV ++AKLQH+NLV+LLG CLE +E +L+YE++ NKSLD LFD+
Sbjct: 369 RLSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDS 428
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
QLDW R II GIARGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+AR
Sbjct: 429 RMQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMAR 488
Query: 542 IFGGNQNQANTNIIAGT 558
IF +Q +A+T + GT
Sbjct: 489 IFEIDQTEAHTRRVVGT 505
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 186/489 (38%), Positives = 255/489 (52%), Gaps = 73/489 (14%)
Query: 109 LYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWY-QVQEC 167
LYYN S G+ P+ VY + +C + + C +CI L+ C EA+ W + C
Sbjct: 61 LYYNGSIGQQPNRVYAIGMCIPGSTSEDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLC 120
Query: 168 MVRFSDHS---------------SSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPS 212
VR+S+ S + +D++ KI++ S A + + PS
Sbjct: 121 YVRYSNTSFSGSADLNPRNWLTNTGDLDSNLTEFTKIWEGLMGRMISAAST---AKSTPS 177
Query: 213 LSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRIL 272
S + ++ ++ + QC P LS DC +CL + Q C G ++
Sbjct: 178 SSDNHYSADSAVLTPLLNIYALMQCTPDLSSGDCENCLRQSAIDYQSCCSQKRGGV--VM 235
Query: 273 FPSCIMGFELYRYSKVPAVGALAPSS-----------------------APGGKRGRAIS 309
PSC + ++LY YS A L +S + G G ++
Sbjct: 236 RPSCFLRWDLYTYSN--AFDNLTVASPPPEPPVTVPQPAGDQDNPTNNDSKGISAGVVVA 293
Query: 310 IAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGG 369
I + T ++ LI+++ G L+ RR+ + R + E
Sbjct: 294 ITVPTVIAILILLVLGFVLFRRRKSYQRTKTES--------------------------- 326
Query: 370 KQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ 429
+ + + ++ + ATN FS NKLG+GGFG VYKG L++G +AVKRLS+ SGQ
Sbjct: 327 ESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQ 386
Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW 489
G +EF+NE L+ KLQH+NLVRLLG CLE +E +LIYE++ NKSLD LFD + QLDW
Sbjct: 387 GTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDW 446
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
RR II GIARGILYLH+DSRLKIIHRDLKASNILLD DMNPKI+DFGLA IFG Q Q
Sbjct: 447 TRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQ 506
Query: 550 ANTNIIAGT 558
NTN IAGT
Sbjct: 507 GNTNRIAGT 515
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 4e-81, Method: Compositional matrix adjust.
Identities = 188/486 (38%), Positives = 264/486 (54%), Gaps = 74/486 (15%)
Query: 110 YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMV 169
+ NA+ G+ PD V GL+LC+ +VS + C+NC+ +VN L C +EA +Y+ +C++
Sbjct: 68 FQNATAGKAPDRVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYE--QCIL 125
Query: 170 RFSDHSSSIMDTSAPLCMKIFQNTYNV----------TKSLAQSFNDVIAMPSLSSFRNA 219
R+S H + + I NT + T ++ + ++ + SS +
Sbjct: 126 RYS-HKNILSTAITNEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLY 184
Query: 220 TKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRI----LFPS 275
T T ++ L QC P L+ DC CL ++I GM RI +PS
Sbjct: 185 TVNTELTAYQNLYGLLQCTPDLTRADCLSCLQSSIN---------GMALSRIGARLYWPS 235
Query: 276 CIMGFELYRYSKVPAVGA---------------------LAPSSAPGGKRGRAISIAIGT 314
C +ELY + A+ ++ SS PG K G + + +
Sbjct: 236 CTARYELYPFYNESAIETPPLPPPPPPPPPRESLVSTPPISSSSLPG-KSGNSTVLVVAV 294
Query: 315 TLSAL--IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQ 372
+ A+ + L G ++++ D ++ EV G
Sbjct: 295 VVLAVLLFIALVGYCFLAKKKKKTFDTA---SASEV--------------------GDDM 331
Query: 373 AESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ 432
A + L R ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG
Sbjct: 332 ATADSLQL-DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEA 390
Query: 433 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
EFK EV ++AKLQH+NLVRLLG L+G+E +L+YEYMPNKSLD LFD T+ +QLDW +R
Sbjct: 391 EFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLDWMQR 450
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+II GIARGILYLH+DSRL IIHRDLKASNILLD D+NPKI+DFG+ARIFG +Q Q NT
Sbjct: 451 YNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNT 510
Query: 553 NIIAGT 558
+ I GT
Sbjct: 511 SRIVGT 516
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (766), Expect = 4e-80, Method: Compositional matrix adjust.
Identities = 203/518 (39%), Positives = 275/518 (53%), Gaps = 72/518 (13%)
Query: 77 SCAVSNNTAS--NTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVS 133
SC S T S +T+ +NL L + A S + A+ G+ PD V GL+LC+ +VS
Sbjct: 35 SCPSSILTYSRNSTYFTNLKTLLSSLSSRNASYSTGFQTATAGQAPDRVTGLFLCRGDVS 94
Query: 134 FQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNT 193
+ C+NC+ +V L C KE ++Y ECM+R+S +I+ T I N
Sbjct: 95 QEVCRNCVAFSVKETLYWCPYNKEVVLYY--DECMLRYSHR--NILSTVTYDGSAILLNG 150
Query: 194 YNVTKS---LAQSFNDVIAMP-SLSSFR--NATKRTNISNIIR---LETFGQCIPVLSVD 244
N++ S F D+++ +L++ N++K+ +I L QC P L+
Sbjct: 151 ANISSSNQNQVDEFRDLVSSTLNLAAVEAANSSKKFYTRKVITPQPLYLLVQCTPDLTRQ 210
Query: 245 DCRDCLNNTIRWIQRCFDPPGMGF----GRILFPSCIMGFELYRYSKVPAVGA------- 293
DC CL +I+ GM GR +PSC +E Y + A +
Sbjct: 211 DCLRCLQKSIK---------GMSLYRIGGRFFYPSCNSRYENYSFYNETATRSSSPPSLP 261
Query: 294 ----------LAPS---SAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQE 340
LAP S G R ++ I + + AL+ +LF +F R ++ + E
Sbjct: 262 PRSTPQQQLKLAPPPLISERGKGRNSSVIIVVVVPIIALL-LLFVAFFSLRAKKTRTNYE 320
Query: 341 EKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLG 400
+ ++E +I G Q F + ATN F + NKLG
Sbjct: 321 REPLTEESD--------------DITTAGSLQ--------FDFKAIEAATNKFCETNKLG 358
Query: 401 QGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460
QGGFG VYKG G +AVKRLS+TSGQG +EF NEV ++AKLQH+NLVRLLG CLE
Sbjct: 359 QGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERD 418
Query: 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520
E +L+YE++PNKSLD +FD+T LDW RR II GIARGILYLH+DSRL IIHRDLK
Sbjct: 419 ERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLK 478
Query: 521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
A NILL DDMN KI+DFG+ARIFG +Q +ANT I GT
Sbjct: 479 AGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGT 516
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | ||||||
| 359477817 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.851 | 0.708 | 0.515 | 1e-122 | |
| 147776074 | 815 | hypothetical protein VITISV_005300 [Viti | 0.892 | 0.611 | 0.492 | 1e-122 | |
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.790 | 0.662 | 0.475 | 1e-107 | |
| 255555021 | 686 | ATP binding protein, putative [Ricinus c | 0.811 | 0.660 | 0.436 | 1e-105 | |
| 356575777 | 671 | PREDICTED: cysteine-rich receptor-like p | 0.813 | 0.676 | 0.446 | 5e-98 | |
| 359474717 | 663 | PREDICTED: cysteine-rich receptor-like p | 0.788 | 0.663 | 0.439 | 4e-97 | |
| 356575779 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.813 | 0.681 | 0.446 | 5e-96 | |
| 356575781 | 659 | PREDICTED: cysteine-rich receptor-like p | 0.808 | 0.684 | 0.432 | 1e-95 | |
| 359496705 | 1453 | PREDICTED: uncharacterized protein LOC10 | 0.870 | 0.334 | 0.407 | 5e-95 | |
| 356575789 | 697 | PREDICTED: cysteine-rich receptor-like p | 0.924 | 0.740 | 0.405 | 5e-95 |
| >gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1148), Expect = e-122, Method: Compositional matrix adjust.
Identities = 253/491 (51%), Positives = 320/491 (65%), Gaps = 16/491 (3%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSC 137
C +++ S F SNL L ++ L++E G S + EGE PD VYGL+LC+ +VS C
Sbjct: 35 CNNNSHAGSTKFQSNLGALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHIC 94
Query: 138 QNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNTYNV 196
Q+CI AA ++Q C KEA IWY EC +R+S+ S S ++ L M QN
Sbjct: 95 QSCIDAATLKIVQVCQHKKEAIIWYN--ECFLRYSNRSFFSNLEMKPTLYMWNTQNASAP 152
Query: 197 TK---SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNT 253
K L + F ++ A + S A + +SN + L QC L + CR CL+
Sbjct: 153 DKFDQKLGEMFQNLTAQATSSDDMYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRRCLDEV 212
Query: 254 IRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKV--PAVGALAPSS-APGGKRGRAIS- 309
+ +I + G GR+L PSC + +E+Y ++ V P V A PSS +P G++GR
Sbjct: 213 VGYIPNFME--GKQGGRVLAPSCYIRYEVYPFAAVEDPVVEAQVPSSISPRGRKGRKTKW 270
Query: 310 IAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEG-RIR-NHYAYNILR 367
IA GT+LS ++VV F + RRR+ A D EEK + ++ L G R+ Y+ L+
Sbjct: 271 IATGTSLSGIVVVAFCVYYVIRRRKGA-DPEEKESKGDLCLLDLGGGRLDAEDYSSETLQ 329
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS 427
G A+S+EFP+ + EAT HFS++NKLG+GGFGPVYKGTL+DGK IAVKRLS TS
Sbjct: 330 G-DMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSSTS 388
Query: 428 GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
GQGLQEFKNEV LIAKLQH+NLVRLLGCCLEG ELLLIYEYMPNKSLD LFD+TR ++L
Sbjct: 389 GQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLEL 448
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
DWK R SIINGIARGI YLHEDSRL+IIHRDLK SNILLD DMNPKISDFGLARIF G++
Sbjct: 449 DWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSE 508
Query: 548 NQANTNIIAGT 558
N NT I G+
Sbjct: 509 NGTNTAKIVGS 519
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1141), Expect = e-122, Method: Compositional matrix adjust.
Identities = 257/522 (49%), Positives = 330/522 (63%), Gaps = 24/522 (4%)
Query: 55 LHLLSIVSSVMSQYFAEEDMVLSCAVSNNTA--------SNTFTSNLNILFNQKLHSEAG 106
+ L+ I ++ +F + + + N+T N SNL L ++ L++E G
Sbjct: 149 IGLVDIAFGWLAYWFEGTEEAVGTKLLNSTTFPRLHAWIQNFKQSNLGALLSRSLNNEGG 208
Query: 107 KSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQE 166
S + EGE PD VYGL+LC+ +VS CQ+CI AA ++Q C KEA IWY E
Sbjct: 209 ISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYN--E 266
Query: 167 CMVRFSDHSS-SIMDTSAPLCMKIFQNTYNVTK---SLAQSFNDVIAMPSLSSFRNATKR 222
C +R+S+ S S ++ L M QN K L + F ++ A + S A +
Sbjct: 267 CFLRYSNRSFFSNLEMKPTLYMWNRQNASAPDKFDQKLGEMFQNLTAKATSSDGMYAIGQ 326
Query: 223 TNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFEL 282
+SN + L QC L + CR CL+ + +I + G GR+L PSC + +E+
Sbjct: 327 VEVSNFLNLYGIVQCTRDLRMSYCRQCLDEVVGYIPNFME--GKEGGRVLAPSCYIRYEI 384
Query: 283 YRYSKV--PAVGALAPSS-APGGKRGRAIS-IAIGTTLSALIVVLFGSFLWYRRRRHARD 338
Y ++ V P V A PSS +P G++GR IA GT+LS ++VV F + RRR+ A D
Sbjct: 385 YPFAAVEDPIVEAQVPSSISPRGRKGRKTKWIATGTSLSGIVVVAFCVYYVIRRRKGA-D 443
Query: 339 QEEKRNSQEVQFLHWEG-RIR-NHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDE 396
EEK + ++ L G R+ Y+ L+G A+S+EFP+ + EAT HFS++
Sbjct: 444 PEEKESKGDLCLLDLGGGRLDAEDYSSETLQG-DMLAKSKEFPVIGFDIVYEATQHFSND 502
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
NKLG+GGFGPVYKGTL+DGK IAVKRLSRTSGQGLQEFKNEV LIAKLQH+NLVRLLGCC
Sbjct: 503 NKLGEGGFGPVYKGTLSDGKEIAVKRLSRTSGQGLQEFKNEVILIAKLQHRNLVRLLGCC 562
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
LEG ELLLIYEYMPNKSLD LFD+TR ++LDWK R SIINGIARGI YLHEDSRL+IIH
Sbjct: 563 LEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIH 622
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
RDLK SNILLD DMNPKISDFGLARIF G++N NT I G+
Sbjct: 623 RDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKIVGS 664
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1016), Expect = e-107, Method: Compositional matrix adjust.
Identities = 234/492 (47%), Positives = 296/492 (60%), Gaps = 51/492 (10%)
Query: 89 FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
+ NLN L + + S+ ++NAS G PD VYGL+ C+ ++S CQNC+ A
Sbjct: 52 YKDNLNTLLSSLASNATSNSIGFFNASAGLEPDDVYGLFFCRGDLSTDVCQNCVANATKD 111
Query: 148 VLQK-CSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNTY-------NVTK 198
++Q+ C K AFIWY EC +R+S+ S M+ + +N +
Sbjct: 112 IVQRRCPTQKVAFIWYD--ECFLRYSNKIMFSTMERDPNYTLWNPENVAVHADFNRELLN 169
Query: 199 SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQ 258
++ + N MP+ + ATK N + L QC P LS DC CL ++
Sbjct: 170 TIFTAVNRAANMPAGAKKFRATK-ANYTTEHYLYVLVQCTPDLSSGDCEQCLLAAYSGLE 228
Query: 259 RCFDPPGMGFGRILFPSCIMGFELY-RYSKVPA-VGALAPSSAP-------GGKRG--RA 307
C + G RILFPSCI+ FE Y Y++ ALAPS P G +G +
Sbjct: 229 ICCNEKRGG--RILFPSCIVNFETYINYNETYVESAALAPSPVPQEKHFCYAGDKGSSKK 286
Query: 308 ISIAIGTTLSALI-VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNIL 366
I IG TLS ++ V+L SF + RR RD S E+ +
Sbjct: 287 TWIIIGATLSTIVGVLLLSSFAYTMWRRKKRDD----CSNEIMY---------------- 326
Query: 367 RGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT 426
+ +SQ+ L L + L+ATN +S+ENKLGQGGFGPVYKG + DGK IAVKRLSRT
Sbjct: 327 ----GEVKSQDSFLIQLDIVLKATNQYSNENKLGQGGFGPVYKGVMEDGKEIAVKRLSRT 382
Query: 427 SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
SGQGL+EF NEVNLIA+LQH+NLV+LLGCCLE E LL+YEYMPNKSLDV LFD+ VQ
Sbjct: 383 SGQGLREFMNEVNLIARLQHRNLVKLLGCCLEKNEKLLVYEYMPNKSLDVFLFDSAMRVQ 442
Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
LDW+RR SIINGIARG+LYLHEDSRL+IIHRDLKASNILLD +MNPKISDFG+ARIFGGN
Sbjct: 443 LDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFGGN 502
Query: 547 QNQANTNIIAGT 558
++ANTN I GT
Sbjct: 503 HSEANTNRIVGT 514
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 388 bits (997), Expect = e-105, Method: Compositional matrix adjust.
Identities = 230/527 (43%), Positives = 311/527 (59%), Gaps = 74/527 (14%)
Query: 81 SNNTA---SNTFTSNLN-ILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQS 136
SN+TA ++T+ +NLN +L + + ++ + +Y+ SEGE D VYGL+ C ++S +
Sbjct: 32 SNSTAFTRNSTYQNNLNRLLLSIRTNAINRPNGFYDTSEGEGEDRVYGLFFCTADLSTEV 91
Query: 137 CQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS-SSIMDTSAPLCMKIFQNTYN 195
CQ+C+++A ++ +C K A +WY EC++R+S+ + SI+ S L M QN +
Sbjct: 92 CQDCVISATRDIVGRCPIEKTAIVWYD--ECILRYSNQTIYSILALSPGLYMWNAQNVSD 149
Query: 196 -------VTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRD 248
+ ++ ++ N A L + + AT N + +L T QC P LS D
Sbjct: 150 QEGFSELLATTMIKTANQAAA--PLGAIKFATLVANFTASQKLYTLAQCTPDLSYSDSAQ 207
Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYR-YSKVPAVGALAP----------- 296
CL+ I + C D G GRIL+PSC + +E Y Y++ ++P
Sbjct: 208 CLHTAISNLPLCCD--GKRGGRILYPSCNIRYEFYPFYNETGFHREVSPFNNTTVVEGNP 265
Query: 297 -----------------------SSAPGGKRGRAISIAIGTTLSALIV--VLFGSFLWYR 331
GG+ + + +++A IV +LF SF +
Sbjct: 266 HSPILPPPPPPPIHPPAPMEKLGKVEKGGEGSKPTRTKVIASVTAAIVGILLFSSFFYIT 325
Query: 332 RRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATN 391
RR + EGR R+ Y+ + G + ++Q+FP+ P + EAT
Sbjct: 326 WRRK---------------IQKEGRTRDEYSCENITG---EMDAQDFPMIPFDIIEEATE 367
Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
HFSD+ KLG+GGFGPVYKGTL DGK IAVKRLSRTSGQGL EF NEV LI KLQH+NLVR
Sbjct: 368 HFSDDAKLGEGGFGPVYKGTLPDGKEIAVKRLSRTSGQGLPEFMNEVTLIFKLQHRNLVR 427
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
LLGCCLE E LLIYEYMPNKSLDV LFD+ V+LDW+RR SII+GIARG+LYLHEDSR
Sbjct: 428 LLGCCLEKSEKLLIYEYMPNKSLDVFLFDSHMGVRLDWQRRLSIISGIARGLLYLHEDSR 487
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
L+IIHRDLKASNILLD DMNPKISDFG+ARIFGGN +++ TN I GT
Sbjct: 488 LRIIHRDLKASNILLDYDMNPKISDFGMARIFGGNDSKS-TNRIVGT 533
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575777|ref|XP_003556013.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 364 bits (935), Expect = 5e-98, Method: Compositional matrix adjust.
Identities = 224/502 (44%), Positives = 296/502 (58%), Gaps = 48/502 (9%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
C + TA++TF N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ
Sbjct: 37 CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96
Query: 136 SCQNCIVAA---VNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---K 188
C C++ A ++S LQ CS +K+A IWY ECMVR+S+ S S +DT + +
Sbjct: 97 LCGQCVINATQKLSSDLQ-CSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSA 153
Query: 189 IFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRD 248
N N + + + N+ ++ + + ATK+ NIS L QC P LS CR
Sbjct: 154 NISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRS 213
Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY--SKVPAVGALAPSSAPGGKRGR 306
CL++ I + C + G GRIL PSC + ++LY + + V A A P + G
Sbjct: 214 CLSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGN 271
Query: 307 AIS-----IAIGTTLSALI-----VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGR 356
IS I+ GT ++ ++ V+LF +W +R A+ KRNS Q E
Sbjct: 272 IISYGGSEISPGTIVAIVVPITVAVLLFIVGIWLLSKRAAK----KRNS--AQDPKTETE 325
Query: 357 IRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGK 416
I A LR F AT+ FSD NKLG+GGFG VYKG L G+
Sbjct: 326 IS---AVESLR-------------FDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQ 369
Query: 417 AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 476
+AVKRLS+ SGQG EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD
Sbjct: 370 EVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDY 429
Query: 477 HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
LFD + LDW RR I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISD
Sbjct: 430 ILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISD 489
Query: 537 FGLARIFGGNQNQANTNIIAGT 558
FG+ARIFG +Q QANTN I GT
Sbjct: 490 FGMARIFGVDQTQANTNRIVGT 511
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 361 bits (927), Expect = 4e-97, Method: Compositional matrix adjust.
Identities = 218/496 (43%), Positives = 288/496 (58%), Gaps = 56/496 (11%)
Query: 87 NTFTSNLNILFNQKLHSEAGKSLYYNASEGEFP-DSVYGLYLCKFNVSFQSCQNCIVAAV 145
+++ +NLN + + + +YN + G P D YGL+LC+ +V+ Q CQ+C+ AV
Sbjct: 39 SSYETNLNFALSSLSSNATRDTGFYNVTAGRTPPDVAYGLFLCRGDVTSQVCQDCVATAV 98
Query: 146 N-SVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSF 204
N +V Q+C G K+A IWY ECM+R+S+ S + +P NT N+T+ F
Sbjct: 99 NETVRQRCRGFKQAIIWYD--ECMLRYSNESFFSQVSESPRVS--MWNTQNITE--PDQF 152
Query: 205 NDVIAMPSLSSFRN-----------ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNT 253
N V+ +L S R ATK N + R+ + QC P LS D C CL T
Sbjct: 153 NQVLG-DTLDSIRTQAVNDQSGKKFATKEENFTGFQRVYSLVQCTPDLSPDQCDRCLIGT 211
Query: 254 IRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSK--------VPAVGALAPSSAPGGKRG 305
I + C G R+LFPSC + +ELY + + PA + + GG
Sbjct: 212 IAILPDCCG--GKQGARVLFPSCNVRYELYPFYQSVAAPPSPPPARPSEPSTEGKGGISS 269
Query: 306 RAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNI 365
+ I I + T + VV+F + RR A+ + + ++ V+F NI
Sbjct: 270 KTIVIIVVPTFVS--VVIFSILCYCFIRRCAKKRYDTLEAENVEF-------------NI 314
Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR 425
Q F L ATN+FSD NK+G+GGFG VYKGTL+ G+ IA+KRLS+
Sbjct: 315 TTEQSLQ--------FDLATIQAATNNFSDHNKIGEGGFGAVYKGTLSSGQEIAIKRLSK 366
Query: 426 TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF---DAT 482
+SGQG EFKNEV L+AKLQH+NLVRLLG CLEG+E +L+YEY+PNKSLD LF T
Sbjct: 367 SSGQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDYFLFGLAQPT 426
Query: 483 RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ QLDW RR II GIARGILYLHEDSRL++IHRDLKASN+LLD DMNPKISDFG+ARI
Sbjct: 427 KRGQLDWSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDGDMNPKISDFGMARI 486
Query: 543 FGGNQNQANTNIIAGT 558
FG +Q Q NTN + GT
Sbjct: 487 FGVDQTQGNTNRVVGT 502
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575779|ref|XP_003556014.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 358 bits (918), Expect = 5e-96, Method: Compositional matrix adjust.
Identities = 222/497 (44%), Positives = 294/497 (59%), Gaps = 43/497 (8%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
C + TA++TF N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ
Sbjct: 37 CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96
Query: 136 SCQNCIVAA---VNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---K 188
C C++ A ++S LQ CS +K+A IWY ECMVR+S+ S S +DT + +
Sbjct: 97 LCGQCVINATQKLSSDLQ-CSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSA 153
Query: 189 IFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRD 248
N N + + + N+ ++ + + ATK+ NIS L QC P LS CR
Sbjct: 154 NISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRS 213
Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY--SKVPAVGALAPSSAPGGKRGR 306
CL++ I + C + G GRIL PSC + ++LY + + V A A P + G
Sbjct: 214 CLSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGG 271
Query: 307 AISIAIGTTLSALI-----VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHY 361
I+ GT ++ ++ V+LF +W +R A+ KRNS Q E I
Sbjct: 272 GSEISPGTIVAIVVPITVAVLLFIVGIWLLSKRAAK----KRNS--AQDPKTETEIS--- 322
Query: 362 AYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVK 421
A LR F AT+ FSD NKLG+GGFG VYKG L G+ +AVK
Sbjct: 323 AVESLR-------------FDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQEVAVK 369
Query: 422 RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
RLS+ SGQG EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD LFD
Sbjct: 370 RLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYILFDP 429
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ LDW RR I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDFG+AR
Sbjct: 430 EKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMAR 489
Query: 542 IFGGNQNQANTNIIAGT 558
IFG +Q QANTN I GT
Sbjct: 490 IFGVDQTQANTNRIVGT 506
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575781|ref|XP_003556015.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 3 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 357 bits (915), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 213/493 (43%), Positives = 288/493 (58%), Gaps = 42/493 (8%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
C + TA++TF N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ
Sbjct: 37 CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96
Query: 136 SCQNCIVAA---VNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---K 188
C C++ A ++S LQ CS +K+A IWY ECMVR+S+ S S +DT + +
Sbjct: 97 LCGQCVINATQKLSSDLQ-CSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSA 153
Query: 189 IFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRD 248
N N + + + N+ ++ + + ATK+ NIS L QC P LS CR
Sbjct: 154 NISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRS 213
Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAP---GGKRG 305
CL++ I + C + G GRIL PSC + ++LY + + + P+S P G
Sbjct: 214 CLSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNV--SAPPASVPPTDSSNSG 269
Query: 306 RAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNI 365
I I + V+LF +W +R A+ H +++
Sbjct: 270 GNIIIVAIVVPITVAVLLFIVGIWLLSKRAAK---------------------KHMSFHF 308
Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR 425
L + + + E F AT+ FSD NKLG+GGFG VYKG L G+ +AVKRLS+
Sbjct: 309 L--AETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQEVAVKRLSK 366
Query: 426 TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSV 485
SGQG EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD LFD +
Sbjct: 367 NSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYILFDPEKQK 426
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
LDW RR I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDFG+ARIFG
Sbjct: 427 SLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMARIFGV 486
Query: 546 NQNQANTNIIAGT 558
+Q QANTN I GT
Sbjct: 487 DQTQANTNRIVGT 499
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496705|ref|XP_003635307.1| PREDICTED: uncharacterized protein LOC100265431, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 355 bits (910), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 231/567 (40%), Positives = 311/567 (54%), Gaps = 81/567 (14%)
Query: 49 SQAIRWLHLL-----------SIVSSV--------------------MSQYFAEEDMVLS 77
S+A+RW+H+ ++SSV M ++F + S
Sbjct: 612 SEALRWIHIALLCVQEEPNDRPLMSSVALMLGSKSVNLPQPSAPPFSMGRHFMSDQ---S 668
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSC 137
+T + + +NL L + L S+A +YN S + +Y LYLC+ +V+ +C
Sbjct: 669 STTGTSTDNANYENNLTALLD-SLSSKASLYSFYNDSANQ----IYSLYLCRGDVNATTC 723
Query: 138 QNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVT 197
QNC+ A V Q+C + A IWY EC +R+S + + ++P + NT N +
Sbjct: 724 QNCVRTASQEVQQQCQSNRTAIIWYD--ECKLRYSSENFFGIAATSPYFL--LWNTRNNS 779
Query: 198 K-------SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFG--QCIPVLSVDDCRD 248
LA + V P+ + ++N + +G QC +S D+CR
Sbjct: 780 SPDERDVGGLAFIYTLVSKAPNSENMFGTDVAEAVNNASQ-NIYGSVQCTRDISNDECRS 838
Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAP-------- 300
CL I I+ C G I+ PSC M +E Y + + P + P+S P
Sbjct: 839 CLLQQIEEIEGCCQ--GKIGWNIMGPSCNMRYEQYLFYQQP-LAPSTPASQPMPDDNPVY 895
Query: 301 ------GGKRGRAISIAIGTTLSALIVVLFGSFLW---YRRRRHARDQEEKRNSQEVQFL 351
GGK I+I +T++ VL G +L+ +RR+R + E+ S+E+ L
Sbjct: 896 NIVAGKGGKNTTDIAIITVSTVTG-AAVLLGFYLYCSIFRRKR----EPEEHVSEEI-LL 949
Query: 352 HWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT 411
H+ + +I + Q S E F L L ATN+FSD NKLG+GGFGPVYKG
Sbjct: 950 HYSTAATHFMEGHI--HARDQDNSGELHCFNLTTILTATNNFSDANKLGEGGFGPVYKGK 1007
Query: 412 LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471
L +GK IAVKRLSR SGQGL+EFKNEV LI KLQHKNLVRLLGCC+E +E LL+YEYM N
Sbjct: 1008 LLNGKEIAVKRLSRKSGQGLEEFKNEVMLIVKLQHKNLVRLLGCCIEREEKLLVYEYMAN 1067
Query: 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531
SLD LFD +S QLDW +R +I+ GIARGILYLHEDSRLKIIHRDLKASN+LLD++MN
Sbjct: 1068 TSLDAFLFDPIKSRQLDWAKRAAIVGGIARGILYLHEDSRLKIIHRDLKASNVLLDEEMN 1127
Query: 532 PKISDFGLARIFGGNQNQANTNIIAGT 558
PKISDFG ARIFG NQ ANTN + GT
Sbjct: 1128 PKISDFGTARIFGSNQIDANTNKVVGT 1154
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575789|ref|XP_003556019.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 355 bits (910), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 219/540 (40%), Positives = 308/540 (57%), Gaps = 24/540 (4%)
Query: 30 FISEVKSYRRTMPTAANLASQAIRWLHL-LSIVSSVMSQYFAEEDMVLSCAVSNNTASNT 88
++S VK + P A +S + +L + +S + ++ + C + TA++T
Sbjct: 11 YVSAVKQLKHINPAMAWNSSFKLLFLFVFVSFLCFATTKAQGPNFLYQDCPSNQTTANST 70
Query: 89 FTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQSCQNCIVAA-- 144
F N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ C C++ A
Sbjct: 71 FQINIRTLFSSLSSNATTNNVFYNSTVTGTNPSDTVYGLFMCRGDVPFQLCGQCVINATQ 130
Query: 145 -VNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---KIFQNTYNVTKS 199
++S LQ CS +K+A IWY ECMVR+S+HS S +DT + + N N +
Sbjct: 131 KLSSDLQ-CSLSKQAVIWYD--ECMVRYSNHSFFSTVDTRPAIGLLNSANISNQANFMRL 187
Query: 200 LAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQR 259
+ + N+ ++ + + ATK+ NIS L QC P LS CR CL++ I + R
Sbjct: 188 MFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPR 247
Query: 260 CFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPGGKRGRAISIAIGTTLSAL 319
C + G GRIL PSC + +ELY + + + +S+P ++S+ T S+
Sbjct: 248 CCE--GKQGGRILNPSCNVRYELYPFFRTNTI-----ASSPAPTPTPSVSVPPTPTTSSN 300
Query: 320 IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQA-ESQEF 378
G ++ + + H + L G + A ES F
Sbjct: 301 SGGSGGISSGTIVAIVVPIAVAVVIFVVGIWILCKRAAKKHMPFLFLAGTEISAVESLRF 360
Query: 379 PLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV 438
+ AT FS+ NKLG+GGFG VYKG L G+ +AVKRLS+ SGQG +EFKNEV
Sbjct: 361 DFSTIE---AATQKFSEANKLGEGGFGEVYKGLLPSGQEVAVKRLSKISGQGGEEFKNEV 417
Query: 439 NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
++AKLQH+NLVRLLG CLEG+E +L+YE++ NKSLD LFD + LDW RR I+ G
Sbjct: 418 EIVAKLQHRNLVRLLGFCLEGEEKILVYEFVVNKSLDYILFDPEKQKSLDWTRRYKIVEG 477
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
IARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDFG+ARIFG +Q QANTN I GT
Sbjct: 478 IARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQTQANTNRIVGT 537
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | ||||||
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.756 | 0.625 | 0.424 | 1.8e-80 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.304 | 0.254 | 0.658 | 1.2e-79 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.310 | 0.268 | 0.643 | 3.2e-79 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.304 | 0.254 | 0.664 | 4.8e-75 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.304 | 0.257 | 0.635 | 2.5e-73 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.310 | 0.255 | 0.632 | 1.1e-72 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.749 | 0.618 | 0.398 | 2e-72 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.318 | 0.214 | 0.617 | 3.3e-72 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.318 | 0.266 | 0.629 | 2.6e-69 | |
| TAIR|locus:2123056 | 656 | CRK32 "cysteine-rich RLK (RECE | 0.311 | 0.265 | 0.590 | 2.9e-68 |
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 808 (289.5 bits), Expect = 1.8e-80, P = 1.8e-80
Identities = 202/476 (42%), Positives = 271/476 (56%)
Query: 108 SLYYNASEGEFPDS--VYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQ 165
SL+ NA+ GE DS VYG++LC+ +VS + C++C+ A N LQ+C K A IWY
Sbjct: 66 SLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYD-- 123
Query: 166 ECMVRFSDHSSSIMDTSAPLCMKIF-QNTYNVTKSLAQSFN--------DVIAMPSLSSF 216
ECMVR+S+ S P +F N N+T++ FN DV +LSS
Sbjct: 124 ECMVRYSNQSIVGQMRIRP---GVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSR 180
Query: 217 RNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSC 276
+ AT++ N + + + QC P L+ DC CL I ++ RC D +G GR++ PSC
Sbjct: 181 KFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDR-SVG-GRVIAPSC 238
Query: 277 IMGFELYR-YSKVPAVGALAP--SS---APG----GKRGRAISIAIGTTLSAL----IVV 322
+ELY Y++ A +AP SS AP ++G+ ++ + T A+ V+
Sbjct: 239 SFRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVL 298
Query: 323 LFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFP 382
L G+ W RR + S E + L +G I + E+ +F
Sbjct: 299 LLGAMCWLLARRR-----NNKLSAETEDLDEDG-ITS-------------TETLQFQFSA 339
Query: 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIA 442
+ A TN FS+ NKLG GGFG VYKG L G+ +A+KRLS+ S QG +EFKNEV+++A
Sbjct: 340 IEAA---TNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVA 396
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
KLQH+NL + +YE++PNKSLD LFD + LDW+RR II GIARG
Sbjct: 397 KLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARG 456
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
ILYLH DSRL IIHRDLKASNILLD DM+PKISDFG+ARIFG +Q QANT I GT
Sbjct: 457 ILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGT 512
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 1.2e-79, Sum P(2) = 1.2e-79
Identities = 112/170 (65%), Positives = 131/170 (77%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
AT+ F + NK+GQGGFG VYKGTL+DG +AVKRLS++SGQG EFKNEV L+AKLQH+N
Sbjct: 344 ATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRN 403
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LVR +YEY+PNKSLD LFD + QLDW RR II G+ARGILYLH+
Sbjct: 404 LVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQ 463
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q + NT+ I GT
Sbjct: 464 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 3.2e-79, Sum P(2) = 3.2e-79
Identities = 112/174 (64%), Positives = 134/174 (77%)
Query: 386 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
A+EA TN F NKLGQGGFG VYKGTL+ G +AVKRLS+TSGQG +EF+NEV ++AKL
Sbjct: 318 AIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKL 377
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
QH+NLV+ +YE++PNKSLD LFD+T ++LDW RR II GIARGIL
Sbjct: 378 QHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGIL 437
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
YLH+DSRL IIHRDLKA NILLDDDMNPKI+DFG+ARIFG +Q +A T + GT
Sbjct: 438 YLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGT 491
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 4.8e-75, Sum P(3) = 4.8e-75
Identities = 113/170 (66%), Positives = 127/170 (74%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
ATN FS NKLG+GGFG VYKG L++G +AVKRLS+ SGQG +EF+NE L+ KLQH+N
Sbjct: 346 ATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRN 405
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LVR IYE++ NKSLD LFD + QLDW RR II GIARGILYLH+
Sbjct: 406 LVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQ 465
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
DSRLKIIHRDLKASNILLD DMNPKI+DFGLA IFG Q Q NTN IAGT
Sbjct: 466 DSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGT 515
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 2.5e-73, Sum P(2) = 2.5e-73
Identities = 108/170 (63%), Positives = 127/170 (74%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
ATN FS+ NK+G+GGFG VYKGT ++G +AVKRLS+TS QG EFKNEV ++A L+HKN
Sbjct: 332 ATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKN 391
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LVR +YEY+ NKSLD LFD + QL W +R II GIARGILYLH+
Sbjct: 392 LVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQ 451
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q Q NT+ I GT
Sbjct: 452 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGT 501
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 1.1e-72, Sum P(2) = 1.1e-72
Identities = 110/174 (63%), Positives = 128/174 (73%)
Query: 386 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
A+EA TN F + NKLGQGGFG VYKG G +AVKRLS+TSGQG +EF NEV ++AKL
Sbjct: 343 AIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKL 402
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
QH+NLVR +YE++PNKSLD +FD+T LDW RR II GIARGIL
Sbjct: 403 QHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGIL 462
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
YLH+DSRL IIHRDLKA NILL DDMN KI+DFG+ARIFG +Q +ANT I GT
Sbjct: 463 YLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGT 516
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 732 (262.7 bits), Expect = 2.0e-72, P = 2.0e-72
Identities = 188/472 (39%), Positives = 257/472 (54%)
Query: 110 YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMV 169
+ N G+ PD V GL+LC+ ++S + C NC+ +VN L +C +EA +Y+ EC++
Sbjct: 78 FQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYE--ECIL 135
Query: 170 RFSDHSS--SIMDTSAPLCMK------IFQNTYNVTKSLAQSFNDVIAMPSLSSFRN-AT 220
R+S H + S + L M+ QN + L QS + A + +S R +T
Sbjct: 136 RYS-HKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFST 194
Query: 221 KRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGF 280
+T ++++ L QC P L+ DC CL ++I + F +G R +PSC +
Sbjct: 195 IKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPLFR---IG-ARQFWPSCNSRY 250
Query: 281 ELYRYSKVPAVGA-----LAPSSAPG-------GKRGRAISIAIGTTLSA--LIVVLFGS 326
ELY + A+G L P S P GK G + + + + A L + L G
Sbjct: 251 ELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGY 310
Query: 327 FLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLA 386
+R + D ++ EV G A + L R
Sbjct: 311 CFLAQRTKKTFDTA---SASEV--------------------GDDMATADSLQL-DYRTI 346
Query: 387 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG EFK EV ++AKLQH
Sbjct: 347 QTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQH 406
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+NLVR +YEYMPNKSLD LFD T+ QLDW +R +II GIARGILYL
Sbjct: 407 RNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYL 466
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
H+DSRL IIHRDLKASNILLD D+NPKI+DFG+ARIFG +Q Q NT+ I GT
Sbjct: 467 HQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGT 518
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 557 (201.1 bits), Expect = 3.3e-72, Sum P(2) = 3.3e-72
Identities = 110/178 (61%), Positives = 130/178 (73%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
F + + ATN+F NKLGQGGFG VYKGT G +AVKRLS+TSGQG +EF+NEV +
Sbjct: 496 FDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVV 555
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
+AKLQH+NLVR +YE++ NKSLD LFD T QLDW RR II GIA
Sbjct: 556 VAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIA 615
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
RGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+ARIFG +Q +ANT + GT
Sbjct: 616 RGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGT 673
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 2.6e-69, Sum P(2) = 2.6e-69
Identities = 112/178 (62%), Positives = 134/178 (75%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
F + AT+ FSD N +G+GGFG VY+G L+ G +AVKRLS+TSGQG +EFKNE L
Sbjct: 333 FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVL 392
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
++KLQHKNLVR +YE++PNKSLD LFD + +LDW RR +II GIA
Sbjct: 393 VSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIA 452
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
RGILYLH+DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q+QANT IAGT
Sbjct: 453 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGT 510
|
|
| TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 2.9e-68, Sum P(2) = 2.9e-68
Identities = 108/183 (59%), Positives = 129/183 (70%)
Query: 385 LALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
+ LEA T+ FS NKLG+GGFG VYKG L + +AVKRLS SGQG QEFKNEV ++AK
Sbjct: 312 MTLEAATDKFSRNNKLGKGGFGEVYKGMLPNETEVAVKRLSSNSGQGTQEFKNEVVIVAK 371
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDV--------HLFDATRSVQLDWKRRQSI 495
LQHKNLVR +YE++PNKSL+ HL D T+ QLDWKRR +I
Sbjct: 372 LQHKNLVRLLGFCLERDEQILVYEFVPNKSLNYFLFGNKQKHLLDPTKKSQLDWKRRYNI 431
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
I GI RG+LYLH+DSRL IIHRD+KASNILLD DMNPKI+DFG+AR F +Q + NT +
Sbjct: 432 IGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDNTRRV 491
Query: 556 AGT 558
GT
Sbjct: 492 VGT 494
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00020409001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (654 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 558 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-18 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 5e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-06 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 4e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-41
Identities = 63/152 (41%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
KLG+G FG VYKGTL +AVK L S Q ++EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V+LLG C E + L+++ EYMP L +L R +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IHRDL A N L+ +++ KISDFGL+R
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 60/152 (39%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
KLG+G FG VYKG L +AVK L S Q ++EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V+LLG C E + L ++ EYM L +L +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IHRDL A N L+ +++ KISDFGL+R
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 62/156 (39%), Positives = 81/156 (51%), Gaps = 14/156 (8%)
Query: 397 NKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
KLG+G FG VYKG L +AVK L S + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHL------FDATRSVQLDWKRRQSIINGIARGILY 505
LLG C E + L L+ EYM L +L F + L K S IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
L K +HRDL A N L+ +D+ KISDFGL+R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG G FG VYK GK +AVK L + Q + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L L+ EY L +L +R L + I I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
IHRDLK NILLD++ KI+DFGLA+ + ++ GT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 59/163 (36%), Positives = 85/163 (52%), Gaps = 10/163 (6%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
LG+GGFG VY GK +A+K + + S L+E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
+ L L+ EY SL L + +L I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 517 RDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
RDLK NILLD D+ K++DFGL+++ +++ T I GT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 59/150 (39%), Positives = 81/150 (54%), Gaps = 11/150 (7%)
Query: 398 KLGQGGFGPVYKGTLADGKA-----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
KLG+G FG VYKGTL +AVK L S + +EF E +++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
LLG C +G+ L ++ EYMP L L + L + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL--QMALQIAKGMEYLES--- 120
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDL A N L+ +++ KISDFGL+R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLV 450
+ KLG+G FG VY GK +A+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL + +L L+ EY L L + +L + + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
I+HRDLK NILLD+D + K++DFGLAR +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE 151
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 58/180 (32%), Positives = 82/180 (45%), Gaps = 37/180 (20%)
Query: 397 NKLGQGGFGPVYKGTLAD-GKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG+G FG VY D G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-------------RQSIING 498
G E L + EY+ SL L K+ RQ
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----------KKFGKLPEPVIRKYTRQ----- 109
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
I G+ YLH I+HRD+K +NIL+D D K++DFG A+ G + T + GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 55/148 (37%), Positives = 79/148 (53%), Gaps = 16/148 (10%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
+G+G FG V G G+ +AVK L S Q F E +++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 459 GQELLLIYEYMPNKSLDVHLFDATRSV-----QLDWKRRQSIINGIARGILYLHEDSRLK 513
G L ++ EYM SL +L R+V QL + + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD------VCEGMEYLEEK---N 122
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDL A N+L+ +D+ K+SDFGLA+
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 41/185 (22%)
Query: 392 HFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKN 448
++ + +G+G FG VYKG L G +A+K++S + L+ E++L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING---------- 498
+V+ +G L +I EY N SL + II
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL------------------RQIIKKFGPFPESLVA 102
Query: 499 -----IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ +G+ YLHE +IHRD+KA+NIL D K++DFG+A +
Sbjct: 103 VYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS- 158
Query: 554 IIAGT 558
+ GT
Sbjct: 159 -VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 56/174 (32%), Positives = 88/174 (50%), Gaps = 21/174 (12%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
F K+G+GGFG VYK GK +A+K + S + ++ NE+ ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGIL---- 504
+ G L+ EL ++ E+ SL D +S + +S I + + +L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLK----DLLKS----TNQTLTESQIAYVCKELLKGLE 112
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
YLH IIHRD+KA+NILL D K+ DFGL+ + +A ++ GT
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMV-GT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 54/154 (35%), Positives = 84/154 (54%), Gaps = 13/154 (8%)
Query: 397 NKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
+LG+G FG V G+ +AVK L+ + Q +F+ E+ ++ L H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 451 RLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ G C + G+ L LI EY+P+ SL +L Q++ KR + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ IHRDL A NIL++ + KISDFGLA++
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 10/153 (6%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
F+ E KLG G FG V++G + +A+K L Q+F+ EV + +L+HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
C G+ + +I E M SL L V S+I+ +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL----PVASLIDMACQVAEGMAYLEEQ 123
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
IHRDL A NIL+ +D+ K++DFGLAR+
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
F KLG+G +G VYK G+ +A+K + LQE E++++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 452 LLGCCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
G + +L ++ EY S D + T L + +I+ +G+ YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNK-TLTEEEIAAILYQTLKGLEYLH--- 116
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
K IHRD+KA NILL+++ K++DFG++ + NT I GT
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 21/172 (12%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
++G+G FG VY +DGK +K LS S + ++ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRQSIINGIARGILYL 506
E +L ++ EY L + + + LDW + + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCLALKYL 119
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
H KI+HRD+K NI L + K+ DFG++++ + A T + GT
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV--GT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 63/185 (34%), Positives = 89/185 (48%), Gaps = 33/185 (17%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKG---TLADGK---AIAVKRLSRT-SGQ 429
E PL +R F +E LG+G FG VYKG + ++A+K L +
Sbjct: 1 EIPLSAVR--------FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK 50
Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHL 478
QEF+ E L++ LQH N+V LLG C + Q +++EY+ + L DV
Sbjct: 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110
Query: 479 FDATRSVQ--LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
+V+ LD I IA G+ YL S +HRDL A N L+ + + KISD
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISD 167
Query: 537 FGLAR 541
FGL+R
Sbjct: 168 FGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 399 LGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVR 451
LG+G FG V+ G + +AVK L T+ ++ F+ E L+ QH+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 452 LLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSVQLDWKRRQ-------SIINGIA 500
G C EG ++++EYM NK L H DA D + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
G++YL + +HRDL N L+ D+ KI DFG++R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 54/162 (33%), Positives = 88/162 (54%), Gaps = 23/162 (14%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKR---------LSRTSGQGLQEFKNEVNLIA 442
+ KLG+G +G VYK G+ +A+K+ + T+ L+E ++L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LRE----ISLLK 53
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
+L+H N+V+LL ++L L++EY +D+ + R L +SI+ + RG
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ Y H S +I+HRDLK NIL++ D K++DFGLAR FG
Sbjct: 111 LAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 55/161 (34%), Positives = 89/161 (55%), Gaps = 20/161 (12%)
Query: 399 LGQGGFGPVYKGT-LADGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VYKG + +G+ +A+K L + + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLF---DATRSVQ-LDWKRRQSIINGIARGILYLHE 508
LG CL ++ LI + MP L ++ D S L+W + IA+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-E 126
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+ RL +HRDL A N+L+ + KI+DFGLA++ ++ +
Sbjct: 127 EKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEF----KNEVNLIAKLQHKNLVR 451
++G+G +G VYK G+ +A+K++ R + F E+ L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-RME-NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 452 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
L + +++EYM + D+ + V+ + + + + G+ YLH +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
I+HRD+K SNIL+++D K++DFGLAR + + TN
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 53/151 (35%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLG G FG V+ GT +AVK L + + F E ++ KL+H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
C E + + ++ EYM SL L R +++ IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKL----RLPQLVDMAAQIAEGMAYLE---SR 122
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIF 543
IHRDL A NIL+ +++ KI+DFGLAR+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 16/188 (8%)
Query: 377 EFPLFPLRLALEA---TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ 432
E L+ + + + K+G+G G VYK T A GK +A+K++ R Q +
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKE 60
Query: 433 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
NE+ ++ +H N+V L G EL ++ EYM SL D +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT----DIITQNFVRMNEP 116
Query: 493 Q--SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
Q + + +G+ YLH +IHRD+K+ NILL D + K++DFG A +++
Sbjct: 117 QIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 551 NTNIIAGT 558
N+ + GT
Sbjct: 174 NS--VVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 53/151 (35%), Positives = 82/151 (54%), Gaps = 16/151 (10%)
Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLS-----RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VY+G L DG AVK +S +T + +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
LG E L + E +P SL L + + + RQ I G+ YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-----ILLGLEYLHDR- 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+HRD+K +NIL+D + K++DFG+A+
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 6e-22
Identities = 51/145 (35%), Positives = 80/145 (55%), Gaps = 6/145 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLVRLLGCC 456
K+G+G FG VYKG L +AVK T L ++F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
++ Q + ++ E +P SL L + +L K+ + A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 517 RDLKASNILLDDDMNPKISDFGLAR 541
RDL A N L+ ++ KISDFG++R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 52/151 (34%), Positives = 87/151 (57%), Gaps = 10/151 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
K+G+G +G VYK G+ +A+K++ T +G+ E++L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 455 CCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+L L++E++ LD+ D++ LD +S + + +GI Y H S +
Sbjct: 66 VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFG 544
++HRDLK N+L+D + K++DFGLAR FG
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 57/162 (35%), Positives = 92/162 (56%), Gaps = 18/162 (11%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGK---AIAVKRLS--RTSGQGLQEFKNEVNLIAKL 444
+H + + +G G FG V++G L G+ A+A+K L T Q Q+F +E +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQF 63
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIAR 501
H N++RL G + + ++I EYM N +LD +L D S QL ++ GIA
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAA 118
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
G+ YL S + +HRDL A NIL++ ++ K+SDFGL+R+
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 55/157 (35%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 397 NKLGQGGFGPVYKGT--LADGK--AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
+LG G FG V KG + GK +AVK L + G +EF E +++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L+G C G+ L+L+ E P L +L D K + + +A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESK-- 114
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+HRDL A N+LL + KISDFG++R G +
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-21
Identities = 57/169 (33%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL 449
F NK+G+G FG V+K AD + A+K+ LS+ + + +E +E ++AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+R L+ +L ++ EY N L L R L + I G+ +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLH-KLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
KI+HRD+K+ N+ LD N KI D G+A++ N N ANT I GT
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 40/169 (23%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN-----------EVNLIAK 443
KLG+G + VYK G+ +A+K++ L E K E+ L+ +
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQE 58
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMP--------NKSLDVHLFDATRSVQLDWKRRQSI 495
L+H N++ LL + L++E+M +KS+ L A D K S
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV--LTPA------DIK---SY 107
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ RG+ YLH I+HRDLK +N+L+ D K++DFGLAR FG
Sbjct: 108 MLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 55/155 (35%), Positives = 81/155 (52%), Gaps = 6/155 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
KLG G FG V+ G +A+K L + S + F E NL+ +LQH LVRL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
+ + + +I EYM N SL V ++L + + IA G+ ++ R I
Sbjct: 70 VTQ-EPIYIITEYMENGSL-VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
HRDL+A+NIL+ + + KI+DFGLAR+ N+ A
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 54/162 (33%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 398 KLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+LG+G FG V+ D +AVK L S Q+F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 452 LLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSV---QLDWKRRQSIINGI 499
G C EG+ LL+++EYM + L D + V QL + +I + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
A G++YL + L +HRDL N L+ + KI DFG++R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 53/157 (33%), Positives = 93/157 (59%), Gaps = 11/157 (7%)
Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLQEFK-NEVNLIAKLQHKNL 449
++ K+G+G +G VYKG G+ +A+K++ S +G+ E++L+ +LQH N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLF-DATRSVQ-LDWKRRQSIINGIARGILYLH 507
V L ++ L LI+E++ S+D+ + D+ Q +D + +S + I +GIL+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+++HRDLK N+L+D+ K++DFGLAR FG
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 10/163 (6%)
Query: 396 ENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
E +G G FG V +G L +A+K L S + +F E +++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL G + + +++I EYM N SLD L + + ++ GIA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ +HRDL A NIL++ ++ K+SDFGL+R ++ T
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 58/165 (35%), Positives = 94/165 (56%), Gaps = 20/165 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAI----AVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VYKG + +G+ + A+K L+ T+G + EF +E ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSL----DVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LG CL + L+ + MP+ L H + + L+W + IA+G++YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+++HRDL A N+L+ + KI+DFGLAR+ G++ + N +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 13/167 (7%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKL 444
+ KLG+G FG VYK + G+ +A+K++ + G + + E+ ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 445 QHKNLVRLLGCCLE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
+H N+V L+ +E ++ +Y P D+ SV+L + + + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
GI YLHE+ I+HRD+KA+NIL+D+ KI+DFGLAR + G
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 14/156 (8%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++KLG G +G VY+G +AVK L + ++EF E ++ +++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRS----VQLDWKRRQSIINGIARGILYLHEDS 510
C +I E+M +L +L + R V L + Q I+ + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-----ISSAMEYLEKKN 124
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
IHRDL A N L+ ++ K++DFGL+R+ G+
Sbjct: 125 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
LGQG G VYK GK A+K++ + ++ E+ + + +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCY 65
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHED 509
G + E+ ++ EYM SL D + V K + ++ IAR IL YLH
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLA----DLLKKVG---KIPEPVLAYIARQILKGLDYLH-- 116
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
++ IIHRD+K SN+L++ KI+DFG++++ +Q NT + GT
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 52/152 (34%), Positives = 80/152 (52%), Gaps = 18/152 (11%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKR-----LSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG VY D G+ +AVK+ S + + + + E+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLHED 509
GC + + L + EYMP S+ L + A T +V + R+ I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLHSN 123
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I+HRD+K +NIL D N K+ DFG ++
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 57/154 (37%), Positives = 79/154 (51%), Gaps = 7/154 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
KLG G FG V+ G + +AVK L + +Q F E NL+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 458 EGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
+ + + +I EYM SL D D V L + IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
RDL+A+N+L+ + + KI+DFGLAR+ N+ A
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 44/162 (27%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLV 450
F+ +G+G FG VYK + +A+K + + +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ G L+G +L +I EY S D + +LD I+ + G+ YLHE+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
IHRD+KA+NILL ++ + K++DFG++ ++ NT
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-20
Identities = 61/151 (40%), Positives = 80/151 (52%), Gaps = 15/151 (9%)
Query: 399 LGQGGFGPV----YKGTLAD-GKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRL 452
LG+G FG V Y G+ +AVK L R GQ +K E+N++ L H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 453 LGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
GCC E G+ L LI EY+P SL +L ++ Q I G+A YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA----YLHSQ- 126
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IHRDL A N+LLD+D KI DFGLA+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++G+G G V+K G+ +A+K+ L R G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--SIINGIARGILYLHEDSRL 512
G +L+ EYMP+ L + R + Q S + + +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
I+HRDLK +N+L+ D KI+DFGLAR+F
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSE 151
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 91.0 bits (224), Expect = 9e-20
Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 10/166 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH-KNLVRLL 453
KLG+G FG VY D K +A+K L++ + ++ F E+ ++A L H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ L L+ EY+ SL+ L R L I+ I + YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 514 IIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
IIHRD+K NILLD D K+ DFGLA++ + ++ + T
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
|
Length = 384 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 24/157 (15%)
Query: 399 LGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG+G FG V L D G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 454 GCCLEG--QELLLIYEYMPNKSL------DVHLFDATRSVQLDWKRRQSIINGIARGILY 505
G C + L L+ EY+P SL D + + + I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L + +HRDL NIL++ + KI DFGL ++
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 57/159 (35%), Positives = 72/159 (45%), Gaps = 20/159 (12%)
Query: 398 KLGQGGFGPVYKGTL--ADGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRL 452
KLG G FG V +G + GK I AVK L + +F E ++ L H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 453 LGCCLEGQELLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
G L L+++ E P SL L S D+ + IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
+ IHRDL A NILL D KI DFGL R N
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRLLG 454
K+G+G +G VYK G+ +A+K++ E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+L L++E+M D++ R L +S + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+HRDLK N+L++ + K++DFGLAR FG
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 7/156 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
KLG G FG V++G + +AVK L + ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 458 EGQELLLIYEYMPNKSLDVHL-FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
+ + ++ E M SL +L A R+++L + + +A G+ YL + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
RDL A N+L+ ++ K++DFGLAR+ + +A
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 399 LGQGGFGPVYKGTLAD------GKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLV 450
LGQG FG VY+G +A+K ++ + + + EF NE +++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLF----DATRSVQLDWKRRQSIIN---GIARGI 503
RLLG GQ L++ E M L +L +A + L Q I IA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
YL K +HRDL A N ++ +D+ KI DFG+ R
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 8e-19
Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFK-----NEVNLIAKL 444
+ F +G+G F V K A+K L + Q ++E K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 445 -QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
H +++L + + L + EY PN L ++ + LD K + I +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLAL 115
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
YLH IIHRDLK NILLD DM+ KI+DFG A++ N
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 30/185 (16%)
Query: 396 ENKLGQGGFGPVYKGTLA------DGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKN 448
+GQG FG V++ +AVK L S +F+ E L+A+ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-------------------RSVQLDW 489
+V+LLG C G+ + L++EYM L+ L + + L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQN 548
+ I +A G+ YL E K +HRDL N L+ ++M KI+DFGL+R I+ +
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 549 QANTN 553
+A+ N
Sbjct: 187 KASEN 191
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 60/160 (37%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 399 LGQGGFGPVYKGT----LADGKA---IAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLV 450
LG G FG VY+GT L G +AVK L + + Q +EF E +L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDA----TRSVQLDWKRRQSIINGIARGILYL 506
+LLG CL + +I E M L +L DA L K I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 507 HEDSRLKIIHRDLKASNILL-----DDDMNPKISDFGLAR 541
++ IHRDL A N L+ D D KI DFGLAR
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 4e-18
Identities = 44/155 (28%), Positives = 79/155 (50%), Gaps = 6/155 (3%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
++G G FG V+ G + + +A+K + R ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
E + L++E+M + L +L + + + + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
DL A N L+ ++ K+SDFG+ R +Q ++T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-18
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 83 NTASNTFTSNLNILFNQKLHSEAGKS---LYYNASEGEFPDSVYGLYLCKFNVSFQSCQN 139
TA++TF SNLN L + L S A S + + G PD+VYGL C+ ++S C++
Sbjct: 13 TTANSTFESNLNALLSS-LSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRS 71
Query: 140 CIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSD 173
C+ AV+ + + C K IWY C +R+
Sbjct: 72 CLATAVSELRRCCPNKKGGRIWY--DSCFLRYES 103
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 6e-18
Identities = 55/168 (32%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVR 451
LG+G FG V K T GK A+K L + + ++ E N+++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
L + +E L L+ EY P L HL ++ + +R + I + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLH--- 110
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
L II+RDLK NILLD D + K++DFGLA+ ++ NT GT
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 45/149 (30%), Positives = 83/149 (55%), Gaps = 14/149 (9%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
++G G +G VYK +A G+ +A+K + G + + E++++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSR 511
L +L ++ EY SL ++ TR +Q+ + R+++ +G+ YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA 540
IHRD+K +NILL +D + K++DFG++
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 19/164 (11%)
Query: 399 LGQGGFGPVYKGTLA--DGKA--IAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+G FG V +G L+ DG +AVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 453 LGCCLEGQEL------LLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGI 503
+G C E L ++I +M + L L +L + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN 546
YL S IHRDL A N +L +DM ++DFGL++ I+ G+
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 8e-18
Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 436
E P LRL E KLGQG FG V+ GT +A+K L + + F
Sbjct: 2 EIPRESLRL----------EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQ 50
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E ++ KL+H+ LV+L E + + ++ EYM SL + L + +
Sbjct: 51 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL-LDFLKGEMGKYLRLPQLVDMA 108
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
IA G+ Y+ R+ +HRDL+A+NIL+ +++ K++DFGLAR+ N+ A
Sbjct: 109 AQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 9e-18
Identities = 53/153 (34%), Positives = 81/153 (52%), Gaps = 16/153 (10%)
Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKR--LSRTSGQG-------LQEFKNEVNLIAKLQHKN 448
+G G FG VY G A G+ +AVK+ L S L E+ L+ +LQH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+ LG L+ L + EY+P S+ L + ++ + I +G+ YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+R IIHRD+K +NIL+D+ KISDFG+++
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 395 DENK----LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
DEN LG+G +G VY L+ IA+K + + +Q E+ L + L+H+N+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----Y 505
V+ LG E + E +P SL L RS K + I + IL Y
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGG 545
LH+ +I+HRD+K N+L++ KISDFG ++ G
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 16/159 (10%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGL-QEFKNEVNLIAKLQ---HKNLV 450
++G+G +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 451 RLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
RLL C +L L++E++ ++ L +L + L + + ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
LH +I+HRDLK NIL+ D KI+DFGLARI+
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 10/146 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGCCL 457
LG+G FG V+KGTL D +AVK Q L+ +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI--ARGILYLHEDSRLKII 515
+ Q + ++ E +P L R + + K +Q + + A G+ YL + I
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 516 HRDLKASNILLDDDMNPKISDFGLAR 541
HRDL A N L+ ++ KISDFG++R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 55/171 (32%), Positives = 84/171 (49%), Gaps = 31/171 (18%)
Query: 399 LGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVR 451
LG+G FG V K T A +AVK L + L++ +E NL+ ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIING--------- 498
L G C + LLLI EY SL L ++ + + D R S ++
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 499 --------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I+RG+ YL E +K++HRDL A N+L+ + KISDFGL+R
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 12/152 (7%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGC 455
KLG+G + VYKG G+ +A+K + + +G E++L+ +L+H+N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 456 CLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+L+L++EYM K +D H LD +S + +GI + HE+
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTH----GVRGALDPNTVKSFTYQLLKGIAFCHEN--- 119
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+++HRDLK N+L++ K++DFGLAR FG
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 11/154 (7%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
NK+G G FG VY L G+ +AVK R+ + ++E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 512
G + +++ + EY +L + LD + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
I+HRD+K +NI LD + K+ DFG A N
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 393 FSDENKLGQGGFGPVYKG---TLADGKAIAVKRL--SRTSGQGL-QEFKNEVNLIAKLQH 446
+ E +G+G +G VYK DGK A+K+ + G+ Q E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 447 KNLVRLLGCCLEGQE--LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGI 503
+N+V L+ LE + + L+++Y + + + V + +S++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIF 543
YLH + ++HRDLK +NIL+ + KI D GLAR+F
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 396 ENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +LG+G FG V+ D +AVK L S ++F E L+ LQH+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 450 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDA------TRSVQLDWKRRQSIINGI 499
V+ G C+EG L++++EYM NK L H DA R +L + I I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
A G++YL + +HRDL N L+ +++ KI DFG++R
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 15/153 (9%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
K+G+G +G V+K + +A+KR+ +G+ E+ L+ +L+HKN+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 455 CCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
++L L++EY D L FD+ +D + +S + + +G+ + H
Sbjct: 67 VLHSDKKLTLVFEY-----CDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
KLG G FG V+ GT +AVK L + + F E ++ KL+H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
E + + ++ EYM SL L D R+++L + +A G+ Y+ R+
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
IHRDL+++NIL+ D + KI+DFGLAR+ N+ A
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLS------RTSGQGLQEFKNEVNLIAKLQHKNLV 450
LG+G +G VY G G+ IAVK++ + + ++ + EV+L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ LG CL+ + + E++P S+ L F +Q I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVAYLHN 120
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ ++HRD+K +N++L + K+ DFG AR
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 57/166 (34%), Positives = 89/166 (53%), Gaps = 18/166 (10%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNL 449
E +G G FG V G L GK +A+K L T Q ++F +E +++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSV-QLDWKRRQSIINGIARGILYL 506
+ L G + + ++++ EYM N SLD L D +V QL ++ GIA G+ YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYL 122
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
S + +HRDL A NIL++ ++ K+SDFGL+R+ + A T
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 47/143 (32%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
LG G FG V+ G +A+K + R +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD 518
+ + ++ EYM N L +L + + +W + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 519 LKASNILLDDDMNPKISDFGLAR 541
L A N L+ +D K+SDFGLAR
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 52/154 (33%), Positives = 87/154 (56%), Gaps = 16/154 (10%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKA---IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
E +G G FG V +G L GK +A+K L S + + ++F +E +++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV-QLDWKRRQSIINGIARGILYLH 507
L G + + +++I E+M N +LD + D +V QL ++ GIA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLS 123
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
E + +HRDL A NIL++ ++ K+SDFGL+R
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 31/176 (17%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------EVNLI 441
+ +G G +G V G+ +A+K++S F + E+ L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLL 53
Query: 442 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSI 495
L+H+N++ LL + ++ ++ E M + L +S Q L Q
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYF 108
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
+ I RG+ YLH +IHRDLK SNIL++ + + KI DFGLAR ++++
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 26/167 (15%)
Query: 396 ENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +LG+G FG V+ D +AVK L + ++F+ E L+ LQH+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 450 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSVQLDWKRRQS----------- 494
V+ G C +G L++++EYM NK L H DA + +D + RQ+
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM--ILVDGQPRQAKGELGLSQMLH 127
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I + IA G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 63/175 (36%), Positives = 91/175 (52%), Gaps = 29/175 (16%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTL---ADG---KAIAVKRLS-RTSGQGLQEFKNEVNLI 441
+T F +E LG+ FG VYKG L A G +A+A+K L + G +EFK+E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW------KRRQS- 494
++LQH N+V LLG + Q L +I+ Y + D+H F RS D K +S
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS--DLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 495 --------IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I+ IA G+ +L S ++H+DL N+L+ D +N KISD GL R
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 58/166 (34%), Positives = 90/166 (54%), Gaps = 18/166 (10%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAI----AVKRLSR-TSGQGLQEFKNEVNLIAKLQH 446
F LG G FG VYKG + +G+ + A+K L TS + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGI 503
++ RLLG CL + LI + MP L D R + D Q ++N IA+G+
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAKGM 122
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
YL E+ RL +HRDL A N+L+ + KI+DFGLA++ G ++ +
Sbjct: 123 NYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 55/146 (37%), Positives = 78/146 (53%), Gaps = 10/146 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
+G+G FG V +G G+ +AVK + Q F E ++ KL HKNLVRLLG L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L ++ E M +L L R+ V + + S+ +A G+ YL K++H
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVH 123
Query: 517 RDLKASNILLDDDMNPKISDFGLARI 542
RDL A NIL+ +D K+SDFGLAR+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV 149
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 46/155 (29%), Positives = 87/155 (56%), Gaps = 8/155 (5%)
Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNL 449
F K+G+G +G VYK G+ +A+K++ T +G+ E++L+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V+LL +L L++E++ ++ L + DA+ + +S + + +G+ + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 50/149 (33%), Positives = 79/149 (53%), Gaps = 16/149 (10%)
Query: 398 KLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+LG G FG VYK G LA K I K S + L+++ E+ ++A H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
LLG +L ++ E+ P ++D + + R + + Q I + + YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICRQMLEALQYLHS--- 128
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA 540
+KIIHRDLKA N+LL D + K++DFG++
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 24/164 (14%)
Query: 399 LGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKNLV 450
LG+G FG V K +AVK L + + L + +E+ ++ + +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRRQSIIN 497
LLG C + L ++ EY + +L L D R L K S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ +L S+ K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 29/172 (16%)
Query: 392 HFSDEN-----KLGQGGFGPVY----KGTLADGK--AIAVKRLSRTSGQGLQ-EFKNEVN 439
F N LG+G FG V+ KG +G + VK L +T + LQ EF+ E++
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEY----------MPNKSLDVHLFDATRSVQLDW 489
+ KL HKN+VRLLG C E + +I EY KS D + + L
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLST 116
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
K++ ++ IA G+ +L S + +HRDL A N L+ K+S L++
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKR--LSRTSGQGLQE--------FKNEVNLIAKLQHK 447
+G+G +G VY G+ +AVK+ L T ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 448 NLVRLLGCCLEGQELLLIY-EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
N+V+ LG +E L I+ EY+P S+ L + + + + + G+ YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR----IFGGNQN 548
H I+HRDLKA N+L+D D KISDFG+++ I+ +QN
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 49/148 (33%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ-HKNLVRLL 453
+LG G FG VY G+ +A+K++ + +E N EV + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
E EL ++EYM +L L + +SII I +G+ ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
HRDLK N+L+ KI+DFGLAR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 436
E P LRL + KLGQG FG V+ GT +A+K L + + F
Sbjct: 2 EIPRESLRL----------DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQ 50
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E ++ KL+H LV L E + + ++ E+M SL + L + +
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMA 108
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
IA G+ Y+ R+ IHRDL+A+NIL+ D++ KI+DFGLAR+ N+ A
Sbjct: 109 AQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLG G FG V+ T +AVK + + ++ F E N++ LQH LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
+ + + +I E+M SL D +S + + +I+ IA G+ ++ + +
Sbjct: 69 VVTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 122
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
IHRDL+A+NIL+ + KI+DFGLAR+ N+ A
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRL 452
+G+G +G V K A G+ +A+K+ + ++ K EV ++ +L+H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
L L++EY+ L+ L +A+ L +S I + + I Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLE--LLEASPG-GLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
IIHRD+K NIL+ + K+ DFG AR T+ +A
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 54/148 (36%), Positives = 79/148 (53%), Gaps = 12/148 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAI----AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG V+KG + +G +I A+K + R+ Q QE + + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
LG C G L L+ + P SL H+ LD +R + IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
+++HR+L A NILL D +I+DFG+A
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 50/169 (29%), Positives = 89/169 (52%), Gaps = 22/169 (13%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQH---KNLVRLL 453
+G+G +G VY+G + G+ +A+K ++ T + + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHED 509
G L+G L +I EY S+ R++ + I+ I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+IHRD+KA+NIL+ + N K+ DFG+A + NQN + + GT
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHK 447
+ + K+G+G +G VYK + IA+K RL + E++L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIARGIL 504
N+VRL + L L++EY LD+ L D++ + + ++ + I RGI
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFG 544
Y H S +++HRDLK N+L+D N K++DFGLAR FG
Sbjct: 117 YCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 459 GQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
+ L ++ EYM SL +L RSV L + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
DL A N+L+ +D K+SDFGL + Q+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 23/171 (13%)
Query: 398 KLGQGGFGPVYK-GTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG+G +G VYK L+D + A+K L S + ++ NE+ ++A + H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-------SIINGIARGILYLH 507
L+G +L ++ EY P L + + KR+ I + RG+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDL------SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
E KI+HRDLK++NILL + KI D G++++ +N A T I GT
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI--GT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIA---VKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRL 452
+++G G FG V G G + A VK L ++ Q F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDS 510
LG C+E LL+ E+ P L +L V ++ Q + +A G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ IH DL N L D++ KI D+GLA
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKN 448
F+D ++G G FG VY + + +A+K++S + Q +++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+ GC L L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEI-----AAICHGALQGLAY 130
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
LH + IHRD+KA NILL + K++DFG A +
Sbjct: 131 LHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 59/152 (38%), Positives = 86/152 (56%), Gaps = 17/152 (11%)
Query: 399 LGQGGFGPVYKGTL--ADGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+G+G FG VY GTL +DG+ I AVK L+R T + +++F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYLHED 509
G CL EG L+++ YM K D+ F RS + + I G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVL-PYM--KHGDLRNF--IRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
K +HRDL A N +LD+ K++DFGLAR
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 16/148 (10%)
Query: 399 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VYK G A K I ++ S + L++F E++++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGL 67
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+L ++ E+ +LD + L + + + + + +LH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALD-SIMLELERG-LTEPQIRYVCRQMLEALNFLHSH--- 122
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
K+IHRDLKA NILL D + K++DFG++
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 45/144 (31%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
+LG G FG VYK + +A ++ T S + L+++ E++++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L ++ E+ ++D + + R L + + + + YLHE+ KIIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 517 RDLKASNILLDDDMNPKISDFGLA 540
RDLKA NIL D + K++DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 47/162 (29%), Positives = 86/162 (53%), Gaps = 9/162 (5%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 450
F+ ++G+G FG VYKG K +A+K + + +++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
R G L+G +L +I EY+ S D + L+ +I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ IHRD+KA+N+LL + + K++DFG+A Q + NT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 54/159 (33%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 397 NKLGQGGFGPVYKGTLA--DGKA----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG G FG VY+G DG A +AVK L S Q +F E +++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILY 505
VRL+G E ++ E M L L + R L K +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 506 LHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLAR 541
L E+ IHRD+ A N LL KI+DFG+AR
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 14/160 (8%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAK 443
E TN + D +G G FG V G+ +A+K++ + T + ++ E+ L+
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65
Query: 444 LQHKNLVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
L+H+N++ L + E + + E + D+H +R ++ + Q + I RG
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFI--QYFLYQILRG 120
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ Y+H ++HRDLK SNIL++++ + KI DFGLARI
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 9/167 (5%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
+G G VY L + + +A+KR+ + E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 455 CCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ G EL L+ Y+ S LD+ R LD +++ + +G+ YLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 514 IIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANT-NIIAGT 558
IHRD+KA NILL +D + KI+DFG+ A + G GT
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 52/154 (33%), Positives = 81/154 (52%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG VY AD G+ +AVK++ S + + + + E+ L+ L H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
GC + E L + E+MP S+ L + A T +V + R+ I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ------ILEGVSYLH 123
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I+HRD+K +NIL D N K+ DFG ++
Sbjct: 124 SN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 44/193 (22%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKA----------------IAV 420
EFP LRL + KLG+G FG V+ A+G A +AV
Sbjct: 1 EFPRQQLRL----------KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAV 49
Query: 421 KRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF 479
K L + + +F E+ ++++L++ N++RLLG C+ L +I EYM N D++ F
Sbjct: 50 KMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG--DLNQF 107
Query: 480 DATRSVQLDWKRRQSIIN-----------GIARGILYLHEDSRLKIIHRDLKASNILLDD 528
+ R ++ + +I + IA G+ YL + L +HRDL N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGN 164
Query: 529 DMNPKISDFGLAR 541
KI+DFG++R
Sbjct: 165 HYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 60/187 (32%), Positives = 87/187 (46%), Gaps = 37/187 (19%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSR-TSGQG 430
E PL +R E LG+ FG +YKG L + +A+K L + Q
Sbjct: 1 ELPLSAVRFMEE----------LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ 50
Query: 431 LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF----------- 479
EF+ E +L+A+L H N+V LLG + Q + +++EY+ D+H F
Sbjct: 51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQG--DLHEFLIMRSPHSDVG 108
Query: 480 -----DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534
D T LD I IA G+ YL S +H+DL A NIL+ + ++ KI
Sbjct: 109 CSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKI 165
Query: 535 SDFGLAR 541
SD GL+R
Sbjct: 166 SDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 22/171 (12%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+G+G FG V K +DGK + K + + + Q+ +EVN++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY-----L 506
+ Q L ++ EY D + +Q K R+ I IL L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGG-------DLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 507 HE-----DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+E D ++HRDLK +NI LD + N K+ DFGLA+I G + + A T
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
FSD ++G G FG VY + + + +A+K++S + S + Q+ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
++ GC L L+ EY + D L + + L ++ +G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAVTHGALQGLAYLHS 133
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ +IHRD+KA NILL + K+ DFG A I
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 52/149 (34%), Positives = 82/149 (55%), Gaps = 12/149 (8%)
Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
+KLG+G + VYKG L D +A+K RL G + EV+L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ L L++EY+ +K L +L D S+ + + + + RG+ Y H R
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM--HNVKLFLFQLLRGLNYCH---RR 123
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
K++HRDLK N+L+++ K++DFGLAR
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 57/169 (33%), Positives = 84/169 (49%), Gaps = 32/169 (18%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE------VNLIAKLQ------- 445
LG+G FG V + A+ I R +T ++ K+ +LI++++
Sbjct: 20 LGEGCFGQVVR---AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRR 492
HKN++ LLG C + L +I EY +L L FD T+ QL +K
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +ARG+ YL +SR + IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 52/154 (33%), Positives = 84/154 (54%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+G FG VY AD G+ +AVK++ S+ + + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
GC + +E L + EYMP S+ L + A T +V + R+ I +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ------ILQGVSYLH 123
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I+HRD+K +NIL D N K+ DFG ++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+ K+G+G G V T + G+ +AVK++ Q + NEV ++ QH N+V
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ L G EL ++ E++ +L D +++ ++ ++ + + + +LH
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFG 538
+IHRD+K+ +ILL D K+SDFG
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
F+D ++G G FG VY + +A+K++S + S + Q+ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+ GC L L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 140
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
LH + +IHRD+KA NILL + K++DFG A I
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 16/160 (10%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+GQG G VY +A G+ +A+K+++ + NE+ ++ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHEDSRL 512
L G EL ++ EY+ SL D +D + I + R L +LH +
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMD----EGQIAAVCRECLQALEFLHSN--- 134
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
++IHRD+K+ NILL D + K++DFG Q++ +T
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 49/146 (33%), Positives = 75/146 (51%), Gaps = 7/146 (4%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGC 455
++G+G FG V+ G L AD +AVK T L+ +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
C + Q + ++ E + + D F T +L K ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 516 HRDLKASNILLDDDMNPKISDFGLAR 541
HRDL A N L+ + KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
+LG G FG V G +A+K + S EF E ++ KL H+ LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
+ + + ++ EYM N L +L + + Q + + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 518 DLKASNILLDDDMNPKISDFGLAR 541
DL A N L+DD K+SDFGL+R
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 456
+G+G +G VYK G+ +A+K + +E K E N++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 457 L------EGQELLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRQS------IINGIARG 502
+ +L L+ E S T V+ +R I+ RG
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGS-------VTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ YLHE+ K+IHRD+K NILL + K+ DFG++
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 27/163 (16%)
Query: 398 KLGQGGFGPVYKGTLADG-------KAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNL 449
+LGQG FG VY+G +A G +A+K ++ + + EF NE +++ + ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----------WKRRQSIING 498
VRLLG +GQ L+I E M L +L RS++ + K+ +
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IA G+ YL+ + K +HRDL A N ++ +D KI DFG+ R
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 6/147 (4%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLG 454
+LG G G V K GK +AVK + + +Q + E++++ K +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
++ + EYM SLD L + + + I + +G+ YLHE KI
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEK--HKI 122
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
IHRD+K SNIL++ K+ DFG++
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKN 448
F +++G G FG VY T + + +AVK++S + Q Q+ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+ GC L+ L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 136
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
LH + +IHRD+KA NILL + K++DFG A
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKL-QHKN 448
LG+G FG V K +AVK L + + L + +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
++ LLG C + L ++ EY +L +L FD + QL +K S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 49/163 (30%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 399 LGQGGFGPVYKGTLADGKAI---AVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG+G FG V +G L +I AVK +++ + +++F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 454 GCCLEGQEL------LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGIL 504
G CL+ E ++I +M + L L + + Q ++ IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGN 546
YL S IHRDL A N +L+++MN ++DFGL+ +I+ G+
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 46/164 (28%), Positives = 88/164 (53%), Gaps = 13/164 (7%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKN 448
F+ ++G+G FG V+KG D + +A+K + + +++ + E+ ++++
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ + G L+G +L +I EY+ S D R+ D + +++ I +G+ YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ K IHRD+KA+N+LL + + K++DFG+A Q + NT
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGLQEFKN---EVN 439
+ E + + + + +G G +G V +A+K+LSR Q K E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELR 66
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
L+ + H+N++ LL L + Y+ + L + + +L Q ++
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQ 126
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I RG+ Y+H IIHRDLK SNI +++D KI DFGLAR
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 55/154 (35%), Positives = 82/154 (53%), Gaps = 18/154 (11%)
Query: 399 LGQGGFGPVYKGTLA-DGKAI----AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VYKG DG+ + A+K L TS + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
LG CL + L+ + MP L D R + D Q ++N IA+G+ YL E
Sbjct: 75 LGICLT-STVQLVTQLMPYGCL----LDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE- 127
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
++++HRDL A N+L+ + KI+DFGLAR+
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 53/154 (34%), Positives = 82/154 (53%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG VY D G+ +A K++ S + + + + E+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 453 LGCCLE-GQELLLIY-EYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
GC + ++ L I+ EYMP S+ L + A T SV + R+ I G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I+HRD+K +NIL D N K+ DFG ++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKL-QHKN 448
LG+G FG V K + +AVK L + + L + +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
++ LLG C + L +I EY +L +L +D R Q+ +K S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 6/144 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
+LG G FG V+ G +A+K + ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
+ + L ++ E+M N L +L R +L S+ + G+ YL +S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 518 DLKASNILLDDDMNPKISDFGLAR 541
DL A N L+ K+SDFG+ R
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 40/181 (22%)
Query: 397 NKLGQGGFGPVYKGTLAD---GKAIAVKRL-----SRTSGQG-------LQEFKNEVNLI 441
KLG+G +G V+K D + +A+K++ + T Q LQE +
Sbjct: 13 QKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD----- 65
Query: 442 AKLQHKNLVRLLGC--CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
H N+V+LL +++ L++EYM D+H R+ L+ ++ I+ +
Sbjct: 66 ----HPNIVKLLNVIKAENDKDIYLVFEYMET---DLH--AVIRANILEDVHKRYIMYQL 116
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF----GGNQNQANTNII 555
+ + Y+H S +IHRDLK SNILL+ D K++DFGLAR +N T+ +
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 556 A 556
A
Sbjct: 174 A 174
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 15/152 (9%)
Query: 399 LGQGGFGPVY------KGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVR 451
LG+G FG V +G G+ +AVK L + G + + K E+ ++ L H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 452 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
G C E G + LI E++P+ SL +L + L + + ++ I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
SR + +HRDL A N+L++ + KI DFGL +
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 27/190 (14%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQ 429
+ EFP + + + K+GQG FG V+K + +A+K++ + G
Sbjct: 1 DQYEFPF------CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF 54
Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCC---------LEGQELLLIYEYMPNKSLDVHLFD 480
+ + E+ ++ L+H+N+V L+ C +G L++E+ + D+
Sbjct: 55 PITALR-EIKILQLLKHENVVNLIEICRTKATPYNRYKGS-FYLVFEFCEH---DLAGLL 109
Query: 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ ++V+ + ++ + G+ Y+H R KI+HRD+KA+NIL+ D K++DFGLA
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166
Query: 541 RIFGGNQNQA 550
R F ++N
Sbjct: 167 RAFSLSKNSK 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 397 NKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLG 454
++LG+G G V K L + I A+K ++ LQ + E+ + + +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 455 CCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---------GIARGI 503
L+ + + EY SLD S+ K+R I + +G+
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLD--------SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
YLH KIIHRD+K SNILL K+ DFG
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 52/165 (31%), Positives = 86/165 (52%), Gaps = 23/165 (13%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKL-QHKNLV 450
++ +G+G FG V K + DG + A+KR+ + + ++F E+ ++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----WKRRQSIING------- 498
LLG C L L EY P+ +L + +R ++ D S ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 499 --IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 11/146 (7%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
++G G +G VYK L G+ AVK + G + E+ ++ + +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 457 LEGQELLLIYEYMPNKSL-DV-HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L ++L + EY SL D+ H+ +Q+ + R+++ +G+ YLH ++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
HRD+K +NILL D+ + K++DFG+A
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 25/162 (15%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
+LGQG FG VY+G D G+A +AVK ++ + S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-----------SIINGI 499
RLLG +GQ L++ E M + L +L RS++ + + + I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
A G+ YL+ K +HRDL A N ++ D KI DFG+ R
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 450
F+ K+G+G FG V+KG K +A+K + + +++ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ G L+ +L +I EY+ S D LD + +I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ IHRD+KA+N+LL + K++DFG+A Q N GT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 4e-13
Identities = 43/163 (26%), Positives = 85/163 (52%), Gaps = 8/163 (4%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
++ K+GQG G V+ +A G+ +A+K+++ + NE+ ++ +L++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L G EL ++ EY+ SL D +D + ++ + + +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
++IHRD+K+ N+LL D + K++DFG Q++ +T +
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 398 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRT-SGQGLQEFKNEVN 439
KLG+G FG V+ K + A +AVK L S ++F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQS 494
++++L N+ RLLG C L +I EYM N L+ L + + +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 495 IIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
++ IA G+ YL L +HRDL N L+ + KI+DFG++R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 398 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLVRL 452
+LG G FG V KG K +AVK L + E E N++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+G C E + +L+ E L+ L ++ + K +++ ++ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+HRDL A N+LL KISDFGL++ G ++N
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 399 LGQGGFGPVYKGTLADGKA---------IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+G+G FG V+ L KA I V+++++ Q NE ++ L H N+
Sbjct: 8 VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNI 61
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ LE + L+++ EY P +L ++ S+ LD +I++ + +L LH
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LD---EDTILHFFVQILLALHHV 117
Query: 510 SRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFG 544
I+HRDLK NILLD M KI DFG+++I
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLQEFKNEVNLIAKLQHK 447
HF +G+G FG V D K + A+K +++ ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
LV L + + + L+ + + L HL ++ V+ ++ + I I + YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
IIHRD+K NILLD+ + I+DF +A + T +GT
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSG----QGLQEFKNEVNLIAKLQ 445
F N++G+G +G VY+ G+ +A+K R+ L+E + L+ L+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLR 64
Query: 446 HKNLVRLLGCCLEGQEL---LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
H N+V L + G+ L L+ EY + L L + + + ++ + RG
Sbjct: 65 HPNIVELKEV-VVGKHLDSIFLVMEYC-EQDLASLLDNMPTP--FSESQVKCLMLQLLRG 120
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ YLHE+ IIHRDLK SN+LL D KI+DFGLAR +G
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 399 LGQGGFGPVYK--GTLADGKAIAVKRLS----------RTSGQGLQEFKNEVNLIAK-LQ 445
LG G FG VYK +A+K ++ R + + + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGIL 504
H N+VR LE L ++ + + L H Q +R +I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
YLH++ R I+HRDL +NI+L +D I+DFGLA+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 20/164 (12%)
Query: 397 NKLGQGGFGPVYK----GTLADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVR 451
N++G G G VYK T G+ A+K + ++ + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 452 LLGCCLEGQELLLIYEYMPNKSLD-VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
E+ ++ E+M SL+ H+ D L RQ I++GIA YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLADVARQ-ILSGIA----YLH--- 185
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
R I+HRD+K SN+L++ N KI+DFG++RI + N+++
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 46/153 (30%), Positives = 80/153 (52%), Gaps = 20/153 (13%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQG---LQEFKNEVNLIAKLQHKNLVR 451
LG G F Y+ + G +AVK+++ TS + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHE 508
+LG E L E+M S+ L +V +++ + + RG+ YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLHE 121
Query: 509 DSRLKIIHRDLKASNILLDDD-MNPKISDFGLA 540
+ +IIHRD+K +N+L+D +I+DFG A
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 12/149 (8%)
Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
KLG+G + V+KG L + +A+K RL G + EV+L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ L L++EY+ +K L ++ D + + + + I RG+ Y H R
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM--HNVKIFLYQILRGLAYCH---RR 123
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
K++HRDLK N+L+++ K++DFGLAR
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 398 KLGQGGFGPVYKGTLAD-GKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
+G+G +G V K + G+ +A+K+ L + +++ E+ ++ +L+H+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
+ L L++E++ + LD D + LD R + + I RGI + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
IIHRD+K NIL+ K+ DFG AR + T+ +A
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVA 162
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 399 LGQGGFGP--VYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+G FG +Y+ T D + K L+R S + ++ NE+ +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 455 CCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
++ LL+ EY +L LF+ + W Q I + Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEE---MVLWYLFQ-----IVSAVSYIH 118
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ I+HRD+K NI L K+ DFG+++I G + A T
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
++G G +G VYK + G+ A+K + G+ + E+ ++ +H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 457 LEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L +L + E+ SL H+ Q+ + R+++ +G+ YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK--- 127
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
+HRD+K +NILL D+ + K++DFG++
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 46/146 (31%), Positives = 69/146 (47%), Gaps = 8/146 (5%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+GGFG V + GK A K+L + +G Q NE ++ K+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+L L+ M L H+++ R I G+ +LH + +I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
++RDLK N+LLDD N +ISD GLA
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ 445
+F E K+G+G F VYK L DG+ +A+K++ + Q+ E++L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSVQLDWKRRQSII 496
H N+++ L +E EL ++ E L L R++ WK
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTI---WK----YF 112
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+ + ++H +I+HRD+K +N+ + K+ D GL R F
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 44/158 (27%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+GQG G VY +A G+ +A+K+++ + NE+ ++ + ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L G EL ++ EY+ SL D +D + ++ + + +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
RD+K+ NILL D + K++DFG Q++ +T +
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 43/153 (28%)
Query: 415 GKAIAVKRLSRTSGQGLQEFKN---------EVNLIAKLQHKNLVRLLGCCLEGQELLLI 465
G+ +A+K+LSR F+N E+ L+ + HKN++ LL
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 466 YEYMPNKSLD--------VHLFDAT--RSVQ--LDWKRRQSIINGIARGILYLHEDSRLK 513
+ P KSL+ + L DA + +Q LD +R ++ + GI +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 50/179 (27%), Positives = 90/179 (50%), Gaps = 25/179 (13%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 446
+ F ++G+G +G VYK D G+ +A+K++ + G + + E+ ++ +L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 447 KNLVRLLGCCLEGQELL----------LIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--S 494
+N+V L + Q+ L L++EYM D L S + + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKS 120
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ + G+ Y H+ + L HRD+K SNILL++ K++DFGLAR++ +++ TN
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 53/151 (35%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 399 LGQGGFGPVYKGT---LADGKA---IAVKRLSRTSGQGLQE-FKNEVNLIAKL-QHKNLV 450
LG G FG V + T L+ A +AVK L T+ +E +E+ +++ L H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
LLG C G +L+I EY L ++ R L + S +A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDL-LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IHRDL A N+LL KI DFGLAR
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG+G + VYKG + +GK +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L L++EY+ D+ + L + + + + RG+ Y+H+ I
Sbjct: 71 IIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDLK N+L+ D K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 31/166 (18%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLQEFKNEVNLI 441
+ + + +G+G +G V T G +A+K++S RT L+E K ++
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIK----IL 57
Query: 442 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
+ +H+N++ +L ++ ++ E M D++ ++ L Q +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLY--KLIKTQHLSNDHIQYFL 112
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
I RG+ Y+H + ++HRDLK SN+LL+ + + KI DFGLARI
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 398 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRTSGQGLQ-EFKNEVN 439
KLG+G FG V+ K D +AVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL--------FDATRSVQLDWKR 491
++++L+ N++RLL C+ L +I EYM N L+ L + V + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ IA G+ YL S L +HRDL N L+ + KI+DFG++R
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 12/166 (7%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+GGFG V + A GK A K+L++ +G + E ++AK+ H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 455 CCLEGQ-ELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ + +L L+ M L H+++ + R I G+ +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+II+RDLK N+LLD+D N +ISD GLA Q++ T AGT
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 24/166 (14%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+ D LG G G V+ +D K +AVK++ T Q ++ E+ +I +L H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 452 L--------------LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
+ +G E + ++ EYM + L + L + + +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY 121
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 542
+ RG+ Y+H + ++HRDLK +N+ ++ +D+ KI DFGLARI
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 42/143 (29%), Positives = 75/143 (52%), Gaps = 8/143 (5%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+G+G G V T+ + GK +AVK++ Q + NEV ++ QH+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L G EL ++ E++ +L D +++ ++ ++ + + + LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 517 RDLKASNILLDDDMNPKISDFGL 539
RD+K+ +ILL D K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFK---NEVNLIAKLQH 446
F ++GQGG+G V+ D I A+KR+ ++ L E + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+ LV+LL + + L L EY+P L + + D R +A +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFY-----MAEMFEAV 114
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
L IHRDLK N L+D + K++DFGL+
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 24/162 (14%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKLQHKN-LVRLL 453
K+G+G +G VYK GK +A+K+ +G+ E++L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 454 GCCLEGQE-------LLLIYEYMPNKSLDVHLF-DATR---SVQLDWKRRQSIINGIARG 502
+E E L L++EY+ D+ F D+ L K +S + + +G
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIF 543
+ + H + ++HRDLK N+L+D KI+D GL R F
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLL 453
+LG G FG V KG K +A+K L + + ++ E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G C E + L+L+ E L + F + + ++ +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+HRDL A N+LL + KISDFGL++ G + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 51/150 (34%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 398 KLGQGGFGPVYKGTLADG---KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLL 453
++G G FG V G + G + VK L ++ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL---DWKRRQSIINGIARGILYLHEDS 510
G C E LL+ E+ P L +L + R +L D Q + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLA 540
IH DL N LL D+ KI D+GL+
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 14/162 (8%)
Query: 398 KLGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
K+G+G FG +Y LA K+ I L++ + + K EV L+AK++H N+V
Sbjct: 7 KIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
E L ++ EY L + + R V + S I+ G+ ++H+
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120
Query: 512 LKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQNQANT 552
KI+HRD+K+ NI L + M K+ DFG+AR + A T
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 43/143 (30%), Positives = 73/143 (51%), Gaps = 8/143 (5%)
Query: 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+G+G G V T GK +AVK++ Q + NEV ++ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L G EL ++ E++ +L D +++ ++ ++ + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 517 RDLKASNILLDDDMNPKISDFGL 539
RD+K+ +ILL D K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 399 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+GGFG V G + K + KRL + SG+ + + E+ + K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
L L+ M L H+++ L+ +R I GIL+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
I++RD+K N+LLDD N ++SD GLA
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 23/165 (13%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKL-QHKNLV 450
E+ +G+G FG V + + DG + A+K L S ++F E+ ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD------------WKRRQ--SII 496
LLG C L + EY P +L + +R ++ D +Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNL-LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +A G+ YL E + IHRDL A N+L+ +++ KI+DFGL+R
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 398 KLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRL 452
+G+G FG VY+G + A+AVK + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+G E + ++ E P L +L LD ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +HRD+ A N+L+ K+ DFGL+R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 32/169 (18%)
Query: 399 LGQGGFGPVYKGTLADG-----------KAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
LG+G FG V +A+ +AVK L S + + L + +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQLDWKRR 492
HKN++ LLG C + L +I EY +L +L QL +K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 43/146 (29%), Positives = 75/146 (51%), Gaps = 14/146 (9%)
Query: 398 KLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
K+G+G G V +A G+ +AVK + Q + NEV ++ QH+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
L G+EL ++ E++ +L D +L+ ++ ++ + + + YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG--- 137
Query: 514 IIHRDLKASNILLDDDMNPKISDFGL 539
+IHRD+K+ +ILL D K+SDFG
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 41/143 (28%), Positives = 76/143 (53%), Gaps = 8/143 (5%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L G EL ++ EY+ SL D +D + ++ + + +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 517 RDLKASNILLDDDMNPKISDFGL 539
RD+K+ NILL D + K++DFG
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 37/178 (20%)
Query: 398 KLGQGGFGPV---------------YKGTLADGKA--IAVKRL-SRTSGQGLQEFKNEVN 439
KLG+G FG V + + G+ +AVK L + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-----HLFDAT--------RSVQ 486
++++L+ N++RLLG C++ L +I EYM N L+ HL D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 487 LDWKRRQSIIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
L S+++ IA G+ YL S L +HRDL N L+ +++ KI+DFG++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 11/163 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL 457
+G G +G VYKG +A ++ +G +E K E+N++ K H+N+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 458 EGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ +L L+ E+ S+ L T+ L + I I RG+ +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
K+IHRD+K N+LL ++ K+ DFG++ + NT I
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQ-GLQ-EFKNEVNLIAKLQ---HKNLVR 451
++G G +G VYK G +A+K + + + GL EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 452 LLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L+ C + ++ L++E++ ++ L +L D L + + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
H + I+HRDLK NIL+ K++DFGLARI+
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 12/154 (7%)
Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG GGFG V + + A+K + + G QE +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSV-QLDWKRRQSIINGIARGILYLHEDSRLK 513
+ + + ++ EY L + R D + I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
II+RDLK N+LLD + K+ DFG A+ Q
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQH-K 447
D ++G+G FG V K G +AVKR+ T + Q +++++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIA----R 501
+V+ G + + E M D+ L + V K + I+ IA +
Sbjct: 64 YIVKFYGALFREGDCWICMELM-----DISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ YL E+ LKIIHRD+K SNILLD + N K+ DFG++
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG+G + VYKG + G+ +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L L++EY+ + L ++ D + + R + + RG+ Y H + ++
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVR--LFLFQLLRGLAYCH---QRRV 124
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDLK N+L+ + K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 47/160 (29%), Positives = 86/160 (53%), Gaps = 21/160 (13%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
N++ +G +G VY+ G+ +A+K+L G + + E+N++ KLQH N+V +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTV 69
Query: 453 ----LGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+G L+ ++ ++ EY+ + KSL + + + ++ + G+ +L
Sbjct: 70 KEVVVGSNLD--KIYMVMEYVEHDLKSL---METMKQPFLQ--SEVKCLMLQLLSGVAHL 122
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
H++ I+HRDLK SN+LL++ KI DFGLAR +G
Sbjct: 123 HDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 27/172 (15%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK--------NEVNLIAKLQHK 447
+ +LG+G FG VY + D KA+A +RL + E E L++KL H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRQSIINGIA 500
+V+ LE +I EY + LD L + + + +W +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLL 116
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
G+ Y+H+ +I+HRDLKA NI L +++ KI DFG++R+ G+ + A T
Sbjct: 117 LGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+KLG+G + V+KG + +A+K RL G + EV+L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ L L++EY+ + D+ + + + + + RG+ Y H + K
Sbjct: 70 DIIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
I+HRDLK N+L+++ K++DFGLAR
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVR 451
+ +G +G V+ K T G A+K + + + + E +++++ Q +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
L +G++ L L+ EY+P L L + S+ D R I I + YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVAR--IYIAEIVLALEYLH--- 110
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
IIHRDLK NIL+D + + K++DFGL++ G + Q N N
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDD 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 53/164 (32%), Positives = 75/164 (45%), Gaps = 34/164 (20%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 450
LG G FG V +KG+ GK A+K LS+ Q ++ NE ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------G 502
L G + L L+ EY+P L HL ++ +AR
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQVVLA 113
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
+ YLH L I++RDLK N+LLD D KI+DFG A+ G
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLSRTSGQGLQE--FKNEVNLIAKLQHKNL 449
E LG G FG + +G L K +A+ L R Q F E + + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
VRL G G ++++ EYM N +LD L QL + ++ G+A G+ YL E
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE- 125
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFG 538
+ +H+ L A +L++ D+ KIS F
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 23/160 (14%)
Query: 399 LGQGGFGPVYKGTL-------ADGKAIAVKRLSRTSGQGLQ---EFKNEVNLIAKLQHKN 448
LGQG F +YKG L G V + + G + F +L+++L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LV+L G C+ E +++ EY+ LDV L +V L WK + +A + YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 509 DSRLKIIHRDLKASNILL---DDDMNP----KISDFGLAR 541
K++H ++ NIL+ + K+SD G+
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 23/162 (14%)
Query: 399 LGQGGFGPVYKGTLA-DGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKL-QHKNLVRLL 453
+G+G FG V K + DG + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD--WKRRQSIINGI------------ 499
G C L L EY P+ +L + +R ++ D + S + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
ARG+ YL + + IHRDL A NIL+ ++ KI+DFGL+R
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK--NEVNLIAKLQHKNLVRLLG 454
KLG+G + VYKG + +G+ +A+K +S + +G+ F E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L ++EYM D+ + L + + + RG+ Y+H I
Sbjct: 71 IIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDLK N+L+ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 11/141 (7%)
Query: 395 DENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+EN + +G G YKG ++ +G VK ++ + E + + KLQH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G C + LI+EY+ K+L L + L W+RR+ I GIA+ + +LH
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 514 IIHRDLKASNILLDDDMNPKI 534
++ +L I++D P +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 47/158 (29%), Positives = 88/158 (55%), Gaps = 17/158 (10%)
Query: 398 KLGQGGFGPVYKG-TLADG-KAIAVKRLS-RTSGQGLQ-EFKNEVNLIAKLQ---HKNLV 450
++G+G +G V+K L +G + +A+KR+ +T +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 451 RLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
RL C + +L L++E++ ++ L +L D + + + ++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
LH +++HRDLK NIL+ K++DFGLARI+
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 50/139 (35%), Positives = 71/139 (51%), Gaps = 25/139 (17%)
Query: 415 GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474
G +AVK+LSR F+N+ + AK ++ LV LL C + L+ + P KSL
Sbjct: 46 GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95
Query: 475 D--------VHLFDATRS----VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 522
+ + L DA ++LD +R ++ + GI +LH IIHRDLK S
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152
Query: 523 NILLDDDMNPKISDFGLAR 541
NI++ D KI DFGLAR
Sbjct: 153 NIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 47/151 (31%), Positives = 65/151 (43%), Gaps = 20/151 (13%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRL------SRTSGQGLQEFKNEVNLIAKLQHKN 448
LG+G FG V YK T G+ A+K L +R + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LV L C + + EY L +H+ R + G+ YLHE
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE 119
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
+ KI++RDLK N+LLD + KI+DFGL
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 20/153 (13%)
Query: 398 KLGQGGFGPVYKGTLADGKAIA---VKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLL 453
++G G FG V + +A VK L + Q EF + + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR-------QSIINGIARGILYL 506
G C+E LL++EY L +L Q W RR Q + IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
H + +H DL N L D+ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK 443
E + + + +G G +G V G +AVK+LSR Q + K E+ L+
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKH 72
Query: 444 LQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
++H+N++ LL + L + Y+ + L + + +L Q +I I RG
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGCC 456
K+G+G +G VYK DGK L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 457 LE--GQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 509
L +++ L+++Y + + F + VQL +S++ I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 510 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIF 543
++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 456
+G G +G VYKG + G+ A+K + T + +E K E+N++ K H+N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 457 LE----GQ--ELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHE 508
++ G +L L+ E+ S+ L T+ +++ DW I I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWI--AYICREILRGLAHLHA 139
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
K+IHRD+K N+LL ++ K+ DFG++ + NT I
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 25/169 (14%)
Query: 398 KLGQGGFGPVYKGTLA----DGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
K+G+G FG K L DGK +K + S+ S + +E + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------LDWKRRQSIINGIARGILY 505
E L ++ +Y L +A R V LDW + I + +
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQ------ICLALKH 116
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+H+ KI+HRD+K+ NI L D K+ DFG+AR+ A T I
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 16/169 (9%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
F E K+G+G F VY+ T L D K +A+K++ + Q+ E++L+ +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRQSIINGIARGI 503
+++ L +E EL ++ E L + F + + + WK + + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H SR +++HRD+K +N+ + K+ D GL R F A++
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVRLLG- 454
+G G +G V G+ +A+K+LSR S + E+ L+ +QH+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 455 --CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ G E Y MP D+ L + Q ++ + G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
IIHRDLK N+ +++D KI DFGLAR
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 399 LGQGGFGPVYKGTL----ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+G FG V + L + +AVK L S ++EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 453 LGCCLEGQEL------LLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRQSIINGIAR 501
+G L + ++I +M K D+H F L + + IA
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFM--KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN 546
G+ YL S IHRDL A N +L+++M ++DFGL++ I+ G+
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGCC 456
K+G+G +G VYK DGK L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 457 L--EGQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 509
L +++ L+++Y + + F + +QL +S++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 510 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIF 543
++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 384 RLALEATNHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGL--QEFKNEVNL 440
+ E + + D ++G G +G V G +A+K+L R L + E+ L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEY---MPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
+ ++H+N++ LL L +++ MP D L + +L R Q ++
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVY 125
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 34/166 (20%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSR----TSGQGLQEFKNEVNLIAKLQHKNLV 450
LG+GG+G V+ K T AD GK A+K L + + + K E N++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI---------INGIAR 501
L+ G +L LI EY+ L +HL R+ I ++ I+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTACFYLSEISL 111
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGG 545
+ +LH + II+RDLK NILLD + K++DFGL + I G
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--------------EVNLI 441
LG+G +G V K GK +A+K++ E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIING 498
+++H+N++ L+ +EG + L+ + M + K +D R ++L + + I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD-------RKIRLTESQVKCILLQ 127
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
I G+ LH+ +HRDL +NI ++ KI+DFGLAR +G
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 48/141 (34%), Positives = 72/141 (51%), Gaps = 25/141 (17%)
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475
+ +A+K+LSR F+N+ + AK ++ LV L+ C + L+ + P KSL+
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 476 --------VHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523
+ L DA ++LD +R ++ + GI +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 524 ILLDDDMNPKISDFGLARIFG 544
I++ D KI DFGLAR G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E L+ + H +++R+ + G ++ +P+ S D++ + RS L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I G+ YLH +IIHRD+K NI ++D I D G A+
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 398 KLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRL 452
K+G+G +G V+K + G+ +A+K+ + + K E+ ++ +L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNL 65
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ ++L L++EY + L + + + + II + + + H +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVL--NELEK-NPRGVPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
IHRD+K NIL+ K+ DFG ARI G
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVN-LIAKLQHKNLVRLL 453
+G+G FG V ADGK AVK L + + +E K+ E N L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+L + +Y+ L HL R R + IA + YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---LN 116
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
II+RDLK NILLD + ++DFGL + G ++ T+ GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 43/175 (24%)
Query: 398 KLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQG------------LQEFKNEVNLI 441
+LGQG +G V T ++ + +A+K+++ + L+ F+
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG----- 60
Query: 442 AKLQHKNLVRLLGCCLEGQELLL------IYEYMPNKSLDVHLFDATRS-VQLDWKRRQS 494
HKN+ CL +++ +Y Y D+H RS L QS
Sbjct: 61 ----HKNIT-----CLYDMDIVFPGNFNELYLYEELMEADLH--QIIRSGQPLTDAHFQS 109
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
I I G+ Y+H + ++HRDLK N+L++ D KI DFGLAR F N +
Sbjct: 110 FIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 15/153 (9%)
Query: 401 QGGFGPVYKGTLADGK-----AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLG 454
+G FG ++ G L D K + VK + + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 455 CCLEGQEL-LLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQSIINGIARGILYLHE 508
C+E E ++Y YM +L + L +A L ++ + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +IH+D+ A N ++D+++ KI+D L+R
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 16/189 (8%)
Query: 378 FPLFPLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ 432
FP L LE+ +D +G+G +G VYK T DG AVK L S +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-E 63
Query: 433 EFKNEVNLIAKL-QHKNLVRLLGCC-----LEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
E + E N++ L H N+V+ G L G +L L+ E S+ + Q
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 487 -LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
LD I+ G G+ +LH + +IIHRD+K +NILL + K+ DFG++
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 546 NQNQANTNI 554
+ + NT++
Sbjct: 181 TRLRRNTSV 189
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 393 FSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ + +G G G V Y L + +A+K+LSR F+N+ + AK ++ L
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIIN 497
V L+ C + L+ + P KSL+ + L DA ++LD +R ++
Sbjct: 68 V-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ GI +LH IIHRDLK SNI++ D KI DFGLAR G
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLS-----RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+GGFG V + A GK A K+L + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
L L+ M L H+++ D +R I G+ LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH---RE 121
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
+I++RDLK NILLDD + +ISD GLA
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 18/153 (11%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ-HKNLVRL 452
K+G+G F V K + GK A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRQSIINGIARGILYLHE 508
+ + + L L++E M D++L++ + + L KR +S + + + + ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
R I HRD+K NIL+ DD K++DFG R
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 399 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+GGFG V G + K + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
L L+ M L H++ + + R I G+ LH++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE--- 121
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
+I++RDLK NILLDD + +ISD GLA
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 16/170 (9%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHK 447
+F E K+G+G F VY+ T L DG +A+K++ + + E++L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRQSIINGIARG 502
N+++ +E EL ++ E L + F + + + WK + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H SR +++HRD+K +N+ + K+ D GL R F A++
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 26/155 (16%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
+G G FG V+ A+K ++ + Q NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GILYL 506
+ + L ++ EY+P L +L + N + YL
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-----------RNSGRFSNSTGLFYASEIVCALEYL 117
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
H +I++RDLK NILLD + + K++DFG A+
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 36/111 (32%), Positives = 57/111 (51%), Gaps = 14/111 (12%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQ-LDWK 490
E+ L+ L H+N++ + ++ ++YE M D L RS Q L
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDD 108
Query: 491 RRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
Q + + RG+ Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 388 EATNHFSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLI 441
E + + +G G +G V Y L + +AVK+LSR Q L + E+ L+
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLL 68
Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
++H+N++ LL + E Y+ + L + + +L + Q +I +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
RG+ Y+H IIHRDLK SN+ +++D +I DFGLAR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+GGFG V + A GK A KRL + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L L+ M L H+++ + +R I G+ LH ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN---T 123
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
++RDLK NILLDD + +ISD GLA
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 399 LGQGGFGPVYKGT---LADGKA-----IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
LGQG F ++KG + D + +K L ++ + F +++++L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
G C+ G E +++ EY+ SLD +L + + WK + +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLEDK- 119
Query: 511 RLKIIHRDLKASNILL-----DDDMNP---KISDFGLA 540
+ H ++ A N+LL NP K+SD G++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 11/147 (7%)
Query: 401 QGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRLLGC 455
+G FG VY + G A+K L ++ + N ++ + + + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
L L+ EY+ L + DW ++ I + G+ LH+ II
Sbjct: 66 FQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG---II 119
Query: 516 HRDLKASNILLDDDMNPKISDFGLARI 542
HRD+K N+L+D + K++DFGL+R
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN 146
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
LG+G FG V L G+ AVK L + LQ+ E + K H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L C L + E++ L +F +S + D R + I +++LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGG 545
II+RDLK N+LLD + + K++DFG+ + IF G
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 15/145 (10%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
+ K +AVK+ L S + L+ + E+ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 457 LEGQELLLIYEYMPNKS----LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ EL ++ M S L H + + + + I+ + + Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH---SK 120
Query: 513 KIIHRDLKASNILLDDDMNPKISDF 537
IHR +KAS+ILL D +S
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG V+ K T D G+ A+K L + + + K E +++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+L LI +++ L L ++ V + + + +A + +LH L
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH---SL 117
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
II+RDLK NILLD++ + K++DFGL++
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 24/164 (14%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQH 446
F +G+G FG V GK A+K L ++ L K E +++A+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRQSIINGI 499
+V L + Q L LI E++P L L D TR +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY-------------M 107
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
A +L + +L IHRD+K NIL+D + K+SDFGL+ F
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 30/156 (19%)
Query: 399 LGQGGFGPVYKGTLA----DGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V+ L G+ A+K L ++ Q + + E +++A +V
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIINGIARGIL 504
+L + +E L L+ EYMP L +F + R IA +L
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IAELVL 112
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
L +L IHRD+K NIL+D D + K++DFGL
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+GGFG V + A GK A K+L + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L L+ M L H+++ D +R + G+ L R +I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
++RDLK NILLDD + +ISD GLA
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 32/160 (20%)
Query: 397 NKLGQGGFGPV----YKGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNL 449
LG G FG V +KGT G+ A+K L + + +Q E +++ +L H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR-------- 501
V ++ + + + E++ L HL A R N +A+
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-----------FPNDVAKFYHAELVL 129
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
YLH II+RDLK N+LLD+ + K++DFG A+
Sbjct: 130 AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 56/173 (32%), Positives = 81/173 (46%), Gaps = 29/173 (16%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKN 448
LG+G FG V KGT + AVK L + LQ+ E + K +H
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 449 LVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
L +L C + ++ L + EY+ L H+ RS + D R + I G+ +LH
Sbjct: 58 LTQLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGT 558
E II+RDLK N+LLD + + KI+DFG+ + I GG T+ GT
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGT 159
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 52/165 (31%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLVRLL 453
+G+G FG V +DG AVK L + + +E + E N++ K L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
++L + +Y+ L HL R R + +A I YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
II+RDLK NILLD + ++DFGL + G + + T+ GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAKLQH-KNLVRLL 453
LG+G +G V K + G +AVKR+ T QE K ++++ + V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 454 GCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
G ++ + E M + SLD ++D ++ D + I I + + YLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHS-- 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+L +IHRD+K SN+L++ + K+ DFG++
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKN-L 449
LG G +G V+ G GK A+K L + + + + + E ++ ++ L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V L +L LI +Y+ L HL+ + I I + +LH+
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQ- 123
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF-GGNQNQANT 552
L II+RD+K NILLD + + ++DFGL++ F + +A +
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 20/149 (13%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGCC 456
LG G G VYK L + +AVK + LQ + +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA----RGILYLHEDSRL 512
+ + E+M SLDV+ K + ++ IA +G+ YL L
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
KI+HRD+K SN+L++ K+ DFG++
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 38/160 (23%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQH--KNLVRL 452
+G G G VYK G +AVK++ RT + +E K +++++ K H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHDCPYIVKC 79
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL-------- 504
G + ++ + E M S LD K + I I IL
Sbjct: 80 YGYFITDSDVFICMELM--------------STCLD-KLLKRIQGPIPEDILGKMTVAIV 124
Query: 505 ----YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
YL E +IHRD+K SNILLD N K+ DFG++
Sbjct: 125 KALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKN 448
LG+G FG V KGT + A+K L + LQ+ + + K +H
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPF 57
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
L L C L + EY+ L +F RS + D R + + +++LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH- 113
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
R +I+RDLK NILLD + + K++DFG+ + G N T GT
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGT 159
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ RG+ Y+H +IHRDLK SN+L+++D +I DFG+AR
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 50/170 (29%), Positives = 74/170 (43%), Gaps = 23/170 (13%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
LG+G FG V+ L + A+K L + L + E ++ K +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
L C + +E L + EY+ L H+ + D R I G+ +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGT 558
I++RDLK NILLD D + KI+DFG+ + + G A T GT
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGT 159
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-LVRL 452
LG+G FG V L G+ AVK L + L + E ++ K L +N +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 453 LGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L C + +E L + E++ L H+ D R D R I G+ +LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANT 552
II+RDLK N++LD D + KI+DFG+ + +FG N+A+T
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLVRLL 453
+G+G FG V DGK AVK L + +E K+ E N++ K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
++L + +++ L HL R R + IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
I++RDLK NILLD + ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCC 456
+G+G +G V+K +G AVK L +E + E N++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 457 LE-----GQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ G +L L+ E S+ D+ R +++ I++ G+ +LH +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
K IHRD+K +NILL + K+ DFG++ + + NT++
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 185
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 19/136 (13%)
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI--YEYMPNKS 473
+ + KR+ S +Q +NE+ + +L H+N++++ +E+L YM +
Sbjct: 193 ERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI-------EEILRSEANTYMITQK 244
Query: 474 LDVHLFDATRSVQLDWKRR------QSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527
D L+ DWK R ++I+ + + Y+H+ K+IHRD+K NI L+
Sbjct: 245 YDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 528 DDMNPKISDFGLARIF 543
D + DFG A F
Sbjct: 302 CDGKIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 32/156 (20%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V K T G A+K+L ++ Q + + E +++A+ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64
Query: 451 RLLGCCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRQSIINGIARGI 503
+L + L LI EY+P + D + TR IA I
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETI 111
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 31/160 (19%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
+G G FG V+ T DGK +A+K++ Q L K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSAL- 65
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWK----RRQSI--------INGIARG 502
++L P+ ++ T +Q D Q + + I RG
Sbjct: 66 ------DIL----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ YLH I+HRD+K N+L++ + KI DFGLAR+
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 13/171 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN----EVNLIAKLQ 445
N F +G+G +G V K + K I A+K+ + +E K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLK 58
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+N+V L +L L++EY+ L++ L + V + + +S I + + I +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEMPNGVPPE--KVRSYIYQLIKAIHW 115
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
H++ I+HRD+K N+L+ + K+ DFG AR N T +A
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 12/163 (7%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
++LG+G +G VYK G +A+K RL + + E++++ K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G + + EYM SLD + + + I + +G+ +L E+
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGN--QNQANTNI 554
IIHRD+K +N+L++ + K+ DFG++ GN + A TNI
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNI 162
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
LG+G FG V L A+K L + L++ E ++ + +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
L C + +E L + EY+ L H+ + R D R + I G+ +LH+
Sbjct: 61 LF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKG 116
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
II+RDLK N+LLD D + KI+DFG+ + + +A+T
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-06
Identities = 20/51 (39%), Positives = 27/51 (52%), Gaps = 2/51 (3%)
Query: 235 GQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY 285
QC LS DCR CL + ++RC P G GRI + SC + +E Y +
Sbjct: 58 AQCRGDLSASDCRSCLATAVSELRRCC-PNKKG-GRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 23/49 (46%), Positives = 33/49 (67%), Gaps = 5/49 (10%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGG 545
IA G+ +LH II+RDLK N++LD + + KI+DFG+ + IFGG
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
+G+G FG VY+ D + I A+K LS+ +E + E N++ + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 455 CCLEGQ---ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
Q +L L+ +YM L HL R R + I + + +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYD- 116
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
I++RDLK NILLD + + DFGL++ + TN GT
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGT 159
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 22/116 (18%)
Query: 437 EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLF-----DATRSVQ 486
E+ L+ L+H ++V + L E +++ +++E M + D+H D T
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTP--- 102
Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ Q + + R + Y+H + + HRDLK NIL + D KI DFGLAR+
Sbjct: 103 ---EHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 25/43 (58%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ +L SR K IHRDL A NILL ++ KI DFGLAR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 12/164 (7%)
Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
LG+G FG V A GK A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L + EY+ L HL +R R + I + YLH KI
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
++RDLK N++LD D + KI+DFGL + G + A GT
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNL 449
LG G +G V+ K + D GK A+K L + + + + + E ++ + Q L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V L +L LI +Y+ L HL ++ + + Q I + +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLALEHLH-- 122
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+L II+RD+K NILLD + + ++DFGL++ F ++ +
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 40/176 (22%)
Query: 399 LGQGGFGPVYKGTL----ADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVR- 451
+G+G +G V +L DGK +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 452 -------------LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
++G C EG +L Y K L + V +W +
Sbjct: 65 RESWEGEDGLLYIVMGFC-EGGDL-----YHKLKEQKGKLLPENQVV--EWFVQ------ 110
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
IA + YLHE I+HRDLK N+ L K+ D G+AR+ + A+T I
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 52/180 (28%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-- 448
LG+G FG V LA+ K A+K L + +Q+ E ++ K LQ K
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPF 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYL 506
L +L C L + EY+ L H+ + +K Q++ I+ G+ +L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFL 117
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGL----------ARIFGGNQNQANTNIIA 556
H II+RDLK N++LD + + KI+DFG+ R F G + IIA
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520
E+ + E+M SLD L A R + + + SI + RG+ YL E + KI+HRD+K
Sbjct: 73 EISICMEHMDGGSLDQVLKKAGR-IPENILGKISI--AVLRGLTYLRE--KHKIMHRDVK 127
Query: 521 ASNILLDDDMNPKISDFGLA 540
SNIL++ K+ DFG++
Sbjct: 128 PSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 15/148 (10%)
Query: 399 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G G V K GT+ K + + S Q L+E + ++ + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE----LQIMHECRSPYIVSF 68
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
G L + + E+M SLD ++ + ++ + I + G+ YL+ R
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD-RIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR- 124
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
I+HRD+K SNIL++ K+ DFG++
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 17/153 (11%)
Query: 415 GKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRLL--GCCLEGQELLLIYEYM 469
G +A+K L + + + F+ E L A+L H N+V LL G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61
Query: 470 PNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-- 526
P ++L +V D + +++ +A H I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA----H---NQGIVHRDLKPQNIMVSQ 114
Query: 527 -DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ K+ DFG+ + G ++ + T
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLV 450
LG G +G V+ K T D GK A+K L + + + ++ + E N++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 451 RLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
L + + +L LI +Y+ + HL+ Q D + IL L
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNFSEDEVRFYSGEIILALEHL 121
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+L I++RD+K NILLD + + ++DFGL++ F
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 32/175 (18%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQE-FKNE------VNLIAK 443
F KLG+G FG VYK +L + ++ + L + + G E + NE N A
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEY---------MPNK----SLDVHLFDATRSVQLDWK 490
+ L + + E L++ Y M +K +++ +L + + +
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251
Query: 491 RRQSIINGIARGILY----LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLA 540
R II I R IL+ LH I+HRD+K NI+ + KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAK-LQHKNLVRLL 453
+G+G FG V A+ K AVK L + + +E K +E N++ K ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+L + +Y+ L HL R R + IA + YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---LN 116
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
I++RDLK NILLD + ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 15/151 (9%)
Query: 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV--R 451
S L G VY D + +K + + EV ++ L K L +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPSREKG--ADREREVAILQLLARKGLPVPK 57
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+L L+ E++ ++LD + + Q +A + LH+
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDE-----VSEEEKEDIAEQ-----LAELLAKLHQLPL 107
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L + H DL NIL+DD I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 399 LGQGGFGP--VYKGTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+G+G FG + + +D K A+ RL ++S +++ + E L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDA-----TRSVQLDWKRRQSIINGIARGILYLHEDS 510
L ++ EY L + L W + G+ ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+++HRD+K+ NI L + K+ DFG AR+
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 22/152 (14%)
Query: 401 QGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
+G FG VY G + K AVK + + + + + + E + +A + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 457 LEGQELLLIYEYMPN---KSLDVHL---FDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ L+ EY+ KSL +H+ FD +V+ I+ +A + YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSL-LHIYGYFDEEMAVKY--------ISEVALALDYLH--- 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
R IIHRDLK N+L+ ++ + K++DFGL+++
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 21/154 (13%)
Query: 399 LGQGGFGPVYKGTLADGK--AIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG G FG V T + +A+KR ++ + + +E ++ + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI-----ARGILYLHE 508
G + L L+ E++ L +R + N + A+ +L
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L I++RDLK N+LLD D K++DFG A++
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 25/155 (16%)
Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-- 448
LG+G FG V LA+ K A+K L + +Q+ E ++ K L K
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPF 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYL 506
L +L C L + EY+ L + R +K ++ IA G+ +L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFL 117
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
H II+RDLK N++LD + + KI+DFG+ +
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 25/43 (58%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ +L SR K IHRDL A NILL ++ KI DFGLAR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVR 451
+G+GGFG VY AD GK A+K L + QG NE ++L++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ +L I + M L HL ++ K + I G+ ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
+++RDLK +NILLD+ + +ISD GLA F + A+
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 24/43 (55%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L SR K IHRDL A NILL ++ KI DFGLAR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G FG V D KA+ A+K L + + K E +++A+ ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L + +Y+P + + L D R IA + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDM-MSLLIRMGIFPEDLARFY-----IAELTCAVESVHKMGF 122
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIF 543
IHRD+K NIL+D D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H LV L C L + EY+ L +F R +L + + I+ + Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
LHE II+RDLK N+LLD + + K++D+G+ +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LV L C L L+ EY+ L +F R +L + + I + +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
II+RDLK N+LLD D + K++D+G+ +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E +++ + H ++++L G + LI +P D++ + A + + +I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ R I YLHE+ IIHRD+KA NI ++ + + DFG A
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLQEFKNEVNLIAKLQHK 447
F +G G FG V D A+ A+K L + K E +++A+ ++
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+V+L + L + +Y+P + + L + D R I + I +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDM-MSLLIRLGIFEEDLAR--FYIAELTCAIESVH 118
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
++ IHRD+K NIL+D D + K++DFGL
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 10/151 (6%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKN 448
F +G+G FG V D G A+K L + + + + E +++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V++ + L LI E++P + T ++ D + IA +L +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDM------MTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I + YLH +++RDLK N++LD D + KI+DFGL +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 37/151 (24%), Positives = 68/151 (45%), Gaps = 10/151 (6%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----QGLQEFKNEVNLIAKLQHKN 448
F +G+G FG V D I ++ R + + + + E +++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V++ + + L LI E++P + T ++ D ++ IA +L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDM------MTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 7/104 (6%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E++++ + H+ ++ L+ + ++ MP D+ + RS L ++ +I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ + YLH IIHRD+K NI LD+ N + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E+ ++ + +V G E+ + E+M SLD L +A R + + + SI
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI- 110
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ RG+ YL E + +I+HRD+K SNIL++ K+ DFG++
Sbjct: 111 -AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V +K T K A+K LS+ + F E +++A +V+
Sbjct: 51 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L + + L ++ EYMP L V+L + V W R + A +L L
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDL-VNLM-SNYDVPEKWARFYT-----AEVVLALDAIHS 160
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFG 538
+ IHRD+K N+LLD + K++DFG
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
LG+G FG V A G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L + EY L HL +R R + I + YLH S +
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
++RDLK N++LD D + KI+DFGL + G ++ A GT
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGK-----AIAVKRLSRTS 427
E EFP L+ LG G FG V + T GK +AVK L ++
Sbjct: 31 EKWEFPRDNLQFG----------KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA 80
Query: 428 GQGLQE-FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 468
+E +E+ +++ L QHKN+V LLG C G +L+I EY
Sbjct: 81 HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 46/149 (30%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVR 451
+G+GGFG VY AD GK A+K L + QG NE ++L++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ +L I + M L HL Q + A IL L
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA 540
+++RDLK +NILLD+ + +ISD GLA
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H LV L C L + E++ L +F R +L + + I+ + +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNF 111
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
LHE II+RDLK N+LLD + + K++D+G+ +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 17/147 (11%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V +K + K A+K LS+ + F E +++A +V+
Sbjct: 51 IGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L + + L ++ EYMP L V+L + V W + + A +L L
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDVPEKWAKFYT-----AEVVLALDAIHS 160
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFG 538
+ +IHRD+K N+LLD + K++DFG
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 12/164 (7%)
Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
LG+G FG V A G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L + EY L HL +R +R + I + YLH +
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---V 116
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
++RD+K N++LD D + KI+DFGL + G + A GT
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 17/156 (10%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRT-SGQGL--QEFKNEVNLIAKLQHKNLVRLL 453
+G+GG G VY + +A+K++ S L + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATR---SVQLDWKRRQS------IINGIARGIL 504
C +G + Y+ +L L + S+ + + S I + I I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
Y+H S+ ++HRDLK NILL I D+G A
Sbjct: 128 YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 33/114 (28%), Positives = 60/114 (52%), Gaps = 12/114 (10%)
Query: 434 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
F +L++++ H +L + G C+ G E +++ E++ + LDV L V + WK
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNIL-----LDDDMNP--KISDFGLA 540
++ +A + YL ED L +H ++ A NIL L + +P K+SD G++
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLV 450
F ++LG G G V+K + I ++L + + E+ ++ + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHED 509
G E+ + E+M SLD L A R Q+ K ++I +G+ YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 121
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ KI+HRD+K SNIL++ K+ DFG++
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G FG V D A+ A+K L + + + K E +++A+ ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L + +Y+P + L ++++ IA L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL------IRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
IHRD+K NIL+D D + K++DFGL F N
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V +K + + A+K LS+ + F E +++A + +V+
Sbjct: 51 IGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L + + L ++ EYMP L V+L + + W R A +L L
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDIPEKWARFY-----TAEVVLALDAIHS 160
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFG 538
+ IHRD+K N+LLD + K++DFG
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 391 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAK 443
F ++ +G+G FG V K T G A+K + ++ + + + F+ E ++++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+ +L + L L+ EY P L + L + Q D Q + + I
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYED-QFDEDMAQFYLAELVLAI 115
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+H+ + +HRD+K N+L+D + K++DFG A
Sbjct: 116 HSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 17/27 (62%), Positives = 19/27 (70%)
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
IHRD+ A N+LL D KI DFGLAR
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 490 KRRQSIINGIARGILY-LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
KR ++I G+ R +L L + R+ I+HRD+K N+L+ D KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 21/43 (48%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L + IHRDL A NILL KI DFGLAR
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 25/161 (15%)
Query: 399 LGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQE----FKNEVNLIAKLQ 445
LG+G +Y G L +K + + ++ F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
HK++V L G C+ E +++ E++ LD+ + + + WK + + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK--VAKQLASALSY 120
Query: 506 LHEDSRLKIIHRDLKASNILL-----DDDMNP--KISDFGL 539
L ED L +H ++ NILL D + P K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 37/167 (22%), Positives = 55/167 (32%), Gaps = 51/167 (30%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVK----------------RLSRTSGQGLQEFKNEVNLI 441
+ QG +Y A+ VK R RT + E ++
Sbjct: 3 LIKQGAEAIIYLTDFLGLPAV-VKERIPKRYRHPELDEKLRRERT--------RREARIL 53
Query: 442 AKLQHKNLVRLLGCC------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI 495
AK R G ++ L++ EY+ + L DA + D R
Sbjct: 54 AKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLK----DALEEARPDLLRE--- 100
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ R + LH+ I+H DL SNI+L DFGL
Sbjct: 101 ---VGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 397 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLVRLLG 454
N +G G FG VY+ D + +A+K++ + ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 455 C----CLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
C + E L ++ E++P A + L + + R + Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQ 547
H I HRDLK N+L+D + + K+ DFG A+ Q
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
|
Length = 440 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 57/196 (29%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR------TSGQGLQEFKN-----EVN 439
N + K+G G FG V+ + KR S +GL+E + EVN
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 440 LIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI-- 495
++ +L+HKN+VR + L Q+L ++ E+ D +R++Q +K I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG-------DLSRNIQKCYKMFGKIEE 117
Query: 496 --INGIARGIL----YLHE----DSRLKIIHRDLKASNILLD-------------DDMN- 531
I I R +L Y H + +++HRDLK NI L +++N
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 532 ---PKISDFGLARIFG 544
KI DFGL++ G
Sbjct: 178 RPIAKIGDFGLSKNIG 193
|
Length = 1021 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
+G+G FG V + D + I +++ S + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
++L L+ ++ L HL R + D R + + + LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK---FNV 114
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
I+RDLK NILLD + + DFGL ++ + ++ NT
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 7/120 (5%)
Query: 410 GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469
GTL + + L + + L+ +NEV L +H N++ G L +I +M
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529
S + L + +I+ G RG+ YLH++ IHR++KAS+IL+ D
Sbjct: 82 AYGSAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.93 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.92 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.91 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.91 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.91 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.91 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.91 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.91 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.91 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.91 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.91 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.91 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.91 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.91 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.9 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.9 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.9 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.9 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.9 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.9 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.9 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.9 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.9 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.9 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.9 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.9 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.89 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.89 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.89 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.89 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.89 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.89 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.89 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.89 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.89 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.89 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.89 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.89 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.89 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.89 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.89 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.89 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.89 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.89 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.89 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.89 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.89 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.89 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.88 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.88 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.88 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.88 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.88 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.88 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.88 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.88 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.88 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.88 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.88 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.88 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.88 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.88 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.88 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.88 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.88 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.88 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.88 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.88 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.88 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.88 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.88 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.87 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.87 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.87 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.87 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.87 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.87 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.87 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.87 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.87 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.87 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.87 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.87 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.87 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.87 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.87 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.87 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.87 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.87 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.87 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.86 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.86 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.86 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.86 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.86 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.86 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.86 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.86 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.86 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.86 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.86 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.86 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.86 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.86 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.86 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.86 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.86 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.86 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.86 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.86 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.86 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.86 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.86 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.85 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.85 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.85 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.85 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.85 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.85 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.85 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.85 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.85 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.85 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.85 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.85 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.85 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.85 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.85 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.85 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.84 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.84 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.84 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.84 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.84 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.84 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.84 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.84 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.84 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.84 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.83 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.83 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.83 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.83 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.83 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.83 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.83 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.83 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.83 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.83 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.83 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.83 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.82 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.82 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.82 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.82 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.82 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.82 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.82 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.82 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.82 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.82 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.82 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.82 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.82 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.81 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.81 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.81 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.81 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.81 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.81 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.81 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.81 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.81 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.81 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.81 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.8 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.8 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.8 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.8 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.8 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.8 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.79 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.79 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.79 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.78 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.78 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.78 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.78 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.77 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.77 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.76 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.74 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.63 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.58 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.57 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.57 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.48 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.21 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.05 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.0 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.14 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.12 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.85 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.82 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.68 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.21 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.17 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.76 | |
| PLN02236 | 344 | choline kinase | 96.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.64 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.48 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.24 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.2 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.15 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.72 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.71 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.69 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.68 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.47 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.2 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.1 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.04 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.61 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.57 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.26 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.23 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.12 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 90.21 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 89.45 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.02 Aligned_cols=168 Identities=55% Similarity=0.901 Sum_probs=155.5
Q ss_pred CccccChHHHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEE
Q 008634 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456 (558)
Q Consensus 377 ~~~~~~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 456 (558)
....|++.++..+|++|+..+.||+|+||.||+|.+.+|..||||++.....+...+|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999998876544245699999999999999999999999
Q ss_pred EeCC-EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 008634 457 LEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 457 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
.+.+ +.+||||||++|+|.++|+..... .|+|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999875544 89999999999999999999999988899999999999999999999999
Q ss_pred ecCcceeeCC
Q 008634 536 DFGLARIFGG 545 (558)
Q Consensus 536 DFGla~~~~~ 545 (558)
|||||+..+.
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999987765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=264.29 Aligned_cols=151 Identities=30% Similarity=0.546 Sum_probs=135.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
..+|...++||+|+|+.||+|+++ ++.+||||.+.+. .++..+.+..|+.+|++++|||||+|++++++++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888889999999999999976 5889999999866 4555677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC------CcEEEEecCcc
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD------MNPKISDFGLA 540 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~------~~~ki~DFGla 540 (558)
|||.+|+|.+|++... .+++.+...++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999996543 5999999999999999999999985 9999999999999865 45899999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
|.+...
T Consensus 163 R~L~~~ 168 (429)
T KOG0595|consen 163 RFLQPG 168 (429)
T ss_pred hhCCch
Confidence 998743
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=264.50 Aligned_cols=160 Identities=33% Similarity=0.540 Sum_probs=139.3
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhc--CCCCCeeeeeEEEEeCC----EEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCLEGQ----ELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~l 464 (558)
......+++|+|+||.||||.+. ++.||||++.... .+.|.+|-.+.+. ++|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34555678999999999999995 5899999997554 4567777777654 58999999999987765 8999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED------SRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
|+||.++|+|.+||. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999994 45689999999999999999999986 34689999999999999999999999999
Q ss_pred cceeeCCCCCccCcccccCC
Q 008634 539 LARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 539 la~~~~~~~~~~~t~~~~Gt 558 (558)
||.++..+..+..+...|||
T Consensus 362 LAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eeEEecCCCCCcchhhhhhh
Confidence 99999988887777778887
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=259.80 Aligned_cols=151 Identities=41% Similarity=0.626 Sum_probs=133.7
Q ss_pred CCcccccccCCcccEEEEEecCCcEEEEEEccccCccc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-EEEEEEEcC
Q 008634 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEYM 469 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~ 469 (558)
+...+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.++. ...+||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999755559999998654322 568999999999999999999999999987 799999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceeeCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGN 546 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~~~~ 546 (558)
++|+|..++++. ....++|..+++++.|||+||.|||++.+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999864 45679999999999999999999999852 99999999999999997 9999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=261.54 Aligned_cols=160 Identities=30% Similarity=0.493 Sum_probs=145.6
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
..|...+.||+|||..+|+++. ..|..||+|++.+. .....+...+||++-+.|+|||||+++++|++.+..|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999997 78999999999874 3445678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+|++++|.+++. +++++++.+...+..||+.||.|||+++ |+|||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999985 4567999999999999999999999984 999999999999999999999999999999877
Q ss_pred CCccCcccccCC
Q 008634 547 QNQANTNIIAGT 558 (558)
Q Consensus 547 ~~~~~t~~~~Gt 558 (558)
..+-+| ++||
T Consensus 172 ~Erk~T--lCGT 181 (592)
T KOG0575|consen 172 GERKKT--LCGT 181 (592)
T ss_pred ccccce--ecCC
Confidence 555555 7887
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=248.55 Aligned_cols=161 Identities=29% Similarity=0.475 Sum_probs=135.9
Q ss_pred HcCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccc-------hHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQG-------LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (558)
..+.|...+.||+|+||.|-+|.- ++|+.||||++++..... .....+|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345677889999999999999985 479999999998653221 233579999999999999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC---CcEEEEec
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDF 537 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~ki~DF 537 (558)
..|+||||++||+|.+++... +.+.+..-..++.|++.|+.|||+++ |+||||||+||||..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999999643 34677777889999999999999986 9999999999999765 78999999
Q ss_pred CcceeeCCCCCccCcccccCC
Q 008634 538 GLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 538 Gla~~~~~~~~~~~t~~~~Gt 558 (558)
||||+....+- .+.++||
T Consensus 324 GlAK~~g~~sf---m~TlCGT 341 (475)
T KOG0615|consen 324 GLAKVSGEGSF---MKTLCGT 341 (475)
T ss_pred chhhcccccee---hhhhcCC
Confidence 99998874332 2346776
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=252.21 Aligned_cols=161 Identities=28% Similarity=0.498 Sum_probs=139.0
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (558)
.+.|+..++||+|.||.||+|+. .+|+.||+|++.... .....-..+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34577788999999999999984 579999999997554 33345568999999999999999999999886 68999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+|||+. +|.-++. .....+++.++..++.|++.||+|+|+.+ |+|||||.+|||||++|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999986 5555552 34557999999999999999999999985 9999999999999999999999999999999
Q ss_pred CCCCccCccccc
Q 008634 545 GNQNQANTNIIA 556 (558)
Q Consensus 545 ~~~~~~~t~~~~ 556 (558)
.+.....|.+++
T Consensus 270 ~~~~~~~T~rVv 281 (560)
T KOG0600|consen 270 PSGSAPYTSRVV 281 (560)
T ss_pred CCCCcccccceE
Confidence 888776777665
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=255.07 Aligned_cols=150 Identities=37% Similarity=0.598 Sum_probs=134.7
Q ss_pred CcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
...++||+|-||.||.|.++....||+|.++... ...+.|.+|+.+|.+|+|+|||+++|+|..++.++||||||++|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3467899999999999999887899999998753 334789999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
|.+||.+ .....++-.+.+.++.|||+||+||+++ ++|||||.++|||+++++.+||+||||||....++-
T Consensus 288 Ll~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 288 LLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred HHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999975 3455688899999999999999999988 599999999999999999999999999996665543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=243.54 Aligned_cols=161 Identities=30% Similarity=0.464 Sum_probs=143.1
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
-++|+..++||+|+||+||.++.+ +++.+|+|.+++.. ..+.+....|..+|.+++||+||++.-.|++++.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999865 58899999998763 23456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+||++||.|..+|.+ .+.+++.....++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999953 456899999999999999999999986 99999999999999999999999999998766
Q ss_pred CCCccCcccccCC
Q 008634 546 NQNQANTNIIAGT 558 (558)
Q Consensus 546 ~~~~~~t~~~~Gt 558 (558)
+...+.| ++||
T Consensus 178 ~~~~t~t--fcGT 188 (357)
T KOG0598|consen 178 DGDATRT--FCGT 188 (357)
T ss_pred CCCcccc--ccCC
Confidence 6554444 8888
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=239.41 Aligned_cols=158 Identities=31% Similarity=0.433 Sum_probs=136.3
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-EEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 468 (558)
+++..+.||+|.-|.|||+.++ +++.+|+|.+... ++...+++.+|++++.+++||+||+++|.|..+. +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445678999999999999976 5888999999544 4455688999999999999999999999999998 59999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
|++|+|+.++... +.+++...-+|+.+|++||.|||+.. +||||||||+|||++..|++||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999999543 45899999999999999999999742 6999999999999999999999999999988654
Q ss_pred ccCcccccCC
Q 008634 549 QANTNIIAGT 558 (558)
Q Consensus 549 ~~~t~~~~Gt 558 (558)
....++||
T Consensus 233 --~a~tfvGT 240 (364)
T KOG0581|consen 233 --IANTFVGT 240 (364)
T ss_pred --hccccccc
Confidence 22235665
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=255.98 Aligned_cols=152 Identities=36% Similarity=0.597 Sum_probs=134.0
Q ss_pred HcCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
...+....+.||+|.||+||+|+.. +...||||.++..... ..++|++|+++|+.++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3445666788999999999999853 2457999999977655 78899999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR-----------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~ 530 (558)
.++|+|||..|+|.+||..... +.+|+..+.+.|+.|||.||+||-++. +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999973211 334889999999999999999999874 99999999999999999
Q ss_pred cEEEEecCcceee
Q 008634 531 NPKISDFGLARIF 543 (558)
Q Consensus 531 ~~ki~DFGla~~~ 543 (558)
.|||+||||+|-+
T Consensus 641 ~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 641 VVKISDFGLSRDI 653 (774)
T ss_pred EEEecccccchhh
Confidence 9999999999953
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=255.99 Aligned_cols=151 Identities=32% Similarity=0.561 Sum_probs=136.8
Q ss_pred CCCcccccccCCcccEEEEEecC----CcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
...++++||.|.||+||+|+++- ...||||.|+.. ..+.+.+|+.|+.+|.+++||||++|.|+....+..++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45677899999999999999762 357999999866 4456789999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|||+||+|+.||++ +.+++++.+..-|..+||.||.||-+. ++|||||.++|||++.+..+||+||||+|.+++|
T Consensus 710 EyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999965 446699999999999999999999876 5999999999999999999999999999998777
Q ss_pred C
Q 008634 547 Q 547 (558)
Q Consensus 547 ~ 547 (558)
.
T Consensus 785 ~ 785 (996)
T KOG0196|consen 785 P 785 (996)
T ss_pred C
Confidence 6
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=236.25 Aligned_cols=165 Identities=28% Similarity=0.459 Sum_probs=139.7
Q ss_pred CCCcccccccCCcccEEEEE-ecCCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEE-EEeCCE-EEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGC-CLEGQE-LLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~-~~~~~~-~~lV~ 466 (558)
+|.+.++||+|.||+|||+. +.+|..||.|.++-. +.+..+....|+.+|++|+|||||+++++ +.++.+ +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 57778899999999999997 568999999998733 45667889999999999999999999994 444444 89999
Q ss_pred EcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDS-RLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~-~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||+..|+|...+...++ ...++++..++++.|++.||.++|+.- +.-|+||||||.||+|+.+|.+||+||||+|++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999988875433 345899999999999999999999842 1239999999999999999999999999999998
Q ss_pred CCCCccCcccccCC
Q 008634 545 GNQNQANTNIIAGT 558 (558)
Q Consensus 545 ~~~~~~~t~~~~Gt 558 (558)
...+.+.+ .+||
T Consensus 180 s~~tfA~S--~VGT 191 (375)
T KOG0591|consen 180 SKTTFAHS--LVGT 191 (375)
T ss_pred chhHHHHh--hcCC
Confidence 87664433 6776
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=244.12 Aligned_cols=154 Identities=32% Similarity=0.552 Sum_probs=135.0
Q ss_pred HcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
+.+.+...++||+|.||+|..++...+..||||+++...... ..+|..|+++|.+++|||||+|+|+|..++.+.+|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 344566778999999999999999888999999999775544 5899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee-eCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI-FGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~-~~~~ 546 (558)
||++|+|..||.+...+. +.-..-.+|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||++|- +.++
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997654333 44555678999999999999976 699999999999999999999999999994 4444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=223.19 Aligned_cols=157 Identities=31% Similarity=0.445 Sum_probs=139.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|+..+.||.|+||.|...+.+ +|.-.|+|++++..- ++.+...+|..+|..+.||+++++.+.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777889999999999999876 588899999987643 34566789999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|.|..+|++. +.+++.....++.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...+.
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999654 45999999999999999999999985 999999999999999999999999999988654
Q ss_pred CCccCcccccCC
Q 008634 547 QNQANTNIIAGT 558 (558)
Q Consensus 547 ~~~~~t~~~~Gt 558 (558)
|..++||
T Consensus 198 -----T~TlCGT 204 (355)
T KOG0616|consen 198 -----TWTLCGT 204 (355)
T ss_pred -----EEEecCC
Confidence 3447776
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=239.91 Aligned_cols=154 Identities=31% Similarity=0.444 Sum_probs=136.2
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (558)
...++|..++.||+|+|++|++|+.. .++++|||++.+.- .+..+-...|-..|.+| .||.|++|+-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 44568999999999999999999854 68999999998652 22234566788889999 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
|+|+||.++|+|.++|++. +.|++.....++.+|+.||+|||+.+ ||||||||+|||||.||++||.|||-|++
T Consensus 150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999654 56999999999999999999999986 99999999999999999999999999999
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
+++.+
T Consensus 224 l~~~~ 228 (604)
T KOG0592|consen 224 LSPSQ 228 (604)
T ss_pred CChhh
Confidence 86543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=220.06 Aligned_cols=150 Identities=33% Similarity=0.606 Sum_probs=132.2
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|.||.||+|+. .+|+.||||+++.....+ .....+||+.|+.++|+||+.|++++...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999985 469999999998654322 3456899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+ .+|...+++ +...+.......++.++.+||+|||++. |+||||||.|+|++++|.+||+||||||.+...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 996 488888855 4456899999999999999999999985 999999999999999999999999999998644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=227.40 Aligned_cols=148 Identities=25% Similarity=0.435 Sum_probs=130.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.|+...++|+|+||.|||++.+ +|+.||||++..... .-.+-.++||++|++++|+|+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4666778999999999999977 499999999976533 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++..-|+++-+ .+..++.....+++.|++.|+.|+|++ ++|||||||+||||+.++.+||+|||+||.+..
T Consensus 83 ~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 83 CDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred cchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99877776542 334588999999999999999999998 499999999999999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=242.49 Aligned_cols=149 Identities=35% Similarity=0.511 Sum_probs=131.4
Q ss_pred CCCCcccccccCCcccEEEEEecC--C--cE-EEEEEccc---cCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD--G--KA-IAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~--g--~~-VaVK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
++....++||+|.||.||+|++.. + .. ||||..+. .......+|.+|+++|.+++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556899999999999998753 2 23 89998885 2355678999999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|||+|+||+|+++|.+.. ..++..+++.++.+.|.||+|||++. +|||||.++|+|++.++.+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999996543 26999999999999999999999984 99999999999999999999999999886
Q ss_pred eC
Q 008634 543 FG 544 (558)
Q Consensus 543 ~~ 544 (558)
-.
T Consensus 312 ~~ 313 (474)
T KOG0194|consen 312 GS 313 (474)
T ss_pred Cc
Confidence 54
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=231.18 Aligned_cols=161 Identities=26% Similarity=0.395 Sum_probs=135.5
Q ss_pred cccChHHHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHH--hcCCCCCeeeeeEEE
Q 008634 379 PLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLI--AKLQHKNLVRLLGCC 456 (558)
Q Consensus 379 ~~~~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l--~~l~H~niv~l~g~~ 456 (558)
...++-..+.........+.||+|.||+||+|.++ |+.||||++...++. .+.+|.++. ..|+|+||+.+++.-
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhcc
Confidence 44555555666677888899999999999999995 789999999876554 345555554 456999999999875
Q ss_pred EeC----CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCCEEEc
Q 008634 457 LEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-----SRLKIIHRDLKASNILLD 527 (558)
Q Consensus 457 ~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDlk~~NILl~ 527 (558)
..+ .++|||+||++.|||.+||.+ ..++-+..++++..+|.||++||.+ +.+.|.|||||++|||+.
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 443 278999999999999999943 5689999999999999999999964 678899999999999999
Q ss_pred CCCcEEEEecCcceeeCCCC
Q 008634 528 DDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~~~~ 547 (558)
.++.+.|+|+|||-.++.+.
T Consensus 351 kn~~C~IADLGLAv~h~~~t 370 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDT 370 (513)
T ss_pred cCCcEEEeeceeeEEecccC
Confidence 99999999999999987764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=237.33 Aligned_cols=159 Identities=30% Similarity=0.524 Sum_probs=140.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|-..+.||+|+||.||||+-+ +.+.||+|.+.+. ..++++.+++|++++++++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45667788999999999999865 5789999999765 34567889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+.+ +|..+|.+ ...|+++....|+.++..||.|||+. +|+|||+||+||||+.++.+|++|||+||-...+.
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 99999965 34599999999999999999999998 49999999999999999999999999999887643
Q ss_pred CccCcccccCC
Q 008634 548 NQANTNIIAGT 558 (558)
Q Consensus 548 ~~~~t~~~~Gt 558 (558)
.+.+.|.||
T Consensus 155 --~vltsikGt 163 (808)
T KOG0597|consen 155 --SVLTSIKGT 163 (808)
T ss_pred --eeeeeccCc
Confidence 344557776
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=228.10 Aligned_cols=150 Identities=25% Similarity=0.521 Sum_probs=136.0
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.+|++.+.||+|.||.|-++.. ..|+.||||.+++. +.+++-.+++||++|+.|+||||+.++.+|+..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577788999999999999985 67999999999876 4455667899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||..+|.|-+|+.+ ...|++.+..+++.||..|+.|+|.+ +++|||||.+|||||.++++||+||||+..|..+
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999954 44699999999999999999999998 5999999999999999999999999999887644
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=226.01 Aligned_cols=150 Identities=30% Similarity=0.503 Sum_probs=130.2
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--------------cchHHHHHHHHHHhcCCCCCeeee
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------------QGLQEFKNEVNLIAKLQHKNLVRL 452 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l 452 (558)
..-++|.+.+.||+|.||.|-+|... +++.||||++.+... ...+..++||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999965 689999999976421 114578999999999999999999
Q ss_pred eEEEEeC--CEEEEEEEcCCCCCHHHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC
Q 008634 453 LGCCLEG--QELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529 (558)
Q Consensus 453 ~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~ 529 (558)
+.+.-++ +.+|||+|||..|.+... ....+ |++.+..+|+.++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998765 579999999999987632 23334 999999999999999999999996 9999999999999999
Q ss_pred CcEEEEecCcceeeC
Q 008634 530 MNPKISDFGLARIFG 544 (558)
Q Consensus 530 ~~~ki~DFGla~~~~ 544 (558)
+++||+|||.+-.+.
T Consensus 247 g~VKIsDFGVs~~~~ 261 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFP 261 (576)
T ss_pred CcEEeeccceeeecc
Confidence 999999999999884
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=222.96 Aligned_cols=150 Identities=31% Similarity=0.517 Sum_probs=132.4
Q ss_pred CCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--EEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 467 (558)
.++...+.||+|.||.||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|.....+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356677899999999999999764 8999999988664444677899999999999999999999855544 6999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~~~~ 545 (558)
|+++|+|.+++.+... .|++....++..||++||.|||+++ ||||||||+||||+. ++.+||+|||+++...+
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999965432 6999999999999999999999885 999999999999999 79999999999998875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=231.01 Aligned_cols=150 Identities=29% Similarity=0.478 Sum_probs=133.5
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc----Cc-cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT----SG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 461 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 461 (558)
..+.|...+.||+|.||.|+.|... +++.||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4567888999999999999999754 6899999977664 22 23456678999999999 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecCcc
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLA 540 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFGla 540 (558)
.++||||+.+|+|.+++.+ .+.+.+....+++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999965 445888999999999999999999985 9999999999999999 99999999999
Q ss_pred eeeC
Q 008634 541 RIFG 544 (558)
Q Consensus 541 ~~~~ 544 (558)
+...
T Consensus 169 ~~~~ 172 (370)
T KOG0583|consen 169 AISP 172 (370)
T ss_pred cccC
Confidence 9885
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=229.61 Aligned_cols=150 Identities=27% Similarity=0.394 Sum_probs=136.0
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
...++|....+||+|+||.||.++-+ +|..+|+|+|++... ......+.|-.+|...++|+||+|+-.|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35688999999999999999999865 599999999998743 34567889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|||||++||++..+|. +...|++.....++.+++.|++-||..+ +|||||||+|+|||..|++||+||||++-+
T Consensus 218 LiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999995 3456999999999999999999999985 999999999999999999999999999644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=231.13 Aligned_cols=160 Identities=32% Similarity=0.532 Sum_probs=143.6
Q ss_pred cCCCCcccccccCCcccEEEEE-ecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
...|...++||+|.-|.||.+. ..++++||||++........+-+.+|+.+|+..+|+|||+++..+...+++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3457777899999999999997 456889999999877666566789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
|++|+|.+.+.. ..+++.+...|+.+++.||+|||.++ |+|||||.+||||+.++.+||+|||++..+...+.
T Consensus 352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999998843 34999999999999999999999986 99999999999999999999999999999998887
Q ss_pred ccCcccccCC
Q 008634 549 QANTNIIAGT 558 (558)
Q Consensus 549 ~~~t~~~~Gt 558 (558)
...| .+||
T Consensus 425 KR~T--mVGT 432 (550)
T KOG0578|consen 425 KRST--MVGT 432 (550)
T ss_pred cccc--ccCC
Confidence 6555 6777
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=222.58 Aligned_cols=152 Identities=31% Similarity=0.525 Sum_probs=131.1
Q ss_pred CCCCcccccccCCcccEEEEEecC-----------------CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeee
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRL 452 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-----------------g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 452 (558)
++|...++||+|+||.||++...+ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999997532 3369999987653 2335679999999999999999999
Q ss_pred eEEEEeCCEEEEEEEcCCCCCHHHHHhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 008634 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDAT----------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516 (558)
Q Consensus 453 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 516 (558)
++++.+.+..++||||+++|+|.+++.... ....++|...++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986421 1134788999999999999999999985 999
Q ss_pred CCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 517 RDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 517 rDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||||+|||++.++.+||+|||+++....
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceeccc
Confidence 99999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=227.56 Aligned_cols=154 Identities=30% Similarity=0.448 Sum_probs=130.4
Q ss_pred HcCCCCcccccccCCcccEEEEEe------cCCcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC-
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG- 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~- 459 (558)
+.++|...++||+|+||.||+|.. .++..||||++..... ...+.+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788899999999999999974 2356899999975432 3356789999999999 899999999998765
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCC--------------------------------------------------------
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATR-------------------------------------------------------- 483 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 483 (558)
+..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 468999999999999999864321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 484 ---SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 484 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
...+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134888999999999999999999875 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-26 Score=210.29 Aligned_cols=155 Identities=31% Similarity=0.504 Sum_probs=136.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
-++|..++.||+|.||.||.|+.+ ++-.||+|++.+.. .+-.+++.+|+++-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 367899999999999999999865 57899999997653 23356899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+||.++|++...|.+. +...+++.....++.|+|.||.|+|.. +||||||||+|+|++.++..||+|||-+-.-+.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999999643 345588888899999999999999987 599999999999999999999999999876654
Q ss_pred CCC
Q 008634 546 NQN 548 (558)
Q Consensus 546 ~~~ 548 (558)
+..
T Consensus 177 ~kR 179 (281)
T KOG0580|consen 177 NKR 179 (281)
T ss_pred CCc
Confidence 433
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=248.93 Aligned_cols=151 Identities=38% Similarity=0.643 Sum_probs=133.7
Q ss_pred CCCCcccccccCCcccEEEEEecC--Cc----EEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD--GK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~--g~----~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
.+....+.||+|.||.||+|...+ |. .||||.+.+.. .+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345567789999999999998653 43 48999998774 456788999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 464 LIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
+++|||++|+|..||.+.+. ...|.-.+.+.++.|||+|+.||++++ +|||||.++|+||+....|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999986532 346899999999999999999999984 99999999999999999999999999
Q ss_pred ce-eeC
Q 008634 540 AR-IFG 544 (558)
Q Consensus 540 a~-~~~ 544 (558)
|| ++.
T Consensus 849 ArDiy~ 854 (1025)
T KOG1095|consen 849 ARDIYD 854 (1025)
T ss_pred hHhhhh
Confidence 99 443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-26 Score=229.12 Aligned_cols=151 Identities=29% Similarity=0.480 Sum_probs=131.6
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHH--HHHHHHHhcCC-CCCeeeeeEEEEeCC-EEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEF--KNEVNLIAKLQ-HKNLVRLLGCCLEGQ-ELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~--~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~l 464 (558)
.++|...++||.|.||.||+|+.. +|..||||++++.-.. +++. ++|++.|.+++ ||||++|.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 356788899999999999999854 6889999999876432 3333 68999999998 999999999999988 9999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|||||+. +|-+++.++ +..+++..+..|+.||.+||+|+|.+| +.|||+||+|||+.....+||+||||||-+.
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999964 777777553 667999999999999999999999996 9999999999999999999999999999876
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
..+
T Consensus 162 Skp 164 (538)
T KOG0661|consen 162 SKP 164 (538)
T ss_pred cCC
Confidence 544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=214.37 Aligned_cols=152 Identities=28% Similarity=0.478 Sum_probs=129.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc-c-hHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-G-LQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (558)
.++|+..++|++|.||.||+|+.+ +++.||+|+++-...+ + --.-++||.+|.+++|||||.+..+.... +.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356777889999999999999975 6889999999854322 1 22357999999999999999999988764 57999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|||||+. +|...+..-. ..+...+...+..|+++|++|||.+. |+|||||++|+|+.+.|.+||+||||||.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 7777775422 45788888999999999999999986 9999999999999999999999999999998
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
...
T Consensus 229 sp~ 231 (419)
T KOG0663|consen 229 SPL 231 (419)
T ss_pred CCc
Confidence 763
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=213.55 Aligned_cols=152 Identities=31% Similarity=0.540 Sum_probs=128.8
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cc-hHHHHHHHHHHhcCCCCC-eeeeeEEEEeCC------E
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QG-LQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQ------E 461 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~-~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------~ 461 (558)
.|...++||+|.||.||+|+.. +|+.||+|++.-... ++ -....+|+.++.+++|+| ||+|++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4555678999999999999954 689999999975533 22 344689999999999999 999999998877 7
Q ss_pred EEEEEEcCCCCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
+++|+||++ -+|..++....+. ..++......++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 899999985 5888888654432 34777889999999999999999985 999999999999999999999999999
Q ss_pred eeeCCCC
Q 008634 541 RIFGGNQ 547 (558)
Q Consensus 541 ~~~~~~~ 547 (558)
|.+.-+.
T Consensus 168 ra~~ip~ 174 (323)
T KOG0594|consen 168 RAFSIPM 174 (323)
T ss_pred HHhcCCc
Confidence 9876443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=229.46 Aligned_cols=163 Identities=28% Similarity=0.437 Sum_probs=139.5
Q ss_pred HHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCE
Q 008634 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 387 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (558)
....++|...++||+|.||+|+.+.++ +++.+|||.+++..- .+.+..+.|-+++... +||.|+.|+.+|++++.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999987 477899999998743 3455677788877766 59999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
+++||||+.||++..+. ....+++.+...++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954433 3346999999999999999999999995 9999999999999999999999999999
Q ss_pred eeCCCCCccCcccccCC
Q 008634 542 IFGGNQNQANTNIIAGT 558 (558)
Q Consensus 542 ~~~~~~~~~~t~~~~Gt 558 (558)
.-....+.++ .++||
T Consensus 517 e~m~~g~~Ts--TfCGT 531 (694)
T KOG0694|consen 517 EGMGQGDRTS--TFCGT 531 (694)
T ss_pred ccCCCCCccc--cccCC
Confidence 8765555444 48998
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=225.10 Aligned_cols=147 Identities=29% Similarity=0.396 Sum_probs=131.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +++.||||++.+.. ....+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999864 68899999986532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||+++|+|.+++.+ ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999854 245889999999999999999999985 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=218.92 Aligned_cols=141 Identities=28% Similarity=0.343 Sum_probs=126.0
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
+.||+|+||.||+++.. +|+.||+|++.+.. ......+.+|+.++.+++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 68899999987542 233456789999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99999854 345899999999999999999999985 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=228.14 Aligned_cols=147 Identities=37% Similarity=0.632 Sum_probs=130.3
Q ss_pred HcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.-+.+...+.||+|+||+||+|++.. .||||+++-.. .+..+.|++|+..+++-+|.||+-+.|+|..+.. .+|+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 33445667899999999999999853 59999998654 3457899999999999999999999999998876 9999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
.+|++.+|..+||..+ .+++..+...|+.||++||.|||.+. |||||||+.||+|.++++|||.||||+..-
T Consensus 467 qwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred hhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999998644 45888999999999999999999984 999999999999999999999999998753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=223.95 Aligned_cols=148 Identities=26% Similarity=0.392 Sum_probs=132.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|+..++||+|+||.||+++.. +++.+|+|++.+.. ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 58899999997542 233456888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999964 345899999999999999999999985 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=229.58 Aligned_cols=153 Identities=19% Similarity=0.273 Sum_probs=133.8
Q ss_pred CCCcccccccCCcccEEEEEec-C-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-D-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.|...+.||+|+||.||++... + +..|++|++..........+.+|+.++++++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999854 3 6788888876555555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
++|+|.+++.+. .....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988643 23446899999999999999999999874 9999999999999999999999999999876543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=235.55 Aligned_cols=154 Identities=32% Similarity=0.548 Sum_probs=134.0
Q ss_pred CCcccccccCCcccEEEEEe-cCC----cEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTL-ADG----KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~-~~g----~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
+..+++||+|.||.||||.+ +.| -+||||++.... .+..++++.|+..|++++||||+||+|+|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34567999999999999974 343 478999987664 345688999999999999999999999998875 89999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+||+.|+|.+|++.. +..+--+..+.+..|||+||.|||++ +++||||.++|||+..-..+||.|||+|++...+
T Consensus 777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999763 34567788899999999999999987 5999999999999999999999999999999888
Q ss_pred CCccCc
Q 008634 547 QNQANT 552 (558)
Q Consensus 547 ~~~~~t 552 (558)
..+..+
T Consensus 852 ~~ey~~ 857 (1177)
T KOG1025|consen 852 EKEYSA 857 (1177)
T ss_pred cccccc
Confidence 776554
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=223.66 Aligned_cols=150 Identities=24% Similarity=0.328 Sum_probs=132.6
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
..++|...++||+|+||.||+++.. +++.+|+|.+.+.. ......+.+|+.++..++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4567889999999999999999975 57899999986532 2234568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999853 24788889999999999999999985 9999999999999999999999999999875
Q ss_pred C
Q 008634 545 G 545 (558)
Q Consensus 545 ~ 545 (558)
.
T Consensus 194 ~ 194 (370)
T cd05621 194 E 194 (370)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=219.70 Aligned_cols=149 Identities=27% Similarity=0.417 Sum_probs=132.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+|+.. +++.||+|++.+.. ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 58899999997542 233567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999954 235889999999999999999999885 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=223.52 Aligned_cols=148 Identities=26% Similarity=0.401 Sum_probs=132.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 58899999997542 233456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998642 35899999999999999999999985 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=219.73 Aligned_cols=149 Identities=26% Similarity=0.408 Sum_probs=133.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++.. +++.||+|.+.+.. ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999976 58899999987542 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999998643 35889999999999999999999985 99999999999999999999999999997754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=212.97 Aligned_cols=150 Identities=25% Similarity=0.420 Sum_probs=134.8
Q ss_pred cCCCCcccccccCCcccEEEEE-ecCCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|+..++||.|.-+.||+|+ .+.+..||||++.-.. ..+.+.+++|+..|..++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678899999999999999998 4568999999997543 3447899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||.+|++.+++...-..+ +++..+..|..++++||.|||.++ .||||||+.||||+.+|.|||+|||.+..+
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999997654433 899999999999999999999986 999999999999999999999999976654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=218.07 Aligned_cols=142 Identities=29% Similarity=0.349 Sum_probs=126.5
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999865 68999999997542 334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 99988854 235899999999999999999999885 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=223.22 Aligned_cols=154 Identities=34% Similarity=0.471 Sum_probs=132.5
Q ss_pred cCCCCcccccccCCcccEEEEEe------cCCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (558)
.++|...++||+|+||.||+++. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44688889999999999999963 235689999997543 33456788999999999 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC----------------------------------------------------------
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 483 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 483 (558)
.++||||+++|+|.+++.+...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 484 --------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 484 --------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
...++|...+.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....+
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124789999999999999999999874 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=220.13 Aligned_cols=150 Identities=25% Similarity=0.347 Sum_probs=132.2
Q ss_pred cCCCCcccccccCCcccEEEEEecC--CcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~--g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.++|...++||+|+||.||+|...+ +..||+|++.+.. ....+.+.+|+.++..++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468888999999999999998643 3689999986542 2345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999643 35899999999999999999999985 9999999999999999999999999999765
Q ss_pred C
Q 008634 545 G 545 (558)
Q Consensus 545 ~ 545 (558)
.
T Consensus 183 ~ 183 (340)
T PTZ00426 183 T 183 (340)
T ss_pred C
Confidence 3
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=216.15 Aligned_cols=140 Identities=25% Similarity=0.342 Sum_probs=125.4
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
||+|+||.||+++.. +++.||+|.+.+. .......+..|+.++.+++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 5789999998753 233456788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 999854 345899999999999999999999885 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=222.99 Aligned_cols=146 Identities=26% Similarity=0.385 Sum_probs=130.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.|...++||+|+||.||+++.. +++.||+|++.+.. ......+.+|++++.+++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778889999999999999864 58899999997542 2345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999998542 35889999999999999999999874 999999999999999999999999998755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=216.46 Aligned_cols=149 Identities=26% Similarity=0.355 Sum_probs=132.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||++... +++.||+|.+.... .+..+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999975 58899999986532 233566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999998542 35899999999999999999999985 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=217.76 Aligned_cols=141 Identities=27% Similarity=0.352 Sum_probs=125.8
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
+.||+|+||.||+++.. +|..||+|.+.... ......+.+|++++.+++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999865 68999999987542 234556788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99988854 235899999999999999999999885 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=221.70 Aligned_cols=154 Identities=33% Similarity=0.432 Sum_probs=132.1
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 461 (558)
.+.|.+.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|++++.+++ ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567888899999999999999852 234799999975433 33567999999999996 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC----------------------------------------------------------
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 483 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 483 (558)
.++||||+++|+|.++|++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999865321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC
Q 008634 484 -----------------------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 528 (558)
Q Consensus 484 -----------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~ 528 (558)
...++|..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788899999999999999999874 999999999999999
Q ss_pred CCcEEEEecCcceeeCCC
Q 008634 529 DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 529 ~~~~ki~DFGla~~~~~~ 546 (558)
++.+||+|||+++.+..+
T Consensus 273 ~~~~kL~DfGla~~~~~~ 290 (400)
T cd05105 273 GKIVKICDFGLARDIMHD 290 (400)
T ss_pred CCEEEEEeCCcceecccc
Confidence 999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=211.38 Aligned_cols=149 Identities=30% Similarity=0.426 Sum_probs=130.9
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
|...+.||+|+||.||++... +|+.||+|.+.+.. ......+.+|+.++.+++|+||+++++.+.+++..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999864 68999999987542 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++|+|..++.... ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998885432 335899999999999999999999885 99999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=215.62 Aligned_cols=151 Identities=22% Similarity=0.289 Sum_probs=132.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +++.||+|.+.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 57889999987532 223455888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999652 235889999999999999999999874 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=214.27 Aligned_cols=143 Identities=27% Similarity=0.339 Sum_probs=125.4
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
+.||+|+||.||++... +|+.||+|.+.+.. ......+.+|++++..++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 68899999987542 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+|..++.+ ...+++.....++.||+.||.|||+.. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99988854 235899999999999999999999731 59999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=216.07 Aligned_cols=151 Identities=21% Similarity=0.309 Sum_probs=132.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++.. +++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999965 5889999998753 2223456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999542 345889999999999999999999985 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-24 Score=215.40 Aligned_cols=155 Identities=29% Similarity=0.487 Sum_probs=133.2
Q ss_pred ccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
+++||.|-||.||-|..+ +|+.||||++.+. ..+....+++|+.+|.+++||.||.|...|+.++..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999865 7999999999865 4455688999999999999999999999999999999999999777
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcceeeCCCCCc
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFGGNQNQ 549 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla~~~~~~~~~ 549 (558)
.|+..|. .+.+.|++.....++.||+.||.|||.+ +|+|+||||+||||.+ --++||+|||+||++++.+-+
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 7776663 3456699998889999999999999988 5999999999999954 347999999999999876643
Q ss_pred cCcccccCC
Q 008634 550 ANTNIIAGT 558 (558)
Q Consensus 550 ~~t~~~~Gt 558 (558)
. .++||
T Consensus 724 r---sVVGT 729 (888)
T KOG4236|consen 724 R---SVVGT 729 (888)
T ss_pred h---hhcCC
Confidence 2 35666
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=220.55 Aligned_cols=146 Identities=25% Similarity=0.387 Sum_probs=129.9
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
+|...++||+|+||.||+++.. +++.||||.+.+.. ......+.+|++++.+++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888899999999999999865 58899999987542 2234668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999954 235888888999999999999999985 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=221.91 Aligned_cols=146 Identities=26% Similarity=0.398 Sum_probs=130.0
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.|...++||+|+||.||+++.. +++.+|+|++.+.. ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999864 58899999987543 2335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999998543 35888888999999999999999985 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=216.51 Aligned_cols=151 Identities=25% Similarity=0.344 Sum_probs=134.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +++.||+|+++... .+..+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999865 68899999997542 234566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999653 246899999999999999999999985 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=226.78 Aligned_cols=161 Identities=30% Similarity=0.480 Sum_probs=137.8
Q ss_pred CCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------CEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELL 463 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~ 463 (558)
.|...+.||+|+||.||+|+. ..|+.||||.+.+.. ....+....|+++|++++|+|||++++.-++. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 345567899999999999995 469999999998653 34567788999999999999999999986554 3679
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc--CCC--cEEEEecCc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDM--NPKISDFGL 539 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~--~~~--~~ki~DFGl 539 (558)
+|||||++|+|...|.+..+...|++...+.+..++..||.|||+++ |+||||||.||++- .++ .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988877788999999999999999999999885 99999999999983 334 479999999
Q ss_pred ceeeCCCCCccCcccccCC
Q 008634 540 ARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 540 a~~~~~~~~~~~t~~~~Gt 558 (558)
||-++.++- -..++||
T Consensus 171 Arel~d~s~---~~S~vGT 186 (732)
T KOG4250|consen 171 ARELDDNSL---FTSLVGT 186 (732)
T ss_pred cccCCCCCe---eeeecCc
Confidence 999987762 2347787
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=231.74 Aligned_cols=154 Identities=31% Similarity=0.437 Sum_probs=136.0
Q ss_pred HHcCCCCcccccccCCcccEEEEEecCC-cEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEE-EEe------
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGC-CLE------ 458 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~~g-~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~------ 458 (558)
....++.+++.|.+|||+.||.+....+ .++|+|++-..+.+.++...+||++|++|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3455677889999999999999998765 999999998888889999999999999996 9999999993 322
Q ss_pred CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 459 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
..+.+|.||||++|.|-+++.+..... |++.++++|+.|+++|+.+||.. +++|||||||.+||||+.+++.||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 247899999999999999997654444 99999999999999999999997 5789999999999999999999999999
Q ss_pred cceee
Q 008634 539 LARIF 543 (558)
Q Consensus 539 la~~~ 543 (558)
-|.--
T Consensus 192 Satt~ 196 (738)
T KOG1989|consen 192 SATTK 196 (738)
T ss_pred ccccc
Confidence 87643
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=220.84 Aligned_cols=154 Identities=34% Similarity=0.494 Sum_probs=131.6
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (558)
.++|...++||+|+||.||+++.. ++..||+|++..... .....+.+|+.+++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 347888899999999999998742 245799999975432 3356788999999999 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC----------------------------------------------------------
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 483 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 483 (558)
.++||||+++|+|.+++.+...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 484 ---------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 484 ---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
...+++....+|+.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..+
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 124788999999999999999999885 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=219.60 Aligned_cols=153 Identities=24% Similarity=0.305 Sum_probs=133.8
Q ss_pred HHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 387 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
....++|...+.||+|+||.||+++.. +++.+|+|.+.+.. ......+.+|+.++..++||||+++++.+.+++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 344578999999999999999999976 57899999986432 23345678999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 119 ~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999853 24788888899999999999999985 99999999999999999999999999998
Q ss_pred eCCC
Q 008634 543 FGGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
....
T Consensus 192 ~~~~ 195 (371)
T cd05622 192 MNKE 195 (371)
T ss_pred cCcC
Confidence 7543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=220.27 Aligned_cols=162 Identities=28% Similarity=0.462 Sum_probs=141.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE-EEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-LLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 466 (558)
++|...+++|+|+||.++..+.+ ++..+++|++.-. .....+...+|+.++++++|||||.+.+.|++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56778899999999999988765 5778999988643 34445578899999999999999999999999988 99999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||++||+|.+.+.+.+ ...++++..+.++.||+.|+.|||++ +|+|||||+.||+++.+..|||.|||+||+...+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997644 56799999999999999999999977 5999999999999999999999999999999887
Q ss_pred CCccCcccccCC
Q 008634 547 QNQANTNIIAGT 558 (558)
Q Consensus 547 ~~~~~t~~~~Gt 558 (558)
...+.+ ++||
T Consensus 160 ~~~a~t--vvGT 169 (426)
T KOG0589|consen 160 DSLAST--VVGT 169 (426)
T ss_pred hhhhhe--ecCC
Confidence 644444 6776
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=212.41 Aligned_cols=148 Identities=30% Similarity=0.487 Sum_probs=120.5
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----EEEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIY 466 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 466 (558)
|...+++|.|+||.||+|.+. ++.+||||+.-....- -..|+++|++++|||||+|+-++.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 556789999999999999975 4789999998655331 146999999999999999999987542 346899
Q ss_pred EcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFGla~~~~ 544 (558)
||||. +|...++.. ..+..++.....-+..||.+||.|||+. +|+||||||+|+|+|.+ +.+||+|||-||++.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 666666532 1234477777788999999999999997 49999999999999976 999999999999987
Q ss_pred CCCC
Q 008634 545 GNQN 548 (558)
Q Consensus 545 ~~~~ 548 (558)
.++.
T Consensus 178 ~~ep 181 (364)
T KOG0658|consen 178 KGEP 181 (364)
T ss_pred cCCC
Confidence 6553
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=219.20 Aligned_cols=150 Identities=24% Similarity=0.329 Sum_probs=131.8
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
..++|...++||+|+||.||+++.. ++..+|+|.+.+.. ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457888999999999999999875 58899999986532 2334557899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999853 24788888889999999999999985 9999999999999999999999999998765
Q ss_pred C
Q 008634 545 G 545 (558)
Q Consensus 545 ~ 545 (558)
.
T Consensus 194 ~ 194 (370)
T cd05596 194 A 194 (370)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=217.55 Aligned_cols=150 Identities=26% Similarity=0.413 Sum_probs=134.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +++.||||++.+.. ......+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999976 68999999987542 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++++|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999653 46899999999999999999999974 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=209.83 Aligned_cols=148 Identities=28% Similarity=0.477 Sum_probs=129.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|...++||+|+||.||+|+.. ++..||+|.++... ......+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 58899999987543 23345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++ +|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 985 898888542 335789999999999999999999885 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=213.64 Aligned_cols=142 Identities=32% Similarity=0.447 Sum_probs=124.8
Q ss_pred cccccCCcccEEEEEe----cCCcEEEEEEccccC----ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~----~~g~~VaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++||+|+||.||+++. .+++.||+|.+++.. ......+.+|+.++..++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357899999987532 23345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++|+|.+++.+ ...+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 999999999854 335788888999999999999999885 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=213.55 Aligned_cols=150 Identities=22% Similarity=0.286 Sum_probs=131.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.+ +++.+|+|.+.+.. ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999976 47789999986432 223445888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.+. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999642 235899999999999999999999875 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=213.04 Aligned_cols=151 Identities=26% Similarity=0.346 Sum_probs=133.6
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|+..++||+|+||.||+++.. ++..+++|.+.... ....+.+.+|++++.+++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999976 57889999887542 2335679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++|+|.+++... ..+++.....++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999998542 35899999999999999999999853 599999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=214.08 Aligned_cols=148 Identities=27% Similarity=0.393 Sum_probs=129.4
Q ss_pred CCCcccccccCCcccEEEEEe----cCCcEEEEEEccccC----ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~VaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (558)
+|...++||+|+||.||+++. .+++.||+|++.+.. ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 357899999987532 22345678899999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999854 335899999999999999999999885 99999999999999999999999999987
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=212.44 Aligned_cols=144 Identities=29% Similarity=0.384 Sum_probs=126.7
Q ss_pred cccccCCcccEEEEEe----cCCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~----~~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
+.||+|+||.||+++. .+|+.+|+|++.+... .....+.+|++++.+++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999975432 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999854 345899999999999999999999985 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=207.41 Aligned_cols=148 Identities=29% Similarity=0.455 Sum_probs=130.9
Q ss_pred CCCCcccccccCCcccEEEEEec----CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...+.||+|+||.||+|.+. .+..|++|.++.... .....|.+|+..+.+++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999753 356899999986533 3346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|||+++|+|.+++.+. ...++|..++.++.||+.||.|||+.+ ++||||||+|||++.++.+|++|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999643 346899999999999999999999885 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=212.60 Aligned_cols=151 Identities=32% Similarity=0.567 Sum_probs=130.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCc----EEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.+|+..+.||+|+||.||+|++. ++. .|++|.++... ....+++.+|+.++..++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 48999987543 34457899999999999999999999999875 5789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+||+++|+|.+++.+. ...+++...+.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999999653 345889999999999999999999874 9999999999999999999999999999876
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
.+.
T Consensus 161 ~~~ 163 (316)
T cd05108 161 ADE 163 (316)
T ss_pred CCC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=212.83 Aligned_cols=141 Identities=26% Similarity=0.413 Sum_probs=124.5
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+.||+|+||.||+++.. +++.+|+|.+++. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 5789999999764 223455678899988877 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999988854 245899999999999999999999985 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=217.15 Aligned_cols=144 Identities=29% Similarity=0.467 Sum_probs=125.9
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+|...++||+|+||.||+++.. +++.|+||.+..... ...+.+.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556788999999999999865 689999999865433 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++|+|.... ..++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999986432 3567778899999999999999885 99999999999999999999999999997753
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=215.98 Aligned_cols=148 Identities=26% Similarity=0.399 Sum_probs=131.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++.. +++.||+|++.... ......+..|+.++.+++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999875 58899999987532 233567888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999854 345899999999999999999999885 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=206.32 Aligned_cols=151 Identities=34% Similarity=0.535 Sum_probs=131.0
Q ss_pred CCCCcccccccCCcccEEEEEe-----cCCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|+..++||+|+||.||+|.. ..+..|++|.+.... .+....+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567788999999999999984 245789999997543 3345678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC
Q 008634 465 IYEYMPNKSLDVHLFDATR--------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~ 530 (558)
||||+++++|.+++..... ...+++...+.++.||+.||.|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 235889999999999999999999885 99999999999999999
Q ss_pred cEEEEecCcceeeC
Q 008634 531 NPKISDFGLARIFG 544 (558)
Q Consensus 531 ~~ki~DFGla~~~~ 544 (558)
.+||+|||+++...
T Consensus 162 ~~kl~dfg~~~~~~ 175 (283)
T cd05090 162 HVKISDLGLSREIY 175 (283)
T ss_pred cEEecccccccccc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=212.52 Aligned_cols=144 Identities=29% Similarity=0.445 Sum_probs=124.5
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHH---hcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLI---AKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
|...++||+|+||.||++... +++.||||.+++.. ....+.+..|++++ .+++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999865 58999999997542 22345566666554 567899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|||+++|+|..++.+ ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999988743 35899999999999999999999885 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=212.43 Aligned_cols=150 Identities=25% Similarity=0.358 Sum_probs=132.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|+..++||+|+||.||++... ++..+++|.+.... ......+.+|++++.+++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999976 57888999887542 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+++|+|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999954 235889999999999999999999753 59999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=206.09 Aligned_cols=145 Identities=32% Similarity=0.451 Sum_probs=127.0
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
||+|+||.||++... +++.+|+|++.+... +..+.+..|++++.+++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 688999999875422 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 475 DVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 475 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 98875432 3346899999999999999999999985 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=210.73 Aligned_cols=142 Identities=27% Similarity=0.423 Sum_probs=124.7
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+|+.. +++.||+|.+.+.. ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 47899999987542 23345678899998876 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+|..++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 9999888543 35899999999999999999999985 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=206.39 Aligned_cols=151 Identities=32% Similarity=0.604 Sum_probs=132.7
Q ss_pred CCCCcccccccCCcccEEEEEec-----CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-----~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 463 (558)
++|...+.||+|+||.||++..+ ++..|++|++........+.+.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778889999999999999742 5789999999877666677899999999999999999999987543 4689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|+||+++|+|.+++.+. ...++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999999643 345899999999999999999999884 999999999999999999999999999977
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
..+
T Consensus 159 ~~~ 161 (284)
T cd05081 159 PQD 161 (284)
T ss_pred cCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=203.65 Aligned_cols=148 Identities=30% Similarity=0.471 Sum_probs=131.9
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...+.||+|+||.||++..+++..+++|.+.... ...+++.+|+.++.+++||||+++++++..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999999888899999886443 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+|+|.+++.+. ...++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999998643 235899999999999999999999885 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=219.91 Aligned_cols=150 Identities=29% Similarity=0.411 Sum_probs=133.0
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.-|..++-||.|+-|.|-.|+. .+|+.+|||++.+.. ......+.+||.+|+-+.|||+++++++|+++.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3567788999999999999985 479999999997662 222456789999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|.|.+++.+ .+.|++.+..+++.||..|+.|+|.. +|+||||||+|+|||.++++||+|||+|.+-.++
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999954 45699999999999999999999987 4999999999999999999999999999875433
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=208.40 Aligned_cols=149 Identities=30% Similarity=0.477 Sum_probs=129.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999976 688999999875432 223467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|++ ++|.+++.+ ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 677777754 2345889999999999999999999985 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=212.21 Aligned_cols=141 Identities=24% Similarity=0.395 Sum_probs=125.1
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+++.. +++.||+|.+++.. ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999865 58899999997542 23355688999999998 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 999988854 245899999999999999999999885 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=207.42 Aligned_cols=149 Identities=24% Similarity=0.424 Sum_probs=130.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...+.||+|+||.||+++.. +++.|++|++.... ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888899999999999999976 57899999987542 2335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999987765542 2345899999999999999999999874 99999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=205.09 Aligned_cols=146 Identities=40% Similarity=0.655 Sum_probs=126.6
Q ss_pred cccccccCCcccEEEEEec-----CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 395 DENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~-----~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
..+.||+|.||.||+|.+. .+..|+||.++... .+..+.|.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999976 25689999996543 33478899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++|+|.++|... ....+++..++.|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||+++...
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999999764 2456899999999999999999999984 9999999999999999999999999999873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-23 Score=210.77 Aligned_cols=141 Identities=30% Similarity=0.418 Sum_probs=121.9
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHH-HHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+++.. +|+.+|+|++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 68999999987542 223345556655 56779999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 999988853 345899999999999999999999885 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=210.74 Aligned_cols=146 Identities=27% Similarity=0.375 Sum_probs=127.3
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCC-CeeeeeEEEEeCCEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 466 (558)
+|...+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777889999999999999875 47899999987542 23456788899999999764 5888999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 999999999988542 35899999999999999999999985 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=206.68 Aligned_cols=143 Identities=18% Similarity=0.343 Sum_probs=125.7
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccc---hHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCEEEEEEEcC
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYM 469 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~ 469 (558)
..|++|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999998654333 4678899999999999999999999977 35789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++|+|.+++.+ ...++|....+++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999954 245899999999999999999999742 478999999999999999999999999987543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=203.33 Aligned_cols=150 Identities=30% Similarity=0.492 Sum_probs=134.8
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.++|...+.||+|++|.||+|...+++.|++|.++... ...+++.+|+.++.+++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999987543 23567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++++|.+++.+.. ...++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999996533 346899999999999999999999885 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=210.19 Aligned_cols=141 Identities=32% Similarity=0.428 Sum_probs=121.7
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHH-HHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+.||+|+||.||+++.. +|+.||+|++.+.. .....++..|.. ++..++||||+++++.+.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 68999999987542 222344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999998854 345889999999999999999999985 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=204.96 Aligned_cols=152 Identities=35% Similarity=0.549 Sum_probs=138.0
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
..+|...++||+|+||.||+|...++..+++|.+..........+..|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45678889999999999999998889999999998776656678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.+. ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 999999999653 3456899999999999999999999885 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=209.53 Aligned_cols=142 Identities=30% Similarity=0.439 Sum_probs=122.4
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+++.. +++.||+|.++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 57889999987542 23344566677777654 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+|..++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 9999988542 35899999999999999999999975 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=202.77 Aligned_cols=149 Identities=34% Similarity=0.556 Sum_probs=132.3
Q ss_pred CCCCcccccccCCcccEEEEEecC----CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...+.||+|+||.||+|.+.. ...|+||.+.... .....+|.+|+.++.+++||||+++++.+.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998742 3579999887543 33356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|||+++++|.+++... ...++|..++.++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998643 236899999999999999999999874 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=209.55 Aligned_cols=147 Identities=26% Similarity=0.358 Sum_probs=127.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 466 (558)
+|...+.||+|+||.||+++.. +++.||+|.+.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777889999999999999866 57899999987542 22344567788888877 5899999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999888542 35899999999999999999999885 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=202.11 Aligned_cols=148 Identities=32% Similarity=0.495 Sum_probs=131.7
Q ss_pred CCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+|...+.||+|+||.||++...++..+++|.+.... ...++|.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466778999999999999998777789999887543 2346789999999999999999999999998899999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+|.+++.+.. ..++|..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 99999986432 36899999999999999999999885 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=215.21 Aligned_cols=153 Identities=31% Similarity=0.459 Sum_probs=131.0
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 461 (558)
.++|...++||+|+||.||+|++. .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345777889999999999999853 346899999976533 23457889999999997 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC----------------------------------------------------------
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 483 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 483 (558)
.++|+||+++|+|.+++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE
Q 008634 484 -------------------------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (558)
Q Consensus 484 -------------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl 526 (558)
...++|.....++.||+.||.|||+. +++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 12478888899999999999999987 49999999999999
Q ss_pred cCCCcEEEEecCcceeeCC
Q 008634 527 DDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 527 ~~~~~~ki~DFGla~~~~~ 545 (558)
++++.+||+|||+++.+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 273 CEGKLVKICDFGLARDIMR 291 (401)
T ss_pred eCCCEEEEEecCcceeccc
Confidence 9999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=209.37 Aligned_cols=141 Identities=28% Similarity=0.479 Sum_probs=124.3
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+++.. +++.||+|.+.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 58899999987542 23456678888888876 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999988543 35899999999999999999999885 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=203.02 Aligned_cols=143 Identities=31% Similarity=0.453 Sum_probs=123.0
Q ss_pred ccccCCcccEEEEEecC---CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 398 KLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~---g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
+||+|+||.||+|...+ ...+++|.+..... .....|.+|+..++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997543 34688888764432 334578899999999999999999999999999999999999999
Q ss_pred HHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 474 LDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 474 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|.+++.+... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999975432 233578888999999999999999884 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=202.27 Aligned_cols=150 Identities=34% Similarity=0.532 Sum_probs=134.3
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|+..++||+|+||.||+|...++..|++|.+.... ...+.+.+|+.++++++|+||+++++.+.+++..++|+||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5678889999999999999998888899999887543 235688999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++|.+++.+. ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999998653 3345899999999999999999999874 99999999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=205.10 Aligned_cols=151 Identities=31% Similarity=0.422 Sum_probs=131.8
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
+|+..++||+|+||.||++... +++.||+|++..... .....+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677789999999999999864 688999999875432 223457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++|+|.+++... ....+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++....+
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888643 2345899999999999999999999985 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=201.43 Aligned_cols=149 Identities=28% Similarity=0.456 Sum_probs=134.0
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||+|+. .+++.|++|++..........+.+|+.++.+++||||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788899999999999999996 46889999998766555566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999999854 235899999999999999999999874 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=209.32 Aligned_cols=141 Identities=32% Similarity=0.413 Sum_probs=120.8
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHH-HHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+++.. +++.||+|.+.+.. ......+..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 58899999987542 222344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999988853 345788888999999999999999874 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=211.68 Aligned_cols=160 Identities=28% Similarity=0.458 Sum_probs=139.1
Q ss_pred HcCCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCcc---chHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 463 (558)
..+.|...+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|.++. |||||.+.+.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45578888999999999999999764 999999999876543 3468999999999998 999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC----CcEEEEecCc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKISDFGL 539 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~----~~~ki~DFGl 539 (558)
+|||++.+|.|.+.+.+. .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999764 3999999999999999999999975 9999999999999643 4799999999
Q ss_pred ceeeCCCCCccCcccccCC
Q 008634 540 ARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 540 a~~~~~~~~~~~t~~~~Gt 558 (558)
|+....+. . ...++||
T Consensus 186 a~~~~~~~-~--~~~~~Gt 201 (382)
T KOG0032|consen 186 AKFIKPGE-R--LHTIVGT 201 (382)
T ss_pred ceEccCCc-e--EeeecCC
Confidence 99998722 2 2336665
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=218.04 Aligned_cols=146 Identities=23% Similarity=0.296 Sum_probs=127.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
...|.+.++||+|+||.||++... .++.|+||... ...+.+|++++++++|+|||++++++..++..++|+|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888999999999999999976 47889999543 23467899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+. ++|..++... ...++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 7888887542 336999999999999999999999885 9999999999999999999999999999875543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=203.95 Aligned_cols=153 Identities=31% Similarity=0.508 Sum_probs=131.7
Q ss_pred HcCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
.+++|+..++||+|+||.||+|... .+..|++|++.... .....++.+|+.++.+++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888999999999999998753 24679999986543 2345678999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
.++|+||+++|+|.+++.+... ...++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865322 234688999999999999999999874 999999999999999999999
Q ss_pred EecCcceeeC
Q 008634 535 SDFGLARIFG 544 (558)
Q Consensus 535 ~DFGla~~~~ 544 (558)
+|||+++...
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=214.41 Aligned_cols=141 Identities=24% Similarity=0.303 Sum_probs=125.5
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.+.|...++||+|+||.||++... +++.||+|+... +.+.+|++++++++||||+++++++..++..++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999865 688999997542 3568999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+. ++|..++.+. ..+++...+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 85 6888887542 35899999999999999999999985 999999999999999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=222.11 Aligned_cols=156 Identities=21% Similarity=0.306 Sum_probs=133.3
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ---- 460 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 460 (558)
...++|...++||+|+||.||+++.. +|+.||||.+... +......+.+|+..+..++|+|++++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999854 6899999998654 3344567889999999999999999988775432
Q ss_pred ----EEEEEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 008634 461 ----ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 461 ----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
..++||||+++|+|.+++.+.. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999986532 2346899999999999999999999874 9999999999999999999999
Q ss_pred ecCcceeeCCC
Q 008634 536 DFGLARIFGGN 546 (558)
Q Consensus 536 DFGla~~~~~~ 546 (558)
|||+++.+...
T Consensus 186 DFGls~~~~~~ 196 (496)
T PTZ00283 186 DFGFSKMYAAT 196 (496)
T ss_pred ecccCeecccc
Confidence 99999987644
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=209.56 Aligned_cols=147 Identities=26% Similarity=0.374 Sum_probs=127.3
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 466 (558)
+|...+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999865 68899999987542 233456788999998885 577888999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999998542 35899999999999999999999885 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-24 Score=207.08 Aligned_cols=158 Identities=31% Similarity=0.520 Sum_probs=138.2
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
-|.+.++||+|+||.|||+..+ .|+.||||++.-. .+++++..|+.+|.+++.|.+|+++|.+....++|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4566789999999999999876 5999999988644 457899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCCcc
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 550 (558)
-|+..+.+.- ++++|.+.+...++.+.++||+|||.. +-||||||+.||||+-+|.+||+|||.|-.+...-.+.
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999954 456799999999999999999999986 58999999999999999999999999998776443333
Q ss_pred CcccccCC
Q 008634 551 NTNIIAGT 558 (558)
Q Consensus 551 ~t~~~~Gt 558 (558)
+| +.||
T Consensus 187 NT--VIGT 192 (502)
T KOG0574|consen 187 NT--VIGT 192 (502)
T ss_pred Cc--cccC
Confidence 33 5665
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=208.87 Aligned_cols=141 Identities=26% Similarity=0.400 Sum_probs=125.0
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+++.. +++.+|+|++++.. ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57899999998642 23356688999999888 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999988853 235899999999999999999999985 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=210.12 Aligned_cols=146 Identities=26% Similarity=0.473 Sum_probs=125.7
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELL 463 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~ 463 (558)
+|...++||+|+||.||+|+.. ++..||||++... .......+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3677889999999999999965 6899999998743 223345788999999999999999999998653 2589
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||++ ++|.+++.. ...+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688888853 335899999999999999999999985 999999999999999999999999999865
Q ss_pred C
Q 008634 544 G 544 (558)
Q Consensus 544 ~ 544 (558)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=204.13 Aligned_cols=152 Identities=32% Similarity=0.598 Sum_probs=133.6
Q ss_pred CCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...+.||+|+||.||++... ++..+++|.+........+.+.+|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56788899999999999999742 345689999887665566789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 465 IYEYMPNKSLDVHLFDAT----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
|+||+++++|.+++.... ....++|..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2235899999999999999999999875 999999999999999999999
Q ss_pred EecCcceeeCC
Q 008634 535 SDFGLARIFGG 545 (558)
Q Consensus 535 ~DFGla~~~~~ 545 (558)
+|||+++....
T Consensus 162 ~dfg~~~~~~~ 172 (288)
T cd05093 162 GDFGMSRDVYS 172 (288)
T ss_pred ccCCccccccC
Confidence 99999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=200.97 Aligned_cols=145 Identities=33% Similarity=0.463 Sum_probs=124.9
Q ss_pred cccccCCcccEEEEEecC---CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 397 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~---g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
+.||+|+||.||+|...+ +..+++|+++.... .....+.+|+.++.+++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799998875543 33457899999999999999999999999999999999999999
Q ss_pred CHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 473 SLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 473 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+|.+++.+.. .....++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999996533 2235678888899999999999999875 9999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=207.15 Aligned_cols=141 Identities=29% Similarity=0.461 Sum_probs=123.0
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhc-CCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAK-LQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+.||+|+||.||+|+.. +++.||||.++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 47899999987642 2334556778888876 4999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999854 235889999999999999999999885 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=202.44 Aligned_cols=150 Identities=35% Similarity=0.539 Sum_probs=126.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCc----EEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...+.||+|+||.||+|... +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45777889999999999999864 344 478888764432 334678889999999999999999998754 56788
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++||+++|+|.+++.+. ...++|.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999643 346899999999999999999999875 9999999999999999999999999999775
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
.+
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=226.07 Aligned_cols=150 Identities=25% Similarity=0.365 Sum_probs=131.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+|+.. +++.||+|++..... ...++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999865 589999999975422 23467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 467 EYMPNKSLDVHLFDATR--------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
||+++|+|.+++..... ...+++...+.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 234677888999999999999999985 9999999999999999999999999
Q ss_pred cceee
Q 008634 539 LARIF 543 (558)
Q Consensus 539 la~~~ 543 (558)
+++..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99987
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=205.18 Aligned_cols=151 Identities=30% Similarity=0.482 Sum_probs=129.8
Q ss_pred CCCCcccccccCCcccEEEEEecC---------------CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD---------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLG 454 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~---------------g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g 454 (558)
++|...++||+|+||.||+++..+ ...|++|.+.... ......|.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987532 2358999987542 333567999999999999999999999
Q ss_pred EEEeCCEEEEEEEcCCCCCHHHHHhccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEE
Q 008634 455 CCLEGQELLLIYEYMPNKSLDVHLFDAT---------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525 (558)
Q Consensus 455 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NIL 525 (558)
++...+..++||||+++++|.+++.+.. ....++|..++.++.|++.||.|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999986432 1124789999999999999999999885 999999999999
Q ss_pred EcCCCcEEEEecCcceeeC
Q 008634 526 LDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 526 l~~~~~~ki~DFGla~~~~ 544 (558)
+++++.+||+|||+++...
T Consensus 162 l~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EcCCCcEEecccccccccc
Confidence 9999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=207.56 Aligned_cols=142 Identities=29% Similarity=0.362 Sum_probs=120.2
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHH-HHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEV-NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+.||+|+||.||+++.. +++.+|+|.+.+.. ......+..|. .++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 57889999987542 12233444444 456789999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+|.+++.+ ...+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999854 234778888889999999999999985 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=213.21 Aligned_cols=152 Identities=30% Similarity=0.488 Sum_probs=135.1
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
....|.+...||+|.|+.|..++.. ++.+||||.+.+.. ...++.+.+|+++|..++|||||+++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567888899999999999999865 58999999998763 33456689999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+.+|.+.++|.+.. .+.+.....++.|+.+|++|||.+. |+|||||++||||+.++++||+|||++.++..
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999996543 3555777889999999999999985 99999999999999999999999999999874
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
+
T Consensus 208 ~ 208 (596)
T KOG0586|consen 208 G 208 (596)
T ss_pred c
Confidence 4
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=207.25 Aligned_cols=141 Identities=30% Similarity=0.450 Sum_probs=123.1
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+++.. +|..||+|.+++.. ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 58899999987542 23345667788888754 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999998854 245889999999999999999999985 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=203.61 Aligned_cols=152 Identities=30% Similarity=0.547 Sum_probs=133.0
Q ss_pred CCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.+|...+.||+|+||.||+++.. ++..+++|.+........+.+.+|++.+++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677789999999999999742 345689999877666666789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc
Q 008634 465 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 531 (558)
||||+++++|.+++.... ....++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996432 1235899999999999999999999885 999999999999999999
Q ss_pred EEEEecCcceeeCC
Q 008634 532 PKISDFGLARIFGG 545 (558)
Q Consensus 532 ~ki~DFGla~~~~~ 545 (558)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=198.75 Aligned_cols=143 Identities=31% Similarity=0.525 Sum_probs=126.9
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
++||+|+||.||++... +++.+++|.+.... .+....+.+|++++.+++||||+++++++...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 68899999886543 33456799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
.+++... ...++|...+.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 9998542 345899999999999999999999885 9999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=199.16 Aligned_cols=147 Identities=31% Similarity=0.481 Sum_probs=131.1
Q ss_pred CCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+|...+.||+|+||.||++..+++..+++|.+.+... ..+++.+|+.++.+++||||+++++++...+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677889999999999999987777899998865432 345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++|.+++.... ..++|...+.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence 99999986432 36899999999999999999999985 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=203.35 Aligned_cols=150 Identities=26% Similarity=0.315 Sum_probs=133.4
Q ss_pred CCCcccccccCCcccEEEEEecC-CcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
+|...+.||.|.-|.||.+++++ +..+|+|++.+..- +...+...|-++|+.++||.++.|++.++.++..++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45667789999999999999875 58899999987643 335567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+||+|...+++ ...+.+++.....++.+|+.||+|||..| ||+|||||+||||-++|++-|+||.|+.....
T Consensus 158 yCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999988865 34566999999999999999999999886 99999999999999999999999999987643
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=200.22 Aligned_cols=149 Identities=30% Similarity=0.536 Sum_probs=125.4
Q ss_pred CcccccccCCcccEEEEEecC-Cc--EEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------CEE
Q 008634 394 SDENKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QEL 462 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~~-g~--~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 462 (558)
...++||+|+||.||+|+..+ +. .+++|.++.. .....+.+..|++++.+++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999764 32 5899988754 233456789999999999999999999988542 246
Q ss_pred EEEEEcCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 463 LLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
++++||+++|+|.+++.... ....++|.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874321 2345899999999999999999999874 99999999999999999999999999
Q ss_pred ceeeCC
Q 008634 540 ARIFGG 545 (558)
Q Consensus 540 a~~~~~ 545 (558)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=202.39 Aligned_cols=150 Identities=35% Similarity=0.516 Sum_probs=129.4
Q ss_pred CCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
+|...+.||+|+||.||+|+.. ....+++|.+..... ...+.+.+|+.++++++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 235789988875533 345678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 008634 465 IYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~N 523 (558)
|+||+++|+|.+++.... ....++|...+.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986422 1235889999999999999999999874 9999999999
Q ss_pred EEEcCCCcEEEEecCcceeeC
Q 008634 524 ILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 524 ILl~~~~~~ki~DFGla~~~~ 544 (558)
||+++++.+||+|||+++...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=201.15 Aligned_cols=150 Identities=37% Similarity=0.595 Sum_probs=130.6
Q ss_pred CCCcccccccCCcccEEEEEecC------CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~------g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
+|+..+.||+|+||.||+|.... ...|++|.+..... .....|.+|+..+.+++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778899999999999998643 25799999875432 335678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc
Q 008634 465 IYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 531 (558)
++||+++|+|.+++..... ...+++...+.++.||+.||.|||+.+ ++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999965321 145889999999999999999999985 999999999999999999
Q ss_pred EEEEecCcceeeC
Q 008634 532 PKISDFGLARIFG 544 (558)
Q Consensus 532 ~ki~DFGla~~~~ 544 (558)
+||+|||+++...
T Consensus 163 ~~L~dfg~~~~~~ 175 (283)
T cd05048 163 VKISDFGLSRDIY 175 (283)
T ss_pred EEECCCcceeecc
Confidence 9999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=211.36 Aligned_cols=148 Identities=28% Similarity=0.477 Sum_probs=128.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----EEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL 463 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 463 (558)
+|+..++||+|+||.||++... +++.||||++... .....+.+.+|++++..++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 6899999998754 2234567889999999999999999999998776 789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|+||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 577777743 345899999999999999999999985 999999999999999999999999999876
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
..+
T Consensus 154 ~~~ 156 (372)
T cd07853 154 EPD 156 (372)
T ss_pred ccC
Confidence 543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=201.55 Aligned_cols=151 Identities=32% Similarity=0.569 Sum_probs=132.7
Q ss_pred CCCCcccccccCCcccEEEEEecC------CcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~------g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
++|...+.||+|+||.||+|...+ +..|+||.+...... ..+.+.+|++++.+++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998632 478999998765444 4578999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 464 LIYEYMPNKSLDVHLFDAT-----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
+||||+++++|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996432 2345889999999999999999999885 9999999999999999999
Q ss_pred EEEecCcceeeC
Q 008634 533 KISDFGLARIFG 544 (558)
Q Consensus 533 ki~DFGla~~~~ 544 (558)
||+|||+++...
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=202.23 Aligned_cols=141 Identities=25% Similarity=0.385 Sum_probs=121.0
Q ss_pred ccccCCcccEEEEEecC-------------------------CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeee
Q 008634 398 KLGQGGFGPVYKGTLAD-------------------------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~-------------------------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 452 (558)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13589998876554445678999999999999999999
Q ss_pred eEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC--
Q 008634 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-- 530 (558)
Q Consensus 453 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-- 530 (558)
++++.++...++||||+++|+|..++.+ ....+++..+..++.||++||.|||+. +|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999854 234588999999999999999999987 499999999999997654
Q ss_pred -----cEEEEecCcceee
Q 008634 531 -----NPKISDFGLARIF 543 (558)
Q Consensus 531 -----~~ki~DFGla~~~ 543 (558)
.+|++|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=216.32 Aligned_cols=152 Identities=31% Similarity=0.535 Sum_probs=136.3
Q ss_pred CCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.+.....+||-|-||.||.|.++. ...||||.|+... -..++|+.|+.+|+.++|||+|+|+|+|......|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345566899999999999999875 5689999998654 34789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
..|+|.+||.+..+ ..++--..+.|+.||+.||+||..+ ++|||||.++|+|+.++..+||+||||+|++.+|.
T Consensus 346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 99999999987654 3477777889999999999999987 59999999999999999999999999999998775
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=209.12 Aligned_cols=152 Identities=30% Similarity=0.447 Sum_probs=128.8
Q ss_pred cCCCCcccccccCCcccEEEEEe------cCCcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC-C
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 460 (558)
.++|...++||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788899999999999999973 3467899999975432 3356788999999999 789999999988654 5
Q ss_pred EEEEEEEcCCCCCHHHHHhccCC---------------------------------------------------------
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 483 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 483 (558)
..++|+||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67999999999999999864211
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 484 -------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 484 -------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
...++|.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 124788899999999999999999885 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=200.42 Aligned_cols=151 Identities=31% Similarity=0.552 Sum_probs=131.7
Q ss_pred CCCCcccccccCCcccEEEEEec-C---CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-D---GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~---g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...+.||+|+||.||+|... + +..+++|.++... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999864 2 3479999987543 23356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++++|.+++.+. ...+++...+.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999643 345899999999999999999999885 99999999999999999999999999997754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=203.05 Aligned_cols=153 Identities=30% Similarity=0.479 Sum_probs=130.7
Q ss_pred HcCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
..++|.+.++||+|+||.||+|..+ .+..|++|.+..... .....+.+|+..+++++||||+++++++.+++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888999999999999999753 245799998865432 334568899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
.++||||+++|+|.+++.+... ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 234678888999999999999999874 999999999999999999999
Q ss_pred EecCcceeeC
Q 008634 535 SDFGLARIFG 544 (558)
Q Consensus 535 ~DFGla~~~~ 544 (558)
+|||+++...
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=198.62 Aligned_cols=155 Identities=27% Similarity=0.404 Sum_probs=134.6
Q ss_pred HHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 387 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
+.+++++.....||+|+||.||+|+.. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345667777789999999999999865 5788999998877666677899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecCcceeeC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFG 544 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~~~ 544 (558)
+||+++++|.+++.+.......++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999965332222378888999999999999999874 999999999999976 6799999999998764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=205.90 Aligned_cols=141 Identities=31% Similarity=0.469 Sum_probs=124.7
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+.||+|+||.||+++.. ++..||+|.+.+.. ....+.+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 47899999997542 33456678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+|..++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999888543 35899999999999999999999884 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=203.96 Aligned_cols=148 Identities=28% Similarity=0.489 Sum_probs=128.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|...++||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++.+++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999865 578899999875432 2344678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++ +|.+++.+. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 788777543 335789999999999999999999885 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=196.28 Aligned_cols=143 Identities=34% Similarity=0.526 Sum_probs=127.8
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHH
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 475 (558)
++||+|+||.||+|...+++.+++|.+...... ....+.+|++++.+++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999998765433 2456889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++... ...++|..+..++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 998542 345899999999999999999999875 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=201.18 Aligned_cols=151 Identities=29% Similarity=0.514 Sum_probs=123.8
Q ss_pred CCCCcccccccCCcccEEEEEec--CCcEEEEEEccccCc--cchHHHHHHHHHHhcC---CCCCeeeeeEEEEe-----
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLE----- 458 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~--~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----- 458 (558)
++|...++||+|+||.||+++.. +++.||+|++..... .....+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36788899999999999999863 468899998865432 2234566777766655 69999999999863
Q ss_pred CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 459 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
....++|+||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 68988886432 345899999999999999999999985 9999999999999999999999999
Q ss_pred cceeeCCC
Q 008634 539 LARIFGGN 546 (558)
Q Consensus 539 la~~~~~~ 546 (558)
+++.....
T Consensus 156 ~~~~~~~~ 163 (290)
T cd07862 156 LARIYSFQ 163 (290)
T ss_pred ceEeccCC
Confidence 99876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=198.30 Aligned_cols=150 Identities=29% Similarity=0.512 Sum_probs=128.3
Q ss_pred CCcccccccCCcccEEEEEecC----CcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE-----
Q 008634 393 FSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 461 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 461 (558)
|.+.+.||+|+||.||+|.... +..||+|+++... ....+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998642 3679999987542 3345679999999999999999999999876554
Q ss_pred -EEEEEEcCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 008634 462 -LLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (558)
Q Consensus 462 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DF 537 (558)
.++|+||+++|+|..++.... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999986432 2346899999999999999999999874 999999999999999999999999
Q ss_pred CcceeeCC
Q 008634 538 GLARIFGG 545 (558)
Q Consensus 538 Gla~~~~~ 545 (558)
|+++....
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99997643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=203.52 Aligned_cols=149 Identities=28% Similarity=0.344 Sum_probs=131.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|...++||+|+||.||++... ++..+++|.+.... .....++.+|++++.+++||||+++++.+.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999865 57888999886542 23345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++++|.+++.+. ..+++.....++.||++||.|||+.. +++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999643 45899999999999999999999742 59999999999999999999999999988653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=203.87 Aligned_cols=153 Identities=32% Similarity=0.519 Sum_probs=131.9
Q ss_pred cCCCCcccccccCCcccEEEEEec--------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (558)
.++|...+.||+|+||.||+++.. ++..|++|.+.... ....+++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456778899999999999999731 24579999887543 34457789999999999 899999999999999
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl 526 (558)
...++||||+++|+|.+++.+... ...++|..+..++.||+.||.|||+.+ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999975321 235889999999999999999999885 9999999999999
Q ss_pred cCCCcEEEEecCcceeeCC
Q 008634 527 DDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 527 ~~~~~~ki~DFGla~~~~~ 545 (558)
+.++.+||+|||+++....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=216.83 Aligned_cols=150 Identities=33% Similarity=0.525 Sum_probs=129.1
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.|++.+.||.|+||.||.++.. +...||||++.-. +...+++++.|+..|.+++|||.+.+.|++......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4667788999999999999854 6789999999744 33447889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
||-| +-.+++.- ..++|.+-.+..|..+.+.||.|||++. .||||||+.||||++.+.|||+|||-|.+..+-.
T Consensus 107 YClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 107 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred HHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 9964 55555532 2345888889999999999999999985 9999999999999999999999999998876543
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=202.45 Aligned_cols=152 Identities=30% Similarity=0.505 Sum_probs=131.1
Q ss_pred CCCCcccccccCCcccEEEEEec-----------------CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeee
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-----------------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRL 452 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-----------------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 452 (558)
++|+..++||+|+||.||++... ++..|++|++.... ....+++.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998532 23468999987543 3345689999999999999999999
Q ss_pred eEEEEeCCEEEEEEEcCCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 008634 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATR--------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (558)
Q Consensus 453 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NI 524 (558)
++++..++..++||||+++|+|.+++.+... ...+++.....++.||+.||.|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999875321 134788999999999999999999885 99999999999
Q ss_pred EEcCCCcEEEEecCcceeeCC
Q 008634 525 LLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 525 Ll~~~~~~ki~DFGla~~~~~ 545 (558)
|++.++.+||+|||+++.+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred EEcCCCCEEeccCcccccccC
Confidence 999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-23 Score=175.88 Aligned_cols=99 Identities=32% Similarity=0.646 Sum_probs=76.5
Q ss_pred cccCC---CCcc-CCCChHHHHHHHHHhhHhhhhcc-C--CCceeeccCCCCCcEEEEEecCCCCChhchHHHHHHHHHH
Q 008634 75 VLSCA---VSNN-TASNTFTSNLNILFNQKLHSEAG-K--SLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147 (558)
Q Consensus 75 ~~~C~---~~~~-~~~s~f~~nl~~l~~~~l~~~a~-~--~~f~~~~~g~~~~~vygl~qC~~Dl~~~~C~~Cl~~a~~~ 147 (558)
|..|+ +.+| +++++|++||+.||+. |.+.++ . .+|+++..|.++++|||++||++|+++.||..||+.|+..
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~-l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSS-LVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHH-HHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHH-HHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 45688 3366 6788899999999999 888877 3 4799998899999999999999999999999999999999
Q ss_pred HHhhCCCCccEEEEeecCceEEEEccCCC
Q 008634 148 VLQKCSGTKEAFIWYQVQECMVRFSDHSS 176 (558)
Q Consensus 148 ~~~~C~~~~~a~i~~~~~~C~lrY~~~~f 176 (558)
+...|+.+++|+||++ +|+||||+++|
T Consensus 80 ~~~~C~~~~g~~v~~~--~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYD--SCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEES--SEEEEEESS--
T ss_pred HHHhCCCCceEEEECC--CEEEEEECCCC
Confidence 9999999999999999 99999999986
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=207.81 Aligned_cols=153 Identities=31% Similarity=0.460 Sum_probs=129.1
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC-C
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 460 (558)
.++|.+.++||+|+||.||+|... +++.|++|++..... ...+.+..|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346888899999999999999632 357899999875432 3345688899999999 899999999988754 5
Q ss_pred EEEEEEEcCCCCCHHHHHhccCC---------------------------------------------------------
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 483 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 483 (558)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999999864221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 484 -SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 484 -~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
...++|..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 125899999999999999999999874 99999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=200.34 Aligned_cols=152 Identities=34% Similarity=0.562 Sum_probs=133.0
Q ss_pred CCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.+|...++||+|+||.||++... ++..+++|.+........+.+.+|++++.+++|+||+++++++.+++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35677889999999999999632 356899999887666667789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 465 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
++||+++++|.+++..... ...++|..++.++.||+.||.|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 135899999999999999999999875 9999999999999999999
Q ss_pred EEEecCcceeeCC
Q 008634 533 KISDFGLARIFGG 545 (558)
Q Consensus 533 ki~DFGla~~~~~ 545 (558)
||+|||+++....
T Consensus 162 kL~dfg~~~~~~~ 174 (280)
T cd05092 162 KIGDFGMSRDIYS 174 (280)
T ss_pred EECCCCceeEcCC
Confidence 9999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=202.54 Aligned_cols=154 Identities=32% Similarity=0.510 Sum_probs=133.0
Q ss_pred HcCCCCcccccccCCcccEEEEEecC------CcEEEEEEcccc-CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~------g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (558)
..++|...+.||+|+||.||++...+ ...+++|.+... ..+...++.+|+.++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34567888899999999999998642 367899988754 233456788999999999 8999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
..+++|||+++|+|..++... .....++|..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 22346899999999999999999999874 99999999999999
Q ss_pred CCCcEEEEecCcceeeCC
Q 008634 528 DDMNPKISDFGLARIFGG 545 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~~ 545 (558)
+++.+||+|||+++.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 167 EDHVMKIADFGLARDIHH 184 (293)
T ss_pred CCCeEEeCcccccccccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=200.62 Aligned_cols=152 Identities=32% Similarity=0.491 Sum_probs=132.0
Q ss_pred cCCCCcccccccCCcccEEEEEecC-----------------CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeee
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVR 451 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~-----------------g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 451 (558)
.++|...++||+|+||.||++...+ +..|++|.+.... ....+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999987542 2468999987553 334678899999999999999999
Q ss_pred eeEEEEeCCEEEEEEEcCCCCCHHHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 008634 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDAT--------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (558)
Q Consensus 452 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~N 523 (558)
+++++..++..++|+||+++++|.+++.+.. ....+++...+.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999996533 1235899999999999999999999874 9999999999
Q ss_pred EEEcCCCcEEEEecCcceeeC
Q 008634 524 ILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 524 ILl~~~~~~ki~DFGla~~~~ 544 (558)
|+++.++.+||+|||+++...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=200.04 Aligned_cols=153 Identities=29% Similarity=0.463 Sum_probs=132.2
Q ss_pred cCCCCcccccccCCcccEEEEEecC------CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~------g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
.++|...+.||+|+||.||+|...+ +..|++|.+.... ......+.+|+.++..++||||+++++++..++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567888999999999999998642 3689999987553 23456789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 008634 463 LLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234789999999999999999999874 9999999999999999999999
Q ss_pred ecCcceeeCC
Q 008634 536 DFGLARIFGG 545 (558)
Q Consensus 536 DFGla~~~~~ 545 (558)
|||+++....
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=205.94 Aligned_cols=140 Identities=28% Similarity=0.377 Sum_probs=120.3
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC---CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
||+|+||.||+++.. +++.||||++.+.. ......+..|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 58999999986542 12234455677776665 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 999988854 345899999999999999999999985 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=197.14 Aligned_cols=149 Identities=34% Similarity=0.565 Sum_probs=133.9
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.++|...+.||+|+||.||++... |+.|++|.+..... ..+++.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 346788899999999999999875 78999999976644 5678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++++|.+++.... ...++|..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999986432 236899999999999999999999885 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=199.19 Aligned_cols=147 Identities=30% Similarity=0.494 Sum_probs=131.5
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
|+..++||+|+||.||++... ++..+++|.+.....+..+.+.+|++++..++|||++++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999976 4778899998766666677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++|..++.+ ....++|..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999988854 2346899999999999999999999985 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-23 Score=183.90 Aligned_cols=149 Identities=30% Similarity=0.497 Sum_probs=127.8
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...++||+|.+|+|+||+.. +++.||+|++.-.+ ..--...++||.+++.++|+|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999965 57889999887443 22245678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|.. +|..+... -.+.++.+....++.|+.+||.|+|++ ++.||||||.|.||+.+|+.|++|||+||-++-.
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 964 66666632 345689999999999999999999998 4999999999999999999999999999987644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=231.76 Aligned_cols=142 Identities=30% Similarity=0.554 Sum_probs=123.7
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
..+...+.||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||+++|++.+++..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999997 47899999998754332 235688999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
++|+|.++++ .++|..+.+|+.||++||.|||..+..+|+||||||+||+++.++.+++. ||+....
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999994 28999999999999999999997766689999999999999999988876 6666544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-23 Score=200.89 Aligned_cols=150 Identities=29% Similarity=0.490 Sum_probs=129.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccc--cCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe-----CCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-----GQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~ 461 (558)
...|...+.||+|.+|.|+.+..+ +|..||||++.+ ......++-.+|+++|+.++|+||+.+++.+.. -.+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555678999999999999865 689999999984 344556788999999999999999999999865 357
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.|+|+|+| ..+|...++. +..|+......++.||++||.|+|+. +|+||||||+|+|++.+...||+||||||
T Consensus 101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 99999999 6688888743 33489999999999999999999998 49999999999999999999999999999
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
....+
T Consensus 174 ~~~~~ 178 (359)
T KOG0660|consen 174 YLDKF 178 (359)
T ss_pred ecccc
Confidence 98654
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=198.63 Aligned_cols=150 Identities=31% Similarity=0.525 Sum_probs=132.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.+|...++||+|+||.||+|... +++.|++|.+... ....+++.+|++++.+++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34677889999999999999865 4888999988754 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++... ....+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999998643 2345899999999999999999999875 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-23 Score=194.45 Aligned_cols=154 Identities=31% Similarity=0.480 Sum_probs=133.2
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC----ccc----hHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS----GQG----LQEFKNEVNLIAKL-QHKNLVRLLGCCLE 458 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~----~~~----~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 458 (558)
.-+.|...+.||.|..+.|-+...+ +|.+.++|++.... +.. ++.-+.|+.+|+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456777789999999999888754 68899999886431 111 34567899999998 69999999999999
Q ss_pred CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 459 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
+...++|+|.|+.|.|.++|. ....++++...+|+.|+.+|+.|||.. +||||||||+|||+|+++++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999994 345699999999999999999999998 59999999999999999999999999
Q ss_pred cceeeCCCCC
Q 008634 539 LARIFGGNQN 548 (558)
Q Consensus 539 la~~~~~~~~ 548 (558)
+|..+..+..
T Consensus 169 Fa~~l~~Gek 178 (411)
T KOG0599|consen 169 FACQLEPGEK 178 (411)
T ss_pred eeeccCCchh
Confidence 9999987664
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=199.29 Aligned_cols=149 Identities=32% Similarity=0.559 Sum_probs=131.1
Q ss_pred CCCcccccccCCcccEEEEEecC-C---cEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~-g---~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.|...+.||+|+||.||+|.... + ..|+||.+... ......+|..|+.++++++||||+++++++.+++..++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998753 3 36999998754 3344578999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998643 346899999999999999999999875 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=199.95 Aligned_cols=153 Identities=27% Similarity=0.464 Sum_probs=133.1
Q ss_pred cCCCCcccccccCCcccEEEEEecC-----CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 462 (558)
.++|...+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++.+++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999765 6889999887543 3345678999999999999999999999876 4678
Q ss_pred EEEEEcCCCCCHHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 008634 463 LLIYEYMPNKSLDVHLFDATRS-----VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DF 537 (558)
++++||+++|+|.+++...... ..+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 46899999999999999999999874 999999999999999999999999
Q ss_pred CcceeeCC
Q 008634 538 GLARIFGG 545 (558)
Q Consensus 538 Gla~~~~~ 545 (558)
|+++.+..
T Consensus 162 g~~~~~~~ 169 (280)
T cd05043 162 ALSRDLFP 169 (280)
T ss_pred CCcccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=223.48 Aligned_cols=149 Identities=26% Similarity=0.400 Sum_probs=132.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|.+.++||+|+||.||+|... +++.||||++.... ......+..|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999976 68899999987543 223467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++++|.+++... ..+++...+.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999998542 35889999999999999999999874 99999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=198.57 Aligned_cols=148 Identities=26% Similarity=0.467 Sum_probs=132.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|...++||+|+||.||+++.. +++.|++|.++.........+.+|+.++..++||||+++++.+..++..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999864 58899999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999999854 335899999999999999999999985 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=201.03 Aligned_cols=152 Identities=24% Similarity=0.421 Sum_probs=133.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..+.||+|+||.||++... ++..|++|.+... .......+.+|+.++.+++|+||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35777889999999999999976 6889999988654 333356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++++|..++........+++..+..++.+|+.||.|||+.. +++|+||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999999865433446899999999999999999999742 59999999999999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=196.70 Aligned_cols=142 Identities=27% Similarity=0.468 Sum_probs=122.8
Q ss_pred cccccCCcccEEEEEecCCc-----------EEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLADGK-----------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~-----------~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976432 5778877654433 5788999999999999999999999988 788999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-------cEEEEecC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-------NPKISDFG 538 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-------~~ki~DFG 538 (558)
+||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999996533 26899999999999999999999874 99999999999999888 79999999
Q ss_pred cceeeCC
Q 008634 539 LARIFGG 545 (558)
Q Consensus 539 la~~~~~ 545 (558)
+++....
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=194.89 Aligned_cols=151 Identities=30% Similarity=0.453 Sum_probs=133.9
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...+.||+|++|.||++... +++.|++|.+... .....+.+.+|++++++++|||++++++.+.+++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999875 5889999988643 334567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++... ....+++.....++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999753 2356899999999999999999999874 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=197.29 Aligned_cols=152 Identities=24% Similarity=0.439 Sum_probs=133.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+|+.. +++.|+||.+... ..+....+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999865 6899999987643 2233457899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.... +...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345889999999999999999999874 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=200.65 Aligned_cols=150 Identities=34% Similarity=0.501 Sum_probs=129.0
Q ss_pred CCCcccccccCCcccEEEEEec------CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
+|...++||+|+||.||+|... ++..|++|++...... ..+.+..|+.++.+++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556778999999999999853 2478999999855433 24568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc
Q 008634 465 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 531 (558)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235889999999999999999999885 999999999999999999
Q ss_pred EEEEecCcceeeC
Q 008634 532 PKISDFGLARIFG 544 (558)
Q Consensus 532 ~ki~DFGla~~~~ 544 (558)
+||+|||+++...
T Consensus 163 ~kl~Dfg~~~~~~ 175 (283)
T cd05091 163 VKISDLGLFREVY 175 (283)
T ss_pred eEecccccccccc
Confidence 9999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.5e-22 Score=197.63 Aligned_cols=144 Identities=31% Similarity=0.437 Sum_probs=124.8
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
||+|+||.||+++.+ +|+.+++|.+..... .....+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 589999999864321 2234556799999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9888543 2345899999999999999999999874 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=198.81 Aligned_cols=142 Identities=27% Similarity=0.439 Sum_probs=121.2
Q ss_pred ccccCCcccEEEEEecCC---cEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 398 KLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~g---~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
+||+|+||.||+++..++ ..+++|.+.... .+..+.|.+|+..+..++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975443 345677666443 3345689999999999999999999999999999999999999999
Q ss_pred HHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 474 LDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 474 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
|.+++.+... ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999975322 234677778899999999999999874 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=197.57 Aligned_cols=150 Identities=34% Similarity=0.607 Sum_probs=132.0
Q ss_pred CCCCcccccccCCcccEEEEEecC-C---cEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g---~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...+.||+|+||.||+|+... + ..+++|++.... ....+++.+|++++.+++|+|++++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999998752 3 379999987553 33456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++++|.+++.+. ...++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998642 346899999999999999999999874 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=197.07 Aligned_cols=149 Identities=33% Similarity=0.516 Sum_probs=130.1
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...++||+|+||.||+|+..+...|++|++..... ..+.+.+|+.++.+++||||+++++.+.+ +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46888899999999999999987777899999975432 34678999999999999999999998754 56899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+|+|.+++.+. ....++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 99999999643 2345899999999999999999999875 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=194.95 Aligned_cols=152 Identities=25% Similarity=0.456 Sum_probs=134.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+|... +|+.|++|.++.. +....+.+.+|++++++++|+|++++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 7899999988643 2333567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|..++.+.. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2345899999999999999999999875 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=195.93 Aligned_cols=151 Identities=35% Similarity=0.556 Sum_probs=135.2
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.++|...++||+|+||.||++...+++.|+||.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888899999999999999988888999999875432 3567899999999999999999999999989999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.+. ....+++..+..++.+|+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999653 2346899999999999999999999885 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=198.58 Aligned_cols=153 Identities=28% Similarity=0.503 Sum_probs=132.0
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC------
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG------ 459 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------ 459 (558)
.+++.|...+.||+|+||.||+|... +++.|++|.+.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35667888899999999999999865 57889999886543 3446788999999998 799999999998763
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
...++||||+++++|.+++... ....++|.....++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999998653 3346899999999999999999999984 99999999999999999999999999
Q ss_pred ceeeCC
Q 008634 540 ARIFGG 545 (558)
Q Consensus 540 a~~~~~ 545 (558)
++....
T Consensus 158 ~~~~~~ 163 (272)
T cd06637 158 SAQLDR 163 (272)
T ss_pred ceeccc
Confidence 987643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=203.14 Aligned_cols=150 Identities=34% Similarity=0.574 Sum_probs=129.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCc--EEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGK--AIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~--~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (558)
++|+..+.||+|+||.||+|... ++. .+++|++.... ......+.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999865 343 46888776543 33456788999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 466 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
+||+++|+|.+++.+.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999997532 1235899999999999999999999874 9999999999999999999
Q ss_pred EEEecCcceee
Q 008634 533 KISDFGLARIF 543 (558)
Q Consensus 533 ki~DFGla~~~ 543 (558)
||+|||+++..
T Consensus 164 kl~dfg~~~~~ 174 (303)
T cd05088 164 KIADFGLSRGQ 174 (303)
T ss_pred EeCccccCccc
Confidence 99999999743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=197.31 Aligned_cols=143 Identities=23% Similarity=0.375 Sum_probs=123.3
Q ss_pred cccccCCcccEEEEEecC-------------CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 397 NKLGQGGFGPVYKGTLAD-------------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~-------------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
+.||+|+||.||+|.... ...|++|.+..........|.+|+.++..++||||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899887655555567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc-------EEEEe
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-------PKISD 536 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~-------~ki~D 536 (558)
+|+||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988542 345899999999999999999999874 999999999999987664 89999
Q ss_pred cCcceeeC
Q 008634 537 FGLARIFG 544 (558)
Q Consensus 537 FGla~~~~ 544 (558)
||++....
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99998664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=202.61 Aligned_cols=151 Identities=34% Similarity=0.512 Sum_probs=131.2
Q ss_pred CCCCcccccccCCcccEEEEEec--------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (558)
++|...++||+|+||.||++... +...+++|.+.... .....++.+|+.++.++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999999742 23469999987543 34456788999999999 7999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
..++|+||+++|+|.+++..... ...++|.+++.++.||+.||.|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999975322 235899999999999999999999874 99999999999999
Q ss_pred CCCcEEEEecCcceeeC
Q 008634 528 DDMNPKISDFGLARIFG 544 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~ 544 (558)
.++.+||+|||+++...
T Consensus 175 ~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 175 EDNVMKIADFGLARDIH 191 (307)
T ss_pred CCCcEEECCCccccccc
Confidence 99999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=200.38 Aligned_cols=149 Identities=28% Similarity=0.464 Sum_probs=134.2
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.+|...++||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999996 468999999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....+
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999843 34789999999999999999999874 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-22 Score=195.41 Aligned_cols=143 Identities=29% Similarity=0.543 Sum_probs=123.7
Q ss_pred ccccCCcccEEEEEec---CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 398 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
.||+|+||.||+|.+. .+..|++|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355799999876543 33467999999999999999999999886 457899999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|.+++.. ....+++..+++++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999854 2346899999999999999999999885 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=201.45 Aligned_cols=150 Identities=32% Similarity=0.551 Sum_probs=129.3
Q ss_pred CCCCcccccccCCcccEEEEEecC-C--cEEEEEEcccc-CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-G--KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g--~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (558)
++|+..+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568888999999999999998754 3 35788888753 334456789999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 466 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
+||+++|+|.+++.+.. ....+++.....++.||+.||.|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1135889999999999999999999874 9999999999999999999
Q ss_pred EEEecCcceee
Q 008634 533 KISDFGLARIF 543 (558)
Q Consensus 533 ki~DFGla~~~ 543 (558)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=200.36 Aligned_cols=148 Identities=26% Similarity=0.461 Sum_probs=133.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.+|...+.||+|+||.||+|... +++.|++|.+........+.+.+|+.++..++|+||+++++.+..++..++|+||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46788889999999999999854 68899999998766556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.+ ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999843 34789999999999999999999885 99999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=199.24 Aligned_cols=150 Identities=31% Similarity=0.554 Sum_probs=130.2
Q ss_pred CCCCcccccccCCcccEEEEEe-----cCCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (558)
..|...++||+|+||.||++.. .++..|++|.+.... ......+.+|+.++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999974 247889999987553 33356789999999999999999999999875 568
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++++|.+++.+. ...++|..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998543 235899999999999999999999885 99999999999999999999999999987
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-22 Score=198.76 Aligned_cols=148 Identities=31% Similarity=0.420 Sum_probs=129.7
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
|...++||+|+||.||++... +++.+|+|.+..... .....+.+|++++.+++|+|++++.+.+..++..++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999865 688999999875422 2234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++++|.+++.... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998886432 345999999999999999999999875 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=197.65 Aligned_cols=149 Identities=34% Similarity=0.572 Sum_probs=130.7
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...+.||+|++|.||+|+.. ++..|++|++.... ....+.+.+|+.++.+++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999975 68899999986442 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++ ++|.+++........+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888865444467999999999999999999999874 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=199.48 Aligned_cols=150 Identities=28% Similarity=0.460 Sum_probs=134.9
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||++... ++..+++|.+........+.+..|++++.+++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999975 5889999998766666667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++++|.+++.+. ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999998543 235899999999999999999999985 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=193.85 Aligned_cols=147 Identities=40% Similarity=0.615 Sum_probs=131.2
Q ss_pred cccccCCcccEEEEEecC----CcEEEEEEccccCccc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||++.... +..|++|.+....... .+.+.+|++.+.+++|+|++++++++.+....++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 7889999998664433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 472 KSLDVHLFDATR------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 472 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++|.+++.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999975421 356999999999999999999999975 99999999999999999999999999998765
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=210.13 Aligned_cols=146 Identities=23% Similarity=0.347 Sum_probs=127.2
Q ss_pred cCCCCcccccccCCcccEEEEEec---CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
...|...++||+|+||.||++... .+..|++|.+... +.+.+|++++.+++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457899999999999999999753 3578999988653 23568999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|++. ++|.+++. ....++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 67888883 2346899999999999999999999885 999999999999999999999999999877544
Q ss_pred C
Q 008634 547 Q 547 (558)
Q Consensus 547 ~ 547 (558)
.
T Consensus 239 ~ 239 (392)
T PHA03207 239 P 239 (392)
T ss_pred c
Confidence 3
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=198.05 Aligned_cols=150 Identities=31% Similarity=0.475 Sum_probs=131.7
Q ss_pred CCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
++|+..++||+|+||.||+++.. +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788889999999999999854 2467999988765443 4578999999999999999999999999989999
Q ss_pred EEEEcCCCCCHHHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 008634 464 LIYEYMPNKSLDVHLFDATRS------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DF 537 (558)
+|+||+++|+|.+++...... ..++|..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654322 25899999999999999999999885 999999999999999999999999
Q ss_pred Ccceee
Q 008634 538 GLARIF 543 (558)
Q Consensus 538 Gla~~~ 543 (558)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=196.47 Aligned_cols=145 Identities=24% Similarity=0.383 Sum_probs=127.9
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..++||+|+||.||++.. .++..|++|.+... ......++.+|+.++.+++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577788999999999999986 46889999998654 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999997553 3688889999999999999999885 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=201.73 Aligned_cols=153 Identities=34% Similarity=0.472 Sum_probs=132.5
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (558)
.++|...++||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888899999999999999741 24579999987553 33356789999999999 79999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++|+||+++|+|.+++.+.. ...+++.++..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999996432 234899999999999999999999874 9999999999999999999999999998
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.+...
T Consensus 190 ~~~~~ 194 (302)
T cd05055 190 DIMND 194 (302)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=198.57 Aligned_cols=149 Identities=31% Similarity=0.491 Sum_probs=134.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+.|...++||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+|++++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56788889999999999999975 48899999998776666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++++|..++.+. ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999998887542 245899999999999999999999874 9999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=199.10 Aligned_cols=150 Identities=32% Similarity=0.458 Sum_probs=133.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||++... +++.+++|.+.+.. .+..+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46788899999999999999875 58899999987542 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 45899999999999999999999974 999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=197.68 Aligned_cols=150 Identities=31% Similarity=0.431 Sum_probs=130.4
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
|+..++||+|+||.||++... +++.+++|.+..... +....+.+|+.++.+++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999865 688999999875432 2234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.....+
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999885432 34589999999999999999999987 4999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=194.97 Aligned_cols=150 Identities=33% Similarity=0.527 Sum_probs=131.4
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|+..++||+|+||.||++...++..+++|.+..... ..+.+.+|+.++.+++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 45777889999999999999988888899999876433 3467899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++|.+++.+. ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..+
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999998653 2345899999999999999999999885 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=197.03 Aligned_cols=151 Identities=32% Similarity=0.521 Sum_probs=129.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCc----EEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
.++|...++||+|+||.||+|+.. +++ .||+|.++... .....++.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356788899999999999999853 444 48999987543 33456789999999999999999999998754 578
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+++||+++|+|.+++.+. ...+++...+.++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998642 345899999999999999999999884 999999999999999999999999999987
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
...
T Consensus 160 ~~~ 162 (279)
T cd05109 160 DID 162 (279)
T ss_pred ccc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-23 Score=213.15 Aligned_cols=157 Identities=29% Similarity=0.471 Sum_probs=131.1
Q ss_pred CcccccccCCcccEEEEEec-CCcEEEEEEccc----cCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE--EEEEE
Q 008634 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR----TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE--LLLIY 466 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~----~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~ 466 (558)
...++||+|.|.+||||... +|.+||--.++. .++..++.|..|+.+|+.|+||||++++..|.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999975 477776443331 245567899999999999999999999999988654 88999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DFGla~~~~~ 545 (558)
|.+..|+|..|+.+.+ .++.+....++.||++||.|||++. +||||||||-+||+|+ .-|.|||+|+|||++...
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999996543 4888899999999999999999984 7899999999999997 568999999999998865
Q ss_pred CCCccCcccccCC
Q 008634 546 NQNQANTNIIAGT 558 (558)
Q Consensus 546 ~~~~~~t~~~~Gt 558 (558)
.... .++||
T Consensus 199 s~ak----svIGT 207 (632)
T KOG0584|consen 199 SHAK----SVIGT 207 (632)
T ss_pred cccc----eeccC
Confidence 4432 36776
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=194.55 Aligned_cols=149 Identities=32% Similarity=0.535 Sum_probs=131.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-----QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...+.||+|++|.||++... +++++++|.+..... ...+.+.+|++++.+++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999864 589999998864321 224578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+||+++++|.+++.+. ..+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988542 35889999999999999999999885 9999999999999999999999999998764
Q ss_pred C
Q 008634 545 G 545 (558)
Q Consensus 545 ~ 545 (558)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=194.29 Aligned_cols=149 Identities=33% Similarity=0.509 Sum_probs=129.7
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
+.|...++||+|++|.||++...++..+++|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3577788999999999999998777789999886543 23467899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+|+|.+++.+. ....++|..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999999653 2345899999999999999999999874 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=197.12 Aligned_cols=152 Identities=24% Similarity=0.435 Sum_probs=133.3
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||++.. .+++.++||.+.... ....+++.+|+.++..++|+||+++++++.+++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788999999999999995 478999999886532 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++++|.+++.... ....++|.....++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2346899999999999999999999885 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=196.56 Aligned_cols=150 Identities=27% Similarity=0.451 Sum_probs=131.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|+..+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.++.+++|+|++++++++..++..++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788889999999999999976 58899999886442 2234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++++|..++.. ...++|..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999999887643 335899999999999999999999974 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=197.23 Aligned_cols=145 Identities=33% Similarity=0.551 Sum_probs=128.4
Q ss_pred CCcccccccCCcccEEEEEecC-CcEEEEEEccccCccch--HHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~--~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
|+..+.||+|+||.||++.... ++.+|+|.+........ .....|+.++.+++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4456889999999999999764 67899999987654332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
++++|.+++. ....+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999996 2345899999999999999999999985 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=194.43 Aligned_cols=149 Identities=35% Similarity=0.548 Sum_probs=131.9
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.+.|...++||+|+||.||++..++++.|++|.+..... ....+.+|+.++++++|+|++++++++. .+..++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356788899999999999999988899999999875443 3467899999999999999999999864 45789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999998643 3456899999999999999999999874 9999999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=194.18 Aligned_cols=144 Identities=36% Similarity=0.516 Sum_probs=128.3
Q ss_pred cccccCCcccEEEEEecC--C--cEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~--g--~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|++|.||+|.+.+ + ..|++|.+..... ...+.+.+|+..+.+++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999987665 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++|.+++.+... ..++|...+.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999976432 56899999999999999999999884 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=198.21 Aligned_cols=152 Identities=33% Similarity=0.579 Sum_probs=132.4
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
.++|...+.||+|+||.||++... ++..|++|.+.... .+..+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999853 46789999987543 33456799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 008634 463 LLIYEYMPNKSLDVHLFDAT-------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~N 523 (558)
++|+||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996421 1234789999999999999999999874 9999999999
Q ss_pred EEEcCCCcEEEEecCcceeeC
Q 008634 524 ILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 524 ILl~~~~~~ki~DFGla~~~~ 544 (558)
|+++.++.+||+|||+++...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=193.27 Aligned_cols=148 Identities=33% Similarity=0.526 Sum_probs=131.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-----ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
+|...+.||+|+||.||+|... ++..|++|.+.... .+..+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 78999999886543 23456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+||+++++|.+++.+. ..+++.....++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998542 35889999999999999999999885 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=196.04 Aligned_cols=150 Identities=33% Similarity=0.558 Sum_probs=130.2
Q ss_pred CCCCcccccccCCcccEEEEEecC-Cc----EEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-GK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~----~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.+|...++||+|+||.||+|...+ |. .+++|.+..... ....++.+|+.++.+++||||+++++++.. +..++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457778899999999999998643 33 589998876543 345678999999999999999999999987 78999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+||+++|+|.+++.+. ...+++...+.++.||+.||.|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999999643 33489999999999999999999987 49999999999999999999999999998765
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
..
T Consensus 161 ~~ 162 (279)
T cd05057 161 VD 162 (279)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=200.09 Aligned_cols=151 Identities=34% Similarity=0.525 Sum_probs=130.4
Q ss_pred CCCCcccccccCCcccEEEEEec--------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (558)
++|...++||+|+||.||+++.. ....+++|.++... .....++.+|+.++.++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 24568999887543 34456789999999999 6999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
..++|+||+++|+|.+++.+... ...++|.....++.||+.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999965321 235899999999999999999999874 99999999999999
Q ss_pred CCCcEEEEecCcceeeC
Q 008634 528 DDMNPKISDFGLARIFG 544 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~ 544 (558)
+++.+||+|||+++...
T Consensus 169 ~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 169 EDNVMKIADFGLARGVH 185 (314)
T ss_pred CCCcEEEcccccccccc
Confidence 99999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=203.02 Aligned_cols=144 Identities=25% Similarity=0.326 Sum_probs=125.9
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
....+|...+.||+|+||.||+|+.. ++..|++|..... ....|+.++.+++||||+++++++..++..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999975 4678999975433 2357999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||+. ++|.+++.. ....++|..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9995 688888754 3346899999999999999999999985 999999999999999999999999999854
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=208.29 Aligned_cols=152 Identities=28% Similarity=0.524 Sum_probs=132.5
Q ss_pred cCCCCcccccccCCcccEEEEEecC---C--cEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD---G--KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~---g--~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
.+.....++||+|-||.||+|...+ | -.||||.-+.. .+...+.|+.|..+|++++||||++|+|+|.+. ..|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 3445566789999999999998532 2 36899998874 556678899999999999999999999999875 789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|||.++-|.|..||.. +...|+......++.||+.||.|||+. ++|||||.++|||+...--+||+||||+|.+
T Consensus 467 ivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999965 344588889999999999999999998 6999999999999999999999999999988
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
+.+.
T Consensus 542 ed~~ 545 (974)
T KOG4257|consen 542 EDDA 545 (974)
T ss_pred cccc
Confidence 7654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=192.03 Aligned_cols=152 Identities=25% Similarity=0.402 Sum_probs=133.7
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|+..+.||+|+||.||.++.. +++.+++|++... +....+++.+|++++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998854 5889999987654 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+++++|.+++.+.. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999996532 356899999999999999999999874 9999999999999999999999999998775433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=201.65 Aligned_cols=152 Identities=33% Similarity=0.513 Sum_probs=130.6
Q ss_pred CCCCcccccccCCcccEEEEEec--------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (558)
.+|...++||+|+||.||++... .+..|++|.+.... ....+++.+|+.++.++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35778899999999999999742 12368999887543 33467899999999999 8999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
..++++||+++|+|.+++.+.. ....++|..++.++.||+.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999996532 1235899999999999999999999875 99999999999999
Q ss_pred CCCcEEEEecCcceeeCC
Q 008634 528 DDMNPKISDFGLARIFGG 545 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~~ 545 (558)
.++.+||+|||+++....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=195.66 Aligned_cols=152 Identities=32% Similarity=0.485 Sum_probs=131.0
Q ss_pred cCCCCcccccccCCcccEEEEEecC------CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~------g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
+++|...+.||+|+||.||+|...+ +..|++|.+.... ......|.+|+.++.+++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678888999999999999998753 5678999886543 23345789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC---cEEEE
Q 008634 463 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS 535 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~ki~ 535 (558)
++||||+++++|.+++.+... ...++|..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865432 235899999999999999999999985 99999999999998654 69999
Q ss_pred ecCcceeeC
Q 008634 536 DFGLARIFG 544 (558)
Q Consensus 536 DFGla~~~~ 544 (558)
|||+++...
T Consensus 162 dfg~~~~~~ 170 (277)
T cd05036 162 DFGMARDIY 170 (277)
T ss_pred cCccccccC
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=196.47 Aligned_cols=145 Identities=40% Similarity=0.618 Sum_probs=126.3
Q ss_pred CcccccccCCcccEEEEEe-----cCCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEEE
Q 008634 394 SDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLI 465 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~-----~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 465 (558)
...++||+|+||.||++.. .++..|++|.+..... .....+.+|++++.+++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999987652 3577899999876532 3456788999999999999999999998764 468999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++++|.+++.+ ..++|..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999854 24899999999999999999999885 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=193.08 Aligned_cols=151 Identities=27% Similarity=0.489 Sum_probs=135.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++.+.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888899999999999999875 5788999999876666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++++|.+++.+. ...+++.....++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999988543 245899999999999999999999874 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=198.06 Aligned_cols=149 Identities=32% Similarity=0.527 Sum_probs=131.0
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc-----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
+|...+.||+|+||.||+|... +++.|+||++...... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999965 6899999999765332 234577899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+ +|+|.+++.+.. ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999995432 36999999999999999999999985 99999999999999999999999999987754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 155 ~ 155 (298)
T cd07841 155 P 155 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=190.80 Aligned_cols=143 Identities=34% Similarity=0.550 Sum_probs=128.8
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHH
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 475 (558)
++||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4678999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++.+. ...+++...+.++.+++.+|.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998643 235889999999999999999999885 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=192.33 Aligned_cols=142 Identities=32% Similarity=0.550 Sum_probs=123.4
Q ss_pred ccccCCcccEEEEEec---CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 398 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
+||+|+||.||+|.++ ++..+++|+++... ....+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999987543 234567899999999999999999999875 45678999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....+
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999998542 35899999999999999999999885 999999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=197.65 Aligned_cols=149 Identities=27% Similarity=0.488 Sum_probs=133.9
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.+|+..++||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588888999999999999985 468999999987665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
++++|.+++.+ ..++|..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....+
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999998843 34899999999999999999999985 999999999999999999999999998876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=194.14 Aligned_cols=146 Identities=31% Similarity=0.561 Sum_probs=129.9
Q ss_pred CCCcccccccCCcccEEEEEecCCcEEEEEEccccCc------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
+|...+.||+|+||.||+|...+++.+++|.+..... .....+.+|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3677889999999999999988899999998864321 2235688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||+++++|.+++.+. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999542 35889999999999999999999875 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=193.84 Aligned_cols=147 Identities=29% Similarity=0.499 Sum_probs=128.5
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---c-------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---Q-------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (558)
+|...+.||+|+||.||+|... +|+.|++|.++.... . ..+.+..|+.++.+++|||++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667789999999999999864 688999998753211 1 1346788999999999999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++|+||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 46899999999999999999999874 999999999999999999999999999
Q ss_pred eeeC
Q 008634 541 RIFG 544 (558)
Q Consensus 541 ~~~~ 544 (558)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=193.68 Aligned_cols=143 Identities=34% Similarity=0.593 Sum_probs=123.7
Q ss_pred cccccCCcccEEEEEecC-Cc--EEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~-g~--~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+.||+|+||.||+|+..+ +. .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 43 56888887543 34456789999999999 899999999999999999999999999
Q ss_pred CCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 472 KSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 472 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
|+|.+++.+.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234889999999999999999999874 9999999999999999999999999
Q ss_pred ccee
Q 008634 539 LARI 542 (558)
Q Consensus 539 la~~ 542 (558)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=195.08 Aligned_cols=148 Identities=36% Similarity=0.593 Sum_probs=130.8
Q ss_pred CCCcccccccCCcccEEEEEec-----CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELL 463 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-----~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 463 (558)
.|...++||+|+||.||+++.. ++..++||.+...... ..+.|.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 5666789999999999999854 3678999999865443 46789999999999999999999999987 55789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|+||+++++|.+++.... ..++|..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999996432 35899999999999999999999875 999999999999999999999999999987
Q ss_pred C
Q 008634 544 G 544 (558)
Q Consensus 544 ~ 544 (558)
.
T Consensus 160 ~ 160 (284)
T cd05038 160 P 160 (284)
T ss_pred c
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=209.54 Aligned_cols=150 Identities=24% Similarity=0.394 Sum_probs=123.1
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--------
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-------- 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 459 (558)
..++|...++||+|+||.||+|... +++.||||++.... ....+|+.++.+++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999875 58899999886432 2345799999999999999999987542
Q ss_pred CEEEEEEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEec
Q 008634 460 QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDF 537 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DF 537 (558)
..+++||||+++ +|.+++... .....+++.....++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 666665432 23456899999999999999999999985 99999999999999664 7999999
Q ss_pred CcceeeCCC
Q 008634 538 GLARIFGGN 546 (558)
Q Consensus 538 Gla~~~~~~ 546 (558)
|+|+.+...
T Consensus 216 Gla~~~~~~ 224 (440)
T PTZ00036 216 GSAKNLLAG 224 (440)
T ss_pred ccchhccCC
Confidence 999977543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-23 Score=205.46 Aligned_cols=160 Identities=29% Similarity=0.485 Sum_probs=139.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
..|...+.||+|.||.||||... .++.||+|++.-.. ....+++.+|+.+++.++++||.+++|.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666689999999999999965 58899999998553 44467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
+.+|++.+.|.. ...+++....-|+.++..||.|||.++ .+|||||+.|||+..++.+||+|||.+-.+..+..
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999842 334577777888999999999999985 99999999999999999999999999999987776
Q ss_pred ccCcccccCC
Q 008634 549 QANTNIIAGT 558 (558)
Q Consensus 549 ~~~t~~~~Gt 558 (558)
...| ++||
T Consensus 167 rr~t--fvGT 174 (467)
T KOG0201|consen 167 RRKT--FVGT 174 (467)
T ss_pred cccc--cccc
Confidence 6544 7887
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=198.30 Aligned_cols=145 Identities=32% Similarity=0.511 Sum_probs=119.8
Q ss_pred ccccccCCcccEEEEEec---CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCEEEEEEEcCC
Q 008634 396 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 470 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 470 (558)
.++||+|+||.||+|+.. +++.+|+|.+..... ...+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 467899999875432 3457889999999999999999999865 456899999986
Q ss_pred CCCHHHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE----cCCCcEEEEecCcc
Q 008634 471 NKSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLA 540 (558)
Q Consensus 471 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DFGla 540 (558)
+ +|.+++... .+...+++.....++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 777776422 12235899999999999999999999985 9999999999999 45678999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07868 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-21 Score=189.90 Aligned_cols=150 Identities=23% Similarity=0.380 Sum_probs=131.8
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+|...++||+|+||.||++... +++.+++|.+... .....+.+.+|+.++++++|+||+++++.+.+++..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999865 6889999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++|+|.+++.+. ....+++.....++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999988542 3345789999999999999999999885 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=191.32 Aligned_cols=148 Identities=31% Similarity=0.479 Sum_probs=128.5
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEE-eCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL-EGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~ 469 (558)
++|...+.||+|+||.||++... |..|++|.++... ..+.+.+|+.++++++|+|++++++++. .++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36778889999999999999874 7789999886543 3467899999999999999999999865 446789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.+.. ...++|..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999986532 335899999999999999999999874 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=192.88 Aligned_cols=150 Identities=32% Similarity=0.506 Sum_probs=132.3
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.+.|...++||+|+||.||++...++..+++|.+.... ...+.+.+|+.++++++|+||+++.+.+.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45688889999999999999998778889999887543 235678999999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.+. ....++|..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999653 3446899999999999999999999874 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-22 Score=205.63 Aligned_cols=137 Identities=33% Similarity=0.504 Sum_probs=122.7
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHH
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 475 (558)
.+-||.|+.|.||.|++. ++.||||+++... ..+|+-|++|+|+||+.+.|+|....-++||||||+.|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 456999999999999995 6789999987543 25788899999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+.|+. ...++......+..+||.||.|||.+ .|||||||+-||||+.+-.+||+|||-++.+..-
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 99953 34577888889999999999999998 5999999999999999999999999999987654
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=190.46 Aligned_cols=150 Identities=39% Similarity=0.621 Sum_probs=131.8
Q ss_pred CCcccccccCCcccEEEEEecC-----CcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~-----g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
|+..+.||+|+||.||+++..+ +..|++|.+...... ..+.+..|+..+.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999998754 378999999765443 5678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999864322 22899999999999999999999884 999999999999999999999999999877544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=197.55 Aligned_cols=146 Identities=22% Similarity=0.369 Sum_probs=130.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||++... .++.|++|.+.... ....+.+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999865 47899999987653 233567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999999542 35899999999999999999999874 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=196.84 Aligned_cols=148 Identities=30% Similarity=0.501 Sum_probs=129.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+.|...++||+|+||.||++... ++..|++|.+.... ......+.+|+.++.+++||||+++++++..++..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999865 57899999987443 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++ ++|..++.+. ...+++.....++.||+.||.|||+.+ ++|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888888543 335889999999999999999999885 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=193.18 Aligned_cols=148 Identities=31% Similarity=0.503 Sum_probs=128.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-----ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (558)
++|...++||+|+||.||++... +++.|++|.+.... .+..+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999865 58899999875322 12345788999999999999999999998764 467
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||+++++|.+++.+. ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998542 34788889999999999999999885 99999999999999999999999999986
Q ss_pred eC
Q 008634 543 FG 544 (558)
Q Consensus 543 ~~ 544 (558)
..
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=194.29 Aligned_cols=150 Identities=25% Similarity=0.428 Sum_probs=129.4
Q ss_pred CCCCcccccccCCcccEEEEEecC----CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...++||+|+||.||+|...+ ...|+||...... .+..+.+.+|+.++.+++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788899999999999998643 2468999887654 3456689999999999999999999999875 457899
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999643 235899999999999999999999874 99999999999999999999999999987654
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 160 ~ 160 (270)
T cd05056 160 E 160 (270)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=195.19 Aligned_cols=157 Identities=26% Similarity=0.393 Sum_probs=132.4
Q ss_pred HHHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEE-----
Q 008634 385 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL----- 457 (558)
Q Consensus 385 ~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~----- 457 (558)
.+....++|+..+.||+|+||.||++... +++.+++|.+..... ...++.+|+.++.++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 33456788999999999999999999875 578999998765322 235678899999999 7999999999884
Q ss_pred eCCEEEEEEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 008634 458 EGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536 (558)
Q Consensus 458 ~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~D 536 (558)
.++..++||||+++++|.+++... .....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 345789999999999999987542 22346889999999999999999999874 99999999999999999999999
Q ss_pred cCcceeeCC
Q 008634 537 FGLARIFGG 545 (558)
Q Consensus 537 FGla~~~~~ 545 (558)
||+++....
T Consensus 168 fg~~~~~~~ 176 (286)
T cd06638 168 FGVSAQLTS 176 (286)
T ss_pred CCceeeccc
Confidence 999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=196.50 Aligned_cols=151 Identities=28% Similarity=0.343 Sum_probs=133.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||++... +++.+++|.+...... ..+.+..|++++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999976 4899999999765332 4567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++++|.+++.+. ....+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998642 3456899999999999999999999875 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=197.13 Aligned_cols=150 Identities=36% Similarity=0.638 Sum_probs=127.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCc----EEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...+.||+|+||.||+|... ++. .|++|.+..... ....++.+|+.++.+++||||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46777889999999999999864 343 578888875433 2345788999999999999999999998764 4678
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998642 335899999999999999999999874 9999999999999999999999999999775
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
..
T Consensus 161 ~~ 162 (303)
T cd05110 161 GD 162 (303)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=193.00 Aligned_cols=149 Identities=33% Similarity=0.572 Sum_probs=131.2
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+|+..++||+|++|.||+|+.. +|..|+||.+...... ..+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 5889999998765332 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88888865444456899999999999999999999874 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-21 Score=189.51 Aligned_cols=153 Identities=27% Similarity=0.466 Sum_probs=135.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..+.||.|+||.||++... ++..+++|++.... ....+.+.+|++.++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999865 57889999987543 33567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++........+++.....++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999965443456899999999999999999999875 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=196.40 Aligned_cols=149 Identities=29% Similarity=0.478 Sum_probs=131.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|+..++||+|+||.||++... +++.|++|++.+... ...+.+.+|++++.+++||||+++++++.+++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999976 588999998865432 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++++|..+... ...++|..++.++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999887643 234899999999999999999999874 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=195.21 Aligned_cols=147 Identities=29% Similarity=0.508 Sum_probs=129.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..++||+|++|.||++..+ +++.|++|.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999976 6889999998754322 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+++ +|.+++.+.. ..+++.....++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 8998886432 36899999999999999999999874 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=191.40 Aligned_cols=147 Identities=35% Similarity=0.595 Sum_probs=129.4
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc---------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
|.....||+|+||.||+|... +++.+++|.+...... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999864 5789999988654321 135688999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999999542 45889999999999999999999875 99999999999999999999999999987
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
...
T Consensus 156 ~~~ 158 (267)
T cd06628 156 LEA 158 (267)
T ss_pred ccc
Confidence 753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=198.58 Aligned_cols=145 Identities=29% Similarity=0.470 Sum_probs=129.1
Q ss_pred CcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
.....||+|+||.||++... ++..|+||++........+.+.+|+..+.+++|+||+++++.+..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33457999999999999864 58899999987665555677899999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99998843 34889999999999999999999984 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=193.50 Aligned_cols=152 Identities=24% Similarity=0.407 Sum_probs=127.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHH-HhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|+..+.||+|+||.||+++.. +|+.||+|+++... .+...++..|+.. ++.++||||+++++++..++..++|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999975 58999999987543 2333456666665 566789999999999999999999999
Q ss_pred cCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|++ |+|.+++.+. .....+++...+.++.||+.||.|||++. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888777542 23356899999999999999999999852 599999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=193.61 Aligned_cols=154 Identities=31% Similarity=0.523 Sum_probs=127.5
Q ss_pred HcCCCCcccccccCCcccEEEEEecC-----CcEEEEEEccccCc-cc-hHHHHHHHHHHhcCCCCCeeeeeEEEEe-CC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSG-QG-LQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQ 460 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~VaVK~l~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 460 (558)
....|+...+||+|.+|.||++.-++ ...+|+|+++.... .+ .....+|+.+++.++||||+.|..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34567888899999999999996432 23789999986532 22 2456799999999999999999999987 77
Q ss_pred EEEEEEEcCCCCCHHHHHh--ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC----CcEEE
Q 008634 461 ELLLIYEYMPNKSLDVHLF--DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKI 534 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~----~~~ki 534 (558)
.+++++||.+. +|...++ +..+...++......|+.||+.|+.|||++- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999876 5666654 2334457899999999999999999999986 9999999999999877 89999
Q ss_pred EecCcceeeCCC
Q 008634 535 SDFGLARIFGGN 546 (558)
Q Consensus 535 ~DFGla~~~~~~ 546 (558)
+||||||++...
T Consensus 178 aDlGlaR~~~~p 189 (438)
T KOG0666|consen 178 ADLGLARLFNNP 189 (438)
T ss_pred ecccHHHHhhcc
Confidence 999999998654
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=190.71 Aligned_cols=149 Identities=30% Similarity=0.509 Sum_probs=133.3
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...+.||+|+||.||++... +++.|++|.+...... ..+.+.+|+.++.+++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999865 6889999998765443 567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++.+. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....+
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999998542 34789999999999999999999885 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=189.82 Aligned_cols=149 Identities=28% Similarity=0.506 Sum_probs=131.8
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
.+|...+.||+|+||.||++...+++.+++|.+..... ...+|.+|++++.+++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677789999999999999987788999998875432 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++|.+++... ...++|.....++.+++.+|.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999998542 345889999999999999999999875 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=189.80 Aligned_cols=149 Identities=28% Similarity=0.511 Sum_probs=134.3
Q ss_pred cCCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||++...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+++..++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578888999999999999999765 78999999875533 67899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++++|.+++... ...++|.....++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999998542 346899999999999999999999874 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=190.81 Aligned_cols=150 Identities=29% Similarity=0.510 Sum_probs=126.4
Q ss_pred CCcccccccCCcccEEEEEec----CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 008634 393 FSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (558)
|...+.||+|+||.||+|... +++.|+||.+... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999853 3678999998754 2344667899999999999999999999986542
Q ss_pred EEEEEEEcCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 008634 461 ELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DF 537 (558)
..++++||+++|+|..++.... +...+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875322 2235899999999999999999999874 999999999999999999999999
Q ss_pred CcceeeCC
Q 008634 538 GLARIFGG 545 (558)
Q Consensus 538 Gla~~~~~ 545 (558)
|+++....
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99997643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=200.11 Aligned_cols=141 Identities=23% Similarity=0.304 Sum_probs=114.0
Q ss_pred HHcCCCCcccccccCCcccEEEEEec--CCcEEEEEEccccC-----ccchHHHHHHHHHHhcCCCCCeee-eeEEEEeC
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVR-LLGCCLEG 459 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~--~g~~VaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~ 459 (558)
...+.|...++||+|+||.||+|... +++.||||++.... ....+.|.+|+++|.+++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34567999999999999999999864 57788999875331 123456899999999999999985 4432
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCEEEcCCCcEEEEecC
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL-KASNILLDDDMNPKISDFG 538 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl-k~~NILl~~~~~~ki~DFG 538 (558)
+..++||||+++++|.. + . .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~-~--~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-A-R--PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-h-C--cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 46799999999999963 2 1 11 1 1457889999999999985 999999 9999999999999999999
Q ss_pred cceeeCC
Q 008634 539 LARIFGG 545 (558)
Q Consensus 539 la~~~~~ 545 (558)
+|+.+..
T Consensus 158 lA~~~~~ 164 (365)
T PRK09188 158 LASVFRR 164 (365)
T ss_pred cceeccc
Confidence 9998754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-22 Score=186.79 Aligned_cols=154 Identities=29% Similarity=0.366 Sum_probs=137.2
Q ss_pred HcCCCCcccccccCCcccEEEEE-ecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 462 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 462 (558)
..++|.+.++||+|||+.||.++ +.+++..|+|++.-.+.++.+..++|++.-++++||||++++++...+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35678899999999999999998 667889999999887777888999999999999999999999987543 359
Q ss_pred EEEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 463 LLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
|+++.|...|+|.+.+.... ++..+++.+.+.|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||-++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999987544 3447999999999999999999999984 579999999999999999999999999887
Q ss_pred ee
Q 008634 542 IF 543 (558)
Q Consensus 542 ~~ 543 (558)
..
T Consensus 178 ~a 179 (302)
T KOG2345|consen 178 QA 179 (302)
T ss_pred cc
Confidence 54
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=200.75 Aligned_cols=150 Identities=29% Similarity=0.464 Sum_probs=127.6
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (558)
..++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3467888999999999999999864 67899999987542 22345678999999999999999999987543
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
...++++|++ +++|..++. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999987 788888773 235899999999999999999999985 99999999999999999999999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++.....
T Consensus 165 ~~~~~~~ 171 (343)
T cd07878 165 ARQADDE 171 (343)
T ss_pred ceecCCC
Confidence 9976543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=194.14 Aligned_cols=144 Identities=25% Similarity=0.426 Sum_probs=123.9
Q ss_pred cccccCCcccEEEEEecC--------CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 397 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~--------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++||+|+||.||+|.... ..+|++|.+........+.+.+|+.++..++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 235888888765555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc--------EEEEecCcc
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--------PKISDFGLA 540 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~--------~ki~DFGla 540 (558)
+++|+|..++.... ..++|..++.++.||+.||.|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996432 36899999999999999999999874 999999999999987765 699999998
Q ss_pred eeeCC
Q 008634 541 RIFGG 545 (558)
Q Consensus 541 ~~~~~ 545 (558)
.....
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=201.79 Aligned_cols=148 Identities=32% Similarity=0.457 Sum_probs=125.3
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----- 460 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 460 (558)
..++|...++||+|+||.||++... +|..||+|++... .......+.+|+.++..++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468999999999999999999865 5889999998754 2233567889999999999999999999986543
Q ss_pred -EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 461 -ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
..++||||++++ |...+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 579999999764 555552 23788889999999999999999985 99999999999999999999999999
Q ss_pred ceeeCC
Q 008634 540 ARIFGG 545 (558)
Q Consensus 540 a~~~~~ 545 (558)
++....
T Consensus 170 a~~~~~ 175 (359)
T cd07876 170 ARTACT 175 (359)
T ss_pred cccccc
Confidence 986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=192.11 Aligned_cols=149 Identities=31% Similarity=0.527 Sum_probs=132.5
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...+.||+|+||.||+|... +|..|++|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999965 68999999987654 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+ +++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999986533 45899999999999999999999874 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=188.92 Aligned_cols=143 Identities=36% Similarity=0.603 Sum_probs=124.2
Q ss_pred cccccCCcccEEEEEecC----CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+|.... +..+++|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 26899999886544 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+|.+++.+.. .++|..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++....+
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999996432 6899999999999999999999874 999999999999999999999999999977443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=197.07 Aligned_cols=144 Identities=28% Similarity=0.464 Sum_probs=128.5
Q ss_pred cccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 395 DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
...+||+|+||.||++... +++.|++|.+........+.+.+|+.++..++||||+++++.+..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999865 688999999876555556778899999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|..++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9988743 34899999999999999999999885 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=195.11 Aligned_cols=145 Identities=32% Similarity=0.508 Sum_probs=119.3
Q ss_pred ccccccCCcccEEEEEec---CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCEEEEEEEcCC
Q 008634 396 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 470 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 470 (558)
+.+||+|+||.||+|+.. ++..||+|.+..... ...+.+|+.++.+++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999865 357899998875432 3467899999999999999999999864 457899999987
Q ss_pred CCCHHHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE----cCCCcEEEEecCcc
Q 008634 471 NKSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLA 540 (558)
Q Consensus 471 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DFGla 540 (558)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666665321 12335899999999999999999999885 9999999999999 56679999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07867 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 987543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=195.03 Aligned_cols=147 Identities=29% Similarity=0.527 Sum_probs=129.8
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|++++++++||||+++++.+..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999865 57889999887543 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.. ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999998842 45899999999999999999999874 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-21 Score=190.87 Aligned_cols=149 Identities=28% Similarity=0.490 Sum_probs=133.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..+.||.|++|.||+|+.. +++.|++|.+.... ......+.+|+.++++++|+|++++++.+.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777889999999999999965 58899999987543 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998542 6899999999999999999999875 999999999999999999999999999887643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=193.74 Aligned_cols=149 Identities=30% Similarity=0.468 Sum_probs=128.4
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++++|...++||+|+||.||+|... +++.|++|.+...... ....+.+|+.++.+++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578889999999999999999864 6889999998754332 2346789999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||++ ++|.+++... ...+++.....++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 6776666432 245788888999999999999999885 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-21 Score=189.48 Aligned_cols=148 Identities=31% Similarity=0.521 Sum_probs=128.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-----QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (558)
.+|...+.||+|+||.||++... +++.|++|++..... +..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999865 588999998864321 2345688999999999999999999998763 578
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++++||+++++|.+++.+. ..+++...+.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998542 34889999999999999999999874 99999999999999999999999999986
Q ss_pred eC
Q 008634 543 FG 544 (558)
Q Consensus 543 ~~ 544 (558)
..
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=193.37 Aligned_cols=160 Identities=31% Similarity=0.426 Sum_probs=135.3
Q ss_pred cChHHHHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEe
Q 008634 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE 458 (558)
Q Consensus 381 ~~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 458 (558)
+.+..+..++++|...+.||+|+||.||++... +++.+++|.+..... ....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344455566889999999999999999999874 688999998865422 235677899999999 89999999999876
Q ss_pred C-----CEEEEEEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 459 G-----QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 459 ~-----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
. +..++|+||+++++|.+++... .....++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999988642 23346899999999999999999999874 9999999999999999999
Q ss_pred EEEecCcceeeC
Q 008634 533 KISDFGLARIFG 544 (558)
Q Consensus 533 ki~DFGla~~~~ 544 (558)
||+|||+++...
T Consensus 168 kl~dfg~~~~~~ 179 (291)
T cd06639 168 KLVDFGVSAQLT 179 (291)
T ss_pred EEeecccchhcc
Confidence 999999988754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-21 Score=190.56 Aligned_cols=147 Identities=29% Similarity=0.512 Sum_probs=130.1
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
-|+..++||+|+||.||+|... ++..|++|.+.... ....+.+.+|+..+.+++||||+++++.+..++..++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3666788999999999999864 68899999876443 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.. ..+++.....++.+++.+|.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999998843 35899999999999999999999875 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-21 Score=190.15 Aligned_cols=148 Identities=29% Similarity=0.548 Sum_probs=131.2
Q ss_pred CCCcccccccCCcccEEEEEe-cCCcEEEEEEcccc-CccchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 466 (558)
.|+..++||+|+||.||+|.. .++..+++|.+... ......++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999996 46889999998754 3344567889999999996 999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++++|.+++.. ..+++.....++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..+
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 26899999999999999999999885 999999999999999999999999999887544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=191.91 Aligned_cols=149 Identities=29% Similarity=0.514 Sum_probs=130.3
Q ss_pred CCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCc------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
+|+..+.||+|++|.||++.. .+++.|++|.+..... ...+.+.+|+.++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 4688999999874321 124678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceee
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 543 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~ 543 (558)
|+||+++++|.+++.+. ..+++.....++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998542 35889999999999999999999985 99999999999998775 6999999999877
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
...
T Consensus 155 ~~~ 157 (268)
T cd06630 155 AAK 157 (268)
T ss_pred ccc
Confidence 543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=192.78 Aligned_cols=148 Identities=28% Similarity=0.376 Sum_probs=129.4
Q ss_pred CCCcccccccCCcccEEEEEe----cCCcEEEEEEccccCc----cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTSG----QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~VaVK~l~~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (558)
+|+..+.||+|+||.||+++. .+|..|++|.+..... ...+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 3688999999875422 2346788999999999 699999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||+++++|.+++... ..+++.....++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998642 35889999999999999999999875 99999999999999999999999999987
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=189.67 Aligned_cols=143 Identities=34% Similarity=0.524 Sum_probs=121.9
Q ss_pred cccccCCcccEEEEEec----CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCEEEEEEEcCC
Q 008634 397 NKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYEYMP 470 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 470 (558)
+.||+|+||.||+|... ++..|++|++... ..+..+.+.+|+.+++.++|||++++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998653 33446788999999999999999999998764 456899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+|+|.+++.+. ...+++.....++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999643 23467888899999999999999987 49999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=189.65 Aligned_cols=146 Identities=35% Similarity=0.543 Sum_probs=127.3
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...+.||+|+||.||++.. +++.|++|.+.... ..+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 67789999886542 246789999999999999999999998764 5799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999996532 345899999999999999999999874 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=193.44 Aligned_cols=149 Identities=28% Similarity=0.472 Sum_probs=133.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|...+.||+|+||.||++... ++..|++|.+........+.+.+|+.++.+++|||++++++.+..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999854 67899999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
++++|.+++.+ ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+...
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999853 24789999999999999999999885 999999999999999999999999998866443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=194.67 Aligned_cols=149 Identities=32% Similarity=0.508 Sum_probs=126.8
Q ss_pred CCcccccccCCcccEEEEEec---CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (558)
|...++||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 667788999999999999965 47899999998643 33346678899999999999999999999988 88999
Q ss_pred EEEcCCCCCHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC----CCcEEEEecC
Q 008634 465 IYEYMPNKSLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD----DMNPKISDFG 538 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~----~~~~ki~DFG 538 (558)
||||+++ +|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+|||++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 5666554322 2236889999999999999999999885 999999999999999 9999999999
Q ss_pred cceeeCC
Q 008634 539 LARIFGG 545 (558)
Q Consensus 539 la~~~~~ 545 (558)
+++.+..
T Consensus 158 ~~~~~~~ 164 (316)
T cd07842 158 LARLFNA 164 (316)
T ss_pred cccccCC
Confidence 9997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.2e-21 Score=188.03 Aligned_cols=151 Identities=28% Similarity=0.428 Sum_probs=135.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|+..+.+++|+|++++++.+..++..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46788899999999999999976 489999999876644 4467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+++++|.+++... ..+++..++.++.|+++||.|||+ .+ ++|+||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999643 468999999999999999999998 74 9999999999999999999999999999775433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-22 Score=210.20 Aligned_cols=148 Identities=28% Similarity=0.469 Sum_probs=131.5
Q ss_pred CCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+.|.+...||.|+||.||++..++ +..-|.|.+...+...+++|+-||++|+.++||+||+|++.|...+.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345556679999999999999765 4445778888888888999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
.||-.+..+.+ -...|++.++.-++.+++.||.|||++ +|||||||+.|||++-+|.++|+|||.+...
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence 99999988865 345699999999999999999999998 5999999999999999999999999987654
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=189.77 Aligned_cols=147 Identities=28% Similarity=0.521 Sum_probs=130.9
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.|+..++||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.++.+++||||+++++.+.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999875 58899999887543 344677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++|+|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+++....
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999998843 3588999999999999999999987 499999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=193.66 Aligned_cols=149 Identities=23% Similarity=0.340 Sum_probs=131.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..++||+|+||.||++... +++.|++|++.... ....+.+.+|++++..++||||+++++.+...+..++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777789999999999999865 58899999876543 34457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++++|.+++.+ ...+++.....++.+++.+|.|||+.. +++||||||+||++++++.++|+|||+++...
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 999999998854 235899999999999999999999742 59999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=191.16 Aligned_cols=149 Identities=28% Similarity=0.427 Sum_probs=133.1
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
+|...++||+|+||.||++... ++..+++|.+.+.. ....+.+.+|++++++++||||+++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 58899999997543 2346789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++++|.+++.+. ..+++.....++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998543 46899999999999999999999875 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-21 Score=195.47 Aligned_cols=143 Identities=19% Similarity=0.280 Sum_probs=124.0
Q ss_pred ccccccC--CcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 396 ENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 396 ~~~LG~G--~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
.++||+| +|+.||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 78999999865 68999999987542 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
+|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||....
T Consensus 83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhc
Confidence 999999985432 234899999999999999999999875 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=186.14 Aligned_cols=150 Identities=25% Similarity=0.383 Sum_probs=129.9
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-CEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 467 (558)
+|...+.||+|++|.||++... +++.+++|++.... ....+.+.+|++++++++|+|++++++.+... ...++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999865 47889999986542 23456789999999999999999999987644 46899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++++|.+++.+. ....+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999653 2345899999999999999999999885 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=215.38 Aligned_cols=157 Identities=26% Similarity=0.397 Sum_probs=130.6
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 463 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 463 (558)
..++|.+.++||+|+||.||++... ++..|++|.+... .......|..|+.++.+++|||||++++++.+. ..++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3467889999999999999999865 4778899988643 233456789999999999999999999998653 5789
Q ss_pred EEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCCEEEcCC---------
Q 008634 464 LIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSR----LKIIHRDLKASNILLDDD--------- 529 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~ivHrDlk~~NILl~~~--------- 529 (558)
|||||+++|+|.++|.+.. ....+++...+.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986532 23469999999999999999999998531 359999999999999642
Q ss_pred --------CcEEEEecCcceeeCC
Q 008634 530 --------MNPKISDFGLARIFGG 545 (558)
Q Consensus 530 --------~~~ki~DFGla~~~~~ 545 (558)
..+||+|||+++.+..
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccCCCCceEEccCCccccccc
Confidence 3489999999987643
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=188.01 Aligned_cols=153 Identities=28% Similarity=0.503 Sum_probs=129.3
Q ss_pred CCCcccccccCCcccEEEEEecC--CcEEEEEEccccC----------ccchHHHHHHHHHHhc-CCCCCeeeeeEEEEe
Q 008634 392 HFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTS----------GQGLQEFKNEVNLIAK-LQHKNLVRLLGCCLE 458 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~--g~~VaVK~l~~~~----------~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 458 (558)
+|+..+.||+|+||.||++.... ++.+++|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999765 6789999875321 1234567788888875 799999999999999
Q ss_pred CCEEEEEEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 008634 459 GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (558)
Q Consensus 459 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DF 537 (558)
++..++|+||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887542 23346899999999999999999999642 5999999999999999999999999
Q ss_pred CcceeeCCC
Q 008634 538 GLARIFGGN 546 (558)
Q Consensus 538 Gla~~~~~~ 546 (558)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-21 Score=191.07 Aligned_cols=149 Identities=30% Similarity=0.539 Sum_probs=123.0
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc--chHHHHHHHHHHhcC---CCCCeeeeeEEEEeC-----C
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKL---QHKNLVRLLGCCLEG-----Q 460 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~-----~ 460 (558)
+|...+.||+|+||.||+++.. +++.|++|.+...... ....+.+|+.++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677889999999999999865 5889999988754221 223456677776655 799999999998652 4
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++|+||+++ +|.+++.... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 58999999984 8888885432 345899999999999999999999985 999999999999999999999999999
Q ss_pred eeeCC
Q 008634 541 RIFGG 545 (558)
Q Consensus 541 ~~~~~ 545 (558)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=200.07 Aligned_cols=148 Identities=33% Similarity=0.468 Sum_probs=125.4
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (558)
..++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999865 58899999997542 23346778999999999999999999998653
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
...++||||+++ +|...+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 5655553 23789999999999999999999985 99999999999999999999999999
Q ss_pred ceeeCC
Q 008634 540 ARIFGG 545 (558)
Q Consensus 540 a~~~~~ 545 (558)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-21 Score=202.99 Aligned_cols=156 Identities=31% Similarity=0.478 Sum_probs=135.8
Q ss_pred ccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHH
Q 008634 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 476 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 476 (558)
+||+|.||.||-|+.. +...+|||-+...+.+..+.+..||.+-++++|+|||+++|.+.+++..-++||-+|||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 466799999998888888889999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEEEEecCcceeeCCCCCccCcccc
Q 008634 477 HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNII 555 (558)
Q Consensus 477 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DFGla~~~~~~~~~~~t~~~ 555 (558)
+|...-.+-+-++.+.-.+..||++||.|||++. |||||||-+|||++ -.|.+||+|||-+|++.+=.. .|+.+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--ccccc
Confidence 9976544333477888889999999999999984 99999999999995 678999999999998865433 34446
Q ss_pred cCC
Q 008634 556 AGT 558 (558)
Q Consensus 556 ~Gt 558 (558)
-||
T Consensus 737 TGT 739 (1226)
T KOG4279|consen 737 TGT 739 (1226)
T ss_pred ccc
Confidence 665
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=191.43 Aligned_cols=150 Identities=28% Similarity=0.482 Sum_probs=129.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 465 (558)
++|...+.||+|+||.||+|... +++.+++|.++..... ....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788889999999999999976 5889999998754322 234567899999999999999999999887 899999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+||++ ++|.+++.... ..+++.....++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 48988885432 36899999999999999999999885 99999999999999999999999999997754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=186.35 Aligned_cols=150 Identities=26% Similarity=0.450 Sum_probs=131.8
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|+..++||+|+||.+|++... +|+.+++|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777889999999999999865 6889999998643 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++++|.+++... ....+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999988642 2335789999999999999999999874 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-22 Score=188.78 Aligned_cols=150 Identities=27% Similarity=0.432 Sum_probs=129.0
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++.|+..+.||+|.|+.||+... ++|+++++|.+... +..+.+++.+|+.+...|+|||||+|..........|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46788888999999999999874 46888888887533 4456788999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla~~~ 543 (558)
|+|.|++|..-+.+. ...++......+.||+++|.|+|.++ |||||+||+|+||-. .--+||+|||+|...
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997655432 34677888899999999999999985 999999999999953 335899999999998
Q ss_pred CC
Q 008634 544 GG 545 (558)
Q Consensus 544 ~~ 545 (558)
++
T Consensus 164 ~~ 165 (355)
T KOG0033|consen 164 ND 165 (355)
T ss_pred CC
Confidence 83
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-20 Score=182.74 Aligned_cols=150 Identities=34% Similarity=0.561 Sum_probs=135.2
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
+|...+.||+|++|.||++... ++..+++|++........+.+.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999976 688999999987665566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++|.+++.... ..+++..+..++.+++.+|.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999985432 4689999999999999999999987 4999999999999999999999999999887654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=188.29 Aligned_cols=148 Identities=31% Similarity=0.530 Sum_probs=128.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-----CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (558)
.+|...+.||+|+||.||++... +++.|++|.+... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 5889999987532 223456789999999999999999999998764 468
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||+++++|.+++... ..+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998532 34789999999999999999999885 99999999999999999999999999987
Q ss_pred eC
Q 008634 543 FG 544 (558)
Q Consensus 543 ~~ 544 (558)
..
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-22 Score=206.23 Aligned_cols=151 Identities=36% Similarity=0.544 Sum_probs=133.6
Q ss_pred CCcccccccCCcccEEEEEec--CCc--EEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA--DGK--AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~--~g~--~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
....++||+|.||.|++|.+. +|+ .||||.+...... ..++|++|+..|.+|+|+|+++|+|+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344578999999999999875 344 5899999866543 57899999999999999999999999988 67899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
.++.|+|.+.|++ .....|-......++.|||.||.||.++ ++|||||.++|+||-....+||+||||.|-+..+.
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999987 4556788888999999999999999988 49999999999999999999999999999987765
Q ss_pred C
Q 008634 548 N 548 (558)
Q Consensus 548 ~ 548 (558)
.
T Consensus 267 d 267 (1039)
T KOG0199|consen 267 D 267 (1039)
T ss_pred c
Confidence 4
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=204.79 Aligned_cols=154 Identities=24% Similarity=0.361 Sum_probs=122.5
Q ss_pred HcCCCCcccccccCCcccEEEEEe-----------------cCCcEEEEEEccccCccchHH--------------HHHH
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTL-----------------ADGKAIAVKRLSRTSGQGLQE--------------FKNE 437 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~-----------------~~g~~VaVK~l~~~~~~~~~~--------------~~~E 437 (558)
..++|.+.++||+|+||.||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999987543322233 3447
Q ss_pred HHHHhcCCCCCe-----eeeeEEEEe--------CCEEEEEEEcCCCCCHHHHHhccC---------------------C
Q 008634 438 VNLIAKLQHKNL-----VRLLGCCLE--------GQELLLIYEYMPNKSLDVHLFDAT---------------------R 483 (558)
Q Consensus 438 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 483 (558)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877655 678888753 356899999999999999986421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 484 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
...++|..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 361 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT 361 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence 123578889999999999999999874 99999999999999999999999999986543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=190.81 Aligned_cols=148 Identities=28% Similarity=0.540 Sum_probs=129.6
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|+..+.||+|+||.||+|+.. ++..|+||++.... ....+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999875 68899999887543 22345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++ ++|..++... ....+++.....++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 6888888643 2356899999999999999999999874 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=183.87 Aligned_cols=149 Identities=32% Similarity=0.520 Sum_probs=133.7
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...++||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3677889999999999999865 578999999986644 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998543 46899999999999999999999885 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=191.20 Aligned_cols=149 Identities=32% Similarity=0.507 Sum_probs=128.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
+.|...++||+|+||.||+|... +++.|++|.+..... +..+++.+|++++.+++||||+++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778889999999999999875 588999998864322 33467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||++ |++.+++... ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5666666432 235899999999999999999999874 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=189.81 Aligned_cols=150 Identities=29% Similarity=0.468 Sum_probs=127.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCE-----
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE----- 461 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 461 (558)
++|+..+.||+|+||.||++... +++.|++|++..... .....+.+|+.++.+++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999965 688999998765432 23457889999999995 6999999999987665
Q ss_pred EEEEEEcCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecC
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFG 538 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFG 538 (558)
.++||||+++ +|.+++..... ...+++.....++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78888764332 346899999999999999999999884 999999999999998 8999999999
Q ss_pred cceeeC
Q 008634 539 LARIFG 544 (558)
Q Consensus 539 la~~~~ 544 (558)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-21 Score=191.81 Aligned_cols=148 Identities=29% Similarity=0.521 Sum_probs=128.1
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...++||+|+||.||+++.. +|..+++|++.... ......+.+|++++.+++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999975 68899999986432 22235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++ ++|.+++... ...+++.....++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 97 4777777542 345899999999999999999999885 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=198.41 Aligned_cols=147 Identities=33% Similarity=0.464 Sum_probs=125.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 460 (558)
.++|...++||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467899999999999999999865 58899999997542 33356788999999999999999999987543 3
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++||||+++ +|..++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999975 5666663 23788999999999999999999885 999999999999999999999999999
Q ss_pred eeeCC
Q 008634 541 RIFGG 545 (558)
Q Consensus 541 ~~~~~ 545 (558)
+....
T Consensus 174 ~~~~~ 178 (364)
T cd07875 174 RTAGT 178 (364)
T ss_pred cccCC
Confidence 87644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=189.37 Aligned_cols=145 Identities=40% Similarity=0.572 Sum_probs=124.9
Q ss_pred cccccCCcccEEEEEecC-------CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 397 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~-------g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+.||+|+||.||+|+..+ +..+++|.+.... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2578999886543 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-----cEEEEecCc
Q 008634 469 MPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-----NPKISDFGL 539 (558)
Q Consensus 469 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-----~~ki~DFGl 539 (558)
+++++|.+++.+.. ....++|..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 2234899999999999999999999874 99999999999999877 899999999
Q ss_pred ceeeC
Q 008634 540 ARIFG 544 (558)
Q Consensus 540 a~~~~ 544 (558)
++...
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=190.33 Aligned_cols=151 Identities=28% Similarity=0.441 Sum_probs=131.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|+..++||+|+||.||++... +++.|++|+++... ....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999976 57899999887542 3335778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|++++.+..+..+ ...+++.....++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9999877766532 344899999999999999999999885 9999999999999999999999999998875543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=196.21 Aligned_cols=157 Identities=31% Similarity=0.417 Sum_probs=139.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.+.|..-++||+|+||.||-.+.+ +|+..|.|++.+.. .++..-.++|-.+|.+++.+.||.+--.++.++.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 466788899999999999999865 58889999887652 34455678999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+..|.||+|..+|..-.. ..+++.+...++.+|+.||++||.. +||.|||||+|||||+.|+++|+|+|||.-+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999976544 4599999999999999999999987 599999999999999999999999999999988
Q ss_pred CCCcc
Q 008634 546 NQNQA 550 (558)
Q Consensus 546 ~~~~~ 550 (558)
.+...
T Consensus 340 g~~~~ 344 (591)
T KOG0986|consen 340 GKPIR 344 (591)
T ss_pred CCccc
Confidence 77654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=188.67 Aligned_cols=147 Identities=27% Similarity=0.464 Sum_probs=130.6
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
|...++||+|++|.||++... +++.+++|++........+.+.+|+.++.+++||||+++++++..++..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999864 6889999998765555566789999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++....+
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999854 35899999999999999999999985 999999999999999999999999998866443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-20 Score=183.53 Aligned_cols=150 Identities=32% Similarity=0.537 Sum_probs=134.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 466 (558)
+|...+.||+|++|.||+|... ++..|++|++..... ...+.+.+|+..+++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999976 688999999876543 4567899999999999999999999999988 8999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++++|.+++.+.. .++|..+..++.+++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986433 6899999999999999999999974 999999999999999999999999999988655
Q ss_pred C
Q 008634 547 Q 547 (558)
Q Consensus 547 ~ 547 (558)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=181.39 Aligned_cols=142 Identities=17% Similarity=0.204 Sum_probs=109.9
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCcc--c-------hHHH-----------------HHHHHHHhcCCCCCe
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--G-------LQEF-----------------KNEVNLIAKLQHKNL 449 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~--~-------~~~~-----------------~~Ei~~l~~l~H~ni 449 (558)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754211 1 1122 349999999988776
Q ss_pred eeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCCEEEcC
Q 008634 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDLKASNILLDD 528 (558)
Q Consensus 450 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDlk~~NILl~~ 528 (558)
.....+.. ...++||||++++++.....+ ...+++.....++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 54433322 234899999999877654322 24588999999999999999999 6764 99999999999998
Q ss_pred CCcEEEEecCcceeeCCC
Q 008634 529 DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 529 ~~~~ki~DFGla~~~~~~ 546 (558)
++.++|+|||+|.....+
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 478999999999866443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=188.55 Aligned_cols=143 Identities=33% Similarity=0.468 Sum_probs=125.4
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
||+|+||.||++... +|+.+++|.+.... ......+.+|++++.+++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999986532 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
.+++.+... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 999865332 45899999999999999999999885 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=188.24 Aligned_cols=150 Identities=31% Similarity=0.520 Sum_probs=134.9
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++.|+..+.||+|++|.||++... ++..+++|.+..... ..+.+.+|++.+.+++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888889999999999999976 688999999976544 45678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+++++|.+++.+.. ..+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999996533 3699999999999999999999987 49999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.7e-21 Score=187.63 Aligned_cols=142 Identities=28% Similarity=0.466 Sum_probs=126.7
Q ss_pred cccCCcccEEEEEecC-CcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
||+|+||.||+++..+ |+.+++|.+..... ...+.+.+|++++.+++||||+++++.+..++..++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999875533 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
.+++.+.. .+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++....+
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 99996432 5899999999999999999999885 999999999999999999999999998875433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=187.81 Aligned_cols=149 Identities=29% Similarity=0.415 Sum_probs=132.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..+.||+|++|.||++... +++.|++|.+.... ....+++.+|++++++++||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777789999999999999976 58899999987653 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++++|.+++.... ..+++.....++.|++.||.|||+ . +++|+||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999986532 568899999999999999999998 5 59999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=185.33 Aligned_cols=156 Identities=29% Similarity=0.473 Sum_probs=131.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIY 466 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 466 (558)
+|+..+.||.|+||.||++... ++..+++|.+... .....+.+.+|++++++++|+||+++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677789999999999999864 6789999988643 23345678899999999999999999998764 45689999
Q ss_pred EcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||+++++|.+++... .....+++...+.++.+|+.||.|||..+ ..+++|+||||+||++++++.+||+|||+++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 22456999999999999999999999332 336999999999999999999999999999987
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 5443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=186.65 Aligned_cols=152 Identities=29% Similarity=0.493 Sum_probs=132.5
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC------
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ------ 460 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------ 460 (558)
++++|...+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+.++.++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999975 578899998875543 346789999999999 7999999999997644
Q ss_pred EEEEEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886432 2456899999999999999999999875 99999999999999999999999999
Q ss_pred ceeeC
Q 008634 540 ARIFG 544 (558)
Q Consensus 540 a~~~~ 544 (558)
++...
T Consensus 160 ~~~~~ 164 (275)
T cd06608 160 SAQLD 164 (275)
T ss_pred ceecc
Confidence 98654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-21 Score=187.50 Aligned_cols=142 Identities=27% Similarity=0.450 Sum_probs=129.1
Q ss_pred ccccccCCcccEEEEE-ecCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
.+.||+|+++.|-.++ +.+|.++|||++.+.....+....+|++++..+ .|+||+.|+.+++++...|||+|-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999999887 668999999999999888889999999999999 59999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc---EEEEecCcceee
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIF 543 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DFGla~~~ 543 (558)
|..++++ ...+++.+..++..+|+.||+|||.++ |.||||||+|||-.+... +||+||.|+.-+
T Consensus 163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 9999965 346899999999999999999999986 999999999999976554 799999887654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=189.77 Aligned_cols=143 Identities=29% Similarity=0.462 Sum_probs=128.2
Q ss_pred ccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
..+||+|+||.||++... ++..|+||++..........+.+|+.++.+++|+|++++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999874 6889999998765555567799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
.+++.. ..+++.....++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 988743 34899999999999999999999885 99999999999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=183.73 Aligned_cols=151 Identities=28% Similarity=0.441 Sum_probs=131.1
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...+.||+|+||.||++... +++.+++|.+... .......+.+|++++++++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677889999999999999864 6889999998654 233466789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++.+.. ...+++..+..++.+++.+|.|||+++ ++|+||||+||+++++ +.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999996532 345899999999999999999999884 9999999999999854 56899999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=188.89 Aligned_cols=162 Identities=28% Similarity=0.327 Sum_probs=137.8
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc---chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.-++|...++||+|.||+|-.++-+ .++-.|+|++++.-.. ....-+.|-++|...+||.+..|--.++.++.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3478888999999999999999854 6899999999876433 23445789999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||..||.|..+|.+ ...+++.+...+...|..||.|||++ +||.||||.+|.|||.+|++||.||||.|--.
T Consensus 246 VMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999988843 34588888888999999999999997 49999999999999999999999999998654
Q ss_pred CCCCccCcccccCC
Q 008634 545 GNQNQANTNIIAGT 558 (558)
Q Consensus 545 ~~~~~~~t~~~~Gt 558 (558)
.+... +..++||
T Consensus 320 ~~g~t--~kTFCGT 331 (516)
T KOG0690|consen 320 KYGDT--TKTFCGT 331 (516)
T ss_pred cccce--eccccCC
Confidence 44333 3347887
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=188.16 Aligned_cols=151 Identities=27% Similarity=0.414 Sum_probs=130.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 466 (558)
++|...++||.|++|.||++... +++.+++|.+..... .....+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999975 578899998875433 3456789999999999999999999998654 4689999
Q ss_pred EcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||+++++|.+++... .....+++.....++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999887542 23445899999999999999999999875 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=205.28 Aligned_cols=154 Identities=23% Similarity=0.384 Sum_probs=118.9
Q ss_pred HcCCCCcccccccCCcccEEEEEecC--CcEEEEEE--------------cc---ccCccchHHHHHHHHHHhcCCCCCe
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKR--------------LS---RTSGQGLQEFKNEVNLIAKLQHKNL 449 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~--g~~VaVK~--------------l~---~~~~~~~~~~~~Ei~~l~~l~H~ni 449 (558)
..++|...++||+|+||.||++..+. +...++|. +. .........+.+|+.++.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999987542 22222221 11 1112234568899999999999999
Q ss_pred eeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 450 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
+++++++...+..++|+|++. ++|.+++..... ...........|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 566666643221 112334566789999999999999985 99999999999999
Q ss_pred CCCcEEEEecCcceeeCCC
Q 008634 528 DDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~~~ 546 (558)
.++.+||+|||+++.+...
T Consensus 302 ~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCEEEEeCCCceecCcc
Confidence 9999999999999987644
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=193.56 Aligned_cols=149 Identities=30% Similarity=0.531 Sum_probs=127.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC--CEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG--QELL 463 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~~ 463 (558)
.++|...++||+|+||.||+|... ++..+++|++... .......+..|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999975 5889999988643 233345677899999999 999999999998654 4689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|+||++ ++|..++.+. .++|..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 5898888432 6889999999999999999999874 999999999999999999999999999876
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
...
T Consensus 158 ~~~ 160 (337)
T cd07852 158 SEL 160 (337)
T ss_pred ccc
Confidence 443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=189.35 Aligned_cols=152 Identities=29% Similarity=0.519 Sum_probs=129.4
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ---- 460 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 460 (558)
...++|+..++||+|+||.||+|... +|+.|++|+++.... .....+.+|++++.+++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567889999999999999999976 588999999875432 22356788999999999999999999987654
Q ss_pred ------EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 461 ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 461 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
..++|+||+++ ++..++... ...+++.....++.||+.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 666666432 346899999999999999999999884 999999999999999999999
Q ss_pred EecCcceeeCC
Q 008634 535 SDFGLARIFGG 545 (558)
Q Consensus 535 ~DFGla~~~~~ 545 (558)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=183.88 Aligned_cols=142 Identities=27% Similarity=0.371 Sum_probs=126.4
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
||.|+||.||+++.. +++.+++|.+.+... ...+.+.+|+.++.+++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 488999999875432 3356799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999543 34899999999999999999999874 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-21 Score=213.10 Aligned_cols=150 Identities=34% Similarity=0.511 Sum_probs=123.0
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (558)
+..++|+..+.||+||||.|||++.+ ||+.+|||++.-. +.+....+.+|+..+++|+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45567888899999999999999976 8999999999755 334456788999999999999999998755210
Q ss_pred --------------------------------------------------------------------------------
Q 008634 460 -------------------------------------------------------------------------------- 459 (558)
Q Consensus 460 -------------------------------------------------------------------------------- 459 (558)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 008634 460 ---------------------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506 (558)
Q Consensus 460 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL 506 (558)
--+|+=||||+..++.+++.+..... .-...++++.+|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 01467788888887777775422111 3556789999999999999
Q ss_pred HhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 507 H~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
|+.+ ||||||||.||+||++..|||+|||+|+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 9986 99999999999999999999999999997
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-20 Score=186.06 Aligned_cols=149 Identities=32% Similarity=0.557 Sum_probs=126.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 688999999865432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~~~ 544 (558)
|++ ++|.+++... ....+++.....++.||+.||.|||+.+ ++|+||+|+||+++. ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 5777776432 2334688888899999999999999874 999999999999985 5679999999998764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=184.11 Aligned_cols=151 Identities=28% Similarity=0.476 Sum_probs=131.0
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...+.||+|+||.||++... +|..+++|.+.... ....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999976 57889999986542 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++.+. ....++|..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||++.....+
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998643 2335899999999999999999999875 99999999999999875 5799999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-20 Score=185.85 Aligned_cols=141 Identities=31% Similarity=0.381 Sum_probs=118.2
Q ss_pred ccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHH---HhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNL---IAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~---l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..+ +...+|||++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865422 112234445443 334579999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+|+|.+++.+ ...++|.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999998854 235899999999999999999999985 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=175.39 Aligned_cols=142 Identities=19% Similarity=0.247 Sum_probs=112.7
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccc--------------------------hHHHHHHHHHHhcCCCCCe
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG--------------------------LQEFKNEVNLIAKLQHKNL 449 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~ni 449 (558)
...||+|+||.||+|...+|+.||||++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 45799999999999998789999999987642210 1123578999999999988
Q ss_pred eeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEEcC
Q 008634 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDD 528 (558)
Q Consensus 450 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlk~~NILl~~ 528 (558)
.....+... ..++||||++++++..... ....++......++.+++.+|.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655544433 2489999999886543321 12347788889999999999999998 64 99999999999999
Q ss_pred CCcEEEEecCcceeeCCC
Q 008634 529 DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 529 ~~~~ki~DFGla~~~~~~ 546 (558)
++.++|+|||+++..+.+
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 889999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=188.69 Aligned_cols=150 Identities=32% Similarity=0.480 Sum_probs=133.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 465 (558)
++|...+.||+|+||.||+++.. ++..|++|.+.+.. .+..+.+.+|++++.+++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999975 68999999987532 233467889999999998 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++++|.+++.+. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999643 36999999999999999999999885 99999999999999999999999999987754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-20 Score=181.12 Aligned_cols=152 Identities=24% Similarity=0.441 Sum_probs=134.8
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...+.||+|+||.||++... ++..+++|++..... ...+.+.+|++.+++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999975 588999999876533 4567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++.+.. ....+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999986532 2356999999999999999999999884 999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-20 Score=188.04 Aligned_cols=148 Identities=32% Similarity=0.526 Sum_probs=127.3
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.|...+.||+|+||.||+++.. ++..|++|++..... +....+.+|++++++++|||++++++++.+++..++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667788999999999999965 588999999874422 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++ +|.+++.. ....++|..+..++.+|+.||.|||+.+ ++||||+|+||+++.++.+||+|||+++....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9974 77766643 2345899999999999999999999885 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=185.40 Aligned_cols=148 Identities=30% Similarity=0.538 Sum_probs=129.3
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIYE 467 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 467 (558)
|...++||+|+||.||+|+.. ++..+++|++.... ....+.+.+|++++.+++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456778999999999999976 48899999998653 33345788999999999999999999999988 89999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++ +|.+++.+. ...+++..++.++.||++||.|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 888887543 246899999999999999999999874 999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=213.50 Aligned_cols=168 Identities=23% Similarity=0.292 Sum_probs=142.9
Q ss_pred HHHHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 008634 384 RLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG 459 (558)
Q Consensus 384 ~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 459 (558)
..+....++|.+.++||+|+||.|...+.+ +++.+|+|++++- ......-|..|-.+|..-+.+-|+.|+-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 444555678999999999999999999976 5788999999873 233345688999999999999999999999999
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
..+|+|||||+||+|-.++.+.. .+++.-...++..|..||+-||+.| +|||||||+|||||..|++||+|||-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999995433 5788888889999999999999875 99999999999999999999999999
Q ss_pred ceeeCCCCCccCcccccCC
Q 008634 540 ARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 540 a~~~~~~~~~~~t~~~~Gt 558 (558)
+-.+..|..-.+. ..|||
T Consensus 222 Clkm~~dG~V~s~-~aVGT 239 (1317)
T KOG0612|consen 222 CLKMDADGTVRSS-VAVGT 239 (1317)
T ss_pred HHhcCCCCcEEec-cccCC
Confidence 8888765543322 36777
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=186.26 Aligned_cols=157 Identities=28% Similarity=0.481 Sum_probs=132.5
Q ss_pred hHHHHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEe--
Q 008634 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE-- 458 (558)
Q Consensus 383 ~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-- 458 (558)
+..+..+.+.|+..+.||+|+||.||+|+.. +++.+++|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344456678888899999999999999974 57889999886543 2345688899999998 79999999999853
Q ss_pred ----CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 459 ----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 459 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
.+..+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999988643 2345888889999999999999999885 999999999999999999999
Q ss_pred EecCcceeeC
Q 008634 535 SDFGLARIFG 544 (558)
Q Consensus 535 ~DFGla~~~~ 544 (558)
+|||+++...
T Consensus 163 ~dfg~~~~~~ 172 (282)
T cd06636 163 VDFGVSAQLD 172 (282)
T ss_pred eeCcchhhhh
Confidence 9999988653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-21 Score=191.51 Aligned_cols=164 Identities=31% Similarity=0.409 Sum_probs=133.0
Q ss_pred CCCCcccccccCCcccEEEEE-ecCCcEEEEEEccccC--c-----cchHHHHHHHHHHhcCCCCCeeeeeEEEE-eCCE
Q 008634 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--G-----QGLQEFKNEVNLIAKLQHKNLVRLLGCCL-EGQE 461 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~--~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~ 461 (558)
++|-....||+|||+.|||+. +...+-||||+-.... . ...+...+|.++-..|+||-||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 345566789999999999998 4567889999754321 1 11344678999999999999999999985 4567
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecC
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFG 538 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFG 538 (558)
.+-|+|||+|.+|+.||.+ ...+++++...|+.||..||.||.+. .+||||-||||.||||.+ -|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 8899999999999999954 34589999999999999999999987 578999999999999954 4679999999
Q ss_pred cceeeCCCCCc-----cCcccccCC
Q 008634 539 LARIFGGNQNQ-----ANTNIIAGT 558 (558)
Q Consensus 539 la~~~~~~~~~-----~~t~~~~Gt 558 (558)
|+++++++... .-|.-.+||
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGT 643 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGT 643 (775)
T ss_pred hhhhccCCccCcccceeeecccCce
Confidence 99999766532 225556665
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=185.38 Aligned_cols=147 Identities=32% Similarity=0.564 Sum_probs=128.2
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
|+..++||+|++|.||+|... +|..|++|++.... ......+.+|++.+++++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999865 68999999987543 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+ ++|.+++.... ...+++..+..++.||++||.|||+. +++||||+|+||+++.++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68998885433 24589999999999999999999987 49999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=191.66 Aligned_cols=153 Identities=26% Similarity=0.359 Sum_probs=133.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccc--hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.-|..++-||+|.|..|-.++.- +|..||||++.+..-.. ...+..|++.|+-++|||||+|+.+.-.+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777888999999999988743 79999999998764433 4568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE-cCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-DDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl-~~~~~~ki~DFGla~~~~~~ 546 (558)
.=.+|+|.+|+.+..+ .+.+....+++.||..|+.|+|..+ +|||||||+||.+ ..-|.|||.|||++-.|.++
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976443 4889999999999999999999875 9999999999876 56789999999999998776
Q ss_pred CC
Q 008634 547 QN 548 (558)
Q Consensus 547 ~~ 548 (558)
+.
T Consensus 173 ~k 174 (864)
T KOG4717|consen 173 KK 174 (864)
T ss_pred ch
Confidence 54
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=197.61 Aligned_cols=147 Identities=29% Similarity=0.417 Sum_probs=126.5
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-C-----CCeeeeeEEEEeCCEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-H-----KNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l 464 (558)
+|.+.+.||+|.||.|-|+... +++.||||++++... ...+-..|+.+|..++ | -|+|++++++...++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6888999999999999999854 699999999986643 3455678999999996 4 589999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC--CcEEEEecCccee
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARI 542 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~--~~~ki~DFGla~~ 542 (558)
|+|.+ .-+|-++|+... -..++......|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|.+
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99987 458999996544 344899999999999999999999875 9999999999999654 4799999999986
Q ss_pred eC
Q 008634 543 FG 544 (558)
Q Consensus 543 ~~ 544 (558)
..
T Consensus 341 ~~ 342 (586)
T KOG0667|consen 341 ES 342 (586)
T ss_pred cC
Confidence 54
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=187.61 Aligned_cols=150 Identities=29% Similarity=0.533 Sum_probs=126.5
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (558)
-++|...++||+|+||.||++... +++.|+||.+..... .....+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888899999999999999865 588999998864422 22345678999999999999999999987654
Q ss_pred --EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 461 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
..++|+||+.+ +|..++.. ....+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999975 77777743 2335899999999999999999999884 9999999999999999999999999
Q ss_pred cceeeCC
Q 008634 539 LARIFGG 545 (558)
Q Consensus 539 la~~~~~ 545 (558)
+++.+..
T Consensus 165 ~~~~~~~ 171 (310)
T cd07865 165 LARAFSL 171 (310)
T ss_pred CcccccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=187.56 Aligned_cols=150 Identities=33% Similarity=0.545 Sum_probs=128.5
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (558)
.++|...++||+|+||.||+|... +|+.|++|++...... ....+.+|+.++.+++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999975 5899999998644322 233567899999999999999999998765 56899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+||+++ +|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 788887542 246899999999999999999999985 9999999999999999999999999999775
Q ss_pred C
Q 008634 545 G 545 (558)
Q Consensus 545 ~ 545 (558)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=190.89 Aligned_cols=149 Identities=28% Similarity=0.491 Sum_probs=127.9
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----- 460 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 460 (558)
..++|...+.||+|+||.||++... ++..||||++.... ....+.+.+|+.++.+++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567888999999999999999854 68999999986432 223456889999999999999999999987653
Q ss_pred -EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 461 -ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 461 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
..++|+||+ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 468999998 7789888742 35899999999999999999999875 99999999999999999999999999
Q ss_pred ceeeCC
Q 008634 540 ARIFGG 545 (558)
Q Consensus 540 a~~~~~ 545 (558)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07880 165 ARQTDS 170 (343)
T ss_pred cccccc
Confidence 987654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=190.93 Aligned_cols=148 Identities=28% Similarity=0.489 Sum_probs=126.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 462 (558)
+++|...++||+|+||.||+|+.. +|+.|++|.+.... ......+.+|+.++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999864 68999999987532 23356688999999999999999999987654 358
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||+++ +|..++. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 7776663 235899999999999999999999985 99999999999999999999999999987
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=182.65 Aligned_cols=141 Identities=31% Similarity=0.371 Sum_probs=118.5
Q ss_pred ccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHH---HHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVN---LIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
.||+|+||.||++... +++.||+|.+.+... +....+..|.. .+....||||+++++.+.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998875422 11223444443 4445689999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+|+|.+++.. ...++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999988853 346999999999999999999999874 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.8e-20 Score=182.72 Aligned_cols=146 Identities=27% Similarity=0.402 Sum_probs=123.4
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeC--CEEEEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIYE 467 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 467 (558)
|...++||+|+||.||+++.. ++..+++|+++... .........|+..+.++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456678999999999999865 68899999987542 222234467899999885 99999999999987 88999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|++ |+|.+++.+. ...++|.....++.||+.||.|||+.+ ++||||||+||+++. +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 5777777542 246899999999999999999999885 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.4e-20 Score=197.15 Aligned_cols=170 Identities=29% Similarity=0.496 Sum_probs=142.4
Q ss_pred ChHHHHHHcCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEe-
Q 008634 382 PLRLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE- 458 (558)
Q Consensus 382 ~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 458 (558)
.++.+...++.|.+.+.||+|.+|.||+++. ++++.+|+|++...... .+++..|..++... +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3344445678899999999999999999984 47888999988755332 35667788888887 79999999999864
Q ss_pred ----CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 459 ----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 459 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
++++|||||||.+|+..+++.... ...+.|....-|+..++.||.+||.. .++|||||-.||||+.++.||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 478999999999999999987654 66799999999999999999999988 4999999999999999999999
Q ss_pred EecCcceeeCCCCCccCcccccCC
Q 008634 535 SDFGLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 535 ~DFGla~~~~~~~~~~~t~~~~Gt 558 (558)
.|||++...........| .+||
T Consensus 165 vDFGvSaQldsT~grRnT--~iGt 186 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNT--FIGT 186 (953)
T ss_pred eeeeeeeeeecccccccC--cCCC
Confidence 999999988765554444 4565
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-20 Score=185.59 Aligned_cols=148 Identities=28% Similarity=0.392 Sum_probs=128.3
Q ss_pred CCCcccccccCCcccEEEEEe----cCCcEEEEEEccccC----ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~VaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (558)
+|...+.||+|++|.||+++. .+++.|+||.+.+.. ....+.+.+|+.++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999874 256889999887532 22345688999999999 699999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++|+|.+++.. ...+++.....++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999854 235889999999999999999999874 99999999999999999999999999987
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=179.82 Aligned_cols=142 Identities=25% Similarity=0.370 Sum_probs=120.1
Q ss_pred cccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHH-hcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLI-AKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+.||+|+||.||+|... +++.|++|.+.+... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 588999999875432 2223445555444 455899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999998542 35889999999999999999999874 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=181.42 Aligned_cols=152 Identities=30% Similarity=0.489 Sum_probs=132.8
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|+..++||+|+||.||++... ++..+++|.+.... .....++.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999754 67899999987542 23356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++++|.+++.+.. ....+++...+.++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999986532 2346899999999999999999999885 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=190.08 Aligned_cols=148 Identities=33% Similarity=0.475 Sum_probs=126.4
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (558)
..+.|...+.||+|+||.||++... +++.|++|.+.+. .....+.+.+|+.++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467888999999999999999865 6899999998653 233345678899999999999999999998643
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
...++|+||+. ++|.+.+.. .+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 477777632 2888999999999999999999985 99999999999999999999999999
Q ss_pred ceeeCC
Q 008634 540 ARIFGG 545 (558)
Q Consensus 540 a~~~~~ 545 (558)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=190.46 Aligned_cols=149 Identities=23% Similarity=0.458 Sum_probs=128.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 462 (558)
.++|+..+.||+|+||.||++... +|..|++|++.... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999865 58999999987542 2345677889999999999999999998763 3468
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 688888843 334899999999999999999999874 99999999999999999999999999987
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
...
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-20 Score=193.12 Aligned_cols=151 Identities=23% Similarity=0.359 Sum_probs=128.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--------cchHHHHHHHHHHhcCC---CCCeeeeeEEEEe
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLE 458 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 458 (558)
.+|...+++|+|+||.|+.+..+ +..+|+||.+.+..- ..+-..-.||.+|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 34788899999999999999976 467899998876521 11223567999999997 9999999999999
Q ss_pred CCEEEEEEEcCC-CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 008634 459 GQELLLIYEYMP-NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (558)
Q Consensus 459 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DF 537 (558)
++..||+||-.. +.+|.+++.- ...+++.+..-|+.||+.|+++||+++ |||||||-+||.+|.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999774 5678888842 345899999999999999999999986 999999999999999999999999
Q ss_pred CcceeeCCCC
Q 008634 538 GLARIFGGNQ 547 (558)
Q Consensus 538 Gla~~~~~~~ 547 (558)
|-|.....++
T Consensus 715 gsaa~~ksgp 724 (772)
T KOG1152|consen 715 GSAAYTKSGP 724 (772)
T ss_pred cchhhhcCCC
Confidence 9988765554
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-20 Score=198.28 Aligned_cols=149 Identities=20% Similarity=0.266 Sum_probs=119.8
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCC------CCeeeeeEEEEeC-
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH------KNLVRLLGCCLEG- 459 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~~~~~- 459 (558)
..+++|.+.++||+|+||.||++... .++.||||+++... ....++..|+.++.+++| .+++++++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34678999999999999999999865 57889999986532 223455667777777654 4588999988765
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC---------
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM--------- 530 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~--------- 530 (558)
+..++|||++ +++|.+++.+. ..+++.....|+.||+.||.|||++. +||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence 5788999987 67888887542 45899999999999999999999741 499999999999998765
Q ss_pred -------cEEEEecCcceee
Q 008634 531 -------NPKISDFGLARIF 543 (558)
Q Consensus 531 -------~~ki~DFGla~~~ 543 (558)
.+||+|||++...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred ccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-20 Score=183.50 Aligned_cols=148 Identities=32% Similarity=0.464 Sum_probs=127.8
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
|...+.||+|+||.||+|+.. +++.|+||++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999976 478899999875432 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+|+|.+++.... ...++|..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 889988886433 346899999999999999999999874 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=188.64 Aligned_cols=153 Identities=31% Similarity=0.464 Sum_probs=129.2
Q ss_pred HHHHHHcCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-
Q 008634 384 RLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG- 459 (558)
Q Consensus 384 ~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~- 459 (558)
..+...+++|...+.||+|+||.||++.. .++..||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34455778999999999999999999985 468899999987542 22345688899999999999999999988643
Q ss_pred -----CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 460 -----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 460 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
...++++|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888876 7899887742 34899999999999999999999885 999999999999999999999
Q ss_pred EecCcceeeC
Q 008634 535 SDFGLARIFG 544 (558)
Q Consensus 535 ~DFGla~~~~ 544 (558)
+|||+++...
T Consensus 162 ~dfg~~~~~~ 171 (345)
T cd07877 162 LDFGLARHTD 171 (345)
T ss_pred eccccccccc
Confidence 9999998654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-19 Score=178.46 Aligned_cols=147 Identities=23% Similarity=0.285 Sum_probs=120.5
Q ss_pred HcCCCCccccc--ccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEE
Q 008634 389 ATNHFSDENKL--GQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 389 ~t~~f~~~~~L--G~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 464 (558)
..++|...+.+ |+|+||.||+++.+ ++..+++|.+........ |+.....+ +|||++++++.+..++..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566666665 99999999999865 578899998865432211 22222212 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceee
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 543 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~ 543 (558)
||||+++++|.+++... ..++|.....++.||++||.|||+.+ ++||||||+||+++.++ .+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999543 26899999999999999999999985 99999999999999988 9999999999876
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
...
T Consensus 161 ~~~ 163 (267)
T PHA03390 161 GTP 163 (267)
T ss_pred CCC
Confidence 543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-19 Score=182.71 Aligned_cols=145 Identities=33% Similarity=0.527 Sum_probs=124.9
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
|...++||+|+||.||+|+.. ++..|++|++..... ...+.+.+|++++.+++|||++++++++.+.+..++|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999865 588999999874422 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+. |++.+++.. ....++|..+..++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 567766643 2345899999999999999999999885 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=185.14 Aligned_cols=144 Identities=22% Similarity=0.227 Sum_probs=122.7
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++.+++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666555 6899999998754 34456789999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|.+++.+.. ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999996532 345889999999999999999999884 9999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=193.80 Aligned_cols=148 Identities=25% Similarity=0.373 Sum_probs=129.1
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
....|...+-||-|.||+|..+..- +...+|+|.|.+.+- ......+.|..+|+..+.+-||+|+-.|.+++.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 3456777888999999999999744 456789999987653 334457889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
||||++||++..+|.+ -+.+.+.....++.++..|+++.|..| +|||||||+|||||.+|.+||.||||..=
T Consensus 707 VMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 9999999999999853 456888888889999999999999875 99999999999999999999999999763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=186.75 Aligned_cols=150 Identities=31% Similarity=0.513 Sum_probs=128.7
Q ss_pred HHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCEE
Q 008634 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQEL 462 (558)
Q Consensus 387 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 462 (558)
...+++|+..+.||+|+||.||++... ++..|++|++.+.. ....+.+..|++++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999855 68999999886432 2335678899999999999999999999876 4678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||+ +++|..++.. ..+++.....++.||++||.|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 5688888742 34788888899999999999999885 99999999999999999999999999986
Q ss_pred eC
Q 008634 543 FG 544 (558)
Q Consensus 543 ~~ 544 (558)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=183.31 Aligned_cols=150 Identities=27% Similarity=0.446 Sum_probs=126.0
Q ss_pred CCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|+||.||++...+ ++.|+||.++.... ....++..|+.++.+. +||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788899999999999999864 88999999875432 2345667788777776 49999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|++ +++..++... ...+++..+..++.||+.||.|||+.. +|+||||+|+||++++++.+||+|||+++.+..
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 4676666432 236899999999999999999999742 599999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=187.98 Aligned_cols=149 Identities=26% Similarity=0.486 Sum_probs=127.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (558)
.++|...+.||+|+||.||+++.. ++..|+||.+... .......+.+|+.++.+++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888899999999999999864 6899999998754 233345678899999999999999999988654 35
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++|+||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 899999996 688888743 345899999999999999999999885 9999999999999999999999999998
Q ss_pred eeCC
Q 008634 542 IFGG 545 (558)
Q Consensus 542 ~~~~ 545 (558)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7644
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-20 Score=187.74 Aligned_cols=148 Identities=30% Similarity=0.481 Sum_probs=130.0
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-----EEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL 463 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 463 (558)
+|...++||+|+||.||+++.. ++..|++|++.... ....+.+..|+..+..++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677889999999999999975 48899999987653 344567899999999999999999999998775 789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|+||++ ++|..++.+. ..+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 4788888532 36999999999999999999999985 999999999999999999999999999987
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=186.14 Aligned_cols=147 Identities=27% Similarity=0.452 Sum_probs=125.9
Q ss_pred CCCC-cccccccCCcccEEEEEec-CCcEEEEEEccccCccc--------------hHHHHHHHHHHhcCCCCCeeeeeE
Q 008634 391 NHFS-DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG--------------LQEFKNEVNLIAKLQHKNLVRLLG 454 (558)
Q Consensus 391 ~~f~-~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g 454 (558)
++|. ..+.||+|+||.||++... +++.|+||++....... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 3567999999999999965 68899999886542211 124778999999999999999999
Q ss_pred EEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 455 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
++..++..++||||++ |+|.+++.. ...+++.....++.||+.||.|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888843 335889999999999999999999875 999999999999999999999
Q ss_pred EecCcceeeC
Q 008634 535 SDFGLARIFG 544 (558)
Q Consensus 535 ~DFGla~~~~ 544 (558)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=184.73 Aligned_cols=147 Identities=31% Similarity=0.437 Sum_probs=123.2
Q ss_pred CCCcccccccCCcccEEEEEec-C--CcEEEEEEccccC--ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC----CE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-D--GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG----QE 461 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~--g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 461 (558)
+|...+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667789999999999999965 3 6789999987532 22346788999999999 599999999976543 45
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++++||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788889886 688888843 345899999999999999999999885 9999999999999999999999999998
Q ss_pred eeCC
Q 008634 542 IFGG 545 (558)
Q Consensus 542 ~~~~ 545 (558)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=178.78 Aligned_cols=149 Identities=32% Similarity=0.560 Sum_probs=124.7
Q ss_pred CCcccccccCCcccEEEEEecC-CcEEEEEEccccCcc--chHHHHHHHHHHhcC---CCCCeeeeeEEEEeCCE-----
Q 008634 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQE----- 461 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 461 (558)
|+..++||+|+||.||+++... +..+++|++...... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567889999999999999864 899999999744222 234566787776655 69999999999998776
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++++||+++ +|.+++.... ...++|..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999974 7888885432 235899999999999999999999874 9999999999999999999999999998
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=180.62 Aligned_cols=147 Identities=35% Similarity=0.545 Sum_probs=129.3
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
|+..++||+|++|.||+|+.. +++.+++|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999976 48999999998653 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+ ++|.+++.+.. ..+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58999986532 45899999999999999999999985 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=180.32 Aligned_cols=149 Identities=30% Similarity=0.516 Sum_probs=129.4
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
|...+.||+|++|.||++... +++.+++|.+...... ....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999875 6889999998755332 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
++ +|..++... ...+++..+..++.+|+.||.|||+.+ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 888777542 246899999999999999999999885 9999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-19 Score=182.17 Aligned_cols=148 Identities=34% Similarity=0.537 Sum_probs=126.7
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.|...+.||+|+||.||+|+.. ++..+++|.+... .....+++.+|++++++++|+|++++++++..+...++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3566678999999999999965 5788999988643 22334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+. |++.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 997 5777766432 235899999999999999999999874 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=181.69 Aligned_cols=150 Identities=28% Similarity=0.408 Sum_probs=124.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+|...++||+|+||.||++... +++.+++|.+.... ......+.+|+.++.++. |+||+++++++..++..++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999865 58899999987543 234567889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+.. ++.++... ......+++.....++.+++.||.|||+.. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 54443211 122356899999999999999999999752 59999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=184.39 Aligned_cols=141 Identities=26% Similarity=0.350 Sum_probs=122.3
Q ss_pred cccccC--CcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G--~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
+.||+| +||.||+++.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 88999999864 68999999987543 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
++|.+++.+.. ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+|++|||.+.
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 99999986532 235899999999999999999999874 9999999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-19 Score=174.98 Aligned_cols=142 Identities=33% Similarity=0.467 Sum_probs=126.4
Q ss_pred cccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
||+|+||.||++... +++.+++|.+.+... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 488999999876532 2356789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999543 2589999999999999999999987 4999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=200.30 Aligned_cols=157 Identities=32% Similarity=0.452 Sum_probs=133.9
Q ss_pred HHcCCCCcccccccCCcccEEEEEecC--------CcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL 457 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~~--------g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 457 (558)
...+++...+.||+|.||.|++|.+.. ...||||.++... ..+.+.+..|+++|..+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 334455666799999999999997431 3579999998653 34577899999999999 6999999999999
Q ss_pred eCCEEEEEEEcCCCCCHHHHHhccC-----C------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 008634 458 EGQELLLIYEYMPNKSLDVHLFDAT-----R------S--VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (558)
Q Consensus 458 ~~~~~~lV~Ey~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NI 524 (558)
..+..++|.||++.|+|.++|.+.+ . . ..++....+.++.|||.||+||++. ++|||||.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999998655 0 0 2388899999999999999999987 599999999999
Q ss_pred EEcCCCcEEEEecCcceeeCCCC
Q 008634 525 LLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 525 Ll~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+.++..+||+||||||....+.
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred EecCCCEEEEccccceeccCCCC
Confidence 99999999999999999765443
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.3e-19 Score=179.38 Aligned_cols=149 Identities=21% Similarity=0.284 Sum_probs=111.1
Q ss_pred cCCCCcccccccCCcccEEEEEecC----CcEEEEEEccccCccch-----------HHHHHHHHHHhcCCCCCeeeeeE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGL-----------QEFKNEVNLIAKLQHKNLVRLLG 454 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~g 454 (558)
.+.|.+.++||+|+||.||+|...+ +..+++|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578899999999999999998654 34556665432221110 11223344566779999999999
Q ss_pred EEEeCC----EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC
Q 008634 455 CCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (558)
Q Consensus 455 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~ 530 (558)
++.... ..++++|++.. ++.+.+... ...++.....|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876543 44778887654 555555321 23578888999999999999999874 99999999999999999
Q ss_pred cEEEEecCcceeeCC
Q 008634 531 NPKISDFGLARIFGG 545 (558)
Q Consensus 531 ~~ki~DFGla~~~~~ 545 (558)
.+||+|||+|+.+..
T Consensus 164 ~~~l~DFGla~~~~~ 178 (294)
T PHA02882 164 RGYIIDYGIASHFII 178 (294)
T ss_pred cEEEEEcCCceeecc
Confidence 999999999998753
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=177.93 Aligned_cols=150 Identities=29% Similarity=0.463 Sum_probs=124.2
Q ss_pred CCCcccccccCCcccEEEEEecC-CcEEEEEEcccc-----CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
+|...++||+|+||.||++.... +..+++|.++.. ......++..|+.++.+++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36778899999999999998653 444555555432 122334577899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 466 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+||+++++|.+++.+. .....++|...+.++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988643 23356999999999999999999999874 999999999999975 569999999998774
Q ss_pred C
Q 008634 545 G 545 (558)
Q Consensus 545 ~ 545 (558)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=182.97 Aligned_cols=150 Identities=35% Similarity=0.556 Sum_probs=126.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (558)
.++|...++||+|+||.||+++.. +++.+++|++...... ....+.+|++++.+++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467889999999999999999965 5889999988654322 2346788999999999999999999875533
Q ss_pred --EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 461 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 461 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
..++|+||+.+ +|...+.. ....+++.....++.||++||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999875 56666643 2346899999999999999999999985 9999999999999999999999999
Q ss_pred cceeeCC
Q 008634 539 LARIFGG 545 (558)
Q Consensus 539 la~~~~~ 545 (558)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=207.85 Aligned_cols=151 Identities=31% Similarity=0.450 Sum_probs=131.8
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
+-++.....||.|.||.||.+.. .+|.-.|+|-+.-.+ ....+...+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44567778999999999999984 568888999776543 344567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|||++|+|.+.+... ..+++.....+..|++.|+.|||++| ||||||||.||+|+.+|.+|++|||-|+.+.++
T Consensus 1314 EyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999998543 33666667778899999999999996 999999999999999999999999999998766
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=186.31 Aligned_cols=147 Identities=30% Similarity=0.511 Sum_probs=126.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC---------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--------- 459 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------- 459 (558)
..+|...+.||+|+||.||+|... ++..|++|++........+.+.+|++++.+++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 357888999999999999999865 5889999999776666677889999999999999999999876543
Q ss_pred -----CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEE
Q 008634 460 -----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPK 533 (558)
Q Consensus 460 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~k 533 (558)
...++|+||++ ++|.+++.+ ..+++.....++.||+.||.|||+.+ ++||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35799999997 588887742 35889999999999999999999885 99999999999997 456799
Q ss_pred EEecCcceeeC
Q 008634 534 ISDFGLARIFG 544 (558)
Q Consensus 534 i~DFGla~~~~ 544 (558)
|+|||+++...
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=185.24 Aligned_cols=162 Identities=25% Similarity=0.396 Sum_probs=138.6
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccc--cCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 466 (558)
...|++.++||.||-+.||++...+.+.+|+|++.. .+.+..+.|.+|+.+|.+| .|.+|++|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456888999999999999999998888999998763 4667788999999999999 5999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|| ...+|..+|.+.. ....+| .+..+..||+.++.++|.++ |||.||||.|+|+- .|.+||+|||+|+.+..|
T Consensus 440 E~-Gd~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 EC-GDIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ec-ccccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 95 6789999996543 333456 56789999999999999985 99999999999994 567999999999999988
Q ss_pred CCccCcccccCC
Q 008634 547 QNQANTNIIAGT 558 (558)
Q Consensus 547 ~~~~~t~~~~Gt 558 (558)
.+.......+||
T Consensus 513 TTsI~kdsQvGT 524 (677)
T KOG0596|consen 513 TTSIVKDSQVGT 524 (677)
T ss_pred ccceeeccccCc
Confidence 776555556776
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=5e-19 Score=183.57 Aligned_cols=146 Identities=30% Similarity=0.519 Sum_probs=124.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 460 (558)
.++|...+.||+|+||.||+|+.. +|+.|++|++.+.. ......+.+|+.++.+++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888899999999999999964 68999999987542 22345688999999999999999999998754 3
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++|+||+.. +|..++ ...+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 56999999964 676654 224899999999999999999999885 999999999999999999999999999
Q ss_pred eeeC
Q 008634 541 RIFG 544 (558)
Q Consensus 541 ~~~~ 544 (558)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-20 Score=166.70 Aligned_cols=155 Identities=26% Similarity=0.408 Sum_probs=128.6
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (558)
..+.+.....||+|++|.|-+-++. +|..+|+|++... ..+..++.++|+.+..+. ..|.+|+++|...+....|+.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3444555678999999999888754 7999999999754 445567788999887665 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 466 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||.|. .+|+.|-.+- .+...+++...-+|+..|.+||.|||++ +.+||||+||+||||+.+|++||+|||++-.+.
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99885 5777665432 3455688999999999999999999986 579999999999999999999999999988764
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
..
T Consensus 201 dS 202 (282)
T KOG0984|consen 201 DS 202 (282)
T ss_pred hh
Confidence 43
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.3e-21 Score=193.02 Aligned_cols=157 Identities=27% Similarity=0.366 Sum_probs=135.9
Q ss_pred CCcccccccCCcccEEEEEecCCc-EEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 393 FSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~g~-~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+....-||-|+||.|-........ .+|+|.+++. +.+..+....|-.+|..++.|.||+|+..+.+.+..|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 333446999999999998876433 4788888765 334456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
|-||.|+..|.+ ++.++..+...++..+.+|++|||.++ ||.|||||+|.|||.+|-+||.|||+||.+..+..
T Consensus 502 ClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 502 CLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999999954 456888999999999999999999985 99999999999999999999999999999976653
Q ss_pred ccCcccccCC
Q 008634 549 QANTNIIAGT 558 (558)
Q Consensus 549 ~~~t~~~~Gt 558 (558)
|..++||
T Consensus 576 ---TwTFcGT 582 (732)
T KOG0614|consen 576 ---TWTFCGT 582 (732)
T ss_pred ---eeeecCC
Confidence 6778887
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-20 Score=171.28 Aligned_cols=146 Identities=23% Similarity=0.462 Sum_probs=125.8
Q ss_pred cCCCCcccccccCCcccEEEEE-ecCCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeC--CEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV 465 (558)
.++|++.+++|+|.+++|+.|. ..+.+.++||.++... .+.+.+|+.+|..+. ||||++|++...++ ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678888999999999999998 4578889999998653 357889999999997 99999999999876 457899
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecCcceeeC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFG 544 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFGla~~~~ 544 (558)
+||+.+.+...+- ..|+......++.+++.||.|+|+.| |+|||+||.||+||.. ...+|+|+|||.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998887654 23667777889999999999999986 9999999999999965 469999999999997
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
..+
T Consensus 185 p~~ 187 (338)
T KOG0668|consen 185 PGK 187 (338)
T ss_pred CCc
Confidence 665
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.6e-19 Score=167.88 Aligned_cols=139 Identities=20% Similarity=0.352 Sum_probs=108.1
Q ss_pred CCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcC-----CCCCeeeeeEEEEeCC---E-EE
Q 008634 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-----QHKNLVRLLGCCLEGQ---E-LL 463 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 463 (558)
+...+.||+|+||.||. ...++.. +||++........+.+.+|+.++..+ +||||++++|+++++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 3233444 69988765555567899999999999 6799999999999873 4 33
Q ss_pred EEEEc--CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCCEEEcC----CCcEEEEe
Q 008634 464 LIYEY--MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI-LYLHEDSRLKIIHRDLKASNILLDD----DMNPKISD 536 (558)
Q Consensus 464 lV~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivHrDlk~~NILl~~----~~~~ki~D 536 (558)
+|+|| +++|+|.+++.+. .+++. ..++.+++.++ .|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 5589999999542 25555 35677888787 8999985 999999999999974 34799999
Q ss_pred -cCccee
Q 008634 537 -FGLARI 542 (558)
Q Consensus 537 -FGla~~ 542 (558)
||....
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 555444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-21 Score=180.05 Aligned_cols=154 Identities=29% Similarity=0.472 Sum_probs=127.7
Q ss_pred CcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CEEEEE
Q 008634 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELLLI 465 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV 465 (558)
+-++.||-|.||.||..+.+ +|+.|+.|++...- -...+.+.+|+++|.-++|.|++..+++..-. .++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34678999999999999865 69999999987542 23356789999999999999999999887654 367888
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+|.|. .+|...+. .+..|+-....-+..||++||.|||+. +|+||||||.|.|++.+...||+||||||..+.
T Consensus 136 TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 88874 46666663 344577788888899999999999998 499999999999999999999999999999988
Q ss_pred CCCccCccc
Q 008634 546 NQNQANTNI 554 (558)
Q Consensus 546 ~~~~~~t~~ 554 (558)
++...+|.-
T Consensus 209 d~~~hMTqE 217 (449)
T KOG0664|consen 209 RDRLNMTHE 217 (449)
T ss_pred hhhhhhHHH
Confidence 887766643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-19 Score=184.67 Aligned_cols=149 Identities=31% Similarity=0.499 Sum_probs=128.4
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE----
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE---- 461 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 461 (558)
..++|...+.||+|++|.||+|+.. ++..|++|++... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999975 5789999998753 22334567889999999999999999998876654
Q ss_pred --EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 462 --LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 462 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888843 35899999999999999999999875 99999999999999999999999999
Q ss_pred ceeeCC
Q 008634 540 ARIFGG 545 (558)
Q Consensus 540 a~~~~~ 545 (558)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-21 Score=178.48 Aligned_cols=151 Identities=32% Similarity=0.625 Sum_probs=121.5
Q ss_pred CCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeC--------CE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEG--------QE 461 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~ 461 (558)
|....++|+|.||+||+++.+ +|+.|++|++--.. ..+ -...++|+++|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444568999999999999966 47788888764322 222 23457899999999999999999988542 35
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++|+++|+. +|.-+|.+ ....++..++.+++.++..||.|+|.. .|+|||+||.||||+.++.+||+|||+||
T Consensus 99 ~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 8999999975 56656632 334588888999999999999999987 59999999999999999999999999999
Q ss_pred eeCCCCCc
Q 008634 542 IFGGNQNQ 549 (558)
Q Consensus 542 ~~~~~~~~ 549 (558)
.+....+.
T Consensus 173 ~fs~~~n~ 180 (376)
T KOG0669|consen 173 AFSTSKNV 180 (376)
T ss_pred ceeccccc
Confidence 88755543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=165.73 Aligned_cols=149 Identities=35% Similarity=0.522 Sum_probs=133.2
Q ss_pred CCcccccccCCcccEEEEEecC-CcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999875 889999999876554 67789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++|.+++..... .+++.....++.+++.+|.|||+. +++|+||+|+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999864322 178999999999999999999988 4999999999999999999999999999988654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-19 Score=173.12 Aligned_cols=161 Identities=24% Similarity=0.373 Sum_probs=138.1
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 464 (558)
.++|...++||+|++.+|..+++. +.+.+|+|++++. +.++.+....|-.++... +||.+|.|..+++....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888999999999999999875 5778899998764 445567788888888877 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|.||+++|+|..++.+ +.+|+++....+...|..||.|||+.+ ||.||||..|||||.++.+||.|+|+.|.--
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999877754 345999999999999999999999986 9999999999999999999999999999754
Q ss_pred CCCCccCcccccCC
Q 008634 545 GNQNQANTNIIAGT 558 (558)
Q Consensus 545 ~~~~~~~t~~~~Gt 558 (558)
.+...+ ..++||
T Consensus 403 ~~gd~t--stfcgt 414 (593)
T KOG0695|consen 403 GPGDTT--STFCGT 414 (593)
T ss_pred CCCccc--ccccCC
Confidence 444333 347776
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=169.66 Aligned_cols=132 Identities=20% Similarity=0.213 Sum_probs=115.1
Q ss_pred CCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhc
Q 008634 402 GGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480 (558)
Q Consensus 402 G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 480 (558)
|.+|.||+++.. +++.+++|++.... .+.+|...+....|||++++++++.+.+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999865 68899999987653 234555666667899999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 481 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
. ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+|++|||+++...
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 3 34899999999999999999999875 9999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.3e-20 Score=174.60 Aligned_cols=151 Identities=30% Similarity=0.432 Sum_probs=124.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++++....||.|.||.|+|-..+ .|+.+|||++.... ..+.++++.|.+...+- +.||||+++|.+...+.-|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34455667999999999998865 69999999998654 35567899999876655 78999999999999999999999
Q ss_pred cCCCCCHHHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
.|. .+|+.+-.. ..+...+++...-+|...+..||.||.+. +.|||||+||+|||||..|.+||+|||++-.+.
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 984 466554321 12344588888889999999999999876 479999999999999999999999999976653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-19 Score=179.30 Aligned_cols=161 Identities=27% Similarity=0.344 Sum_probs=131.3
Q ss_pred cCCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCcc---chHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~---~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 464 (558)
..+|....+||+|+||.|..++-+. .+.+|||+|++.... +.+--..|-++|+.. +-|.++.+..+++.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3468888899999999999998664 567899999876322 122235566777766 57899999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+.+|+|..++.+-. .+.+.....++..||-||-|||+++ ||.||||.+|||||.+|.+||+|||+.+.--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999986543 3677788899999999999999986 9999999999999999999999999998643
Q ss_pred CCCCccCcccccCC
Q 008634 545 GNQNQANTNIIAGT 558 (558)
Q Consensus 545 ~~~~~~~t~~~~Gt 558 (558)
-+.. .|+.++||
T Consensus 502 ~~~~--TTkTFCGT 513 (683)
T KOG0696|consen 502 FDGV--TTKTFCGT 513 (683)
T ss_pred cCCc--ceeeecCC
Confidence 3222 24457776
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.1e-19 Score=169.90 Aligned_cols=149 Identities=26% Similarity=0.349 Sum_probs=123.3
Q ss_pred HcCCCCcc-cccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEe----CCE
Q 008634 389 ATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQE 461 (558)
Q Consensus 389 ~t~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~ 461 (558)
.+++|++. ++||-|-.|.|-.+..+ +|+.+|+|+|... ...++|+++--.. .|||||.++++++. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34556554 57999999999998865 6889999988644 3457888875444 69999999999865 357
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecC
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFG 538 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFG 538 (558)
+++|||.|+||.|...+.+.. ...+++.+.-.|+.||+.|+.|||+. +|.||||||+|+|.+. |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999986543 45699999999999999999999987 5999999999999964 5579999999
Q ss_pred cceeeCCC
Q 008634 539 LARIFGGN 546 (558)
Q Consensus 539 la~~~~~~ 546 (558)
+||.-..+
T Consensus 210 FAK~t~~~ 217 (400)
T KOG0604|consen 210 FAKETQEP 217 (400)
T ss_pred cccccCCC
Confidence 99987643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=190.58 Aligned_cols=150 Identities=24% Similarity=0.334 Sum_probs=107.0
Q ss_pred HcCCCCcccccccCCcccEEEEEec-C----CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEE------EE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-D----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC------CL 457 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~----g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~ 457 (558)
..++|...++||+|+||.||+|++. + +..||||++...... +...+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999975 4 689999988654321 111121 1222222233222221 24
Q ss_pred eCCEEEEEEEcCCCCCHHHHHhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 008634 458 EGQELLLIYEYMPNKSLDVHLFDATRS-----------------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (558)
Q Consensus 458 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 520 (558)
.....++|+||+++++|.+++.+.... ....+.....++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999988643211 01123345578999999999999874 9999999
Q ss_pred CCCEEEcC-CCcEEEEecCcceeeCC
Q 008634 521 ASNILLDD-DMNPKISDFGLARIFGG 545 (558)
Q Consensus 521 ~~NILl~~-~~~~ki~DFGla~~~~~ 545 (558)
|+|||+++ ++.+||+|||+|+.+..
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~ 308 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV 308 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc
Confidence 99999986 67999999999986643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-17 Score=156.67 Aligned_cols=143 Identities=37% Similarity=0.622 Sum_probs=127.6
Q ss_pred cccCCcccEEEEEecC-CcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHH
Q 008634 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 476 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 476 (558)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..+.+++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 889999998866443 35679999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecCcceeeCCC
Q 008634 477 HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 477 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~~~~~ 546 (558)
++.... ..+++..+..++.+++++|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 985432 35899999999999999999999984 999999999999999 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.2e-19 Score=166.16 Aligned_cols=149 Identities=26% Similarity=0.425 Sum_probs=123.2
Q ss_pred CcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
.....||.|.-|.|++.+.+ .|..+|||.+.+.. .+..++++..++++.+. +.|.||+.+|+|..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 33456999999999999875 58999999998664 44567788888877666 48999999999999999999999884
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
- -++.+|.. -.+++++...-++...+.+||.||.+++ .|+|||+||+|||+|+.|++|++|||++-++-...
T Consensus 175 ~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 175 T-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred H-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 3 34444432 2345888888899999999999999886 79999999999999999999999999998775443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=159.39 Aligned_cols=136 Identities=19% Similarity=0.291 Sum_probs=114.6
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCcc--------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+.||+|++|.||+|.. +|..|++|+....... ....+.+|+.++..++|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778889976543211 124578899999999999998888888788889999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+++++|.+++... .+ .+..++.+++.+|.++|+.+ ++|+|++|+|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988431 22 77899999999999999885 99999999999999 7889999999998643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.6e-18 Score=183.42 Aligned_cols=159 Identities=33% Similarity=0.467 Sum_probs=123.4
Q ss_pred CCCcccccccCCcc-cEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 392 HFSDENKLGQGGFG-PVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 392 ~f~~~~~LG~G~fG-~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
-|...+.+|.|.-| .||+|.+ +|++||||++-... .+-..+|+.+|..- +|||||++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35566789999885 4699999 58899999986543 23457899999888 6999999999999999999999998
Q ss_pred CCCCHHHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---C--CcEEEEecCcceee
Q 008634 470 PNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---D--MNPKISDFGLARIF 543 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~--~~~ki~DFGla~~~ 543 (558)
.-+|++++........ ..-.....+..|++.||++||+. +||||||||.||||+. + ..++|+|||++|.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5689999965311111 11133466888999999999986 5999999999999975 2 57999999999999
Q ss_pred CCCCCccC-cccccCC
Q 008634 544 GGNQNQAN-TNIIAGT 558 (558)
Q Consensus 544 ~~~~~~~~-t~~~~Gt 558 (558)
+.+++..+ .....||
T Consensus 662 ~~~~sS~~r~s~~sGt 677 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGT 677 (903)
T ss_pred CCCcchhhcccCCCCc
Confidence 88875432 2334554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=160.72 Aligned_cols=138 Identities=34% Similarity=0.506 Sum_probs=124.4
Q ss_pred CcccEEEEEec-CCcEEEEEEccccCccc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhc
Q 008634 403 GFGPVYKGTLA-DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480 (558)
Q Consensus 403 ~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 480 (558)
+||.||+++.. +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999998765544 68899999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 481 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
.. .+++..+..++.+++.+|.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 32 289999999999999999999997 4999999999999999999999999999987653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.6e-19 Score=184.60 Aligned_cols=153 Identities=27% Similarity=0.464 Sum_probs=137.3
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
...++|....++|.|.+|.|||++.. .++..|+|.++-....+..-...|+-++...+|||||.++|.+...+.+|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 34567888899999999999999965 58889999998887777888889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|||.+|+|++.-+- .++|++.+...++....+||.|||+.+ -+|||||-.|||+++.+.+|++|||.+-.+...
T Consensus 92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999987653 346888888899999999999999986 899999999999999999999999998877544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=180.64 Aligned_cols=141 Identities=19% Similarity=0.295 Sum_probs=113.6
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCc-------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
...|...++||+|+||.||+|.+.+...++.+++.+... ...+.+.+|++++.+++|++++....++.+.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 344566789999999999999876544333332322111 1235688999999999999999888888887888
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998883 34678999999999999985 9999999999999 678899999999997
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
...
T Consensus 477 ~~~ 479 (535)
T PRK09605 477 SDL 479 (535)
T ss_pred CCc
Confidence 643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=160.17 Aligned_cols=148 Identities=17% Similarity=0.172 Sum_probs=113.7
Q ss_pred HcCCCCcccccccCCcccEEEEE--ecCCcEEEEEEccccCcc------------------------chHHHHHHHHHHh
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQ------------------------GLQEFKNEVNLIA 442 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~--~~~g~~VaVK~l~~~~~~------------------------~~~~~~~Ei~~l~ 442 (558)
..-.|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|+.++.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34457788999999999999998 568999999988754210 0123568999999
Q ss_pred cCCCCC--eeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 008634 443 KLQHKN--LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (558)
Q Consensus 443 ~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 520 (558)
++.+.+ +++++++ ...++||||+++++|...... ...+.......++.||+.+|.+||+.+ +++|||||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 997533 4455543 235899999999888765422 223555666789999999999999874 39999999
Q ss_pred CCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 521 ASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 521 ~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+||+++ ++.++|+|||+++.....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCCc
Confidence 9999999 889999999999876543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-17 Score=158.45 Aligned_cols=142 Identities=13% Similarity=0.131 Sum_probs=116.3
Q ss_pred HcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchH---H------HHHHHHHHhcCCCCCeeeeeEEEEeC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ---E------FKNEVNLIAKLQHKNLVRLLGCCLEG 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~---~------~~~Ei~~l~~l~H~niv~l~g~~~~~ 459 (558)
-.++|...++||.|+||.||.... ++..++||.+.+....... . +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999766 5778999999765433222 2 67899999999999999999887643
Q ss_pred --------CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc
Q 008634 460 --------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (558)
Q Consensus 460 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 531 (558)
...++||||++|.+|.++.. ++. ....+|+.+|..+|..+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35899999999999987641 222 24558999999999985 99999999999999988
Q ss_pred EEEEecCcceeeCCC
Q 008634 532 PKISDFGLARIFGGN 546 (558)
Q Consensus 532 ~ki~DFGla~~~~~~ 546 (558)
++|+|||..+.+..+
T Consensus 173 i~liDfg~~~~~~e~ 187 (232)
T PRK10359 173 LRIIDLSGKRCTAQR 187 (232)
T ss_pred EEEEECCCcccccch
Confidence 999999999877543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=162.57 Aligned_cols=153 Identities=24% Similarity=0.357 Sum_probs=130.8
Q ss_pred HHcCCCCcccccccCCcccEEEEEec------CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG- 459 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~- 459 (558)
....++.....+.+|.||.||+|.+. +.++|.+|.++.. ++-+...++.|..++..+.|||+..+.+++.+.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 34566777788999999999999654 3457888888765 344567799999999999999999999999764
Q ss_pred CEEEEEEEcCCCCCHHHHHh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 460 QELLLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
+..+++|.++.-|+|..||. +......++-.+...++.|++.||+|||+++ +||.||.++|++||+..++||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEe
Confidence 67899999999999999998 4444556788888999999999999999985 999999999999999999999
Q ss_pred EecCcceee
Q 008634 535 SDFGLARIF 543 (558)
Q Consensus 535 ~DFGla~~~ 543 (558)
+|=.|+|-+
T Consensus 438 tDsaLSRDL 446 (563)
T KOG1024|consen 438 TDSALSRDL 446 (563)
T ss_pred ccchhcccc
Confidence 999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.7e-17 Score=154.67 Aligned_cols=132 Identities=22% Similarity=0.341 Sum_probs=107.9
Q ss_pred ccccCCcccEEEEEecCCcEEEEEEccccCc--c------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--Q------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~--~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.||+|+||.||+|.. ++..|++|....... . ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 577899998654321 1 1255778999999999887766666666677789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998874311 078999999999999885 99999999999999 8999999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=155.19 Aligned_cols=144 Identities=21% Similarity=0.203 Sum_probs=111.5
Q ss_pred HHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCcc----------------------chHHHHHHHHHHhcCC
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----------------------GLQEFKNEVNLIAKLQ 445 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~ 445 (558)
.....|...+.||+|+||.||++..++|+.|+||++...... ....+..|+.++.++.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333347778899999999999999888999999986543210 0123567889999998
Q ss_pred CCC--eeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 008634 446 HKN--LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (558)
Q Consensus 446 H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~N 523 (558)
|++ ++..++. ...++||||+++++|...... .....++.+|+.++.++|+. +++||||||+|
T Consensus 92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 774 4444442 456899999999998765420 23456888999999999987 49999999999
Q ss_pred EEEcCCCcEEEEecCcceeeCCCC
Q 008634 524 ILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 524 ILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|++++++.+||+|||++.....+.
T Consensus 156 ill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred EEEcCCCcEEEEECCccccCCCcc
Confidence 999999999999999997765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=150.71 Aligned_cols=133 Identities=20% Similarity=0.169 Sum_probs=106.2
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccccCccc----hHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG----LQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~----~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
....|++|+||+||.+.- .+.+++.+.+.....-. ..-+.+|+++|.++. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997665 67788877776554311 225789999999995 5889999986 4579999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL-KASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl-k~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
.+.+|...+.. . ...++.++..+|.++|+.+ |+|||| ||+|||++.++.++|+|||+|+....
T Consensus 81 ~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99998644311 1 1357789999999999985 999999 79999999999999999999996654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-17 Score=152.09 Aligned_cols=149 Identities=23% Similarity=0.347 Sum_probs=124.4
Q ss_pred cCCCCcccccccCCcccEEEEE-ecCCcEEEEEEccccCccchHHHHHHHHHHhcCCC-CCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 467 (558)
.+.|...++||.|+||.+|.|. ..+|.+||||.-+..... .++..|..+...++| ..|+.+..+..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4578889999999999999998 568999999987655433 356788899888865 678888888888888899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla~~~~ 544 (558)
.+ +.+|++++.=. ...++.++.+.++-|+..-++|+|.++ +|||||||+|+|..- -..+.++||||||.+-
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 76 78998887533 234788999999999999999999985 999999999999964 4568999999999885
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
+.
T Consensus 166 d~ 167 (341)
T KOG1163|consen 166 DI 167 (341)
T ss_pred cc
Confidence 43
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.9e-17 Score=155.04 Aligned_cols=147 Identities=24% Similarity=0.454 Sum_probs=120.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeE-EEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLG-CCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g-~~~~~~~~~lV~ 466 (558)
.+.|.+.+.||+|.||.+-.++.+ .+..+++|.+.+.. ....+|.+|...--.| .|.||+.-++ .++..+...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356888899999999999999976 46788888876542 3357888888765555 6899987664 466778889999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE-c-CCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-D-DDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl-~-~~~~~ki~DFGla~~~~ 544 (558)
||+|.|+|.+-+. ...+.+.-..+++.|++.||.|+|++ ++||||||.+|||| + +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999987763 34477888889999999999999998 59999999999999 3 44589999999998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=166.86 Aligned_cols=146 Identities=23% Similarity=0.388 Sum_probs=122.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++.|.....+|+|+|+.|-++... +++..+||++.+... +-.+|+.++... +|||++++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567788888999999999998854 578899999987632 234567665555 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE-cCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-DDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl-~~~~~~ki~DFGla~~~~~~ 546 (558)
.+.++-+.+.+.... ... ..+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998887774322 122 566779999999999999985 9999999999999 59999999999999987655
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=152.21 Aligned_cols=150 Identities=24% Similarity=0.386 Sum_probs=123.1
Q ss_pred CCCCcccccccCCcccEEEEE-ecCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
-+|.++++||+|.||.++.|+ +-+++.||||.-...+.. -++..|.+..+.| .-++|...+-+-.++..-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 478999999999999999998 558999999976544332 3456676666666 468888888888888888999997
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-----CCcEEEEecCcceee
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARIF 543 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-----~~~~ki~DFGla~~~ 543 (558)
+ |.+|+++..= ....++.++...|+.|+..-++|+|++. +|.|||||+|+||.. ...+.|+|||+||.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 6 7889887742 3446899999999999999999999985 999999999999964 346899999999998
Q ss_pred CCCCC
Q 008634 544 GGNQN 548 (558)
Q Consensus 544 ~~~~~ 548 (558)
....+
T Consensus 180 rDp~T 184 (449)
T KOG1165|consen 180 RDPKT 184 (449)
T ss_pred cCccc
Confidence 66544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.9e-16 Score=158.23 Aligned_cols=145 Identities=25% Similarity=0.337 Sum_probs=120.4
Q ss_pred CCCcccccccCCcccEEEEEecCC--cEEEEEEccccCccchHHHHHHHHHHhcCCC----CCeeeeeEEE-EeCCEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADG--KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH----KNLVRLLGCC-LEGQELLL 464 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g--~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 464 (558)
.|.+.++||+|+||.||.+..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999996543 4778887765533333367889999888863 5888888888 47778899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-----CcEEEEecCc
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-----MNPKISDFGL 539 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-----~~~ki~DFGl 539 (558)
||+.+ +.+|.++..... ...++..+.++|+.|+..+|.+||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99965 889998775444 567999999999999999999999986 9999999999999754 4699999999
Q ss_pred ce
Q 008634 540 AR 541 (558)
Q Consensus 540 a~ 541 (558)
+|
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-15 Score=137.96 Aligned_cols=137 Identities=22% Similarity=0.204 Sum_probs=116.4
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCC--CCeeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++++...++..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34679999999999999854 7899998865543 4678999999999976 58999999988888899999999988
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
.+..+ ++.....++.+++++|.+||.....+++|+|++|+||++++++.++++|||+++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 77533 556677889999999999998754569999999999999999999999999998654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-16 Score=134.77 Aligned_cols=68 Identities=32% Similarity=0.520 Sum_probs=55.7
Q ss_pred ccccccccccccCcceEEEEEeeeccCChhhHhHHHHHHHHHHhhhcCCCCCCcceEeccccccccccccc
Q 008634 215 SFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY 285 (558)
Q Consensus 215 ~~~~a~~~~~~~~~~~vy~laQC~~Dls~~dC~~CL~~~~~~~~~~~~~~~~~~g~v~~~~C~~ry~~y~f 285 (558)
+.+|+++.. ..+..+||||+||++||+++||+.||+.++..++.+|+ ++.||+|+.++|++||+.|+|
T Consensus 39 ~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~--~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 39 SKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCP--GSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp -TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTT--SBSSEEEEESSEEEEEESS--
T ss_pred ccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCC--CCceEEEECCCEEEEEECCCC
Confidence 578999876 46788999999999999999999999999999999999 899999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.9e-16 Score=156.14 Aligned_cols=148 Identities=28% Similarity=0.516 Sum_probs=127.9
Q ss_pred HcCCCCcccccccCCcccEEEEEec----CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (558)
..+.|...++||+|.|+.||++++. ..+.||+|.+...+.- ..+.+|+++|..+ -+.||+++.+++..++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3467888899999999999999854 3678999999765433 4688999999999 5899999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecCccee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARI 542 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~ 542 (558)
+|+||++.-...+++.. ++......++..+..||.++|.++ ||||||||+|+|.+. .+.-.|.|||||..
T Consensus 112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999988843 667888899999999999999986 999999999999974 56789999999987
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
++.++
T Consensus 183 ~d~~~ 187 (418)
T KOG1167|consen 183 YDGYQ 187 (418)
T ss_pred HHhhh
Confidence 65444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=141.73 Aligned_cols=139 Identities=20% Similarity=0.272 Sum_probs=99.5
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCcc--chHHH----------------------HHHHHHHhcCCCCC--e
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--GLQEF----------------------KNEVNLIAKLQHKN--L 449 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~--~~~~~----------------------~~Ei~~l~~l~H~n--i 449 (558)
.+.||+|+||.||++...+++.|+||++...... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987653221 11111 34566666664432 4
Q ss_pred eeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEEcC
Q 008634 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDD 528 (558)
Q Consensus 450 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlk~~NILl~~ 528 (558)
.+.++. ...++||||++++.+......... .. .....++.+++.++.++|. . +|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 246899999999554321111000 11 4567889999999999998 5 599999999999999
Q ss_pred CCcEEEEecCcceeeCCC
Q 008634 529 DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 529 ~~~~ki~DFGla~~~~~~ 546 (558)
++.++|+|||.++....+
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 999999999999877653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=142.17 Aligned_cols=137 Identities=23% Similarity=0.273 Sum_probs=106.8
Q ss_pred ccccc-cCCcccEEEEEecCCcEEEEEEccccC-------------ccchHHHHHHHHHHhcCCCCCe--eeeeEEEEeC
Q 008634 396 ENKLG-QGGFGPVYKGTLADGKAIAVKRLSRTS-------------GQGLQEFKNEVNLIAKLQHKNL--VRLLGCCLEG 459 (558)
Q Consensus 396 ~~~LG-~G~fG~Vyk~~~~~g~~VaVK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~ 459 (558)
...|| .|+.|.||+.... +..++||+..... ......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 7999999999885 6778888775321 1123567889999999998875 6777775443
Q ss_pred C----EEEEEEEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 460 Q----ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 460 ~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
. ..++|+||+++ .+|.+++.+ ..++.. .+.+|+.+|.+||+.+ |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 799888743 234443 3568999999999985 999999999999999999999
Q ss_pred EecCcceeeC
Q 008634 535 SDFGLARIFG 544 (558)
Q Consensus 535 ~DFGla~~~~ 544 (558)
+|||.++...
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999999865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.3e-14 Score=142.33 Aligned_cols=150 Identities=35% Similarity=0.521 Sum_probs=127.8
Q ss_pred CCcccccccCCcccEEEEEecCCcEEEEEEccccCcc---chHHHHHHHHHHhcCCCC-CeeeeeEEEEeCCEEEEEEEc
Q 008634 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 468 (558)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+..++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 456678999999999999986 77899988765432 367899999999999988 799999999877778999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceeeCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQ 547 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~~~~~ 547 (558)
+.++++.+++........+.......+..+++.++.|+|+.+ ++|||+||+||+++... .+|+.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977643221135888899999999999999999985 99999999999999988 79999999999765544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.2e-15 Score=146.51 Aligned_cols=146 Identities=33% Similarity=0.475 Sum_probs=117.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------CE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QE 461 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 461 (558)
.+|.....+|.|.- .|..+... .++.|++|++... .....+...+|..++..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666667888776 55555432 5889999988654 233456678999999999999999999998543 36
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.|+|||+|. .+|...++ ..++-++...|..|++.|+.|||+.+ |+||||||+||++..+...||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 899999995 46766664 24677888899999999999999985 9999999999999999999999999999
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.-..+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 76554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.2e-15 Score=145.63 Aligned_cols=152 Identities=20% Similarity=0.275 Sum_probs=124.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCC--C----CeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--K----NLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~ 462 (558)
+++|.+...+|+|.||.|-+.... .+..||||+++.-. ...+.-+-|++.+.++.+ | -+|.+.+|+.-.+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678888999999999999999864 47889999887543 334566789999999942 2 267888889889999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC--------------
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------------- 528 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-------------- 528 (558)
++|+|.+ |.++.++|.. +.-.+++......|+.|+++++.|||+. +++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999976 6689999954 3445688899999999999999999998 4999999999999832
Q ss_pred ------CCcEEEEecCcceeeCCCC
Q 008634 529 ------DMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 529 ------~~~~ki~DFGla~~~~~~~ 547 (558)
+..+||+|||-|+.-..+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc
Confidence 2248999999999876554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.6e-14 Score=145.77 Aligned_cols=134 Identities=25% Similarity=0.379 Sum_probs=109.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-----C---CCeeeeeEEEEe---
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----H---KNLVRLLGCCLE--- 458 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~--- 458 (558)
.+|-..++||.|.|++||.+... +.+-||+|+.+.. ....+..+.||++|.+++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57888899999999999999864 5778999987643 233456788999999883 3 469999999976
Q ss_pred -CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC
Q 008634 459 -GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529 (558)
Q Consensus 459 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~ 529 (558)
+.++++|+|++ |-+|..++.... -.-++...+.+|+.||+.||.|||.++ +|||-||||+||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 35899999998 556666665433 344888999999999999999999987 89999999999999544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.1e-14 Score=148.07 Aligned_cols=143 Identities=23% Similarity=0.269 Sum_probs=102.0
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccc----------------------------------------hHHHH
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG----------------------------------------LQEFK 435 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~----------------------------------------~~~~~ 435 (558)
.+.||.|++|+||+|++++|+.||||+.+....+. .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999976542110 01355
Q ss_pred HHHHHHhcCC----CCCeeeeeEEE-EeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 008634 436 NEVNLIAKLQ----HKNLVRLLGCC-LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR-GILYLHED 509 (558)
Q Consensus 436 ~Ei~~l~~l~----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~ 509 (558)
+|...+.++. |.+-+.+-..+ ......+|||||++|++|.++...... ..+ +..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhC
Confidence 5666666652 33333333333 224567999999999999887643211 122 3456666665 46788877
Q ss_pred CCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 510 ~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+ ++|+|++|.||++++++.++++|||+++.++..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 4 999999999999999999999999999988643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.4e-14 Score=144.84 Aligned_cols=155 Identities=23% Similarity=0.312 Sum_probs=129.8
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC------CCCeeeeeEEEEeCC
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ------HKNLVRLLGCCLEGQ 460 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~~~~ 460 (558)
.-.+.|.+.--.|+|-|+.|.+|... .|..||||++..+..- .+.=+.|+++|.+|+ --+.++|+..|....
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 33456777777899999999999865 4789999999866322 233467999999995 357899999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecCc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGL 539 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFGl 539 (558)
+++||+|-+ .-+|.+.|.+......|....+..++.|+.-||..|... +|+|.||||.|||+++. ...||||||-
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcc
Confidence 999999976 468999998888888899999999999999999999876 49999999999999865 5689999999
Q ss_pred ceeeCCCC
Q 008634 540 ARIFGGNQ 547 (558)
Q Consensus 540 a~~~~~~~ 547 (558)
|-..+.++
T Consensus 584 A~~~~ene 591 (752)
T KOG0670|consen 584 ASFASENE 591 (752)
T ss_pred cccccccc
Confidence 98877664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.1e-14 Score=157.53 Aligned_cols=146 Identities=23% Similarity=0.305 Sum_probs=115.6
Q ss_pred HHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCEEE
Q 008634 387 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 387 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~ 463 (558)
....+.|.+.+.||+|+||.||+|...+|+.||+|.-+....- +|.-=.+++.||+ -+.|..+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3345677888899999999999999888999999987766543 2323334455554 233445555556677889
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-------CCcEEEEe
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------DMNPKISD 536 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-------~~~~ki~D 536 (558)
||+||.+.|+|.+++. ..+.++|...+.++.|+++-++.||..+ |||+||||+|.||.. ..-++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999995 4556999999999999999999999985 999999999999942 33589999
Q ss_pred cCcce
Q 008634 537 FGLAR 541 (558)
Q Consensus 537 FGla~ 541 (558)
||-+-
T Consensus 845 fG~si 849 (974)
T KOG1166|consen 845 FGRSI 849 (974)
T ss_pred cccce
Confidence 99875
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.7e-12 Score=115.80 Aligned_cols=131 Identities=22% Similarity=0.190 Sum_probs=97.3
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCEEEEEEEcCCCCCHH
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLD 475 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~ 475 (558)
+.|+.|.++.||+.+.. +..+++|....... ....+..|+..+..+.+.++ ++++.+. .+..++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56889999999999875 77899998765432 22356789999998865554 4555543 33458999999998875
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
... . ....+..+++++|..||..+ +..++|+|++|.||+++ ++.++++|||.+..-
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 320 1 11235678999999999875 23469999999999999 668999999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.3e-11 Score=133.41 Aligned_cols=144 Identities=17% Similarity=0.212 Sum_probs=95.5
Q ss_pred CCCcccccccCCcccEEEEEecC-CcEEEEEEccccCcc---------------------------------c-h-----
Q 008634 392 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ---------------------------------G-L----- 431 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~---------------------------------~-~----- 431 (558)
.|+. +.||.|++|+||+|++++ |++||||+..+.-.+ + .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 689999999999999987 999999998754110 0 0
Q ss_pred -HHHHHHHHHHhcCC----CCCeeeeeEEEEe-CCEEEEEEEcCCCCCHHHHH--hccC-CCCCCCHHHHHHHHHHHHHH
Q 008634 432 -QEFKNEVNLIAKLQ----HKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHL--FDAT-RSVQLDWKRRQSIINGIARG 502 (558)
Q Consensus 432 -~~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~~ia~a 502 (558)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++- .... ....+.......++.||
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 12445555555552 4444444444433 45678999999999997642 1111 00112222222333333
Q ss_pred HHHHHhCCCCCeeeCCCCCCCEEEcCCC----cEEEEecCcceeeCCC
Q 008634 503 ILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGLARIFGGN 546 (558)
Q Consensus 503 L~yLH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DFGla~~~~~~ 546 (558)
+.. +++|+|+||.||+++.++ +++++|||+...++..
T Consensus 277 ----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 334 599999999999999888 9999999999988654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.3e-12 Score=143.31 Aligned_cols=87 Identities=17% Similarity=0.201 Sum_probs=67.7
Q ss_pred cCCC-CCeeeeeEEE-------EeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 008634 443 KLQH-KNLVRLLGCC-------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514 (558)
Q Consensus 443 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 514 (558)
.++| +||+++++++ .+.+..++++||+ +++|.++|.+. ...+++.+.+.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5888888877 3334677888987 66999999542 345999999999999999999999885 9
Q ss_pred eeCCCCCCCEEEcCCCcEEEE
Q 008634 515 IHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 515 vHrDlk~~NILl~~~~~~ki~ 535 (558)
+||||||+||||+..+.+|++
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~ 122 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFI 122 (793)
T ss_pred eeccCCchhEEEcccCcEEEe
Confidence 999999999999654433333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.6e-11 Score=135.16 Aligned_cols=146 Identities=28% Similarity=0.371 Sum_probs=111.5
Q ss_pred CcccccccCCcccEEEEEec-CCcEEEEEEcc----cc-Ccc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS----RT-SGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~----~~-~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
...+.+|.|.+|.|+..... .......|... .. ... ....+..|..+-..++|+|++..+....+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34568999999977776533 22223333221 11 111 1122566777888899999988888877777777779
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||++. +|..++... ..++...+..++.|+..|+.|+|+.+ |.|||+|++|++++.++.+||+|||.+..+.-+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999988542 35788888999999999999999986 999999999999999999999999999987543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.3e-10 Score=110.56 Aligned_cols=143 Identities=18% Similarity=0.288 Sum_probs=111.3
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCc-cchHHHHHHHHHHhcCCC--CCeeeeeEEEEeCC---EEEEEEEcCC
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ---ELLLIYEYMP 470 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 470 (558)
+.|+.|..+.||+.+..+|..+++|....... .....+..|.+++..+.+ .++++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998765432 235678899999999975 45677888776542 5689999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS---------------------------------------- 510 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------------- 510 (558)
+.++...+.. ..++...+..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 24677777888888888888888531
Q ss_pred -------------CCCeeeCCCCCCCEEEcC--CCcEEEEecCcceee
Q 008634 511 -------------RLKIIHRDLKASNILLDD--DMNPKISDFGLARIF 543 (558)
Q Consensus 511 -------------~~~ivHrDlk~~NILl~~--~~~~ki~DFGla~~~ 543 (558)
...++|+|+++.||++++ ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 677899999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-09 Score=103.45 Aligned_cols=137 Identities=15% Similarity=0.150 Sum_probs=99.0
Q ss_pred cccccCCcccEEEEEecC-------CcEEEEEEccccCc----------------------cchHHH----HHHHHHHhc
Q 008634 397 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTSG----------------------QGLQEF----KNEVNLIAK 443 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~-------g~~VaVK~l~~~~~----------------------~~~~~~----~~Ei~~l~~ 443 (558)
..||.|.-+.||.|...+ +..+|||+.+.... ...+.+ ..|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47899997542210 001223 379999999
Q ss_pred CC--CCCeeeeeEEEEeCCEEEEEEEcCCCCCHHH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCC
Q 008634 444 LQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDL 519 (558)
Q Consensus 444 l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDl 519 (558)
+. .-++++++++ ...++||||+.++.+.. .+.+ ..++......+..++..+|..| |.. +++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 85 3567777765 46689999998754422 2211 2345555667889999999999 766 4999999
Q ss_pred CCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 520 KASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 520 k~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++.|||++ ++.+.|+|||.+-....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46799999999877653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.1e-10 Score=101.13 Aligned_cols=134 Identities=23% Similarity=0.332 Sum_probs=100.7
Q ss_pred ccccCCcccEEEEEecCCcEEEEE-EccccCcc-------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 398 KLGQGGFGPVYKGTLADGKAIAVK-RLSRTSGQ-------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~g~~VaVK-~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.+++|+-..+|.+.+.+ .++++| ++.+.-.. ....-.+|+.++.+++--.|....=+..+++...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 57889999999997743 344444 33332111 1235678999999997666655555666788889999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
++..|.+.+... +..++..|-.-+.-||..+ |+|+||.++||++..+. +.++||||+++-...
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~ 144 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV 144 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence 999999998543 2456677777788999986 99999999999997766 999999999965543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.7e-11 Score=113.88 Aligned_cols=136 Identities=28% Similarity=0.470 Sum_probs=112.9
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
..+|.+...|+.|+|++.. ..+++|++.-. ...-.++|..|.-.|+-+.||||+.++|.|..+..+.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 3478889999999999964 45666776533 22334678899999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee-CCCCCCCEEEcCCCcEEEE
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH-RDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH-rDlk~~NILl~~~~~~ki~ 535 (558)
|...|++.. ....+-.+..+++.+||+|+.|||+.. +++- --|.++.|++|++.+++|+
T Consensus 274 lynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 274 LYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee
Confidence 999998643 345777888999999999999999986 4444 4689999999999998875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-11 Score=127.41 Aligned_cols=143 Identities=27% Similarity=0.301 Sum_probs=117.7
Q ss_pred ccccCCcccEEEEE----ecCCcEEEEEEccccCcc--chHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 398 KLGQGGFGPVYKGT----LADGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~----~~~g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
.+|+|.||.|+... ...|...++|.+.+.... .......|..+++.++ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998654 234666788887765322 1225567888999997 9999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+|.|...+.+ ...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||++|..-..
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 9999887743 345777777788889999999999885 999999999999999999999999999977443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.6e-09 Score=96.47 Aligned_cols=146 Identities=25% Similarity=0.319 Sum_probs=106.2
Q ss_pred cccccccCCcccEEEEEecCCcEEEEE-EccccCc-------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 395 DENKLGQGGFGPVYKGTLADGKAIAVK-RLSRTSG-------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~g~~VaVK-~l~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
....+-+|+-+.|+++.++ |+...|| ++.+.-. -..+..++|++++.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999999985 5554555 4443321 12456788999999987656555555666777778999
Q ss_pred EcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC---cEEEEecCccee
Q 008634 467 EYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARI 542 (558)
Q Consensus 467 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DFGla~~ 542 (558)
||+++ .++.+++...-.....+ .....++..|-+.+.-||..+ |+|+||..+||+|..++ .+.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 57788876544333222 233678888999999999985 99999999999996554 468999999876
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
-..
T Consensus 166 s~~ 168 (229)
T KOG3087|consen 166 SRL 168 (229)
T ss_pred ccC
Confidence 543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.5e-11 Score=131.98 Aligned_cols=142 Identities=19% Similarity=0.243 Sum_probs=114.4
Q ss_pred CCCcccccccCCcccEEEEEecCCcEEEEEEccccC-ccchHHHHHHHHH--HhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS-GQGLQEFKNEVNL--IAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++...+.||.+.|=+|.+++.++|. |+||++-+.+ .-.++.|.++++- ....+|||.+.+.-+-+..+..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999998887 8889887665 4456666655544 4455899999998887777788888888
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
..+ +|.+.| ..+..|...++.-|+.|+..||.-+|..+ |.|+|||.+||||+..+-+.|+||.--|
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 754 555555 22344677788889999999999999885 9999999999999999999999996544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.2e-10 Score=116.79 Aligned_cols=100 Identities=34% Similarity=0.587 Sum_probs=90.9
Q ss_pred HhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 008634 441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (558)
Q Consensus 441 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 520 (558)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+.. ....++|.-...++.+|+.||.|||.-. -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999964 4567999999999999999999999752 23899999
Q ss_pred CCCEEEcCCCcEEEEecCcceeeC
Q 008634 521 ASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 521 ~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++|+++|..+.+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.7e-08 Score=98.02 Aligned_cols=141 Identities=19% Similarity=0.135 Sum_probs=101.5
Q ss_pred ccccCCcccEEEEEecCCcEEEEEEccccCc-----------cchHHHHHHHHHHhcCCC--CCeeeeeEEEEe-----C
Q 008634 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-----------QGLQEFKNEVNLIAKLQH--KNLVRLLGCCLE-----G 459 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~-----~ 459 (558)
.+-+.....|.+.++ +|+.+.||+...... .....+.+|...+.++.. -..+.++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445677666 577899997643321 111247789999988843 344556666654 2
Q ss_pred CEEEEEEEcCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-------CCc
Q 008634 460 QELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------DMN 531 (558)
Q Consensus 460 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-------~~~ 531 (558)
...++|+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 8988874321 223456677789999999999999985 999999999999975 468
Q ss_pred EEEEecCcceee
Q 008634 532 PKISDFGLARIF 543 (558)
Q Consensus 532 ~ki~DFGla~~~ 543 (558)
+.++||+.+++.
T Consensus 184 ~~LIDl~r~~~~ 195 (268)
T PRK15123 184 LSVIDLHRAQIR 195 (268)
T ss_pred EEEEECCccccc
Confidence 999999998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.6e-09 Score=102.27 Aligned_cols=147 Identities=24% Similarity=0.309 Sum_probs=96.1
Q ss_pred CcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCC----------CCeeeeeEEEE--
Q 008634 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH----------KNLVRLLGCCL-- 457 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~~-- 457 (558)
...+.||.|+++.||.++.. +|++++||..... .....+++++|...+..+.+ -.++.-++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 44678999999999999976 4899999987533 23446777777766666443 11221122211
Q ss_pred -------eC--C------EEEEEEEcCCCCCHHHHHh---ccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 008634 458 -------EG--Q------ELLLIYEYMPNKSLDVHLF---DATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD 518 (558)
Q Consensus 458 -------~~--~------~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 518 (558)
.. . ..+++|+-+ .++|.+++. .... ...+....++.+..|+.+.+++||+.+ ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 235566655 677876643 2221 223455667888899999999999986 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 519 LKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 519 lk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|||+|++++.+|.++|+||+.....+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g 196 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAG 196 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred cceeeEEEcCCCCEEEcChHHHeecC
Confidence 99999999999999999998877654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.4e-08 Score=92.11 Aligned_cols=126 Identities=25% Similarity=0.295 Sum_probs=82.1
Q ss_pred EEEEEecCCcEEEEEEccccCc---------------------cc-----hHHHHHHHHHHhcCCCC--CeeeeeEEEEe
Q 008634 407 VYKGTLADGKAIAVKRLSRTSG---------------------QG-----LQEFKNEVNLIAKLQHK--NLVRLLGCCLE 458 (558)
Q Consensus 407 Vyk~~~~~g~~VaVK~l~~~~~---------------------~~-----~~~~~~Ei~~l~~l~H~--niv~l~g~~~~ 458 (558)
||.|...+|..+|||....... .. .....+|.+.|.++... ++++++.+.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 8999998999999997543210 00 23457899999999765 567776552
Q ss_pred CCEEEEEEEcCC--CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 008634 459 GQELLLIYEYMP--NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 459 ~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
...|||||++ +..+..+... . ++......++.++...+..+ |.. +|+|+||.+.|||++++ .+.|+
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred --CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999999 6555443321 1 11233455677777766664 565 59999999999999988 89999
Q ss_pred ecCcceeeCC
Q 008634 536 DFGLARIFGG 545 (558)
Q Consensus 536 DFGla~~~~~ 545 (558)
|||.+.....
T Consensus 149 Df~qav~~~~ 158 (188)
T PF01163_consen 149 DFGQAVDSSH 158 (188)
T ss_dssp -GTTEEETTS
T ss_pred ecCcceecCC
Confidence 9999876653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-08 Score=102.25 Aligned_cols=88 Identities=30% Similarity=0.543 Sum_probs=69.0
Q ss_pred CCCCeeeeeEEEEe---------------------------CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHH
Q 008634 445 QHKNLVRLLGCCLE---------------------------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497 (558)
Q Consensus 445 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 497 (558)
+|||||++.+.|.+ +..+|+||.-.+ -+|++++... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 69999999988743 235788887664 4788888542 245556667889
Q ss_pred HHHHHHHHHHhCCCCCeeeCCCCCCCEEE--cCCC--cEEEEecCcc
Q 008634 498 GIARGILYLHEDSRLKIIHRDLKASNILL--DDDM--NPKISDFGLA 540 (558)
Q Consensus 498 ~ia~aL~yLH~~~~~~ivHrDlk~~NILl--~~~~--~~ki~DFGla 540 (558)
|+++|+.|||.++ |.|||+|++|||| |+|. ...|+|||-+
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccccee
Confidence 9999999999986 9999999999998 3444 4689999964
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-07 Score=98.43 Aligned_cols=140 Identities=24% Similarity=0.359 Sum_probs=112.7
Q ss_pred ccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCEEEEEEEcCCC-CCHHHHH
Q 008634 405 GPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYMPN-KSLDVHL 478 (558)
Q Consensus 405 G~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l 478 (558)
...||+... +|..+++|+++....+.......-++.++++.|+|+|++..++.. +..+.+||+|+|+ ++|-++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 567888854 799999999954433333233456789999999999999999873 3578999999997 6776655
Q ss_pred hccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 479 FDAT------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 479 ~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+... .+...++...|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|+..++..|
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 2235788999999999999999999985 888999999999999999999999999988777
Q ss_pred C
Q 008634 547 Q 547 (558)
Q Consensus 547 ~ 547 (558)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 6
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=9.1e-08 Score=102.65 Aligned_cols=124 Identities=21% Similarity=0.307 Sum_probs=101.6
Q ss_pred ecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHH
Q 008634 412 LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491 (558)
Q Consensus 412 ~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 491 (558)
..++.+|.|...+.......+...+-++.|+.++||||++++..++..+..|||+|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34688899988887766434556788899999999999999999999999999999874 45555643 23445
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 492 ~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
..-.+.||+.||.|||+.+ +++|++|.-..|+++..|..||.+|-++...++
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 5567889999999999876 799999999999999999999999988765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.7e-09 Score=113.67 Aligned_cols=151 Identities=26% Similarity=0.393 Sum_probs=117.3
Q ss_pred CCCCcccccccCCcccEEEEEecC--CcEEEEEEccccC--ccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~--g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 465 (558)
..|...+.||+|.|+.|-...... ...+++|.+.... ....+....|..+=..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345666779999999998877533 4556777665443 222333445666666665 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceee
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-EDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 543 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~ 543 (558)
+||..++++.+.+... .....+......++.|+..++.|+| +.+ +.|||+||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998777311 1113455566778999999999999 664 99999999999999999 9999999999988
Q ss_pred CC
Q 008634 544 GG 545 (558)
Q Consensus 544 ~~ 545 (558)
..
T Consensus 176 ~~ 177 (601)
T KOG0590|consen 176 RN 177 (601)
T ss_pred cc
Confidence 66
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.6e-07 Score=88.02 Aligned_cols=136 Identities=21% Similarity=0.234 Sum_probs=94.6
Q ss_pred CCcccccccCCcccEEEEEecCCcEEEEEEccccC----------c-------c-----chHHHHHHHHHHhcCCCC--C
Q 008634 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----------G-------Q-----GLQEFKNEVNLIAKLQHK--N 448 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~----------~-------~-----~~~~~~~Ei~~l~~l~H~--n 448 (558)
..++++||.|.-+.||.|..++|.+++||.=.... . . ......+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45568899999999999999999999999532110 0 0 123457799999999655 7
Q ss_pred eeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC
Q 008634 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 528 (558)
Q Consensus 449 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~ 528 (558)
+++.+++ +...+||||+++-.|...- ++.+..-.|+..|.+-+.-+-.. ++||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 7777776 5678999999986664221 11111222333333333333333 4999999999999999
Q ss_pred CCcEEEEecCcceee
Q 008634 529 DMNPKISDFGLARIF 543 (558)
Q Consensus 529 ~~~~ki~DFGla~~~ 543 (558)
+|.+.++||=-+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.9e-07 Score=85.01 Aligned_cols=109 Identities=27% Similarity=0.283 Sum_probs=87.0
Q ss_pred hHHHHHHHHHHhcCC--CCCeeeeeEEEEeCC----EEEEEEEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 008634 431 LQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQ----ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503 (558)
Q Consensus 431 ~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 503 (558)
.....+|...+.++. .-..++.+++.+... ..++|+|++++ -+|.+++.+... ++...+..++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 346788888888875 445567777776632 46899999998 489998854222 55667788999999999
Q ss_pred HHHHhCCCCCeeeCCCCCCCEEEcCCC---cEEEEecCcceeeCC
Q 008634 504 LYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIFGG 545 (558)
Q Consensus 504 ~yLH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DFGla~~~~~ 545 (558)
.-||+.+ |+|+|+++.|||++.+. .+.++||+-+++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~~ 173 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRPS 173 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCCC
Confidence 9999986 99999999999999887 899999999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.7e-07 Score=98.40 Aligned_cols=142 Identities=16% Similarity=0.212 Sum_probs=94.4
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCcc--------------------------c--------------hHHHHH
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------------------------G--------------LQEFKN 436 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~--------------------------~--------------~~~~~~ 436 (558)
+.|+.++-|+||+|++++|+.||||+..+.-.+ . .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 579999999999999999999999986653110 0 012345
Q ss_pred HHHHHhcCC-----CCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 008634 437 EVNLIAKLQ-----HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG-ILYLHEDS 510 (558)
Q Consensus 437 Ei~~l~~l~-----H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~~~ 510 (558)
|...+.+++ .+++.--.=+++-.....|+|||++|-.+.+...-.. ...+.+. |+..++++ +.-+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhc-
Confidence 665555552 3444322223333567899999999999887742211 2244333 33333332 1222222
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 511 ~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++|.|..|.||+++.++++-+.|||+...+++.
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 4999999999999999999999999999887654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.4e-06 Score=81.08 Aligned_cols=139 Identities=18% Similarity=0.152 Sum_probs=103.2
Q ss_pred cccCCcccEEEEEecCCcEEEEEEccccC------ccchHHHHHHHHHHhcCCC--CCeeeeeEEEEeC----CEEEEEE
Q 008634 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEG----QELLLIY 466 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~------~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~----~~~~lV~ 466 (558)
-|+||-+.|++-.+. |..+-+|+-...- +-+...|.+|...|.++.. -++++........ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467888889987774 4468888765221 3356789999999999853 3355555222221 2478999
Q ss_pred EcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc--EEEEecCccee
Q 008634 467 EYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLARI 542 (558)
Q Consensus 467 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~--~ki~DFGla~~ 542 (558)
|-+++ -+|.+++.+.. ..+.+...+..+..+|+..+.-||..+ +.|+|+.+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 78888884422 224677788899999999999999985 999999999999986666 99999976664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.9e-06 Score=79.96 Aligned_cols=141 Identities=17% Similarity=0.183 Sum_probs=87.2
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCC--eeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
-.+||+|..+.||+. .+..+++|...... ......+|.+.+..+..-+ +.+.+++....+...+|||+++|..
T Consensus 6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred heeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 357899999999984 24456778776433 2345688999998886433 4678888888888889999999963
Q ss_pred -HHHH---------------------HhccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeeeCC
Q 008634 474 -LDVH---------------------LFDATRSVQLDWKRRQS-IIN----------GIAR-GILYLHED-SRLKIIHRD 518 (558)
Q Consensus 474 -L~~~---------------------l~~~~~~~~l~~~~~~~-i~~----------~ia~-aL~yLH~~-~~~~ivHrD 518 (558)
+... +|... ....+...+.. +-. .+.+ ...+|... ....++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 2111 11110 00111111000 000 0111 12222211 234578999
Q ss_pred CCCCCEEEcCCCcEEEEecCcceee
Q 008634 519 LKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 519 lk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+.|.||++++++ +.|+||+.+..-
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999888 999999988643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.36 E-value=1e-06 Score=81.80 Aligned_cols=62 Identities=24% Similarity=0.095 Sum_probs=54.1
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+|.+++.+. ...++|..+..|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 7899999642 345999999999999999999999873 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.5e-07 Score=98.35 Aligned_cols=149 Identities=24% Similarity=0.237 Sum_probs=118.8
Q ss_pred HHcCCCCcccccccCCcccEEEEEec--CCcEEEEEEccccCccchHH--HHHHHHHHhcC-CCCCeeeeeEEEEeCCEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTSGQGLQE--FKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~--~g~~VaVK~l~~~~~~~~~~--~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (558)
..+.+|....+||.|.|+.|++...+ ++..+++|.+.+......++ -..|+.+...+ .|.+++++...|...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888889999999999988744 56788888887654333222 24566666666 588999988888888888
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecCcce
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLAR 541 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFGla~ 541 (558)
++-.||+.++++...+ .-...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999987665 22335788889999999999999999774 9999999999999886 889999999986
Q ss_pred e
Q 008634 542 I 542 (558)
Q Consensus 542 ~ 542 (558)
.
T Consensus 416 ~ 416 (524)
T KOG0601|consen 416 R 416 (524)
T ss_pred c
Confidence 3
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.6e-07 Score=90.15 Aligned_cols=96 Identities=26% Similarity=0.340 Sum_probs=80.5
Q ss_pred HHHhcCCCCCeeeeeEEEEeC-----CEEEEEEEcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 008634 439 NLIAKLQHKNLVRLLGCCLEG-----QELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 512 (558)
Q Consensus 439 ~~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 512 (558)
..|-.+.|.|||+++.||.+. .+..+++|||+.|++..+|++.++ ...+..+...+++.||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345566799999999998654 357899999999999999986443 33466666778999999999999997 57
Q ss_pred CeeeCCCCCCCEEEcCCCcEEEE
Q 008634 513 KIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 513 ~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
+|+|+++..+-|++..++-+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 89999999999999999988885
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.2e-07 Score=95.36 Aligned_cols=150 Identities=23% Similarity=0.253 Sum_probs=116.9
Q ss_pred CCCccccccc--CCcccEEEEEe--c-CCcEEEEEEcccc--CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEE
Q 008634 392 HFSDENKLGQ--GGFGPVYKGTL--A-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 392 ~f~~~~~LG~--G~fG~Vyk~~~--~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (558)
.|.....+|. |.+|.||.+.. + ++..+++|+-+.. .++....=.+|+....++ .|+|.++....++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555677899 99999999986 3 5778899974432 223333335677777777 4999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecC
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR----GILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFG 538 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFG 538 (558)
+-+|++. .+|..+-+. ....++....+.+..+... ||.++|+. +++|-|+||.||++..+ ...++.|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 9999875 677777643 2234666777777778878 99999987 59999999999999998 899999999
Q ss_pred cceeeCCCC
Q 008634 539 LARIFGGNQ 547 (558)
Q Consensus 539 la~~~~~~~ 547 (558)
+.+.+....
T Consensus 269 ~v~~i~~~~ 277 (524)
T KOG0601|consen 269 LVSKISDGN 277 (524)
T ss_pred eeEEccCCc
Confidence 998876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.7e-07 Score=99.23 Aligned_cols=111 Identities=23% Similarity=0.380 Sum_probs=76.8
Q ss_pred cCCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
..+|...+.+-.|++|.||..+.+. .+.+|+ ++.++.- -.++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch----hhhc---cccccCCccee------------------
Confidence 3678888999999999999998764 566777 4433211 1111 22233344443
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+-...+. ..++++-. ++.+++|||+.+ |+|||+||+|.+|+.-|.+|+.||||.++.
T Consensus 136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 44444442 22233332 278899999885 999999999999999999999999999865
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.3e-06 Score=89.98 Aligned_cols=144 Identities=15% Similarity=0.169 Sum_probs=91.3
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccc-------------------------------------hHHHHHHH
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-------------------------------------LQEFKNEV 438 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~-------------------------------------~~~~~~Ei 438 (558)
.+.||.-+.|+||+|++++|+.||||+-++.-.+. .-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35799999999999999999999999754431110 11355566
Q ss_pred HHHhcC----CCCC---eeeeeEEEEe-CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008634 439 NLIAKL----QHKN---LVRLLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510 (558)
Q Consensus 439 ~~l~~l----~H~n---iv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 510 (558)
+...++ .|-+ -|++=.++++ .....|+||||+|..+.+...- +...++......-+.+...-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~~--- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFKT--- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHhc---
Confidence 555544 4555 1122233332 2467999999999877655321 1222444433333333222222222
Q ss_pred CCCeeeCCCCCCCEEEcC----CCcEEEEecCcceeeCCC
Q 008634 511 RLKIIHRDLKASNILLDD----DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 511 ~~~ivHrDlk~~NILl~~----~~~~ki~DFGla~~~~~~ 546 (558)
+++|.|-.|.||+++. ++.+.+-|||+.+.+...
T Consensus 321 --GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 --GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred --CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 4999999999999984 678999999998876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.3e-05 Score=77.20 Aligned_cols=141 Identities=15% Similarity=0.151 Sum_probs=87.3
Q ss_pred cccCCc-ccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEcCCCCCHHH
Q 008634 399 LGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 476 (558)
Q Consensus 399 LG~G~f-G~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 476 (558)
|-.|.. ..||+.... +..+.||+..... ......|++++..+. +--+++++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 788998764 4678888776543 235677888888773 4556688888877777899999999987764
Q ss_pred HH-------------------hccCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----CC
Q 008634 477 HL-------------------FDATR-SVQLDW--KRRQSIIN--------------------GIARGILYLHE----DS 510 (558)
Q Consensus 477 ~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~ia~aL~yLH~----~~ 510 (558)
.. |.... ...+.. ..+..-.. .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 001110 00000000 01112222211 12
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 511 ~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
.+.++|+|+.|.|||++++..+.|+||+.+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 345899999999999999888899999988754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.14 E-value=8.5e-06 Score=76.87 Aligned_cols=105 Identities=23% Similarity=0.226 Sum_probs=81.6
Q ss_pred HHHHHHHhcCCC-CCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 008634 435 KNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513 (558)
Q Consensus 435 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 513 (558)
.+|..++..+++ +++++++|.|- .++|.||...+++...-..-..-..-+|..|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468888888976 69999999994 3778999997765321000001123689999999999999999999864445
Q ss_pred eeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 514 IIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 514 ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+.-.|++++|+-+++++++|++|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.8e-07 Score=93.52 Aligned_cols=81 Identities=30% Similarity=0.396 Sum_probs=72.5
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
.+++.|+++...+|.+||.........+|...+.++.|++.|++| + ..+|||+||.||+...+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766666678899999999999999999 4 4999999999999999999999999999
Q ss_pred eeeCCCC
Q 008634 541 RIFGGNQ 547 (558)
Q Consensus 541 ~~~~~~~ 547 (558)
.......
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8776655
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.9e-05 Score=74.23 Aligned_cols=144 Identities=23% Similarity=0.245 Sum_probs=86.6
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCC--CeeeeeEEEEe---CCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGCCLE---GQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~Ey~~~ 471 (558)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++..... ....+++||++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568899999999999877 68999986654 3446677888888887433 45677775533 3457999999999
Q ss_pred CCHHH----------------HH---hcc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh-
Q 008634 472 KSLDV----------------HL---FDA-TRSVQLDWKRR---------QSI------------INGIAR-GILYLHE- 508 (558)
Q Consensus 472 gsL~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~ia~-aL~yLH~- 508 (558)
..+.. .+ ++. .....+.+... ... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 111 11111111110 000 112222 3333332
Q ss_pred ---CCCCCeeeCCCCCCCEEEc-CCCcEEEEecCcceee
Q 008634 509 ---DSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIF 543 (558)
Q Consensus 509 ---~~~~~ivHrDlk~~NILl~-~~~~~ki~DFGla~~~ 543 (558)
.....++|+|+.|.|||++ +++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666789999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.9e-05 Score=74.94 Aligned_cols=138 Identities=19% Similarity=0.278 Sum_probs=92.9
Q ss_pred ccccCCcccEEEEEecCCcEEEEEEccccCccc------------------------hHHHHHHHHHHhcCC--CCCeee
Q 008634 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG------------------------LQEFKNEVNLIAKLQ--HKNLVR 451 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~------------------------~~~~~~Ei~~l~~l~--H~niv~ 451 (558)
.|..|.-..||+|...++..+|||+........ ......|...|.++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 456778889999998889999999876432111 112345777777763 444555
Q ss_pred eeEEEEeCCEEEEEEEcCCCCC-HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC
Q 008634 452 LLGCCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (558)
Q Consensus 452 l~g~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~ 530 (558)
-+++. +-.|||||+.... -.-.| +...+.......+..++.+.+.-|-... ++||+||..-|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence 55552 4589999997541 11111 1112233345566777778887776643 699999999999999 88
Q ss_pred cEEEEecCcceeeCCC
Q 008634 531 NPKISDFGLARIFGGN 546 (558)
Q Consensus 531 ~~ki~DFGla~~~~~~ 546 (558)
.+.|+|||-|-....+
T Consensus 204 ~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 EPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEEEECccccccCCC
Confidence 9999999998766533
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.7e-05 Score=72.10 Aligned_cols=139 Identities=18% Similarity=0.186 Sum_probs=89.7
Q ss_pred HcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHH---------HHHHHHHhcCCCC---CeeeeeEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEF---------KNEVNLIAKLQHK---NLVRLLGCC 456 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~---------~~Ei~~l~~l~H~---niv~l~g~~ 456 (558)
..++|...+++.......|.+-.. +|....+|..........+.| .+++..+.+++.. ....++...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346677767776666665655555 567888887765543322222 3344444444322 222222222
Q ss_pred Ee-----CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc
Q 008634 457 LE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (558)
Q Consensus 457 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 531 (558)
+. ....+++|||++|..|.++.. ++. .+...|.+.|.-||+.| ++|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 21 245679999999988865531 222 24456778899999986 99999999999998655
Q ss_pred EEEEecCcceee
Q 008634 532 PKISDFGLARIF 543 (558)
Q Consensus 532 ~ki~DFGla~~~ 543 (558)
++++||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999887653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00014 Score=84.33 Aligned_cols=148 Identities=17% Similarity=0.281 Sum_probs=92.3
Q ss_pred ccccccCCcccEEEEEecCC---cEEEEEEccccC-ccchHHHHHHHHHHhcCC-CCCe--eeeeEEEEeC---CEEEEE
Q 008634 396 ENKLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNL--VRLLGCCLEG---QELLLI 465 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g---~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 465 (558)
.++++.|.+..+|+-...++ ..+++|+..... ......+.+|.+++..+. |.++ +++++++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45788999999999877654 356777654332 123456889999999995 6665 7888888764 467899
Q ss_pred EEcCCCCCHHH--------------------H---HhccCCC--------CCCCH--------HHHHHH---------HH
Q 008634 466 YEYMPNKSLDV--------------------H---LFDATRS--------VQLDW--------KRRQSI---------IN 497 (558)
Q Consensus 466 ~Ey~~~gsL~~--------------------~---l~~~~~~--------~~l~~--------~~~~~i---------~~ 497 (558)
|||+++..+.+ . ||..... .+.++ ...+.- .-
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999864321 0 1111000 01111 111100 11
Q ss_pred HHHHHHHHHHhCC--------CCCeeeCCCCCCCEEEcCC-C-cEEEEecCcceee
Q 008634 498 GIARGILYLHEDS--------RLKIIHRDLKASNILLDDD-M-NPKISDFGLARIF 543 (558)
Q Consensus 498 ~ia~aL~yLH~~~--------~~~ivHrDlk~~NILl~~~-~-~~ki~DFGla~~~ 543 (558)
.+.+.+.||..+- +..++|+|+++.|||++.+ . ..-|.||.++.+-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2334467775432 1349999999999999853 3 3579999997753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0002 Score=67.98 Aligned_cols=137 Identities=20% Similarity=0.297 Sum_probs=92.4
Q ss_pred CcccccccCCcccEEEEEecCCcEEEEEEccccC----------------ccchHHHHHHHHHHhcCC------CCCeee
Q 008634 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----------------GQGLQEFKNEVNLIAKLQ------HKNLVR 451 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~ 451 (558)
+....||+|+.-.||.- ++....+||++.... ....++..+|+.....+. +..|.+
T Consensus 4 ~~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 34567999999888864 344556888876554 122456667766555554 889999
Q ss_pred eeEEEEeCCEEEEEEEcCCC------CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEE
Q 008634 452 LLGCCLEGQELLLIYEYMPN------KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525 (558)
Q Consensus 452 l~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NIL 525 (558)
++|+.+++...-+|+|.+.+ -+|.+++.+ ..++. ...+. +-+-..||-++ .|+.+|++|.||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEE
Confidence 99999999989999998753 356666632 33555 22333 33345566655 3999999999999
Q ss_pred EcCC---C-cEEEEe-cCcceee
Q 008634 526 LDDD---M-NPKISD-FGLARIF 543 (558)
Q Consensus 526 l~~~---~-~~ki~D-FGla~~~ 543 (558)
+... . .+.|+| ||-..++
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~~~i 173 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEKELI 173 (199)
T ss_pred EEecCCCceEEEEEeCCCCcccc
Confidence 9532 2 577887 5655543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00018 Score=66.00 Aligned_cols=132 Identities=22% Similarity=0.232 Sum_probs=88.4
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCee-eeeEEEEeCCEEEEEEEcCCCCC
Q 008634 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
..+.|++|.+|.||.+.+. |.++++|+=...++ ...+..|+++|..+...++. +++.+- +-++.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3467999999999999996 45788887554433 46788999999998876654 455553 3356699999988
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC-CCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK-ASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk-~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|.+.-.. .+-++... +++.---|... +|-|..|. |...+|..++.+.|+||--|++-..+
T Consensus 99 L~~~~~~------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 99 LGKLEIG------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hhhhhhc------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence 8765421 12233333 33332222222 48888776 55566666669999999999855443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00032 Score=71.23 Aligned_cols=77 Identities=10% Similarity=0.052 Sum_probs=56.6
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCC---CCeeeeeEEEEeC---CEEEEEEEc
Q 008634 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGCCLEG---QELLLIYEY 468 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV~Ey 468 (558)
..+.||.|..+.||+-...+++ +.+|..+... ....|..|.+.|+.+.. ..++++++++..+ +..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3457999999999998876664 5556533211 22578899999988843 4688899888653 668999999
Q ss_pred CCCCCH
Q 008634 469 MPNKSL 474 (558)
Q Consensus 469 ~~~gsL 474 (558)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00031 Score=68.80 Aligned_cols=141 Identities=19% Similarity=0.215 Sum_probs=77.0
Q ss_pred cccccCCcc-cEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCC---CeeeeeEEEEeC---CEEEEEEEcC
Q 008634 397 NKLGQGGFG-PVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCLEG---QELLLIYEYM 469 (558)
Q Consensus 397 ~~LG~G~fG-~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~ 469 (558)
+.++.|+.. .||+. +..+++|..... .....+..|.+.+..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 58874 234666764432 2245788899998877532 344555544332 2358899999
Q ss_pred CCCCHHHH------------------HhccCCCC-C------------C-CHHHHH--HHH-------HHHHHH-HH-HH
Q 008634 470 PNKSLDVH------------------LFDATRSV-Q------------L-DWKRRQ--SII-------NGIARG-IL-YL 506 (558)
Q Consensus 470 ~~gsL~~~------------------l~~~~~~~-~------------l-~~~~~~--~i~-------~~ia~a-L~-yL 506 (558)
+|.++.+. ||+-.... . + .|.... .+. .+.... +. ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98776321 11111000 0 0 121110 000 011111 11 11
Q ss_pred Hh--CCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 507 HE--DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 507 H~--~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+. .....++|+|+.+.|||++++...-|+||+.+..-
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 11 12344899999999999997766789999987643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0011 Score=64.58 Aligned_cols=141 Identities=20% Similarity=0.272 Sum_probs=81.1
Q ss_pred cccccCCcccEEEEEecC--CcEEEEEEccccCccchHHHHHHHHHHhcCCCC-CeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 397 NKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~--g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
+.|..|-...+|+....+ +..+.+|......... ..-.+|+.++..+... -.+++++... -.+++||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 456777778999988764 5678888765432221 2234688888887433 3445554432 247999999876
Q ss_pred HHHH-----------------HhccCCCC--------CC-CHHHHHHHHH----------------------HHHHHHHH
Q 008634 474 LDVH-----------------LFDATRSV--------QL-DWKRRQSIIN----------------------GIARGILY 505 (558)
Q Consensus 474 L~~~-----------------l~~~~~~~--------~l-~~~~~~~i~~----------------------~ia~aL~y 505 (558)
+... +|+..... .. .|.....+.. .+..-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6311 11111111 11 1222111111 11111122
Q ss_pred H----HhC-CCCCeeeCCCCCCCEEEcC-CCcEEEEecCccee
Q 008634 506 L----HED-SRLKIIHRDLKASNILLDD-DMNPKISDFGLARI 542 (558)
Q Consensus 506 L----H~~-~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~ 542 (558)
| -.. ....++|+|+.+.|||+++ +..+.|+||-.|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 2346999999999999998 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0017 Score=61.33 Aligned_cols=125 Identities=26% Similarity=0.381 Sum_probs=89.2
Q ss_pred CCCCcccccccCCc-ccEEEEEecCCcEEEEEEccc---cCc------------------cchHHHHHHHHHHhcCC---
Q 008634 391 NHFSDENKLGQGGF-GPVYKGTLADGKAIAVKRLSR---TSG------------------QGLQEFKNEVNLIAKLQ--- 445 (558)
Q Consensus 391 ~~f~~~~~LG~G~f-G~Vyk~~~~~g~~VaVK~l~~---~~~------------------~~~~~~~~Ei~~l~~l~--- 445 (558)
.+++..+.||+|.- |.||+.++ +|+.+|+|.... ... ...+.|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 99999999 577999998321 100 11246888999888885
Q ss_pred CCCe--eeeeEEEEeC------------------CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 008634 446 HKNL--VRLLGCCLEG------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505 (558)
Q Consensus 446 H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y 505 (558)
+.++ |+.+||..-. ....||.||.+... .+ ..+-+.+|.+-|.-
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4466 8999997322 12466777765533 11 12335567777888
Q ss_pred HHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 506 LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99875 999999999985 3589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0015 Score=68.77 Aligned_cols=75 Identities=13% Similarity=0.235 Sum_probs=54.7
Q ss_pred cccccCCcccEEEEEecCC-cEEEEEEcccc-----C--ccchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLADG-KAIAVKRLSRT-----S--GQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g-~~VaVK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 465 (558)
+.||.|.+..||+....+| +.|.||.-... . +...+.+..|.+.|..+. ...+++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998877 48999975421 1 223456777888887762 3467788877 44567999
Q ss_pred EEcCCCCC
Q 008634 466 YEYMPNKS 473 (558)
Q Consensus 466 ~Ey~~~gs 473 (558)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0011 Score=65.78 Aligned_cols=138 Identities=17% Similarity=0.135 Sum_probs=78.4
Q ss_pred cccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCEEEEEEEcCCCCCHHHH
Q 008634 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLDVH 477 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 477 (558)
+..|-...+|+... ++..+++|..........-...+|.+++..+...++ +++++... -++|+||++|..+..-
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45567788998874 566788887554332211235778888888854333 44554432 3689999998765321
Q ss_pred -----------------HhccCC-CCCCCHHHHH-HHHHH---------HHHHHHHHHhC-----CCCCeeeCCCCCCCE
Q 008634 478 -----------------LFDATR-SVQLDWKRRQ-SIING---------IARGILYLHED-----SRLKIIHRDLKASNI 524 (558)
Q Consensus 478 -----------------l~~~~~-~~~l~~~~~~-~i~~~---------ia~aL~yLH~~-----~~~~ivHrDlk~~NI 524 (558)
||.... ...++...+. .+..+ +..-+..+-.. .+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 122111 1122222111 11111 11112222111 123589999999999
Q ss_pred EEcCCCcEEEEecCccee
Q 008634 525 LLDDDMNPKISDFGLARI 542 (558)
Q Consensus 525 Ll~~~~~~ki~DFGla~~ 542 (558)
++++++ ++|+||..|..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.01 Score=60.09 Aligned_cols=143 Identities=20% Similarity=0.192 Sum_probs=86.4
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCC--CeeeeeEE------EEeCCEEEEEEE
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGC------CLEGQELLLIYE 467 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E 467 (558)
.+.|..|....+|+....+ ..+++|+.... .......|++++..+.+. .+++++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 3457777778899887644 46788877642 234566777777777433 34455442 233456789999
Q ss_pred cCCCCCHHH----H----------HhccC----C----CCCCCHHHHHH----------HHHHHHHHHHHHHh----CCC
Q 008634 468 YMPNKSLDV----H----------LFDAT----R----SVQLDWKRRQS----------IINGIARGILYLHE----DSR 511 (558)
Q Consensus 468 y~~~gsL~~----~----------l~~~~----~----~~~l~~~~~~~----------i~~~ia~aL~yLH~----~~~ 511 (558)
|++|..+.. . +|... . .....|..... ....+...+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876531 1 11110 0 01123332211 11223444555553 123
Q ss_pred CCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 512 LKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 512 ~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999988789999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.011 Score=60.54 Aligned_cols=141 Identities=17% Similarity=0.206 Sum_probs=77.0
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCC--CCeeeeeE------EEEeCCEEEEEEEc
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLG------CCLEGQELLLIYEY 468 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g------~~~~~~~~~lV~Ey 468 (558)
+.|..|....+|+....+| .+++|+....+. +....|+.++..|.. -.+++.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566677778999887655 578887752222 333345555554421 22334442 12335668999999
Q ss_pred CCCCCHH-----------HH---HhccCC--------CCCCCH-HHHHH------------HH-HHHHHHHHHHHhC---
Q 008634 469 MPNKSLD-----------VH---LFDATR--------SVQLDW-KRRQS------------II-NGIARGILYLHED--- 509 (558)
Q Consensus 469 ~~~gsL~-----------~~---l~~~~~--------~~~l~~-~~~~~------------i~-~~ia~aL~yLH~~--- 509 (558)
++|..+. .. +|.... ...+.| ..... .. ..+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9987541 11 111110 011222 21111 11 1111222333211
Q ss_pred -CCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 510 -SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 510 -~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
-+..++|+|+.+.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977666899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.019 Score=58.62 Aligned_cols=142 Identities=18% Similarity=0.194 Sum_probs=81.9
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCC--CCeeeeeEE------EEeCCEEEEEEEc
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGC------CLEGQELLLIYEY 468 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~------~~~~~~~~lV~Ey 468 (558)
+.++.|....+|+....+| ..++|+...... .++...|.+++..|.. -++++++.. ....+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4566676688998876555 466787654321 2345566676666632 224454442 1224567899999
Q ss_pred CCCCCHH----H----------HHhccCCC---------CCCCHHHHH------------HHHHHHHHHHHHHHh----C
Q 008634 469 MPNKSLD----V----------HLFDATRS---------VQLDWKRRQ------------SIINGIARGILYLHE----D 509 (558)
Q Consensus 469 ~~~gsL~----~----------~l~~~~~~---------~~l~~~~~~------------~i~~~ia~aL~yLH~----~ 509 (558)
++|..+. . .+|..... ..-.|.... .....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9985532 0 01211110 011222111 011223345555543 2
Q ss_pred CCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 510 ~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
-+..++|+|+.+.||++++++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23569999999999999998877999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0034 Score=62.96 Aligned_cols=139 Identities=17% Similarity=0.136 Sum_probs=91.9
Q ss_pred HHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEcccc-----------------Cccc-----hHHHHHHHHHHh
Q 008634 385 LALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT-----------------SGQG-----LQEFKNEVNLIA 442 (558)
Q Consensus 385 ~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~-----------------~~~~-----~~~~~~Ei~~l~ 442 (558)
.+.....-++.+++||-|.-+-||.+...+|.+.++|.-... .... +-....|...|+
T Consensus 86 tL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk 165 (465)
T KOG2268|consen 86 TLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK 165 (465)
T ss_pred HHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence 333333456778999999999999999999999888832110 0001 122456778888
Q ss_pred cCCC--CCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 008634 443 KLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (558)
Q Consensus 443 ~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 520 (558)
.+.. --+++.+++ ...++|||++.+-.|...-+ ..+..+...- +..-+.-|..+| +||+|+.
T Consensus 166 aL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~---lm~~Iv~la~~G---lIHgDFN 229 (465)
T KOG2268|consen 166 ALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDD---LMGLIVRLANHG---LIHGDFN 229 (465)
T ss_pred HHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHH---HHHHHHHHHHcC---ceecccc
Confidence 8742 234455544 46689999998877653221 1233333332 333345566664 9999999
Q ss_pred CCCEEEcCCCcEEEEecCc
Q 008634 521 ASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 521 ~~NILl~~~~~~ki~DFGl 539 (558)
-=||+++++..++++||=-
T Consensus 230 EFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 230 EFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred hheeEEecCCCEEEeechH
Confidence 9999999999999999953
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.018 Score=59.77 Aligned_cols=141 Identities=19% Similarity=0.302 Sum_probs=81.2
Q ss_pred ccccCCcccEEEEEecC-----CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCEEEEEEEcCCC
Q 008634 398 KLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~-----g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
.|-.|-.-.+|+....+ ++.+++|..........+. .+|..++..+...++ .++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45446667888876532 3578888776554333333 678888888754333 3566665332 58999987
Q ss_pred CCHHHH-----------------HhccCCC--C-CCCHHHHHHHHH-----------------HHHHHHHHH----Hh-C
Q 008634 472 KSLDVH-----------------LFDATRS--V-QLDWKRRQSIIN-----------------GIARGILYL----HE-D 509 (558)
Q Consensus 472 gsL~~~-----------------l~~~~~~--~-~l~~~~~~~i~~-----------------~ia~aL~yL----H~-~ 509 (558)
.++... +|+...+ . ...|.+...... .+...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 1221111 1 112332222221 111122222 21 2
Q ss_pred CCCCeeeCCCCCCCEEEcC-CCcEEEEecCcceee
Q 008634 510 SRLKIIHRDLKASNILLDD-DMNPKISDFGLARIF 543 (558)
Q Consensus 510 ~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~~ 543 (558)
.+..++|+|+++.|||+++ ++.++++||..|..-
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2346899999999999986 478999999888743
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.021 Score=57.99 Aligned_cols=141 Identities=25% Similarity=0.350 Sum_probs=82.1
Q ss_pred ccccCCcccEEEEEecC-------CcEEEEEEccccCccchHHHHHHHHHHhcCCCCC-eeeeeEEEEeCCEEEEEEEcC
Q 008634 398 KLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~-------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.|..|--..+|+....+ ++.+++|....... ...+..+|.+++..+...+ .+++++.+.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 44455556888887654 47788888655432 2234567888877774322 3456665532 3589999
Q ss_pred CCCCHHHH-----------------HhccCCCC--------CCCHHHHHH--------------------------HHHH
Q 008634 470 PNKSLDVH-----------------LFDATRSV--------QLDWKRRQS--------------------------IING 498 (558)
Q Consensus 470 ~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~~~ 498 (558)
+|..+... +|+..... ..-|..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 98766421 11111110 011111100 1122
Q ss_pred HHHHHHHHHh------CCCCCeeeCCCCCCCEEEcCC----CcEEEEecCcceee
Q 008634 499 IARGILYLHE------DSRLKIIHRDLKASNILLDDD----MNPKISDFGLARIF 543 (558)
Q Consensus 499 ia~aL~yLH~------~~~~~ivHrDlk~~NILl~~~----~~~ki~DFGla~~~ 543 (558)
+..-+.+|-. ..+..++|+|+.+.|||++++ +.++++||..|..-
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 2233444432 234568999999999999985 88999999988643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.018 Score=57.78 Aligned_cols=32 Identities=28% Similarity=0.511 Sum_probs=26.8
Q ss_pred CCeeeCCCCCCCEEEcCCCc-EEEEecCcceee
Q 008634 512 LKIIHRDLKASNILLDDDMN-PKISDFGLARIF 543 (558)
Q Consensus 512 ~~ivHrDlk~~NILl~~~~~-~ki~DFGla~~~ 543 (558)
..++|+|+++.|||+++++. .-|+||+.+.+-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997554 579999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.015 Score=59.40 Aligned_cols=140 Identities=18% Similarity=0.232 Sum_probs=96.0
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEcccc-----Cc----cc-----------------hHHHHHHHHHHhcCCCCCee
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRT-----SG----QG-----------------LQEFKNEVNLIAKLQHKNLV 450 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~-----~~----~~-----------------~~~~~~Ei~~l~~l~H~niv 450 (558)
..|..|.-.-||.+.-.+|..+|||+.+.. +. .+ ..+...|++.|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 457788889999999999999999976532 00 00 11234578888888765554
Q ss_pred eeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC
Q 008634 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (558)
Q Consensus 451 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~ 530 (558)
..--+... ...|||+|+.... |-...-+...++......+-.+++.-|.-|...+ ++||.||.--|+|+ .+|
T Consensus 230 ~PePIlLk--~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 230 CPEPILLK--NHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDG 301 (520)
T ss_pred CCCceeee--cceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECC
Confidence 33333332 3478999996321 1111123345666667778888888888888776 79999999999988 667
Q ss_pred cEEEEecCcceeeC
Q 008634 531 NPKISDFGLARIFG 544 (558)
Q Consensus 531 ~~ki~DFGla~~~~ 544 (558)
.+.|+|-+-+--..
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 79999988765443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.047 Score=55.63 Aligned_cols=130 Identities=18% Similarity=0.273 Sum_probs=76.7
Q ss_pred CcEEEEEEcc-ccCccchHHHHHHHHHHhcCCC--CCeeeeeEEEEeCC--EEEEEEEcCCCCCHH--------------
Q 008634 415 GKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ--ELLLIYEYMPNKSLD-------------- 475 (558)
Q Consensus 415 g~~VaVK~l~-~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~-------------- 475 (558)
+++.++.+-. ...........+|.+.|+.+.- .-+.+.++.|.++. ..|.||||++|..+.
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 6667776221 1222334556778888887743 34456677777665 679999999873321
Q ss_pred ----HHHh---cc--------C------CCCCCCHHHHHHHH--------HHHHHHHHHHHhC-----CCCCeeeCCCCC
Q 008634 476 ----VHLF---DA--------T------RSVQLDWKRRQSII--------NGIARGILYLHED-----SRLKIIHRDLKA 521 (558)
Q Consensus 476 ----~~l~---~~--------~------~~~~l~~~~~~~i~--------~~ia~aL~yLH~~-----~~~~ivHrDlk~ 521 (558)
++|. +- . ....-.|...+..+ -....-..||+.+ ++..++|+|+.+
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 1111 00 0 00011222222111 1122234566544 345699999999
Q ss_pred CCEEEcCCCcEEEEecCcceeeC
Q 008634 522 SNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 522 ~NILl~~~~~~ki~DFGla~~~~ 544 (558)
.|++++++.-+=|.||+++..-+
T Consensus 208 gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCEEEeCCCeeEEEeccccccCC
Confidence 99999999889999999987643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.03 Score=56.47 Aligned_cols=138 Identities=18% Similarity=0.270 Sum_probs=72.7
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcC---CCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
..+.++-|....+|+.. .+++.+-||.-... ....|..|.+-|+.| .--.+++.+++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34568888889999877 56778888876622 235677888877777 345678999998887788999999987
Q ss_pred CCHH-----------HHHhc-cCCC------------------CCCCHHHHH-----HHH--------------HHHHHH
Q 008634 472 KSLD-----------VHLFD-ATRS------------------VQLDWKRRQ-----SII--------------NGIARG 502 (558)
Q Consensus 472 gsL~-----------~~l~~-~~~~------------------~~l~~~~~~-----~i~--------------~~ia~a 502 (558)
+... --||+ .... -.-+|..-. .-. ..+.+.
T Consensus 97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~ 176 (288)
T PF03881_consen 97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER 176 (288)
T ss_dssp ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence 7110 11333 1111 013443211 111 111111
Q ss_pred HH-HHHhC-CCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 008634 503 IL-YLHED-SRLKIIHRDLKASNILLDDDMNPKISD 536 (558)
Q Consensus 503 L~-yLH~~-~~~~ivHrDlk~~NILl~~~~~~ki~D 536 (558)
+. .|+.. ..+.++|+||-+.|++.+.++.+.|.|
T Consensus 177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~D 212 (288)
T PF03881_consen 177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFD 212 (288)
T ss_dssp HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S
T ss_pred HHHHhcCCCCCceeeEcCccccceeecCCCCceeec
Confidence 11 12211 245799999999999999999899987
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.048 Score=56.40 Aligned_cols=72 Identities=15% Similarity=0.197 Sum_probs=48.3
Q ss_pred ccccCCcccEEEEEecCC-cEEEEEEcccc-------CccchHHHHHHHHHHhcCC--CC-CeeeeeEEEEeCCEEEEEE
Q 008634 398 KLGQGGFGPVYKGTLADG-KAIAVKRLSRT-------SGQGLQEFKNEVNLIAKLQ--HK-NLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~g-~~VaVK~l~~~-------~~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 466 (558)
.||-|....||++..++| +.|+||.-... -+-..++...|.+.|.... -| .+++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478899999999998754 68999964321 1233455566777776652 23 45556555 556678999
Q ss_pred EcCCC
Q 008634 467 EYMPN 471 (558)
Q Consensus 467 Ey~~~ 471 (558)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.17 Score=51.47 Aligned_cols=29 Identities=31% Similarity=0.406 Sum_probs=25.3
Q ss_pred CCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 512 ~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46899999999999987 668999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.0011 Score=75.11 Aligned_cols=150 Identities=19% Similarity=0.233 Sum_probs=101.4
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
..-+.+.+.+.+..|.++.+..+.-. .|...++|..... ...+.+..+.+-.+.-..+||-+++..--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34566777778889999999877533 2322233322221 1112223333333444455677776666656667899
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||++|+.+++|...|+... ..+.+-....+..+..+++|||.. .+.|||++|.|.|+..++..++.|||+.+..
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999887544 233333334455678899999975 4899999999999999999999999955543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.0019 Score=69.88 Aligned_cols=138 Identities=19% Similarity=0.185 Sum_probs=91.7
Q ss_pred CcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCC-eeeeeEEEEeCCEEEEEEEcCCCC
Q 008634 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
..-+-++++..++++|.+-...+....+.+... ....-++++|.+++||| .++.++-+...+..+++++++..+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 334457899999999987544444445554433 34567899999999999 777777777778899999999887
Q ss_pred -CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 473 -SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 473 -sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+-..-. ......+..-+...+...-+++|+|||+. .-+|+| ||+..+ ...|..||+....+...
T Consensus 320 rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 320 RSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred ccccccC--ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc
Confidence 211100 00001122222334455567889999975 258998 777655 67899999988776543
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.02 Score=38.69 Aligned_cols=32 Identities=22% Similarity=0.443 Sum_probs=19.8
Q ss_pred CCCceeEEEEehhHHHHHHHHHHHhhheeecc
Q 008634 303 KRGRAISIAIGTTLSALIVVLFGSFLWYRRRR 334 (558)
Q Consensus 303 ~~~~~i~i~i~~~v~~~~l~~~~~~~~~rrrr 334 (558)
+...++++.++++++++++++.+++++++||+
T Consensus 8 ~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 8 SNTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred CceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 34556677777777777666666555555443
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.063 Score=55.41 Aligned_cols=140 Identities=15% Similarity=0.259 Sum_probs=77.1
Q ss_pred ccccCCcccEEEEEecC----CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCEEEEEEEcCCCC
Q 008634 398 KLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNK 472 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~g 472 (558)
.|..|-.-.+|+....+ +..+++|.......... .-.+|..++..+...++ +++++++. ++ +|.||+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 34445567788876543 23788887765443222 23578888888855444 45666653 22 589999876
Q ss_pred CHHH-------H----------HhccCCC--C-CCCHHHHHHHHHH----------------------HHHHHH----HH
Q 008634 473 SLDV-------H----------LFDATRS--V-QLDWKRRQSIING----------------------IARGIL----YL 506 (558)
Q Consensus 473 sL~~-------~----------l~~~~~~--~-~l~~~~~~~i~~~----------------------ia~aL~----yL 506 (558)
.+.. . +|+...+ . .--|....++..+ +..-+. ++
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6521 1 1221101 1 1123322222211 111122 22
Q ss_pred Hh-CCCCCeeeCCCCCCCEEEcC-CCcEEEEecCccee
Q 008634 507 HE-DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARI 542 (558)
Q Consensus 507 H~-~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~ 542 (558)
.. ..+.-+.|.|+.+.|||+++ ++.++++||..|-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 12234789999999999974 57899999987753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.16 Score=53.53 Aligned_cols=73 Identities=12% Similarity=0.114 Sum_probs=49.1
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccC---c----cchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCEEEEE
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS---G----QGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~---~----~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 465 (558)
.+.||-|..-.||+.... +..++||.-.... + ....+-..|.+.|..+. ...+++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 457899999999998764 4568888765211 1 12333445566665543 357888998877 446888
Q ss_pred EEcCCC
Q 008634 466 YEYMPN 471 (558)
Q Consensus 466 ~Ey~~~ 471 (558)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.071 Score=50.97 Aligned_cols=101 Identities=17% Similarity=0.186 Sum_probs=68.6
Q ss_pred EEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHH
Q 008634 417 AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI 495 (558)
Q Consensus 417 ~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i 495 (558)
+..+|++...+-. ...-|.++.+++++++ .|++|..- ..-..-+++|.|-.... +.- -.|
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~---N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFS---NFI 147 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chh---HHH
Confidence 3566777655444 3456788999999886 46777632 33466788898743211 111 112
Q ss_pred HHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 496 ~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
..+ ...|.-.|+. ....+|+|-.|+|||-|..|.+||.|-+
T Consensus 148 ~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 148 TAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChh
Confidence 222 3667778865 3479999999999999999999999976
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.24 Score=50.90 Aligned_cols=139 Identities=26% Similarity=0.372 Sum_probs=81.8
Q ss_pred cccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCC------eeeeeEEEE--eCC--EEEEEEEc
Q 008634 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLGCCL--EGQ--ELLLIYEY 468 (558)
Q Consensus 399 LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~--~~~--~~~lV~Ey 468 (558)
|.+ .--.+|+....+|+. ++|..... ....++..|+..|..+.-.+ +..+-|-.. -.. ..+-++||
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 446788888877776 77776654 33455666777776663211 233333221 123 78889999
Q ss_pred CCCCCHHH-----H----------Hhcc----C--CC---CCCCHHH---H----------HHHHHHHHHHHHHHHhC--
Q 008634 469 MPNKSLDV-----H----------LFDA----T--RS---VQLDWKR---R----------QSIINGIARGILYLHED-- 509 (558)
Q Consensus 469 ~~~gsL~~-----~----------l~~~----~--~~---~~l~~~~---~----------~~i~~~ia~aL~yLH~~-- 509 (558)
++|..+.. . +|.. . .+ ....|.. + .....++...+..+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987762 1 1110 0 11 1244541 0 11233344445544433
Q ss_pred -----CCCCeeeCCCCCCCEEEcCCCc-EEEEecCcce
Q 008634 510 -----SRLKIIHRDLKASNILLDDDMN-PKISDFGLAR 541 (558)
Q Consensus 510 -----~~~~ivHrDlk~~NILl~~~~~-~ki~DFGla~ 541 (558)
.+..+||+|+.|.||+++.+.. +.++||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1122999999999999998885 9999999876
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.077 Score=55.60 Aligned_cols=73 Identities=11% Similarity=0.137 Sum_probs=50.0
Q ss_pred cccccCCcccEEEEEecC-CcEEEEEEcccc------CccchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCEEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT------SGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~------~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 466 (558)
+.||-|.-.-||++..++ ++.|+||.-... -+-..++..-|.+.|.... -..+++++.+ +++...+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 468999999999999753 567999964321 1233566677777777652 2346667665 555678999
Q ss_pred EcCCC
Q 008634 467 EYMPN 471 (558)
Q Consensus 467 Ey~~~ 471 (558)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99965
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.45 Score=56.59 Aligned_cols=141 Identities=23% Similarity=0.314 Sum_probs=76.9
Q ss_pred ccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcC--CCCC--eeeee----EE----EEe-CC--EE
Q 008634 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL--QHKN--LVRLL----GC----CLE-GQ--EL 462 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l--~H~n--iv~l~----g~----~~~-~~--~~ 462 (558)
.|+ |..-.+|+....+|..+++|+.+..... .....|...|..| +++. +.+++ |- ... .+ ..
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 453 4457789888878888999998764322 2333444455433 1122 22322 11 111 12 46
Q ss_pred EEEEEcCCCCCHHHH-----------------Hhc----c---CCCCCCCHHH-----------------HHHHHHHHHH
Q 008634 463 LLIYEYMPNKSLDVH-----------------LFD----A---TRSVQLDWKR-----------------RQSIINGIAR 501 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~-----------------l~~----~---~~~~~l~~~~-----------------~~~i~~~ia~ 501 (558)
+.+++|++|..+.+. ++. - .....+.|.. +..++.++.+
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 778999999777541 110 0 0111234432 1122222222
Q ss_pred HHH-----HHHhCCCCCeeeCCCCCCCEEEcCCC--cEE-EEecCccee
Q 008634 502 GIL-----YLHEDSRLKIIHRDLKASNILLDDDM--NPK-ISDFGLARI 542 (558)
Q Consensus 502 aL~-----yLH~~~~~~ivHrDlk~~NILl~~~~--~~k-i~DFGla~~ 542 (558)
... .|.. -+..+||+|+.+.|||++.+. ++. |+|||.+..
T Consensus 189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 221 1222 234699999999999999875 555 999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.33 Score=49.51 Aligned_cols=32 Identities=25% Similarity=0.371 Sum_probs=28.4
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 511 ~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
+..++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44699999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.11 Score=53.20 Aligned_cols=72 Identities=22% Similarity=0.277 Sum_probs=55.0
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
...|+++++. ++++.. ...-.|++.+.|+.+-+.-+.-+..+ .+.=|||+.-.||||+ +|++.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 3557777764 444431 12247889999998877777666654 4789999999999999 99999999999
Q ss_pred cee
Q 008634 540 ARI 542 (558)
Q Consensus 540 a~~ 542 (558)
+|.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 994
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.61 E-value=1.4 Score=45.42 Aligned_cols=72 Identities=13% Similarity=0.046 Sum_probs=43.9
Q ss_pred CCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCC--CCeee---eeE--EEEeCCEEEEEEEcCCCCCH
Q 008634 402 GGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVR---LLG--CCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 402 G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~---l~g--~~~~~~~~~lV~Ey~~~gsL 474 (558)
+.-..||+....++..+++|..... .....+...|++.+..+.. -.++. .-| ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3446789988877888888876532 2234566677777766632 12222 112 12334677889999987643
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.12 Score=51.01 Aligned_cols=76 Identities=21% Similarity=0.212 Sum_probs=55.7
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHH---HHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC-CC
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV---NLIAKLQHKNLVRLLGCCLEGQELLLIYEYM-PN 471 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei---~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~-~~ 471 (558)
...+..|..+.|++++..+|.+.++|....... +..|. ..|...+-...|++++.- .+.-.+++|.+ ++
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g 79 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPG 79 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCC
Confidence 345667889999999999999999998765432 22333 558888888899999884 34567888998 55
Q ss_pred CCHHHHH
Q 008634 472 KSLDVHL 478 (558)
Q Consensus 472 gsL~~~l 478 (558)
.+|.+..
T Consensus 80 ~~L~~~~ 86 (253)
T PF04655_consen 80 RSLASLP 86 (253)
T ss_pred Cchhhcc
Confidence 5775544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.43 Score=46.04 Aligned_cols=58 Identities=22% Similarity=0.345 Sum_probs=43.0
Q ss_pred CcEEEEEEccccCccchHHHHHHHHHHhcC---CCCCeeeeeEEEEeCCEEEEEEEcCCCCCHH
Q 008634 415 GKAIAVKRLSRTSGQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (558)
Q Consensus 415 g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 475 (558)
..++-||.-.. ..+..|..|+.-|..+ +--++.+++.+-.+....|+|+||++-|.++
T Consensus 39 ~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 39 TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 45677775432 2345678887766665 4466888899888999999999999987775
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.23 E-value=0.77 Score=48.36 Aligned_cols=73 Identities=22% Similarity=0.396 Sum_probs=43.8
Q ss_pred ccccCCcccEEEEEecCCc-------EEEEEEccccCccchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCEEEEEEEcC
Q 008634 398 KLGQGGFGPVYKGTLADGK-------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~~g~-------~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~ 469 (558)
.|..|-...+|+....++. .|.++.......... +-.+|++++..+...++ .++++.+.. ++|+||+
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI 131 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV 131 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence 4545667889988765431 244443222222222 22568888888865444 456666542 6999999
Q ss_pred CCCCHH
Q 008634 470 PNKSLD 475 (558)
Q Consensus 470 ~~gsL~ 475 (558)
++..|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.12 E-value=0.23 Score=51.77 Aligned_cols=61 Identities=16% Similarity=0.155 Sum_probs=43.4
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
...++-+|..+-++..++.... .+++.+.+++.-.++||.-+-.-. +++|.|+.|.||++-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 3467778888999988884322 455566667766677765443322 599999999999994
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=90.21 E-value=0.12 Score=44.89 Aligned_cols=45 Identities=18% Similarity=0.361 Sum_probs=34.0
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhc
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~ 443 (558)
.+.|+.|+.|+||+|++++|++|+||+.+..-. +.+..++.+|..
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~---~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGIE---EQIEADLRILRR 60 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcchHHH---HHHHHHHHHHHH
Confidence 467999999999999999999999998876533 334444444443
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.45 E-value=0.32 Score=45.68 Aligned_cols=29 Identities=21% Similarity=0.280 Sum_probs=25.7
Q ss_pred CeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 513 KIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 513 ~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
..+|+|+.|.|+++++++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 478999999999998887 99999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 558 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-31 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-24 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 2e-97
Identities = 79/197 (40%), Positives = 107/197 (54%), Gaps = 14/197 (7%)
Query: 372 QAESQEFPLFPLRLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLS- 424
+ F F TN+F + NK+G+GGFG VYKG + + +AVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 425 ---RTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
T+ + Q+F E+ ++AK QH+NLV LLG +G +L L+Y YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ L W R I G A GI +LHE+ IHRD+K++NILLD+ KISDFGLAR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 542 IFGGNQNQANTNIIAGT 558
T+ I GT
Sbjct: 182 ASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 1e-94
Identities = 83/180 (46%), Positives = 112/180 (62%), Gaps = 3/180 (1%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVN 439
F LR A+++FS++N LG+GGFG VYKG LADG +AVKRL QG + +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIING 498
+I+ H+NL+RL G C+ E LL+Y YM N S+ L + S LDW +RQ I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
ARG+ YLH+ KIIHRD+KA+NILLD++ + DFGLA++ T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 1e-87
Identities = 75/180 (41%), Positives = 112/180 (62%), Gaps = 6/180 (3%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
PL EATN+F + +G G FG VYKG L DG +A+KR + S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGI 499
++ +H +LV L+G C E E++LIY+YM N +L HL+ + + W++R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF-GGNQNQANTNIIAGT 558
ARG+ YLH + IIHRD+K+ NILLD++ PKI+DFG+++ +Q +T + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 6e-65
Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
+ +G FG V+K L + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 441 IAKLQHKNLVRLLGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
+ ++H+N+++ +G G +L LI + SL L ++ + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 497 NGIARGILYLHED-------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+ARG+ YLHED + I HRD+K+ N+LL +++ I+DFGLA F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 550 ANTNIIAGT 558
+T+ GT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-54
Identities = 54/187 (28%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
++ +G+G +G VYKG+L D + +AVK S + Q K + + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 449 LVRLLGCCLEG-----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+ R + E LL+ EY PN SL +L T DW + + + RG+
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 504 LYLHED------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN------QNQAN 551
YLH + + I HRDL + N+L+ +D ISDFGL+ GN +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 552 TNIIAGT 558
GT
Sbjct: 185 AISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-50
Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 6/165 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+ K+G G FG V++ G +AVK L + + EF EV ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G + L ++ EY+ SL L + QLD +RR S+ +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
I+HR+LK+ N+L+D K+ DFGL+R+ + + AGT
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGT 202
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-48
Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+G FG K T G+ + +K L R + + F EV ++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ + L I EY+ +L + Q W +R S IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
IHRDL + N L+ ++ N ++DFGLAR+ + Q
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 47/153 (30%), Positives = 68/153 (44%), Gaps = 6/153 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
E +G+G FG V K K +A+K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L G CL + L+ EY SL L A S ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 511 RLKIIHRDLKASNILLDDDMN-PKISDFGLARI 542
+IHRDLK N+LL KI DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-45
Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 7/157 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKN 448
+ KL + G ++KG G I VK L S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 449 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
++ +LG C LI +MP SL L + T V +D + +ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFL 127
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
H I L + ++++D+DM +IS + F
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-45
Identities = 54/163 (33%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
++G G FG VYKG A+ + ++ + Q LQ FKNEV ++ K +H N++ +G
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
Q L ++ ++ SL HL + + K+ I ARG+ YLH II
Sbjct: 89 STAPQ-LAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
HRDLK++NI L +D KI DFGLA ++G+
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-45
Identities = 53/159 (33%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL----SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
E +G GGFG VY+ G +AVK Q ++ + E L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L G CL+ L L+ E+ L ++ + IARG+ YLH+++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 512 LKIIHRDLKASNILLDDDMNP--------KISDFGLARI 542
+ IIHRDLK+SNIL+ + KI+DFGLAR
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-44
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 18/165 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-------LQEFKNEVNLIA 442
N E ++G+GGFG V+KG + D +A+K L +G QEF+ EV +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
L H N+V+L G ++ E++P L L D ++ + W + ++ IA G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLD-----DDMNPKISDFGLARI 542
I Y+ + I+HRDL++ NI L + K++DFGL++
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+G+G FG VY G G+ +A++ + R + L+ FK EV + +H+N+V +
Sbjct: 38 GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G C+ L +I ++L + D + LD + + I I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN---IIAGT 558
I+H+DLK+ N+ D+ I+DFGL I G Q + I G
Sbjct: 151 ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 21/176 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
+G+G +G V++G+ G+ +AVK S + + + E + L+H+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ + +L LI Y SL +L + LD I+ IA G+ +LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGT 558
+ I HRDLK+ NIL+ + I+D GLA + NQ N GT
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 21/176 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
++G+G +G V+ G G+ +AVK + E + ++H+N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
++G +L LI +Y N SL +L +S LD K + G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGT 558
+ I HRDLK+ NIL+ + I+D GLA F + N+ + N GT
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 21/176 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
+ +G+G FG V++G G+ +AVK S + + + E + L+H+N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ +L L+ +Y + SL FD + + + A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGT 558
+ I HRDLK+ NIL+ + I+D GLA + + N GT
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +LG+G FG V+ + +AVK L S Q+F+ E L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL------------FDATRSVQLDWKRRQSIIN 497
VR G C EG+ LL+++EYM + L+ L + L + ++ +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A G++YL + L +HRDL N L+ + KI DFG++R
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-36
Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +LG+G FG V+ + +AVK L + ++F+ E L+ LQH+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRQSII 496
V+ G C +G L++++EYM + L+ L +L + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ IA G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 7/149 (4%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
++G+G FG V+ G L AD +AVK +F E ++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G C + Q + ++ E + L T +L K ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARI 542
IHRDL A N L+ + KISDFG++R
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 52/161 (32%), Positives = 74/161 (45%), Gaps = 15/161 (9%)
Query: 396 ENKLGQGGFGPVYKGTL---ADGKAI--AVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
LG+G FG V DG AVK L +G Q +K E++++ L H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
++ GCC + L L+ EY+P SL +L + + I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
IHRDL A N+LLD+D KI DFGLA+
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 56/166 (33%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
+LG+ FG VYKG L A+A+K L + G +EF++E L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRQSI 495
+V LLG + Q L +I+ Y + L L D T L+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ IA G+ YL S ++H+DL N+L+ D +N KISD GL R
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 397 NKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
+LGQG FG VY+G +A+K + S + EF NE +++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------FDATRSVQLDWKRRQSIINGIARG 502
VRLLG +GQ L+I E M L +L + + + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ YL+ K +HRDL A N ++ +D KI DFG+ R
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 396 ENKLGQGGFGPVYKGTLA-----DGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG+G FG V G+ +AVK L + G + + K E+ ++ L H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
V+ G C E G + LI E++P+ SL +L +++ K++ I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ +HRDL A N+L++ + KI DFGL + ++
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 396 ENKLGQGGFGPVYKGT---LADGKAI--AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+LG+G FG V L D AVK+L ++ + L++F+ E+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ G C L LI EY+P SL +L ++D + + I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ IHRDL NIL++++ KI DFGL ++ ++
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 396 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
++LG+G FG V G +AVK+L + ++F+ E+ ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ G L L+ EY+P+ L L +LD R + I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ +HRDL A NIL++ + + KI+DFGLA++ +++
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 396 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+LG+G FG V G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ G C L LI EY+P SL +L ++D + + I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ IHRDL NIL++++ KI DFGL ++ ++
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 33/204 (16%)
Query: 357 IRNHYAYNILRGGKQQAESQEFPLFPL-RLALEATNHFSDENKLGQGGFGPVYKGTLADG 415
++ H+ GK + +P+ + + + +G+G FG V K +
Sbjct: 1 MKKHH---HHHHGKNNPDPTIYPVLDWNDIKFQ--------DVIGEGNFGQVLKARIKKD 49
Query: 416 KA---IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 470
A+KR+ S ++F E+ ++ KL H N++ LLG C L L EY P
Sbjct: 50 GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109
Query: 471 NKSLDVHL-------------FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
+ +L L + + L ++ +ARG+ YL S+ + IHR
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 166
Query: 518 DLKASNILLDDDMNPKISDFGLAR 541
DL A NIL+ ++ KI+DFGL+R
Sbjct: 167 DLAARNILVGENYVAKIADFGLSR 190
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG G FG VYKG +A+K L TS + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYL 506
RLLG CL + LI + MP L ++ + ++ Q ++N IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS-----QYLLNWCVQIAKGMNYL 133
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+++HRDL A N+L+ + KI+DFGLA++ G +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 31/174 (17%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
LG+G FG V K T K +AVK L S L++ +E N++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSL---------------------DVHLFDATRSVQL 487
+++L G C + LLLI EY SL + D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S I++G+ YL + +K++HRDL A NIL+ + KISDFGL+R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 6/159 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++KLG G +G VY+G +AVK L + ++EF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
C +I E+M +L +L + R ++ + I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
IHRDL A N L+ ++ K++DFGL+R+ G+ A+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 57/241 (23%), Positives = 87/241 (36%), Gaps = 35/241 (14%)
Query: 326 SFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRL 385
S+ + + L+++G + + + K + + P
Sbjct: 2 SYYHHHHHHDYDIPTTEN-------LYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYC 54
Query: 386 ALEATNHFSDE-----------NKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTS 427
T+ SD LG G FG VY+G ++ +AVK L S
Sbjct: 55 FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114
Query: 428 GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATR 483
Q +F E +I+K H+N+VR +G L+ ++ E M L L ++
Sbjct: 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLA 540
L + IA G YL IHRD+ A N LL KI DFG+A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
Query: 541 R 541
R
Sbjct: 232 R 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+LG G FG V G +A+K + + EF E ++ L H+ LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
C + + + +I EYM N L +L + ++ + + + YL + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL A N L++D K+SDFGL+R ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
+ +G+G FG VY G D A+K LSR T Q ++ F E L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
L+G L + ++ YM + L + R+ + K S +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL--- 140
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ K +HRDL A N +LD+ K++DFGLAR
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 51/162 (31%), Positives = 85/162 (52%), Gaps = 10/162 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
E +G G G V G L +A+K L + + + ++F +E +++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL G G+ +++ EYM N SLD L T Q + ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
L +HRDL A N+L+D ++ K+SDFGL+R+ + + A T
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 41/233 (17%)
Query: 328 LWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLAL 387
+ Y+ ++ + Q + + + N Y + I E EFP L+
Sbjct: 2 VDYKYKQKPKYQVRWKIIESYE--------GNSYTF-IDPTQLPYNEKWEFPRNNLQF-- 50
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNL 440
LG G FG V + T +AVK L S + +E+ +
Sbjct: 51 --------GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 441 IAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHLFDATRSVQLD 488
++ L QH+N+V LLG C G +L+I EY L + A +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ + +A+G+ +L + IHRD+ A N+LL + KI DFGLAR
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 46/153 (30%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++KLG G +G VY+G +AVK L + + ++EF E ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
C +I E+M +L +L + R ++ + I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 339
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
IHR+L A N L+ ++ K++DFGL+R+ G+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+LG G FG V G +AVK + + EF E + KL H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
C + + ++ EY+ N L +L + L+ + + + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL A N L+D D+ K+SDFG+ R +Q
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 26/169 (15%)
Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
LG+G FG V +AVK L + + L + +E+ ++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
HKN++ LLG C + L +I EY +L +L + Q+ +K
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
++G G FG V+ G + +A+K + R ++F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
CLE + L+ E+M + L +L T+ + + + G+ YL +I
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL A N L+ ++ K+SDFG+ R +Q
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 456 CLEGQELL-LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+E + L ++ EYM SL +L RS L + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDL A N+L+ +D K+SDFGL +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNL 449
LG+G FG V +G L +AVK + +S + ++EF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 450 VRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIAR 501
+RLLG C+E + ++I +M L +L T + + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
G+ YL S +HRDL A N +L DDM ++DFGL++
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 50/152 (32%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG VY GTL D AVK L+R T + +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
LLG CL + L++ YM + L + + K +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
K +HRDL A N +LD+ K++DFGLAR
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 26/169 (15%)
Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
LG+G FG V +AVK L + + L + +E+ ++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
HKN++ LLG C + L +I EY +L +L + Q+ +K
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 18/161 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
LG G FG V+KG + +K + SG Q Q + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYL 506
VRLLG C L L+ +Y+P SL H+ ++ Q ++N IA+G+ YL
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP-----QLLLNWGVQIAKGMYYL 131
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
++HR+L A N+LL +++DFG+A + +
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
+G+G FG V++ +AVK L S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL---------------------FDATRSVQL 487
+V+LLG C G+ + L++EYM L+ L + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I +A G+ YL S K +HRDL N L+ ++M KI+DFGL+R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 456 CLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+E + L ++ EYM SL +L RS L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDL A N+L+ +D K+SDFGL +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 11/153 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +G G FG VYKG L +A+K L + + + +F E ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+RL G + + +++I EYM N +LD L + + + ++ GIA G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ + +HRDL A NIL++ ++ K+SDFGL+R+
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 49/160 (30%), Positives = 67/160 (41%), Gaps = 17/160 (10%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
LG G FG VY+G ++ +AVK L S Q +F E +I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATRSVQLDWKRRQSIINGIARGIL 504
+VR +G L+ ++ E M L L ++ L + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 505 YLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLAR 541
YL IHRD+ A N LL KI DFG+AR
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 53/152 (34%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+LG G FG V+ G +AVK L + F E NL+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
+ + + +I EYM N SL L ++L + + IA G+ ++ I
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL+A+NIL+ D ++ KI+DFGLAR+ N+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 50/169 (29%), Positives = 67/169 (39%), Gaps = 26/169 (15%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
LG G FG V + T +AVK L + +E+ +++ L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSL---------------DVHLFDATRSVQLDWKRR 492
N+V LLG C G L+I EY L + LD +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +A+G+ +L + IHRDL A NILL KI DFGLAR
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 28/170 (16%)
Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
LG+G FG V +AVK L S + + L + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING------- 498
HKN++ LLG C + L +I EY +L +L A R L++ S
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 499 -------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG+G FG V + L +AVK L + ++EF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 450 VRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIA 500
+L+G L + ++I +M + L L L + + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
G+ YL S IHRDL A N +L +DM ++DFGL+R
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 10/152 (6%)
Query: 396 ENKLGQGGFGPVYKGTL--ADGKAI--AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ +G G FG V G L K I A+K L + + ++F E +++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL G + + ++++ EYM N SLD L Q + ++ GIA G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ +HRDL A NIL++ ++ K+SDFGL R+
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG G FG VYKG +A+K L TS + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
RLLG CL + LI + MP L ++ + + + + IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+++HRDL A N+L+ + KI+DFGLA++ G +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLG G FG V+ T +AVK + + ++ F E N++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
+ + + +I E+M SL L S + + IA G+ ++ + I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL+A+NIL+ + KI+DFGLAR+ N+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 25/167 (14%)
Query: 397 NKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
LG+G FG V + + +AVK L + + +E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 449 LVRLLGCCL-EGQELLLIYEYMPNKSL-------------DVHLFDATRSVQLDWKRRQS 494
+V LLG C G L++I E+ +L + L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L + K IHRDL A NILL + KI DFGLAR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 54/165 (32%), Positives = 71/165 (43%), Gaps = 21/165 (12%)
Query: 396 ENKLGQGGFGPVYKGTL--ADGKAI--AVKRL---SRTSGQGLQEFKNEVNLIAKLQHKN 448
KLG G FG V +G GK + AVK L + + + +F EVN + L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ----LDWKRRQSIINGIARGIL 504
L+RL G L + ++ E P SL L + +A G+
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMG 135
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
YL E R IHRDL A N+LL KI DFGL R N +
Sbjct: 136 YL-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG VY GTL D AVK L+R T + +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
LLG CL + L++ YM + L + + + K +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ K +HRDL A N +LD+ K++DFGLAR
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+ +LG G FG V +G K I A+K L T +E E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L+G C + L+L+ E L L + ++ +++ ++ G+ YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+HRDL A N+LL + KISDFGL++ G + +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 396 ENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK 447
LGQG F ++KG + +K L + + F ++++KL HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+LV G C+ G E +L+ E++ SLD +L + + WK + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL- 129
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP--------KISDFGLAR 541
+IH ++ A NILL + + K+SD G++
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 43/174 (24%), Positives = 68/174 (39%), Gaps = 31/174 (17%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
LG G FG V T +AVK L + + +E+ ++ +L H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSL------------DVHLFDATRSVQLDWKRRQSI 495
N+V LLG C + LI+EY L + + + + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 496 ING--------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V++G + A+A+K + TS ++F E + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L+G E + +I E L L R LD ++ + YL
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---E 133
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ +HRD+ A N+L+ + K+ DFGL+R
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA---IAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ +LG G FG V KG K +AVK L E E N++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
R++G C + +L+ E L+ +L ++ + K +++ ++ G+ YL
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+HRDL A N+LL KISDFGL++ ++N
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
LG+G FG VY+G + K +AVK + + ++F +E ++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L+G E + +I E P L +L S+++ I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ +HRD+ NIL+ K+ DFGL+R
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 9/164 (5%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
K+G+G FG DG+ +K +SR S + +E + EV ++A ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
E L ++ +Y L +A + V + I + ++H+ KI
Sbjct: 91 SFEENGSLYIVMDYCEGGDLF-KRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+HRD+K+ NI L D ++ DFG+AR+ A GT
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 7/162 (4%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
LG+G +G VY G L++ IA+K + + Q E+ L L+HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
E + + E +P SL L ++ + + I G+ YLH++ +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 518 DLKASNILLDDDM-NPKISDFGLARIFGGNQNQANTNIIAGT 558
D+K N+L++ KISDFG ++ G T GT
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 43/176 (24%), Positives = 68/176 (38%), Gaps = 17/176 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKN 448
F LG+GGFG V++ D A+KR+ ++ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 449 LVRLLGCCLEGQE------------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
+VR LE L + + ++L + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
IA + +LH ++HRDLK SNI D K+ DFGL ++ +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 9/157 (5%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
H+ KLG+GGF V L DG A+KR+ Q +E + E ++ H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 451 RLLGCCLE----GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILY 505
RL+ CL E L+ + +L + + L + ++ GI RG+
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+H HRDLK +NILL D+ P + D G
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-31
Identities = 52/152 (34%), Positives = 82/152 (53%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
E + + ++ EYM SL L T L + + IA G+ Y+ R+ +
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL+A+NIL+ +++ K++DFGLAR+ N+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 10/182 (5%)
Query: 371 QQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKA---IAVKRL-SRT 426
+ S L +L L+ N + +LG G FG V +G K +A+K L T
Sbjct: 316 ESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT 375
Query: 427 SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
+E E ++ +L + +VRL+G C + L+L+ E L L + +
Sbjct: 376 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREE 432
Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
+ +++ ++ G+ YL +HR+L A N+LL + KISDFGL++ G +
Sbjct: 433 IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 547 QN 548
+
Sbjct: 490 DS 491
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 38/173 (21%), Positives = 77/173 (44%), Gaps = 10/173 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 446
+F E K+G+G F VY+ L DG +A+K++ + + E++L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILY 505
N+++ +E EL ++ E L + + + + + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+H +++HRD+K +N+ + K+ D GL R F A++ + GT
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GT 199
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 53/158 (33%), Positives = 83/158 (52%), Gaps = 6/158 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
E + + ++ EYM SL L T L + + IA G+ Y+ R+ +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
HRDL+A+NIL+ +++ K++DFGLAR+ N+ A
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 28/185 (15%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
F + +G GGFG V+K DGK +KR+ + ++ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 450 VRLLGC----------------CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
V GC + + L + E+ +L+ + R +LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRGEKLDKVLAL 125
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ I +G+ Y+H K+I+RDLK SNI L D KI DFGL N + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRS 181
Query: 554 IIAGT 558
GT
Sbjct: 182 K--GT 184
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 39/151 (25%), Positives = 68/151 (45%), Gaps = 11/151 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V++G + A+A+K + TS ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L+G E + +I E L L R LD ++ + YL
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +HRD+ A N+L+ + K+ DFGL+R
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 51/180 (28%), Positives = 77/180 (42%), Gaps = 24/180 (13%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ F + LGQG FG V K D + A+K++ T + L +EV L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 449 LVRLLGCCLE-------------GQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQ 493
+VR LE L + EY N +L +D + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ I + Y+H IIHRDLK NI +D+ N KI DFGLA+ + + +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 45/167 (26%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
++ K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L G EL ++ EY+ SL D +D + ++ + + +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
++IHRD+K+ NILL D + K++DFG Q++ +T + GT
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 12/172 (6%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ +LG G FG VYK G A K + S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--SIINGIARGILYL 506
+V+LLG +L ++ E+ P ++D + Q + + + +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
H +IIHRDLKA N+L+ + + +++DFG++ + ++ I GT
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GT 180
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
K+G+G G V G+ +AVK + Q + NEV ++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ L G+EL ++ E++ +L D V+L+ ++ ++ + + + YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+IHRD+K+ +ILL D K+SDFG + + + + GT
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++G+G F VYKG +A + + + Q FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 455 CCLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ ++L+ E M + +L +L R + K +S I +G+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 511 RLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547
IIHRDLK NI + + KI D GLA + +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 12/166 (7%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
I+H DLK +N L+ D K+ DFG+A + + GT
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 10/169 (5%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
+G G +G K +DGK + K + Q +EVNL+ +L+H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 455 CCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHE--D 509
++ L ++ EY L + T+ Q LD + ++ + + H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
++HRDLK +N+ LD N K+ DFGLARI + + A T + GT
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GT 179
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 11/169 (6%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNL 449
F+ K+G+G FG V+KG K +A+K + + +++ + E+ ++++ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ G L+ +L +I EY+ S D LD + +I+ I +G+ YLH +
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
K IHRD+KA+N+LL + K++DFG+A Q + NT + GT
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GT 182
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 16/173 (9%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ 445
FSD ++G G FG VY + + + +A+K++S + S + Q+ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H N ++ GC L L+ EY + D+ L ++ +G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 169
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
LH +IHRD+KA NILL + K+ DFG A AN+ + GT
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFV--GT 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 12/168 (7%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
F KLG+G +G VYK G+ +A+K++ LQE E++++ + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 452 LLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
G + +L ++ EY S+ D+ R+ L +I+ +G+ YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ IHRD+KA NILL+ + + K++DFG+A + NT I GT
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--GT 188
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 12/166 (7%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
I+H DLK +N L+ D K+ DFG+A + + GT
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 12/166 (7%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
I+H DLK +N L+ D K+ DFG+A + + G
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 11/158 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGC 455
LGQG V++G G A+K + S + E ++ KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 456 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ +LI E+ P SL L + + + L ++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 514 IIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
I+HR++K NI+ D K++DFG AR ++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 22/162 (13%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAK 443
F K+G+G +G VYK G+ +A+K++ L E++L+ +
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKE 58
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARG 502
L H N+V+LL +L L++E++ D+ DA+ + +S + + +G
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ + H +++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 18/177 (10%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQ 445
E + + + ++G+G FG V++ G AVK++ L+ F+ E+ A L
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLS 108
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+V L G EG + + E + SL + + L R + G+ Y
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEY 165
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANT---NIIAGT 558
LH +I+H D+KA N+LL D + + DFG A + + + I GT
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 11/158 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGC 455
LGQG V++G G A+K + S + E ++ KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 456 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ +LI E+ P SL L + + + L ++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 514 IIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
I+HR++K NI+ D K++DFG AR ++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHK 447
F +G G +G VYKG + G+ A+K + +G +E K E+N++ K H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81
Query: 448 NLVRLLGCCLEG------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
N+ G ++ +L L+ E+ S+ L T+ L + I I R
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILR 140
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
G+ +LH+ K+IHRD+K N+LL ++ K+ DFG++ + NT I GT
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GT 192
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 10/157 (6%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLL 453
L +GGF VY+ + G+ A+KRL + + EV + KL H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 454 GCCL-------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
GQ L+ + L L L I R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
H + IIHRDLK N+LL + K+ DFG A
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHKN 448
K+G+G +G VYK + G+ +A+KR+ L E++L+ +L H N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPN 80
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V L+ + L L++E+M D+ L + + + + RG+ + H+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+I+HRDLK N+L++ D K++DFGLAR FG
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+GGF ++ + + A K + ++ +E E+++ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
+ + ++ E +SL + + + L + + I G YLH R +
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLA 540
+IHRDLK N+ L++D+ KI DFGLA
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 21/157 (13%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
K+G+G +G V+K + +A+KR+ L + E+ L+ +L+HK
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHK 61
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
N+VRL ++L L++E+ D+ + + + LD + +S + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
++HRDLK N+L++ + K+++FGLAR FG
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+GGF ++ + + A K + ++ +E E+++ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
+ + ++ E +SL + + + L + + I G YLH R +
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLA 540
+IHRDLK N+ L++D+ KI DFGLA
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 44/156 (28%), Positives = 81/156 (51%), Gaps = 20/156 (12%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHKN 448
K+G+G +G VYK G+ A+K++ L++ E++++ +L+H N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSN 61
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+L + L+L++E++ D+ L+ +S + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+++HRDLK N+L++ + KI+DFGLAR FG
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 18/157 (11%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
+ LG+G F VYK + +A+K++ + + E K+ E+ L+ +L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHR--SEAKDGINRTALREIKLLQELSHP 72
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
N++ LL + L++++M D+ + S+ L ++ + +G+ YLH
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ I+HRDLK +N+LLD++ K++DFGLA+ FG
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKN 448
+ + + +G G V + +A+KR++ Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGIL--- 504
+V + EL L+ + + S+ D+ + +S I I R +L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 505 -YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
YLH++ IHRD+KA NILL +D + +I+DFG++
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LQEFKNEVNL 440
+ +++ F KLG G + VYKG G +A+K + S +G ++E ++L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISL 56
Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRQSIING 498
+ +L+H+N+VRL +L L++E+M N K L+ +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ +G+ + HE+ KI+HRDLK N+L++ K+ DFGLAR FG
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 40/175 (22%), Positives = 71/175 (40%), Gaps = 20/175 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVR 451
F ++ LG G G + + D + +AVKR+ + EV L+ + +H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHED 509
+ Q + E L + + +++ G+ +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 510 SRLKIIHRDLKASNILL-----DDDMNPKISDFGLARIFGGNQN-QANTNIIAGT 558
L I+HRDLK NIL+ + ISDFGL + ++ + + + GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 45/146 (30%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+G F VY+ + G +A+K + + + G+ + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ + L+ E N ++ +L + + + R ++ I G+LYLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYLH---SHGI 133
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
+HRDL SN+LL +MN KI+DFGLA
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 9/168 (5%)
Query: 390 TNHFSDENKLGQG--GFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKL 444
+ +G+G V G+ + V+R L S + + + E+++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
H N+V + EL ++ +M S L ++ I+ G+ + +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
Y+H +HR +KAS+IL+ D +S + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 47/233 (20%), Positives = 73/233 (31%), Gaps = 19/233 (8%)
Query: 330 YRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEA 389
+ H+ + + + +++ + P P +
Sbjct: 2 HHHHHHSSGVDLGTENL---YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ- 57
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKL-Q 445
F ++LG G +G V+K DG+ AVK + EV K+ Q
Sbjct: 58 --SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H VRL EG L L E SL H L + + + +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
LH ++H D+K +NI L K+ DFGL G G
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE--GD 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
K+G+G +G V+K G+ +A+K+ E E+ ++ +L+H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
NLV LL + L L++EY V + +SI + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ IHRD+K NIL+ K+ DFG AR+
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 8e-25
Identities = 52/205 (25%), Positives = 76/205 (37%), Gaps = 29/205 (14%)
Query: 373 AESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ 432
+ P F L N E LG G G V G+ +AVKR+
Sbjct: 1 SRIANIPNFEQSL----KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCD 53
Query: 433 EFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV---HLFDATRSVQLD 488
E+ L+ + H N++R + L + E D+
Sbjct: 54 IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK 113
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-------------DDMNPKIS 535
S++ IA G+ +LH LKIIHRDLK NIL+ +++ IS
Sbjct: 114 EYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 536 DFGLARIFGGNQN--QANTNIIAGT 558
DFGL + Q+ + N N +GT
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGT 195
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 21/186 (11%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT 426
G S L L ++ + + +G+G +G V K G+ +A+K+
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-- 59
Query: 427 SGQGLQEFKN--------EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL 478
+ E+ L+ +L+H+NLV LL C + + L++E++ +
Sbjct: 60 ----ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILD 112
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
LD++ Q + I GI + H IIHRD+K NIL+ K+ DFG
Sbjct: 113 DLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169
Query: 539 LARIFG 544
AR
Sbjct: 170 FARTLA 175
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 45/185 (24%), Positives = 84/185 (45%), Gaps = 34/185 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQH 446
+ +++ +G G FG V++ L + +A+K++ + + FKN E+ ++ ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKH 91
Query: 447 KNLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-- 498
N+V L + L L+ EY+P V+ R+ + K +Q++
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVY-----RASRHYAKLKQTMPMLLI 143
Query: 499 ------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQAN 551
+ R + Y+H + I HRD+K N+LLD K+ DFG A+I + N
Sbjct: 144 KLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPN 198
Query: 552 TNIIA 556
+ I
Sbjct: 199 VSYIC 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LQEFKNEVNLIAKL 444
+ +KLG+G + VYKG +A+K + +G ++E V+L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
+H N+V L + L L++EY+ D+ + ++ + + + RG+
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
Y H K++HRDLK N+L+++ K++DFGLAR
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 6e-24
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 14/161 (8%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL-- 453
+LG GGFG V + G+ +A+K+ + +E + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 454 ----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
LL EY L +L L +++++ I+ + YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 510 SRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQ 547
+IIHRDLK NI+L + KI D G A+ +
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 14/165 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH 446
++ LG+G FG V K + AVK +++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILY 505
N+++L + ++ E LFD + + II + GI Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 506 LHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
+H+ I+HRDLK NILL + D + KI DFGL+ F N
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 398 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
K+G+G +G VYK D K A+K++ +G + + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 455 CCLEGQE--LLLIYEYMPN---KSLDVH--LFDATRSVQLDWKRRQSIINGIARGILYLH 507
L + + L+++Y + + H + VQL +S++ I GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFG 544
+ ++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 51/176 (28%), Positives = 77/176 (43%), Gaps = 23/176 (13%)
Query: 388 EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------QE 433
+T+ F + LG+G V + K AVK + T G +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 434 FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKR 491
EV+++ K+ H N+++L L+++ M L FD T V L K
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ I+ + I LH+ L I+HRDLK NILLDDDMN K++DFG + +
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 23/175 (13%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK-----RLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+G+G F V + G+ AVK + + + G ++ K E ++ L+H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFD-----ATRSVQLDWKRRQSIINGIARGILYL 506
LL L +++E+M L A + I + Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 507 HEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
H+ IIHRD+K +LL ++ K+ FG+A G + A GT
Sbjct: 147 HD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGT 196
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 40/181 (22%), Positives = 77/181 (42%), Gaps = 24/181 (13%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHK 447
+ F + KLG G FG V+ + G +K +++ Q +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-------SIINGIA 500
N++++ + + ++ E L + R V + + ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LE--RIVSAQARGKALSEGYVAELMKQMM 134
Query: 501 RGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
+ Y H ++H+DLK NIL KI DFGLA +F +++ N AG
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAG 188
Query: 558 T 558
T
Sbjct: 189 T 189
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 12/163 (7%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+++ EN +G+G +G V A K++ + + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
++RL + ++ L+ E LF+ I+ + + Y H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
+ L + HRDLK N L D K+ DFGLA F +
Sbjct: 124 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 41/170 (24%), Positives = 68/170 (40%), Gaps = 23/170 (13%)
Query: 398 KLGQGGFGPVY---------------KGTLADGKAIAVKRLSRTSGQGLQE-FKNEVNLI 441
L QG F + K L + + S + + FKNE+ +I
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQSII 496
++++ + G E+ +IYEYM N S+ D + + + + II
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
+ Y+H + I HRD+K SNIL+D + K+SDFG +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 29/163 (17%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
KLG+G +G VYK + +A+KR+ L+ + EV+L+ +LQH+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARGILYL 506
N++ L L LI+EY D+ D ++ + + +S + + G+ +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA---ENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFC 148
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-----KISDFGLARIFG 544
H + +HRDLK N+LL KI DFGLAR FG
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 369 GKQQAESQEFPLFPLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRL 423
G + Q A F + + +G+G V + A G AVK +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 424 SRTSGQGLQE--------FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474
T+ + E + E +++ ++ H +++ L+ + L+++ M L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 475 DVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533
FD T V L K +SI+ + + +LH I+HRDLK NILLDD+M +
Sbjct: 188 ----FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240
Query: 534 ISDFGLARIFGGNQ 547
+SDFG + +
Sbjct: 241 LSDFGFSCHLEPGE 254
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 46/193 (23%), Positives = 69/193 (35%), Gaps = 33/193 (17%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKL-Q 445
T F + K+G G FG V+K DG A+KR Q EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGIL 504
H ++VR E +L+ EY SL + + R + + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNP-------------------KISDFGLARIFGG 545
Y+H ++H D+K SNI + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185
Query: 546 NQNQANTNIIAGT 558
+ + G
Sbjct: 186 -----SPQVEEGD 193
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 31/167 (18%)
Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQ- 445
++G+G +G V+K G+ +A+KR+ +Q + EV ++ L+
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLET 70
Query: 446 --HKNLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIIN 497
H N+VRL C + L L++E++ D+ D + + + ++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ RG+ +LH +++HRDLK NIL+ K++DFGLARI+
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 15/174 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+++ +LG G FG V++ A G+ K ++ KNE++++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYL 506
L+ L + E++LI E++ LFD A ++ + + G+ ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSG----GELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGT 558
HE I+H D+K NI+ + KI DFGLA ++ + T
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKN----EVNLIAKLQ---HK 447
++G G +G VYK G +A+K + G G EV L+ +L+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 448 NLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIAR 501
N+VRL+ C + + L++E++ D+ D L + + ++ R
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
G+ +LH + I+HRDLK NIL+ K++DFGLARI+
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 8e-23
Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
S LG G FG V+K A G +A K + + +E KNE++++ +L H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRQSIINGIARGILYL 506
L +++L+ EY V LFD S L + I GI ++
Sbjct: 151 LYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 507 HEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQN 548
H+ + I+H DLK NIL D KI DFGLAR + +
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-23
Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLVR 451
LG+G FG VY +A+K L + +G Q + EV + + L+H N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L G + + LI EY P ++ L ++ D +R + I +A + Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---S 127
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA 540
++IHRD+K N+LL KI+DFG +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHK 447
++D +G G FG VY+ L D G+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 448 NLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--- 498
N+VRL E L L+ +Y+P V+ R + + +Q++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVY-----RVARHYSRAKQTLPVIYVK 159
Query: 499 -----IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANT 552
+ R + Y+H I HRD+K N+LLD D K+ DFG A+ + + N
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 214
Query: 553 NIIA 556
+ I
Sbjct: 215 SYIC 218
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 48/193 (24%), Positives = 74/193 (38%), Gaps = 22/193 (11%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 422
G + + P H S+ KLG G +G V A+K
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 423 LSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480
+ +T S + EV ++ L H N+++L + + L+ E LFD
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LFD 125
Query: 481 ATRSVQLDW---KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKI 534
+ II + G+ YLH+ I+HRDLK N+LL + D KI
Sbjct: 126 --EIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKI 180
Query: 535 SDFGLARIFGGNQ 547
DFGL+ +F +
Sbjct: 181 VDFGLSAVFENQK 193
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 15/174 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+H+ +LG G FG V++ T A G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYL 506
LV L + E+++IYE+M LF+ A ++ + + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMS----GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGT 558
HE +H DLK NI+ + K+ DFGL Q + + GT
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 18/169 (10%)
Query: 390 TNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIA 442
+ FSD +LG+G F V + G A K ++ S + Q+ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
KLQH N+VRL E L+++ + LF+ I I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I Y H I+HR+LK N+LL K++DFGLA ++
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 29/169 (17%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
K+GQG FG V+K G+ +A+K++ ++ K E+ ++ L+H+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHE 76
Query: 448 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
N+V L+ C + L++++ D+ + V+ + ++ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
G+ Y+H + KI+HRD+KA+N+L+ D K++DFGLAR F +N
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 36/177 (20%), Positives = 75/177 (42%), Gaps = 22/177 (12%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ LG+G FG V++ + K K + + G K E++++ +H+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRQSIINGIARGI 503
++ L +EL++I+E+ + +F+ T + +L+ + S ++ + +
Sbjct: 63 ILHLHESFESMEELVMIFEF-------ISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGT 558
+LH I H D++ NI+ + KI +FG AR N ++
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTA 166
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 43/191 (22%), Positives = 82/191 (42%), Gaps = 11/191 (5%)
Query: 370 KQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG 428
+Q+ + F ++ + F ++LG G G V+K + G +A K +
Sbjct: 12 QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71
Query: 429 QGLQEF-KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
++ E+ ++ + +V G E+ + E+M SLD + +
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPE 130
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ + + +G+ YL E KI+HRD+K SNIL++ K+ DFG++
Sbjct: 131 QILGK--VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--ID 184
Query: 548 NQANTNIIAGT 558
+ AN+ + GT
Sbjct: 185 SMANSFV--GT 193
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHK 447
D ++G+G +G V K G+ +AVKR+ T + ++ +++++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGIL- 504
+V+ G + + E M + S D + V + I+ I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFD----KFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 505 ---YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
+L E+ LKIIHRD+K SNILLD N K+ DFG
Sbjct: 137 ALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH 446
++ LG+G FG V K + AVK +++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGI 503
N+++L + ++ E LFD ++ II + GI
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD--EIIKRKRFSEHDAARIIKQVFSGI 134
Query: 504 LYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
Y+H+ I+HRDLK NILL + D + KI DFGL+ F N
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQ 445
++ + + LG+G FG V G+ AVK +S+ + EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARG 502
H N+++L + L+ E LFD + II + G
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD--EIISRKRFSEVDAARIIRQVLSG 138
Query: 503 ILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I Y+H+ KI+HRDLK N+LL D N +I DFGL+ F ++
Sbjct: 139 ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 20/156 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG+G +G V + AVK L + G K E+ L+ +L+HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 454 G--CCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRR--QSIINGIARGILYLH 507
E Q++ ++ EY + + D + + +I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
I+H+D+K N+LL KIS G+A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 33/188 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRL-------SRTSGQGLQEFKNEVN 439
+ + F E GQG FG V G G ++A+K++ +R LQ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQ---- 71
Query: 440 LIAKLQHKNLVRLLGCCLEGQE-------LLLIYEYMPNKSLDVHLF---DATRSVQLDW 489
+A L H N+V+L E L ++ EY+P +H R V
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPP 128
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQN 548
+ + + R I LH S + + HRD+K N+L+++ K+ DFG A+ + +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185
Query: 549 QANTNIIA 556
+ N I
Sbjct: 186 EPNVAYIC 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 21/188 (11%)
Query: 382 PLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEF 434
+ A+ FSD +LG+G F V + G A K ++ S + Q+
Sbjct: 16 GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 435 KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQ 493
+ E + KLQH N+VRL E L+++ + LF+
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS 131
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQA 550
I I I Y H I+HR+LK N+LL K++DFGLA ++
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--- 185
Query: 551 NTNIIAGT 558
+ AGT
Sbjct: 186 AWHGFAGT 193
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 18/176 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVN-LIAKLQHK 447
+ +LG+G +G V K + G+ +AVKR+ T Q + +++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-RQSIINGIARGIL-- 504
V G ++ + E M + SLD + V + + I+ IA I+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLD----KFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+LH S+L +IHRD+K SN+L++ K+ DFG++ + + + G
Sbjct: 122 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA--GC 172
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE--------FKNEVNLIAKLQHKN 448
LG G G V K +A+K +S+ + E+ ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
++++ + ++ ++ E M L FD + +L + + + YLH
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
E IIHRDLK N+LL ++D KI+DFG ++I G
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSR--------TSGQGLQEFKNEVNLIAKLQHKN 448
LG G G V K +A++ +S+ + E+ ++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
++++ + ++ ++ E M L FD + +L + + + YLH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
E IIHRDLK N+LL ++D KI+DFG ++I G
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
LG+G +G V +A+AVK + E K E+ + L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 LEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDSR 511
EG L EY L FD + +R ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ I HRD+K N+LLD+ N KISDFGLA +F N
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 18/170 (10%)
Query: 390 TNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
+ F D E+ LG+G V L + AVK + + G EV ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 444 LQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
Q H+N++ L+ E L++E M S+ + + ++ +A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVAS 122
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQN 548
+ +LH I HRDLK NIL + KI DF L N +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 47/240 (19%), Positives = 77/240 (32%), Gaps = 50/240 (20%)
Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--- 421
+ + +E F LE + + +GQG +G V A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 422 --RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP--------- 470
++ + + + ++ K EV L+ KL H N+ RL + Q + L+ E
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 471 --NKSLDVHLFDATRSVQLDWKRRQ--------------------------SIINGIARG 502
Q+ +I+ I
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 503 ILYLHEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQNQANTNI--IAGT 558
+ YLH I HRD+K N L + K+ DFGL++ F N + AGT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 33/204 (16%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 422
G++ Q + P + + KLG G +G V A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 423 LSR-------------TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469
+ + + +E NE++L+ L H N+++L + + L+ E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 470 PNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526
L F+ + + +I+ I GI YLH+ I+HRD+K NILL
Sbjct: 129 EGGEL----FE--QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILL 179
Query: 527 ---DDDMNPKISDFGLARIFGGNQ 547
+ +N KI DFGL+ F +
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDY 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
LG+G +G V +A+AVK + E K E+ + L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 LEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDSR 511
EG L EY L FD + +R ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ I HRD+K N+LLD+ N KISDFGLA +F N
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+G FG VY + +A+K L ++ +G++ + E+ + + L+H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ + + L+ E+ P L L R D +R + + +A + Y H K+
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH---ERKV 135
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
IHRD+K N+L+ KI+DFG +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS 161
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 21/214 (9%), Positives = 42/214 (19%), Gaps = 36/214 (16%)
Query: 364 NILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR 422
++ Q L + L G V+ + + A+K
Sbjct: 35 AMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKV 94
Query: 423 L---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC----------------------- 456
+ S L+ A+L ++
Sbjct: 95 FTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154
Query: 457 ---LEGQELLLIYEYMPNKSLDV-HLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDS 510
LL+ + D + + R L
Sbjct: 155 QDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ--- 211
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
++H N+ + D + D G
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
+ + +LG G F V K + G A K + G +E + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
++ H N++ L +++LI E + LFD + L + S I I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILD 126
Query: 502 GILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
G+ YLH KI H DLK NI+L + K+ DFGLA
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G F V+ GK A+K + ++ +NE+ ++ K++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------IINGIARGILYL 506
L+ + + L FD R ++ R +I + + YL
Sbjct: 74 IYESTTHYYLVMQLVSGGEL----FD--RILE-----RGVYTEKDASLVIQQVLSAVKYL 122
Query: 507 HEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
HE I+HRDLK N+L +++ I+DFGL+++
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
+ + +LG G F V K + G A K + G +E + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
++ H N++ L +++LI E + LFD + L + S I I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILD 126
Query: 502 GILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
G+ YLH KI H DLK NI+L + K+ DFGLA
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 26/171 (15%), Positives = 54/171 (31%), Gaps = 22/171 (12%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
+ + LG+G F VY+ T + + +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRQSIINGIAR 501
++ L +L+ E +L ++L+ T + S +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNP-----------KISDFGLAR 541
I +H+ +IIH D+K N +L + + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 20/185 (10%)
Query: 385 LALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNE 437
+A F++E +LG+G F V + + G+ A ++ S + Q+ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 438 VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSII 496
+ L+H N+VRL E LI++ + L F+ I
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCI 116
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTN 553
I +L+ H+ + ++HR+LK N+LL K++DFGLA G Q
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172
Query: 554 IIAGT 558
AGT
Sbjct: 173 -FAGT 176
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 44/172 (25%), Positives = 69/172 (40%), Gaps = 23/172 (13%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
+H+ +LG G F V K GK A K S G +E + EVN++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGI 499
+++H N++ L +++LI E + L FD + + + I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FD--FLAEKESLTEDEATQFLKQI 117
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
G+ YLH +I H DLK NI+L + K+ DFG+A
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL------SRTSGQGLQEFKNEVNLIA 442
+++ +LG G F V K + G A K + S G ++ + EV+++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFDA-TRSVQLDWKRRQSIING 498
++QH N++ L +++LI E V LFD L + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILEL-------VAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
I G+ YLH L+I H DLK NI+L KI DFGLA
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 41/195 (21%), Positives = 73/195 (37%), Gaps = 25/195 (12%)
Query: 376 QEFPLFPLRLAL-EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ 429
Q + + L + F+D +G G + + A AVK + ++
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 430 GLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQL 487
E+ ++ + QH N++ L +G+ + ++ E M L D R
Sbjct: 62 P----TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF 113
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNP-KISDFGLARIF 543
+ +++ I + + YLH ++HRDLK SNIL + +I DFG A+
Sbjct: 114 SEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 544 GGNQNQANTNIIAGT 558
T T
Sbjct: 171 RAENGLLMT--PCYT 183
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 42/177 (23%), Positives = 73/177 (41%), Gaps = 22/177 (12%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQE--FKN--------- 436
+ ++ + + G +G V G ++G +A+KR+ T G +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 437 EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
E+ L+ H N++ L + +L L+ E M D+ + + + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQH 135
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
Q + I G+ LHE ++HRDL NILL D+ + I DF LAR + N
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHK 447
N + ++G G G V+K G IAVK++ R+ + + +++++ K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+V+ G + ++ + E M + + + + I + + YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK 141
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
E +IHRD+K SNILLD+ K+ DFG++
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 19/153 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+G+G F V + G+ +A+K + +T + LQ+ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDS 510
+ L LI EY + FD A ++ R + I++ + Y H
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH--- 131
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+ +I+HRDLKA N+LLD DMN KI+DFG + F
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 47/210 (22%), Positives = 77/210 (36%), Gaps = 39/210 (18%)
Query: 371 QQAESQEFPLFPLRLALEATNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVK--R 422
S L L ++ +F++ +LG+G F V + + G+ A K +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 423 LSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
R E +E+ ++ + ++ L E++LI EY +F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE----IFS- 118
Query: 482 TRSVQLDWKR----------RQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DD 528
+ + +Q I G+ YLH+ I+H DLK NILL
Sbjct: 119 -LCLPELAEMVSENDVIRLIKQ-----ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYP 169
Query: 529 DMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ KI DFG++R G I GT
Sbjct: 170 LGDIKIVDFGMSRKIGHAC---ELREIMGT 196
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 38/169 (22%), Positives = 69/169 (40%), Gaps = 18/169 (10%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLL 453
+ LG+G F K +A AVK +S+ + E+ + + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ L+ E + L F+ + I+ + + ++H+ +
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 513 KIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
++HRDLK N+L +D++ KI DFG AR+ + T T
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 41/182 (22%), Positives = 82/182 (45%), Gaps = 31/182 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ + + + +G G +G V + + + +A+K++ R F++ E
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILRE 102
Query: 438 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKR 491
+ ++ +L H ++V++L + EL ++ E D LF V L
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRT--PVYLTELH 157
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
++++ + G+ Y+H I+HRDLK +N L++ D + K+ DFGLAR +N +
Sbjct: 158 IKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 552 TN 553
Sbjct: 215 QL 216
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 25/180 (13%), Positives = 56/180 (31%), Gaps = 37/180 (20%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ--------- 445
LGQ + T G++ V R +++ K EV + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 446 -------------HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------ 486
+++ L+ +++ ++ + + +L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 487 --LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
L R + + R + LH ++H L+ +I+LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 28/180 (15%), Positives = 54/180 (30%), Gaps = 37/180 (20%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQ--------- 445
LGQ + T G++ V T +++ K EV + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 446 ----------------HKNLVRLLGCC--LEGQELLLIYEYMPNKSLDV--HLFD-ATRS 484
K ++R+ + +Y M + L ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 485 VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
L R + + R + LH ++H L+ +I+LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 36/165 (21%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------SGQGLQEFKNEVNLIAKLQHKNL 449
LG G FG V+ K + VK + + L + E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 450 VRLLGCCLEGQELLLIYEYMPNKS-----LDVH-----LFD-ATRSVQLDWKRRQSIING 498
+++ + N+ ++ H LF R +LD I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+ + YL IIHRD+K NI++ +D K+ DFG A
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 8e-19
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G FG V G G +AVK L+R S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
+ ++ EY+ L FD V+ RR Q I++ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH-- 128
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
R ++HRDLK N+LLD MN KI+DFGL+ +
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 46/188 (24%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------------------------SGQGL 431
+G+G +G V D A+K LS+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 432 QEFKNEVNLIAKLQHKNLVRLLGCCLEG---QELLLIYEYMPNKSLDVHLFDATRSVQLD 488
++ E+ ++ KL H N+V+L+ L+ L +++E + + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 489 ----WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
Q +I GI YLH KIIHRD+K SN+L+ +D + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 545 GNQNQANT 552
G+ +
Sbjct: 189 GSDALLSN 196
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 32/175 (18%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG+G F V T + A+K L + + E +++++L H V+
Sbjct: 38 LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
L + ++L Y N L ++ ++ S R +
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYI-----------RKIGSFDETCTRFYTAEIVSAL 143
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
YLH IIHRDLK NILL++DM+ +I+DFG A++ QA N GT
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G FG V G G +AVK L+R S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
++ ++ EY+ LFD + RR Q I++G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGG----ELFDYICKNGRLDEKESRRLFQQILSGVD----YCH-- 133
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
R ++HRDLK N+LLD MN KI+DFGL+ +
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 28/162 (17%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
+LG+G VY+ K A+K L +T + + + E+ ++ +L H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------IINGIARGILYLHE 508
E+ L+ E + L FD R V+ + + I + YLHE
Sbjct: 118 ETPTEISLVLELVTGGEL----FD--RIVE-----KGYYSERDAADAVKQILEAVAYLHE 166
Query: 509 DSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I+HRDLK N+L D KI+DFGL++I
Sbjct: 167 ---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 31/175 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
E + D +G G +G V G +A+K+L R F++ E
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRE 74
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ ++H+N++ LL + + L+ +M L + +L R
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
Q ++ + +G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 17/156 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQHK--NL 449
LG GGFG VY G ++D +A+K + + E N EV L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHE 508
+RLL +LI E P D LFD T L + +S + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCH- 166
Query: 509 DSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIF 543
++HRD+K NIL+D + K+ DFG +
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
KLG GG VY +A+K + R + L+ F+ EV+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
E L+ EY+ +L ++ L + N I GI + H ++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
I+HRD+K NIL+D + KI DFG+A+ + TN + GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 39/173 (22%), Positives = 65/173 (37%), Gaps = 40/173 (23%)
Query: 395 DENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRL 452
+ LG G G V + G+ A+K L + + + EV+ + ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKR---RQ--SIIN 497
L +YE M + + LF R + + R+ I+
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMR 135
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I I +LH I HRD+K N+L + D K++DFG A+ N
Sbjct: 136 DIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 42/182 (23%), Positives = 85/182 (46%), Gaps = 31/182 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+++ ++ +G+G +G VY K +A+K+++R F++ E
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILRE 75
Query: 438 VNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKR 491
+ ++ +L+ ++RL + + EL ++ E + D+ ++ L +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---DLK--KLFKTPIFLTEEH 130
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
++I+ + G ++HE IIHRDLK +N LL+ D + K+ DFGLAR ++
Sbjct: 131 IKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 552 TN 553
N
Sbjct: 188 VN 189
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 21/154 (13%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+G FG V T + +A+K +SR + + E++ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
+++++ EY + LFD + + D RR Q II I Y H
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
R KI+HRDLK N+LLDD++N KI+DFGL+ I
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 44/158 (27%), Positives = 66/158 (41%), Gaps = 19/158 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT------SGQGLQEFKNEVNLIAKL----QHK 447
LG+GGFG V+ G L D +A+K + R EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYL 506
++RLL + +L+ E P + D LFD T L + + I +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIF 543
H ++HRD+K NIL+D K+ DFG +
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 5e-18
Identities = 33/169 (19%), Positives = 64/169 (37%), Gaps = 23/169 (13%)
Query: 398 KLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL- 453
+ GG G +Y +G+ + +K L + Q E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 454 -GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ + Y EY+ +SL +L + + I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ +++ DLK NI+L ++ K+ D G + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 32/176 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ + +G G G V + +A+K+LSR F+N E
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRE 74
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ + HKN++ LL E Q++ ++ E M D +L + +LD +R
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQM-ELDHER 128
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
++ + GI +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 36/179 (20%), Positives = 83/179 (46%), Gaps = 31/179 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ +++ + +G+G +G V + +A+K++S F++ E
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLRE 75
Query: 438 VNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
+ ++ + +H+N++ + + +++ ++ + M + L+ ++ L
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHI 130
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
+ I RG+ Y+H + ++HRDLK SN+LL+ + KI DFGLAR+ + +
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 45/200 (22%), Positives = 75/200 (37%), Gaps = 34/200 (17%)
Query: 368 GGKQQAESQEFPLFPLRLALEA-TNHFSDE-----NKLGQGGFGPVYKGT-LADGKAIAV 420
Q+FP F ++ L+ N D+ LG G G V + + A+
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92
Query: 421 KRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLG----CCLEGQELLLIYEYMPNKSLD 475
K L + + EV L + ++VR++ + LL++ E + L
Sbjct: 93 KMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL- 146
Query: 476 VHLFDATRSVQLDWKR---RQ--SIINGIARGILYLHEDSRLKIIHRDLKASNILL---D 527
F R + R+ I+ I I YLH + I HRD+K N+L
Sbjct: 147 ---FS--RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKR 198
Query: 528 DDMNPKISDFGLARIFGGNQ 547
+ K++DFG A+ +
Sbjct: 199 PNAILKLTDFGFAKETTSHN 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 32/175 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
E + +G G +G V G+ +A+K+LSR F++ E
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRE 73
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ +QH+N++ LL + L+ +M L + ++
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL-KFSEEK 127
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
Q ++ + +G+ Y+H ++HRDLK N+ +++D KI DFGLAR
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 43/189 (22%), Positives = 80/189 (42%), Gaps = 42/189 (22%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ + + D LG GG G V+ K +A+K++ + E
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALRE 58
Query: 438 VNLIAKLQHKNLVRLL--------------GCCLEGQELLLIYEYMPNKSLDVHLFDATR 483
+ +I +L H N+V++ G E + ++ EYM + L +
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE 113
Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 542
L + + + + RG+ Y+H + ++HRDLK +N+ ++ +D+ KI DFGLARI
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 543 FGGNQNQAN 551
+ +
Sbjct: 171 MDPHYSHKG 179
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 40/170 (23%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKN 448
++ LG G G V + + A+K L + + EV L + Q +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKR---RQ-- 493
+VR++ +YE + + LF R + R+
Sbjct: 73 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREAS 120
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLA 540
I+ I I YLH + I HRD+K N+L + K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 31/181 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLQEFKNE 437
++ F ++ LG+G +G V T G+ +A+K++ RT L+E K
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIK-- 61
Query: 438 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
++ +H+N++ + E+ +I E M L + L
Sbjct: 62 --ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHI 114
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
Q I R + LH + +IHRDLK SN+L++ + + K+ DFGLARI + +
Sbjct: 115 QYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 553 N 553
Sbjct: 172 P 172
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 32/176 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ + +G G G V + +A+K+LSR F+N E
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRE 111
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ + HKN++ LL E Q++ L+ E M ++ ++LD +R
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLC---QVIQMELDHER 165
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
++ + GI +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 43/216 (19%), Positives = 83/216 (38%), Gaps = 67/216 (31%)
Query: 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHK 447
+ +S LG G FG V + + GK A+K++ + +KN E++++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 448 NLVRLLGC--------------------------------------CLEGQELLLIYEYM 469
N+++L+ + + L +I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 470 PNKSLDVHLFDATRSVQLDWKRRQSIING--------IARGILYLHEDSRLKIIHRDLKA 521
P +H + ++ + +SI + R + ++H L I HRD+K
Sbjct: 121 P---DTLH-----KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKP 169
Query: 522 SNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIA 556
N+L++ D K+ DFG A+ ++ + I
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 31/170 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
E + + + +G G +G V G +AVK+LSR F++ E
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRE 78
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ ++H+N++ LL E ++ L+ M L + + +L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
Q +I I RG+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 134 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 46/171 (26%), Positives = 69/171 (40%), Gaps = 17/171 (9%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL 453
LG GG V+ L D + +AVK R F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 454 --GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
G E L Y EY+ +L + + KR +I + + + H
Sbjct: 79 DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNIIAGT 558
+ IIHRD+K +NI++ K+ DFG+AR + N T + GT
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 28/179 (15%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ KLG+G +G V+K G+ +AVK++ F+N E
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFRE 58
Query: 438 VNLIAKLQ-HKNLVRLLGCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 494
+ ++ +L H+N+V LL +++ L+++YM + L R+ L+ +Q
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQY 113
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
++ + + I YLH S ++HRD+K SNILL+ + + K++DFGL+R F + N
Sbjct: 114 VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 16/151 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
+G G FG + +AVK + R G + E + E+ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDSRLKI 514
L L +I EY L + +A R D R Q +++G++ Y H ++I
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVS----YCH---SMQI 137
Query: 515 IHRDLKASNILLDDD--MNPKISDFGLARIF 543
HRDLK N LLD KI DFG ++
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 26/130 (20%), Positives = 45/130 (34%), Gaps = 3/130 (2%)
Query: 424 SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR 483
+S + ++ + KN V L L + + ++L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+ I IA + +LH ++HRDLK SNI D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 544 GGNQNQANTN 553
++ +
Sbjct: 215 DQDEEEQTVL 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 36/167 (21%), Positives = 60/167 (35%), Gaps = 11/167 (6%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLQE-FKNEVNLIAKLQHKNLVR 451
+G+GG G VY+ + +A+K +S +S + + E +LQ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ +L + + L L L R +I+ I + H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
HRD+K NIL+ D + DFG+A GT
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 23/232 (9%)
Query: 339 QEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEAT----NHFS 394
+ + + F + H ++ +S F F LEA + F
Sbjct: 132 ARARAGAGDGLFQPLLRAVLAHLGQAPF---QEFLDSLYFLRFLQWKWLEAQPMGEDWFL 188
Query: 395 DENKLGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHK 447
D LG+GGFG V+ K T GK A K+L++ +G Q E ++AK+ +
Sbjct: 189 DFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYL 506
+V L +L L+ M + H+++ + R I G+ +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
H+ II+RDLK N+LLDDD N +ISD GLA Q + AGT
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 49/167 (29%), Positives = 70/167 (41%), Gaps = 17/167 (10%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVR 451
LG+GGFG V + T GK A K+L + +G NE ++ K+ + +V
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L L+ M L H++ ++ R I G+ LH
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR--- 304
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+I++RDLK NILLDD + +ISD GLA Q GT
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 348
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 28/200 (14%)
Query: 374 ESQEFPLFPLRLALEATNHFSDEN-----KLGQGGFGPVY----KGTLADGKAIAVKRLS 424
ES +F F +E H + + +G+GGFG VY T GK A+K L
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLD 223
Query: 425 RT---SGQGLQEFKNEVNLIAKLQHKN---LVRLLGCCLEGQELLLIYEYMPNKSLDVHL 478
+ QG NE +++ + + +V + +L I + M L HL
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 283
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
++ + I G+ ++H +++RDLK +NILLD+ + +ISD G
Sbjct: 284 ---SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 539 LARIFGGNQNQANTNIIAGT 558
LA F + + GT
Sbjct: 338 LACDFSKKK----PHASVGT 353
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 35/166 (21%), Positives = 73/166 (43%), Gaps = 19/166 (11%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ- 445
+ + KLG+G + V++ + + + + VK L ++ K E+ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89
Query: 446 HKNLVRLLGCCLEGQE--LLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARG 502
N++ L + L++E++ N D L+ L + + I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQT-----LTDYDIRFYMYEILKA 142
Query: 503 ILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547
+ Y H S I+HRD+K N+++D + ++ D+GLA + Q
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 19/163 (11%)
Query: 396 ENKLGQGGFGPVYKGTL------ADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
LG+G FG V + A + +AVK L + + +E+ ++ + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 448 NLVRLLGCCL-EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
N+V LLG C G L++I E+ +L +L +R + +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+ I DLK + + S F + + +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L + K IHRDL A NILL + KI DFGLAR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 45/175 (25%), Positives = 69/175 (39%), Gaps = 37/175 (21%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG G FG V K + G A+K L + L++ NE ++ + LV+
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
L + L ++ EY+ + HL +R AR
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRFSEPHARFYAAQIVLTF 154
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
YLH L +I+RDLK N+L+D +++DFG A+ G T + GT
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGT 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 3e-13
Identities = 31/217 (14%), Positives = 61/217 (28%), Gaps = 52/217 (23%)
Query: 371 QQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--- 427
Q F T K+G+G FG V++ AD +A+K ++
Sbjct: 6 SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDL 58
Query: 428 -----GQGLQEFKNEVNLIAKLQ---------HKNLVRLLGCCL----EGQELLLIYEYM 469
+ +E E+ + +L + + L LL +++
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 470 PNK----------------------SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+ + R+ +SI++ + +
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
L+ HRDL N+LL K+ +
Sbjct: 179 A--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 17/150 (11%), Positives = 43/150 (28%), Gaps = 16/150 (10%)
Query: 398 KLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVR 451
G ++ D + +A+ + LQE + ++++ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+L L++ E++ SL + + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---R 147
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ S + + D + ++
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 19/175 (10%)
Query: 391 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK 443
+HF +G+G FG V T K A+K +++ E +N E+ ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
L+H LV L + +++ ++ + + L HL ++V + + I + +
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMAL 128
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
YL +IIHRD+K NILLD+ + I+DF +A + Q T +AGT
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGT 177
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 8e-13
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 32/157 (20%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG G FG V+ + G+ A+K L + L++ +E +++ + H ++R
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
+ G + Q++ +I +Y+ L L ++ Q N +A+ +
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFYAAEVCLAL 119
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
YLH II+RDLK NILLD + + KI+DFG A
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 41/175 (23%), Positives = 66/175 (37%), Gaps = 34/175 (19%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V K T K A+K LS+ + F E +++A +V+
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
L + + L ++ EYMP L + + AR +
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM------------SNYDVPEKWARFYTAEVVLAL 181
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+H + IHRD+K N+LLD + K++DFG + GT
Sbjct: 182 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGT 232
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 39/175 (22%), Positives = 68/175 (38%), Gaps = 32/175 (18%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V K K A+K L++ E F+ E +++ K +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
L + L L+ +Y L L K + +AR I
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS----------KFEDRLPEEMARFYLAEMVIAI 188
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+H+ L +HRD+K NIL+D + + +++DFG + +++ GT
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 16/167 (9%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G F V K T G+ A+K +++ E F+ E +++ + + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L + L L+ EY L L + + R + I I +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDSVHR--- 180
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
L +HRD+K NILLD + +++DFG + + + GT
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGT 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 45/161 (27%), Positives = 65/161 (40%), Gaps = 15/161 (9%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG+G FG V K T G+ A+K L + E E ++ +H L
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L + EY L HL +R R + I + YLH S
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SE 267
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+++RDLK N++LD D + KI+DFGL + + T
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTSGQGLQEFKNEV-------NLIAKLQHK 447
LG+GG+G V+ K T A+ I A+K L + + + N++ +++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+V L+ G +L LI EY+ L + L R + I+ + +LH
Sbjct: 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLH 138
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ II+RDLK NI+L+ + K++DFGL + + +T
Sbjct: 139 Q---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 44/160 (27%), Positives = 84/160 (52%), Gaps = 12/160 (7%)
Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG V+ K + +D + + A+K L + + + K E +++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+L LI +++ L L ++ V + + + +A + +LH L
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS---L 145
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
II+RDLK NILLD++ + K++DFGL++ ++ +A +
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 43/161 (26%), Positives = 65/161 (40%), Gaps = 16/161 (9%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG+G FG V K T G+ A+K L + E E ++ +H L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L + EY L HL +R +R + I + YLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS--- 123
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+++RD+K N++LD D + KI+DFGL + + T
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
LG+G FG V K T G AVK L + + + ++V L H
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLKK---DVILQ-DDDVECTMTEKRILSLARNH 83
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L +L C L + E++ L H+ +S + D R + I +++L
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAAEIISALMFL 140
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H+ II+RDLK N+LLD + + K++DFG+ + N T
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
LG+G FG V +K T + A+K L + + ++V L +H
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L + + L + EY+ L H+ + D R I G+ +L
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 134
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H I++RDLK NILLD D + KI+DFG+ + + NT
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
LG+G FG V KGT + AVK L + + ++V L +
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKK----DVVIQDDDVECTMVEKRVLALPGKP 401
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L +L C L + EY+ L H+ + + IA G+ +L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
II+RDLK N++LD + + KI+DFG+ + + T
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
LG+G FG V KGT + AVK L + + + ++V L +
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKP 80
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L +L C L + EY+ L H+ + + IA G+ +L
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
II+RDLK N++LD + + KI+DFG+ + + T
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 46/166 (27%), Positives = 68/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
+G+G FG V K AVK L + L+ K E L+ ++H
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQK--KAILK--KKEEKHIMSERNVLLKNVKH 98
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
LV L +L + +Y+ L HL R R + IA + YL
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYL 155
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H L I++RDLK NILLD + ++DFGL + + + +T
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
+G+G + V K T + A+K + + L +++ H
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVKK----ELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
LV L C L + EY+ L H+ R +L + + I+ + YL
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYL 126
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
HE II+RDLK N+LLD + + K++D+G+ + + +T
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
N + K+G G FG +Y GT +A G+ +A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ + C EG +++ E + SL+ LF+ S + K + + + I Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFC-SRKFSLKTVLLLADQMISRIEYIHS 123
Query: 509 DSRLKIIHRDLKASNILLDDDMNPK---ISDFGLARIF 543
+ IHRD+K N L+ I DFGLA+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 16/169 (9%)
Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS----GQGLQEFKNEVNLIAKLQHKN-L 449
LG G +G V+ K + D + A+K L + + + + + E ++ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V L +L LI +Y+ L HL ++ + Q + I + +LH+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLALEHLHK- 177
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
L II+RD+K NILLD + + ++DFGL++ F ++ + GT
Sbjct: 178 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
+G+G + V K T + A++ + + L +++ H
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVKK----ELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
LV L C L + EY+ L H+ R +L + + I+ + YL
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYL 169
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
HE II+RDLK N+LLD + + K++D+G+ + + +T
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 36/166 (21%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
H+ ++G+G FG +++GT L + + +A+K R S + ++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67
Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--INGIARGIL-- 504
+ + EG +L+ + + SL+ L D R+ S+ + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLC-------GRKFSVKTVAMAAKQMLAR 118
Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPK-----ISDFGLARIF 543
+HE S +++RD+K N L+ + + DFG+ + +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 38/166 (22%), Positives = 66/166 (39%), Gaps = 27/166 (16%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KN 448
+F K+G G FG + G L + +A+K S + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--INGIARGIL-- 504
+ ++ G+ ++ E + SL+ LFD R S+ + IA ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLC-------DRTFSLKTVLMIAIQLISR 117
Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPK-----ISDFGLARIF 543
Y+H + +I+RD+K N L+ N I DF LA+ +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 35/168 (20%), Positives = 69/168 (41%), Gaps = 33/168 (19%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ----------- 445
KLG G F V+ + + +A+K + R + ++E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 446 HKNLVRLLGC----CLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIING 498
++++LL G +++++E L +L + + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP------KISDFGLA 540
+ G+ Y+H R IIH D+K N+L++ +P KI+D G A
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 39/181 (21%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI------AVKRLSRTSGQGLQEFK-----NEVN 439
+ +GQGGFG +Y + +++ VK +G E K +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 440 LIAKLQHKNLVRLLGCCL---EGQELLLIYEY----MP--NKSLDVHLFDATRSVQLDWK 490
I K ++ LG G Y M L +++A
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEAN-------A 146
Query: 491 RRQSI--INGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARI 542
+R S + ++ IL Y+HE +H D+KASN+LL+ ++ D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 543 F 543
+
Sbjct: 204 Y 204
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
N F K+G G FG +Y GT + + +A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI-------INGIAR 501
+ + +EG +L+ + + SL+ LF+ R+ S+ I R
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFC-------SRKLSLKTVLMLADQMINR 115
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK---ISDFGLARIF 543
+ ++H S +HRD+K N L+ I DFGLA+ +
Sbjct: 116 -VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 30/180 (16%), Positives = 66/180 (36%), Gaps = 37/180 (20%)
Query: 391 NHFSDENKLGQGGFGPVYKGT---------LADGKAIAVKRLSRTSGQGLQEFK------ 435
+ ++ + G +Y+ + ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 436 --NEVNLIAKLQHKNLV---RLLGCCLEGQEL-LLIYEYMPNKSLDVHLFDATRSVQLDW 489
+VN KL L+ +G + + L+ + +SL D + L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE 158
Query: 490 KRRQSIINGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARIF 543
+ S++ +A +L +LHE+ +H ++ A NI +D + ++ + +G A +
Sbjct: 159 R---SVLQ-VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 39/166 (23%), Positives = 65/166 (39%), Gaps = 25/166 (15%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQ 445
+ + ++ +G+G FG V K + + +A+K Q EV L+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMN 108
Query: 446 H------KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ---LDWKRRQSII 496
+V L + L L++E L +L+D R+ + +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLA 540
+ +L+L L IIH DLK NILL + KI DFG +
Sbjct: 164 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 34/157 (21%), Positives = 64/157 (40%), Gaps = 27/157 (17%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHK------N 448
+G+G FG V K + +A+K + R Q E+ ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTMN 160
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGILY 505
++ +L + + +E L ++L++ + + + I + +
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLA 540
LH + +IIH DLK NILL K+ DFG +
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 33/180 (18%), Positives = 61/180 (33%), Gaps = 40/180 (22%)
Query: 391 NHFSDENKLGQGGFGPVYKG----TLADGKAIAVKRLSRTSGQGLQEFK-----NEVNLI 441
N + K+G GGFG +Y VK + +G E K + + I
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 442 AKLQHKNLVRLLG----------CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
K + + LG ++ E + L +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISG--------QNG 146
Query: 492 RQSI--INGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARIF 543
+ + +L Y+HE+ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 3e-06
Identities = 66/473 (13%), Positives = 127/473 (26%), Gaps = 115/473 (24%)
Query: 119 PDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQ-ECMVRFSDHSSS 177
D+V G F + + V VL+ F+ ++ E
Sbjct: 58 KDAVSGTLRL-FWTLLSKQEEMVQKFVEEVLRINYK----FLMSPIKTEQR--------- 103
Query: 178 IMDTSAPLCMKIFQNTYNVTKSLAQSFN--DVIAMPSLSSFRNATKRTNISNIIRLET-- 233
S +++ + + Q F +V + R A + + ++
Sbjct: 104 --QPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 234 -FGQCIPVLSVDDCRD-----CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSK 287
G+ +++D C ++ I W+ P ++ +
Sbjct: 160 GSGK--TWVALDVCLSYKVQCKMDFKIFWL---------NLKNCNSPETVLEMLQKLLYQ 208
Query: 288 V-PAVGALAPSSAPGGKRGRAISIAIGTTLS------ALIV---VLFGSFLWYRRRRHAR 337
+ P + + S+ R +I + L L+V V + +A
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV------QNAKAWNAF 262
Query: 338 DQEEK-----RNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLF-------PLRL 385
+ K R Q FL H + + E + L P L
Sbjct: 263 NLSCKILLTTRFKQVTDFL--SAATTTHISLDHHSMTLTPDEVKS--LLLKYLDCRPQDL 318
Query: 386 ALEATNHFSDENKLGQGGFGPVYKGTLA--DG-KAIAVKRLSRTSGQGLQE--------- 433
E N + LA D K + +L+ L
Sbjct: 319 PREVLTT----NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 434 ------FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
F ++ L L L+ + +++++ + SL V+
Sbjct: 375 FDRLSVFPPSAHIPTIL----LS-LIWFDVIKSDVMVVVNKLHKYSL----------VEK 419
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS-NILLD---DDMNPKISD 536
K I I + + +HR + NI DD+ P D
Sbjct: 420 QPKESTISIPSIY--LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 6e-06
Identities = 34/246 (13%), Positives = 73/246 (29%), Gaps = 66/246 (26%)
Query: 326 SFLW--YRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYA-YNILRGGKQQAESQEFPLFP 382
FL + + + ++ L+ + ++ +A YN+ R P
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV---FAKYNVSR---------LQPYLK 139
Query: 383 LRLALEATNHFSDENKL---GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN 439
LR AL + G G G K +A + V + + ++
Sbjct: 140 LRQALL---ELRPAKNVLIDGVLGSG---KTWVA----LDVCLSYKV----QCKMDFKIF 185
Query: 440 LIAKLQHKNLVRLLGCCLEGQELL-----LIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 494
+ L C + +L L+Y+ PN + + +
Sbjct: 186 WLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE-- 233
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD-FGL-ARIFGGNQNQANT 552
RL + + + ++L + N K + F L +I + + T
Sbjct: 234 --------------LRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278
Query: 553 NIIAGT 558
+ ++
Sbjct: 279 DFLSAA 284
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 36/151 (23%), Positives = 61/151 (40%), Gaps = 24/151 (15%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQH-----KN 448
K+G G FG V + + K AVK + + + K E +++ K+Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ---LDWKRRQSIINGIARGILY 505
+V+ G + + LI+E L L++ + + I + + Y
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
L + + + H DLK NILLDD K
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLI 180
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.98 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.93 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.93 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.93 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.93 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.93 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.92 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.92 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.92 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.92 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.92 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.92 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.92 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.92 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.92 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.92 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.92 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.92 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.92 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.92 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.92 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.92 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.92 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.92 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.92 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.92 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.92 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.92 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.92 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.92 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.92 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.92 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.92 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.92 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.92 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.92 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.91 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.91 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.91 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.91 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.91 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.91 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.91 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.91 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.91 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.91 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.91 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.91 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.91 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.91 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.91 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.91 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.91 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.91 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.91 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.91 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.91 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.91 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.91 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.91 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.91 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.91 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.91 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.91 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.91 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.91 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.91 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.91 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.91 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.91 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.91 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.91 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.91 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.91 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.91 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.91 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.91 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.91 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.91 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.91 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.91 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.91 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.91 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.91 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.91 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.91 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.91 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.91 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.91 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.91 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.91 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.91 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.91 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.91 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.9 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.9 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.9 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.9 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.9 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.9 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.9 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.9 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.9 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.9 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.9 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.9 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.9 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.9 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.9 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.9 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.9 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.9 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.9 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.9 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.9 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.9 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.9 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.9 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.9 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.9 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.9 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.9 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.9 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.9 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.89 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.89 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.89 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.89 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.89 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.89 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.89 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.89 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.89 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.89 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.89 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.89 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.89 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.89 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.89 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.89 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.89 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.88 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.88 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.88 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.88 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.88 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.88 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.88 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.88 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.88 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.87 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.87 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.87 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.87 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.87 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.87 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.87 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.86 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.7 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.7 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.79 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.56 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.29 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.69 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.2 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.71 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.22 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 83.98 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.57 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.18 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.78 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.01 Aligned_cols=165 Identities=29% Similarity=0.513 Sum_probs=141.2
Q ss_pred CCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...++||+|+||.||+|++. ++..||||+++..+.+..++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777899999999999999864 477899999987776777889999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 465 IYEYMPNKSLDVHLFDAT----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
||||+++|+|.++|++.. ....++|..++.|+.||++||.|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 3456999999999999999999999984 999999999999999999999
Q ss_pred EecCcceeeCCCCCccCcccccCC
Q 008634 535 SDFGLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 535 ~DFGla~~~~~~~~~~~t~~~~Gt 558 (558)
+|||+|+..........+....||
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred CCcccceecCCCCceeecCceecC
Confidence 999999987654433333334454
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.11 Aligned_cols=165 Identities=30% Similarity=0.483 Sum_probs=134.1
Q ss_pred CCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...++||+|+||.||+|++. +++.||||+++..+.+..++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478899999988777777899999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 465 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
||||+++|+|.++|++... ...++|.+++.|+.||++||.|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975432 346999999999999999999999974 9999999999999999999
Q ss_pred EEEecCcceeeCCCCCccCcccccCC
Q 008634 533 KISDFGLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 533 ki~DFGla~~~~~~~~~~~t~~~~Gt 558 (558)
||+|||+|+..........+...+||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EECCCC----------------CCCC
T ss_pred EEcccccceeccCCCcceecCccccc
Confidence 99999999987655443333345555
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.47 Aligned_cols=163 Identities=33% Similarity=0.453 Sum_probs=137.7
Q ss_pred CCcccccccCCcccEEEEEec------CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
+...++||+|+||.||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 455678999999999999863 46789999997553 34467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 466 YEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
|||+++|+|.++|..... ...++|..+++|+.|||+||.|||+++ ||||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 999999999999975321 245999999999999999999999984 9999999999999999999
Q ss_pred EEEecCcceeeCCCCCccCcccccCC
Q 008634 533 KISDFGLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 533 ki~DFGla~~~~~~~~~~~t~~~~Gt 558 (558)
||+|||+||..........+...+||
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred EECCcccceeccCCCceeEecccccC
Confidence 99999999987554433333345555
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.58 Aligned_cols=159 Identities=27% Similarity=0.442 Sum_probs=142.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999975 69999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCCc
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 549 (558)
++|+|.+++.+ ..+++.....|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..+...
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999964 34899999999999999999999985 999999999999999999999999999988765443
Q ss_pred cCcccccCC
Q 008634 550 ANTNIIAGT 558 (558)
Q Consensus 550 ~~t~~~~Gt 558 (558)
. ..++||
T Consensus 227 ~--~~~~GT 233 (346)
T 4fih_A 227 R--KSLVGT 233 (346)
T ss_dssp B--CCCCSC
T ss_pred c--cccccC
Confidence 3 236776
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=286.42 Aligned_cols=162 Identities=28% Similarity=0.417 Sum_probs=145.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999965 6899999999754 2344678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+. +.+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999653 35999999999999999999999985 999999999999999999999999999999766
Q ss_pred CCccCcccccCC
Q 008634 547 QNQANTNIIAGT 558 (558)
Q Consensus 547 ~~~~~t~~~~Gt 558 (558)
.....+..++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 655555567887
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=286.21 Aligned_cols=161 Identities=30% Similarity=0.517 Sum_probs=131.9
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.+++...++||+|+||.||+|++.+ .||||+++.. +.+..+.|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567788999999999999999753 5999998754 33456789999999999999999999998754 56899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+++|+|.++|+.. ...++|..++.|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999653 346999999999999999999999984 9999999999999999999999999999876544
Q ss_pred CccCcccccCC
Q 008634 548 NQANTNIIAGT 558 (558)
Q Consensus 548 ~~~~t~~~~Gt 558 (558)
....+...+||
T Consensus 187 ~~~~~~~~~GT 197 (307)
T 3omv_A 187 GSQQVEQPTGS 197 (307)
T ss_dssp -------CCCC
T ss_pred cceeecccccC
Confidence 43344456676
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.47 Aligned_cols=162 Identities=24% Similarity=0.424 Sum_probs=135.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++++++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 67999999999999999999965 6999999999754 33446789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+++|+|.++|.+. +...+++.....|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999653 3445899999999999999999999985 9999999999999999999999999999875432
Q ss_pred CccCcccccCC
Q 008634 548 NQANTNIIAGT 558 (558)
Q Consensus 548 ~~~~t~~~~Gt 558 (558)
.. ++.++||
T Consensus 180 ~~--~~~~~GT 188 (350)
T 4b9d_A 180 EL--ARACIGT 188 (350)
T ss_dssp HH--HHHHHSC
T ss_pred cc--ccccCCC
Confidence 21 2235666
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=290.76 Aligned_cols=159 Identities=27% Similarity=0.442 Sum_probs=142.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+.|...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888999999999999999975 69999999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCCc
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 549 (558)
++|+|.+++.. ..+++.....|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..+...
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999854 24899999999999999999999985 999999999999999999999999999988765443
Q ss_pred cCcccccCC
Q 008634 550 ANTNIIAGT 558 (558)
Q Consensus 550 ~~t~~~~Gt 558 (558)
. ..++||
T Consensus 304 ~--~~~~GT 310 (423)
T 4fie_A 304 R--KSLVGT 310 (423)
T ss_dssp B--CCCEEC
T ss_pred c--cccccC
Confidence 3 236776
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=278.56 Aligned_cols=161 Identities=26% Similarity=0.357 Sum_probs=129.8
Q ss_pred CCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----EEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 467 (558)
+|...++||+|+||.||+|++ +|+.||||+++....+ ...+..|+..+.+++|||||+++|++.+++ .++||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466778999999999999998 5899999999754322 122334566667899999999999998753 6899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
|+++|+|.++|++. .++|..+.+|+.||++||.|||++ +.++||||||||+|||||.++++||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999653 489999999999999999999986 245799999999999999999999999999998
Q ss_pred eCCCCCc--cCcccccCC
Q 008634 543 FGGNQNQ--ANTNIIAGT 558 (558)
Q Consensus 543 ~~~~~~~--~~t~~~~Gt 558 (558)
....... ..+...+||
T Consensus 158 ~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EETTTTEESCC-----CC
T ss_pred ccCCCCceeeeccccccc
Confidence 8655432 223345666
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=275.72 Aligned_cols=153 Identities=28% Similarity=0.427 Sum_probs=127.6
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC---------
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--------- 460 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--------- 460 (558)
+|+..+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5788899999999999999965 689999999975543 34567999999999999999999999997654
Q ss_pred ---EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 008634 461 ---ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (558)
Q Consensus 461 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DF 537 (558)
.+|+||||+++|+|.+++.+.......++...+.|+.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 37999999999999999976554455778888999999999999999985 999999999999999999999999
Q ss_pred CcceeeCCCC
Q 008634 538 GLARIFGGNQ 547 (558)
Q Consensus 538 Gla~~~~~~~ 547 (558)
|+|+.+..+.
T Consensus 163 Gla~~~~~~~ 172 (299)
T 4g31_A 163 GLVTAMDQDE 172 (299)
T ss_dssp CCC-------
T ss_pred ccceecCCCc
Confidence 9999886553
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=271.94 Aligned_cols=157 Identities=30% Similarity=0.429 Sum_probs=133.1
Q ss_pred CcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCEEEEEE
Q 008634 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIY 466 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 466 (558)
..+++||+|+||.||+|... ++..||+|++... .....+.|.+|++++++++|||||++++++++ ++.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999975 5889999999754 33346779999999999999999999999976 34689999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 45999999999999999999999874 35999999999999984 78999999999987544
Q ss_pred CCCccCcccccCC
Q 008634 546 NQNQANTNIIAGT 558 (558)
Q Consensus 546 ~~~~~~t~~~~Gt 558 (558)
.. +..++||
T Consensus 185 ~~----~~~~~GT 193 (290)
T 3fpq_A 185 SF----AKAVIGT 193 (290)
T ss_dssp TS----BEESCSS
T ss_pred Cc----cCCcccC
Confidence 32 2336776
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=277.51 Aligned_cols=157 Identities=27% Similarity=0.342 Sum_probs=132.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+.|...++||+|+||.||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999975 689999999975432 247999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceeeCCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQN 548 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~~~~~~ 548 (558)
++|+|.++|.+. ..+++.....|+.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999653 35999999999999999999999985 99999999999999887 699999999998865432
Q ss_pred c---cCcccccCC
Q 008634 549 Q---ANTNIIAGT 558 (558)
Q Consensus 549 ~---~~t~~~~Gt 558 (558)
. ..+..++||
T Consensus 207 ~~~~~~~~~~~GT 219 (336)
T 4g3f_A 207 GKSLLTGDYIPGT 219 (336)
T ss_dssp -------CCCCCC
T ss_pred ccceecCCccccC
Confidence 1 123346777
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=277.31 Aligned_cols=160 Identities=28% Similarity=0.361 Sum_probs=130.9
Q ss_pred CCCCcccccccCCcccEEEEEec----CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|+..++||+|+||.||+++.. +++.||||++++.. ......+.+|+++|++++|||||++++++++++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999852 47899999997543 2334578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.+. ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 35999999999999999999999985 9999999999999999999999999999775
Q ss_pred CCCCccCcccccCC
Q 008634 545 GNQNQANTNIIAGT 558 (558)
Q Consensus 545 ~~~~~~~t~~~~Gt 558 (558)
....... .++||
T Consensus 178 ~~~~~~~--~~~GT 189 (304)
T 3ubd_A 178 DHEKKAY--SFCGT 189 (304)
T ss_dssp ---CCCC--SCCCC
T ss_pred CCCcccc--ccccC
Confidence 5443322 35676
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=266.66 Aligned_cols=149 Identities=26% Similarity=0.486 Sum_probs=125.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|+..++||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999965 69999999997542 233567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+ +|+|.+++.+. ..+++.....++.||+.||.|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 68999998653 45999999999999999999999985 999999999999999999999999999987544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=281.26 Aligned_cols=171 Identities=26% Similarity=0.348 Sum_probs=143.2
Q ss_pred HHHHHcCCCCcccccccCCcccEEEEEecC------CcEEEEEEccccCc-cchHHHHHHHHHHhcCCC-CCeeeeeEEE
Q 008634 385 LALEATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQH-KNLVRLLGCC 456 (558)
Q Consensus 385 ~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~------g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H-~niv~l~g~~ 456 (558)
..+...++|...++||+|+||.||+|++.. ++.||||++..... ...+.|.+|+++|.+++| ||||+++|+|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 334456788999999999999999998642 36899999986543 345779999999999965 8999999999
Q ss_pred EeC-CEEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 008634 457 LEG-QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 522 (558)
Q Consensus 457 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~ 522 (558)
.+. +.+++|||||++|+|.++|++... ...++|..++.|+.|||+||.|||+++ ||||||||+
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 214 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcc
Confidence 765 568999999999999999975321 345899999999999999999999984 999999999
Q ss_pred CEEEcCCCcEEEEecCcceeeCCCCCccCcccccCC
Q 008634 523 NILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 523 NILl~~~~~~ki~DFGla~~~~~~~~~~~t~~~~Gt 558 (558)
||||++++.+||+|||+||.+..+.....+....||
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 999999999999999999988766654444445555
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=264.46 Aligned_cols=161 Identities=22% Similarity=0.413 Sum_probs=134.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe------CCE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE 461 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 461 (558)
++|...++||+|+||.||+|+.. +|+.||||++++.. ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999965 69999999997543 2335678899999999999999999999764 357
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
+|+||||++ |+|.+++.+ ...+++.....|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 679998854 346999999999999999999999985 9999999999999999999999999999
Q ss_pred eeCCCCC--ccCcccccCC
Q 008634 542 IFGGNQN--QANTNIIAGT 558 (558)
Q Consensus 542 ~~~~~~~--~~~t~~~~Gt 558 (558)
.+..... .......+||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp CC-------CCCCCSSCCC
T ss_pred ecccCccccccccccceeC
Confidence 8754321 2223346676
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-29 Score=271.16 Aligned_cols=158 Identities=30% Similarity=0.376 Sum_probs=135.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHH---HHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEF---KNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~---~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
++|...++||+|+||.||+++.. +|+.||||++.+.. .+....+ ..++.++..++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57888999999999999999975 69999999997542 1222233 34467778889999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||++||+|..+|.+. ..+++.....++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999653 35999999999999999999999985 999999999999999999999999999988
Q ss_pred CCCCCccCcccccCC
Q 008634 544 GGNQNQANTNIIAGT 558 (558)
Q Consensus 544 ~~~~~~~~t~~~~Gt 558 (558)
..+.. ..++||
T Consensus 343 ~~~~~----~t~~GT 353 (689)
T 3v5w_A 343 SKKKP----HASVGT 353 (689)
T ss_dssp SSCCC----CSCCSC
T ss_pred CCCCC----CCccCC
Confidence 65543 235777
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=253.84 Aligned_cols=147 Identities=25% Similarity=0.385 Sum_probs=130.8
Q ss_pred HcCCCCcccccccCCcccEEEEEec----CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (558)
..+.|...++||+|+||.||+|+.+ +++.||||++.+.. ...++.+|+++|..+ +|||||++++++.+++..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3567999999999999999999753 46789999987543 235688999999998 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecCccee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARI 542 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFGla~~ 542 (558)
+||||+++|+|.+++. .+++.....++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999983 3899999999999999999999985 9999999999999877 7999999999997
Q ss_pred eCCC
Q 008634 543 FGGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
....
T Consensus 168 ~~~~ 171 (361)
T 4f9c_A 168 THDT 171 (361)
T ss_dssp CTTC
T ss_pred cCCc
Confidence 7543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=268.22 Aligned_cols=152 Identities=26% Similarity=0.451 Sum_probs=137.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|.+.++||+|+||.||+++.+ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+++.+++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57899999999999999999975 69999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC--CcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~--~~~ki~DFGla~~~~~~~ 547 (558)
++|+|.++|.+ +...+++.....++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+..+.
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999853 3346999999999999999999999985 9999999999999854 899999999999987654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=245.47 Aligned_cols=162 Identities=44% Similarity=0.766 Sum_probs=145.3
Q ss_pred ChHHHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 382 PLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 382 ~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
+...+...+++|...+.||+|+||.||+|+..+++.||||++........+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 33344567889999999999999999999988899999999987777777889999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
.++||||+++|+|.+++.+... ...++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999865432 235999999999999999999999985 999999999999999999999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.....
T Consensus 187 ~~~~~~ 192 (321)
T 2qkw_B 187 KKGTEL 192 (321)
T ss_dssp EECSSS
T ss_pred cccccc
Confidence 976543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=241.66 Aligned_cols=172 Identities=45% Similarity=0.767 Sum_probs=150.6
Q ss_pred CCccccChHHHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeE
Q 008634 376 QEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLG 454 (558)
Q Consensus 376 ~~~~~~~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g 454 (558)
.....++..++....++|...++||+|+||.||+|+..+++.||||++..... .....+.+|++++.+++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34566888999999999999999999999999999988899999999986543 23447899999999999999999999
Q ss_pred EEEeCCEEEEEEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEE
Q 008634 455 CCLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533 (558)
Q Consensus 455 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 533 (558)
++.+++..++||||+++|+|.+++.+.. ....++|..+..|+.||+.||.|||+....+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999997644 234599999999999999999999998444599999999999999999999
Q ss_pred EEecCcceeeCCCC
Q 008634 534 ISDFGLARIFGGNQ 547 (558)
Q Consensus 534 i~DFGla~~~~~~~ 547 (558)
|+|||+++......
T Consensus 175 l~Dfg~~~~~~~~~ 188 (326)
T 3uim_A 175 VGDFGLAKLMDYKD 188 (326)
T ss_dssp ECCCSSCEECCSSS
T ss_pred eccCccccccCccc
Confidence 99999999876443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-27 Score=235.51 Aligned_cols=169 Identities=44% Similarity=0.699 Sum_probs=149.7
Q ss_pred CCccccChHHHHHHcCCCCcc------cccccCCcccEEEEEecCCcEEEEEEccccC----ccchHHHHHHHHHHhcCC
Q 008634 376 QEFPLFPLRLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQ 445 (558)
Q Consensus 376 ~~~~~~~~~~~~~~t~~f~~~------~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~----~~~~~~~~~Ei~~l~~l~ 445 (558)
.....|+..++...+++|... ++||+|+||.||+|.. +++.|+||++.... ....+.+.+|+.++.+++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345678899999999999877 8999999999999997 57899999987532 233577999999999999
Q ss_pred CCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEE
Q 008634 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525 (558)
Q Consensus 446 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NIL 525 (558)
||||+++++++.+.+..++||||+++|+|.+++........++|..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999976555567999999999999999999999985 999999999999
Q ss_pred EcCCCcEEEEecCcceeeCCCCC
Q 008634 526 LDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 526 l~~~~~~ki~DFGla~~~~~~~~ 548 (558)
++.++.+||+|||+++.......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSS
T ss_pred EcCCCcEEEeecccccccccccc
Confidence 99999999999999998765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=236.90 Aligned_cols=162 Identities=27% Similarity=0.400 Sum_probs=142.4
Q ss_pred cccChHHHHHHcCC----------CCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCC
Q 008634 379 PLFPLRLALEATNH----------FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK 447 (558)
Q Consensus 379 ~~~~~~~~~~~t~~----------f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ 447 (558)
+.++.+++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.+++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 44566666665543 556678999999999999976 6999999999877666678899999999999999
Q ss_pred CeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 448 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
||+++++++...+..++||||+++++|.+++.+ ..++|..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999999843 35899999999999999999999985 99999999999999
Q ss_pred CCCcEEEEecCcceeeCCCC
Q 008634 528 DDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~~~~ 547 (558)
.++.+||+|||+++.+..+.
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS
T ss_pred CCCcEEEeeeeeeeecccCc
Confidence 99999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=235.72 Aligned_cols=152 Identities=32% Similarity=0.544 Sum_probs=137.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|...++||+|+||.||+++.. +++.|++|++...+....+.|.+|++++.+++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46788899999999999999975 58999999998777777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
++|+|.+++... ...++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999653 345899999999999999999999985 9999999999999999999999999999875443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=250.14 Aligned_cols=168 Identities=21% Similarity=0.275 Sum_probs=142.8
Q ss_pred HHHHHcCCCCcccccccCCcccEEEEEecC-CcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 008634 385 LALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 385 ~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (558)
......++|...++||+|+||.||+++..+ ++.||+|++.+.. ......+.+|+.++..++||||+++++++.+++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 334456789999999999999999999764 7899999997532 222345899999999999999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++||||+++|+|.+++.+. ...+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence 999999999999999999652 345999999999999999999999985 999999999999999999999999999
Q ss_pred eeeCCCCCccCcccccCC
Q 008634 541 RIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 541 ~~~~~~~~~~~t~~~~Gt 558 (558)
+.+..+.....+ ..+||
T Consensus 223 ~~~~~~~~~~~~-~~~GT 239 (437)
T 4aw2_A 223 LKLMEDGTVQSS-VAVGT 239 (437)
T ss_dssp EECCTTSCEECC-SCCSC
T ss_pred hhcccCCCcccc-cccCC
Confidence 987665443222 24554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=232.84 Aligned_cols=152 Identities=27% Similarity=0.466 Sum_probs=138.2
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||++.. .+++.||||++........+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788899999999999999985 46899999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
+++|+|.+++.+. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....+..
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999643 4899999999999999999999985 99999999999999999999999999998765543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=235.28 Aligned_cols=153 Identities=27% Similarity=0.417 Sum_probs=135.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--------
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-------- 460 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------- 460 (558)
++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46788899999999999999976 78999999997543 334678999999999999999999999987653
Q ss_pred -------------------------------------------------EEEEEEEcCCCCCHHHHHhccCCCCCCCHHH
Q 008634 461 -------------------------------------------------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491 (558)
Q Consensus 461 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 491 (558)
..++||||+++|+|.+++.+.......++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2899999999999999998766556678888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 492 ~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 9999999999999999985 999999999999999999999999999988655
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=240.92 Aligned_cols=155 Identities=32% Similarity=0.512 Sum_probs=135.9
Q ss_pred cCCCCcccccccCCcccEEEEEec--------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (558)
.++|...+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356888899999999999999852 35679999997653 33467899999999999 899999999999999
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl 526 (558)
+..++||||+++|+|.+++.+... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 235899999999999999999999985 9999999999999
Q ss_pred cCCCcEEEEecCcceeeCCCC
Q 008634 527 DDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 527 ~~~~~~ki~DFGla~~~~~~~ 547 (558)
+.++.+||+|||+++.+....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~ 257 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNID 257 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCC
T ss_pred CCCCCEEEccccCCcccCccc
Confidence 999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=234.88 Aligned_cols=151 Identities=32% Similarity=0.490 Sum_probs=136.2
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788999999999999999997 47999999999754 3344667899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999653 34899999999999999999999985 999999999999999999999999999877544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=235.85 Aligned_cols=149 Identities=27% Similarity=0.342 Sum_probs=134.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++.. +|+.||+|++++. .......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46888899999999999999975 6899999999754 2344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|..++.+. ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998643 35899999999999999999999985 99999999999999999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=234.93 Aligned_cols=152 Identities=31% Similarity=0.464 Sum_probs=133.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++..++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999976 689999999865432 334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+.
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999998843 345999999999999999999999985 9999999999999999999999999999875443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=243.34 Aligned_cols=159 Identities=20% Similarity=0.259 Sum_probs=139.6
Q ss_pred HHHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 008634 385 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 385 ~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (558)
......++|...++||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|..++.+++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33345678999999999999999999975 68999999997532 223456889999999999999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++||||+++|+|.+++.+.. ..+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence 9999999999999999996532 35899999999999999999999985 999999999999999999999999999
Q ss_pred eeeCCCCC
Q 008634 541 RIFGGNQN 548 (558)
Q Consensus 541 ~~~~~~~~ 548 (558)
+.+..+..
T Consensus 210 ~~~~~~~~ 217 (412)
T 2vd5_A 210 LKLRADGT 217 (412)
T ss_dssp EECCTTSC
T ss_pred eeccCCCc
Confidence 98865543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=243.39 Aligned_cols=155 Identities=23% Similarity=0.294 Sum_probs=137.0
Q ss_pred HHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 386 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 386 ~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
+....++|...++||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++..++|||||++++++.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345678999999999999999999976 58899999987532 2334568899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++||||+++|+|.+++.+. .+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999998642 4899999999999999999999985 9999999999999999999999999999
Q ss_pred eeCCCC
Q 008634 542 IFGGNQ 547 (558)
Q Consensus 542 ~~~~~~ 547 (558)
......
T Consensus 217 ~~~~~~ 222 (410)
T 3v8s_A 217 KMNKEG 222 (410)
T ss_dssp ECCTTS
T ss_pred eeccCC
Confidence 876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=236.74 Aligned_cols=151 Identities=26% Similarity=0.433 Sum_probs=133.7
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (558)
..++|...++||+|+||.||+++.. +|+.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3468999999999999999999975 5899999999754 223456688999999988 7999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||+++|+|..++.+. ..+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999653 35899999999999999999999985 999999999999999999999999999865
Q ss_pred CC
Q 008634 544 GG 545 (558)
Q Consensus 544 ~~ 545 (558)
..
T Consensus 175 ~~ 176 (353)
T 3txo_A 175 IC 176 (353)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=232.77 Aligned_cols=163 Identities=30% Similarity=0.473 Sum_probs=135.5
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----EEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV 465 (558)
.++|...++||+|+||.||+|+.. ++.||||++..... ....+..|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 356888899999999999999875 78999999975433 2345567899999999999999999998743 47999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-------SRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
|||+++|+|.+++.+. .++|..+..++.||+.||.|||+. ...+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999642 389999999999999999999987 11249999999999999999999999999
Q ss_pred cceeeCCCCCccCcccccCC
Q 008634 539 LARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 539 la~~~~~~~~~~~t~~~~Gt 558 (558)
+++.+.............||
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCC
T ss_pred cccccccccCccccccCccC
Confidence 99988765543333334444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=239.07 Aligned_cols=149 Identities=24% Similarity=0.377 Sum_probs=131.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 464 (558)
.++|...++||+|+||.||+++.. +++.||+|++++.. ....+.+..|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357888999999999999999976 57899999997652 23345688999999887 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999999653 35999999999999999999999985 9999999999999999999999999999743
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-26 Score=233.57 Aligned_cols=152 Identities=26% Similarity=0.406 Sum_probs=134.3
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (558)
...++|...+.||+|+||.||+++.. +|+.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999976 58899999997642 23456788899999877 999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999653 35899999999999999999999985 99999999999999999999999999997
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
...
T Consensus 168 ~~~ 170 (345)
T 1xjd_A 168 NML 170 (345)
T ss_dssp CCC
T ss_pred ccc
Confidence 543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=239.04 Aligned_cols=153 Identities=31% Similarity=0.569 Sum_probs=128.3
Q ss_pred cCCCCcccccccCCcccEEEEEec----CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.++|...++||+|+||.||+|+.. ++..||||+++... ....+.|.+|+.++.+++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888999999999999999865 46789999997653 3446789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.+ ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999964 3346899999999999999999999985 9999999999999999999999999999876
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
.+.
T Consensus 199 ~~~ 201 (373)
T 2qol_A 199 DDP 201 (373)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=232.89 Aligned_cols=152 Identities=30% Similarity=0.542 Sum_probs=133.7
Q ss_pred CCCCcccccccCCcccEEEEEec----CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...++||+|+||.||+|+.. .+..||||++... .....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999974 3456999999865 334467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999999542 346999999999999999999999985 99999999999999999999999999998765
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
+.
T Consensus 204 ~~ 205 (325)
T 3kul_A 204 DP 205 (325)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=233.34 Aligned_cols=155 Identities=33% Similarity=0.565 Sum_probs=130.8
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+++. +|+.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788889999999999999987 58899999987653 2335679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++|+|.+++.+......+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999975433335899999999999999999999873 24999999999999999999999999999876443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=237.99 Aligned_cols=150 Identities=19% Similarity=0.211 Sum_probs=131.3
Q ss_pred HcCCCCcccccccCCcccEEEEE------ecCCcEEEEEEccccCccchHHHHHHHHHHhcCC---CCCeeeeeEEEEeC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEG 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~------~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 459 (558)
..++|...++||+|+||.||+|. ..+++.||||++.... ..++..|++++.+++ |+||+++++++..+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45778889999999999999994 4468899999997543 456778888888886 99999999999999
Q ss_pred CEEEEEEEcCCCCCHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---------
Q 008634 460 QELLLIYEYMPNKSLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--------- 528 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~--------- 528 (558)
+..++||||+++|+|.+++.... ....++|..++.|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999997432 3456999999999999999999999985 999999999999998
Q ss_pred --CCcEEEEecCcceeeC
Q 008634 529 --DMNPKISDFGLARIFG 544 (558)
Q Consensus 529 --~~~~ki~DFGla~~~~ 544 (558)
++.+||+|||+|+.+.
T Consensus 217 ~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp --CTTEEECCCTTCEEGG
T ss_pred cccCCEEEeeCchhhhhh
Confidence 8999999999998765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=232.57 Aligned_cols=148 Identities=25% Similarity=0.383 Sum_probs=132.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46788899999999999999976 58899999997653 23356688999999988 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999653 35899999999999999999999985 9999999999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=231.56 Aligned_cols=151 Identities=28% Similarity=0.403 Sum_probs=135.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
.+.|...+.||+|+||.||+++.. +|+.||+|.+.+.... ..+.+.+|+.++.+++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888999999999999999975 5899999999765322 356799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC----cEEEEecC
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG 538 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DFG 538 (558)
++||||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999953 346999999999999999999999985 99999999999998877 79999999
Q ss_pred cceeeCCC
Q 008634 539 LARIFGGN 546 (558)
Q Consensus 539 la~~~~~~ 546 (558)
+++.+..+
T Consensus 165 ~a~~~~~~ 172 (361)
T 2yab_A 165 LAHEIEDG 172 (361)
T ss_dssp SCEECCTT
T ss_pred CceEcCCC
Confidence 99987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=229.31 Aligned_cols=149 Identities=27% Similarity=0.408 Sum_probs=134.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46888899999999999999975 68999999997542 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999653 35899999999999999999999885 99999999999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=238.24 Aligned_cols=163 Identities=28% Similarity=0.391 Sum_probs=138.3
Q ss_pred ChHHHHHHcCCCCcccccccCCcccEEEEEe------cCCcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeee
Q 008634 382 PLRLALEATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLL 453 (558)
Q Consensus 382 ~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~ 453 (558)
.........++|...++||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444445667899999999999999999973 2467899999986533 3456799999999999 799999999
Q ss_pred EEEEeCC-EEEEEEEcCCCCCHHHHHhccCC-------------------------------------------------
Q 008634 454 GCCLEGQ-ELLLIYEYMPNKSLDVHLFDATR------------------------------------------------- 483 (558)
Q Consensus 454 g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------- 483 (558)
+++.+.+ ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998865 48999999999999999975432
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 484 --------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 484 --------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+.
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999985 9999999999999999999999999999775544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-26 Score=227.15 Aligned_cols=151 Identities=28% Similarity=0.437 Sum_probs=133.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...++||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999965 688999999864432 3356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999653 35899999999999999999999985 99999999999999999999999999987754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 164 ~ 164 (294)
T 4eqm_A 164 T 164 (294)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-26 Score=227.15 Aligned_cols=150 Identities=28% Similarity=0.473 Sum_probs=128.5
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--------------------------cchHHHHHHHHHHh
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------------------------QGLQEFKNEVNLIA 442 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 442 (558)
.++|...++||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367888999999999999999865 688999999865431 12356899999999
Q ss_pred cCCCCCeeeeeEEEEe--CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 008634 443 KLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (558)
Q Consensus 443 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 520 (558)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||+.||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56899999999999998765 3346999999999999999999999985 9999999
Q ss_pred CCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 521 ASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 521 ~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+|||++.++.+||+|||+++.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=235.56 Aligned_cols=150 Identities=25% Similarity=0.436 Sum_probs=135.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888899999999999999965 58899999987542 334577899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..+
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999964 345999999999999999999999985 999999999999999999999999999987644
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-26 Score=230.92 Aligned_cols=149 Identities=29% Similarity=0.399 Sum_probs=124.7
Q ss_pred CCCCcccccccCCcccEEEEEe----cCCcEEEEEEccccC----ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~----~~g~~VaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
++|...++||+|+||.||+++. .+++.||+|++++.. ......+.+|+.++.+++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688899999999999999986 468999999997652 23345688999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999643 35899999999999999999999985 99999999999999999999999999987
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
...
T Consensus 171 ~~~ 173 (327)
T 3a62_A 171 SIH 173 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=227.19 Aligned_cols=154 Identities=28% Similarity=0.417 Sum_probs=136.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--EEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 466 (558)
++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888899999999999999976 48999999997643 334677889999999999999999999998765 789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE----cCCCcEEEEecCccee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARI 542 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DFGla~~ 542 (558)
||+++|+|.+++.+......+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976555555999999999999999999999985 9999999999999 7888899999999998
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
+..+.
T Consensus 166 ~~~~~ 170 (319)
T 4euu_A 166 LEDDE 170 (319)
T ss_dssp CCTTC
T ss_pred cCCCC
Confidence 76554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=238.81 Aligned_cols=151 Identities=30% Similarity=0.489 Sum_probs=134.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+|+.. +++.||||.+..... ...+.|.+|++++.+++||||+++++++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356778899999999999999986 689999999975532 334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999643 235899999999999999999999985 99999999999999999999999999997644
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=232.33 Aligned_cols=154 Identities=31% Similarity=0.548 Sum_probs=136.2
Q ss_pred HcCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
..++|...+.||+|+||.||+++.. +++.||||.++.... ...+.+.+|+.++.+++||||+++++++.+++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578899999999999999999974 347899999986543 335679999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 520 (558)
.++||||+++|+|.+++.+... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999975321 256999999999999999999999985 9999999
Q ss_pred CCCEEEcCCCcEEEEecCcceeeCC
Q 008634 521 ASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 521 ~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+|||++.++.+||+|||+++.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTG
T ss_pred cceEEECCCCeEEEeecCCCccccc
Confidence 9999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=231.55 Aligned_cols=150 Identities=26% Similarity=0.338 Sum_probs=134.1
Q ss_pred cCCCCcccccccCCcccEEEEEecC-CcEEEEEEccccC---ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 464 (558)
.++|...++||+|+||.||+++... ++.||||++.+.. ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4678899999999999999999764 7899999997642 23456788999999988 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999653 34899999999999999999999985 9999999999999999999999999999754
Q ss_pred C
Q 008634 545 G 545 (558)
Q Consensus 545 ~ 545 (558)
.
T Consensus 173 ~ 173 (353)
T 2i0e_A 173 W 173 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=222.72 Aligned_cols=150 Identities=28% Similarity=0.485 Sum_probs=130.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999975 589999999975432 335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++ ++.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 45444433 2345999999999999999999999985 999999999999999999999999999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=227.65 Aligned_cols=155 Identities=34% Similarity=0.501 Sum_probs=135.9
Q ss_pred cCCCCcccccccCCcccEEEEEe------cCCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
.++|...+.||+|+||.||+++. .++..||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45688889999999999999985 235789999997653 34457899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 008634 463 LLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 521 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~ 521 (558)
++||||+++|+|.+++.+... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 234899999999999999999999985 99999999
Q ss_pred CCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 522 SNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 522 ~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+|||++.++.+||+|||+++......
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTS
T ss_pred heEEEcCCCCEEEccccccccccccc
Confidence 99999999999999999999875543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=226.89 Aligned_cols=150 Identities=31% Similarity=0.521 Sum_probs=131.7
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+++..+|+.||+|++..... ...+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 367888999999999999999998899999999975432 235678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++ +|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9985 77777754 3345899999999999999999999985 99999999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=230.59 Aligned_cols=150 Identities=25% Similarity=0.372 Sum_probs=135.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 68999999997542 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999653 34899999999999999999999985 999999999999999999999999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=222.37 Aligned_cols=149 Identities=29% Similarity=0.492 Sum_probs=134.9
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...++||+|+||.||++...+++.||+|++..... ..+++.+|++++.+++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46778899999999999999998889999999986543 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999964 3346899999999999999999999985 99999999999999999999999999987644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=234.92 Aligned_cols=154 Identities=33% Similarity=0.483 Sum_probs=135.5
Q ss_pred cCCCCcccccccCCcccEEEEEec--------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (558)
.++|...++||+|+||.||+|+.. .+..||||++.... ....+.+.+|++++.++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457888899999999999999852 23579999997653 34457899999999999 999999999999999
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl 526 (558)
+..++||||+++|+|.+++.+... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976432 245999999999999999999999985 9999999999999
Q ss_pred cCCCcEEEEecCcceeeCCC
Q 008634 527 DDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 527 ~~~~~~ki~DFGla~~~~~~ 546 (558)
+.++.+||+|||+++.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCC
T ss_pred cCCCcEEEcccCcccccccc
Confidence 99999999999999977544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=228.51 Aligned_cols=151 Identities=33% Similarity=0.603 Sum_probs=131.7
Q ss_pred CCCCcccccccCCcccEEEEEe-----cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 463 (558)
++|...++||+|+||.||++++ .+++.||||++........+.+.+|+.++.+++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5678889999999999999984 35889999999877666678899999999999999999999998654 4589
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 90 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999653 235899999999999999999999985 999999999999999999999999999987
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
..+
T Consensus 165 ~~~ 167 (295)
T 3ugc_A 165 PQD 167 (295)
T ss_dssp ---
T ss_pred cCC
Confidence 544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-25 Score=225.25 Aligned_cols=152 Identities=21% Similarity=0.356 Sum_probs=135.1
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357888999999999999999976 58899999987543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC--CCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~--~~~~ki~DFGla~~~~~~ 546 (558)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..+
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999954 2346899999999999999999999985 999999999999987 789999999999988654
Q ss_pred C
Q 008634 547 Q 547 (558)
Q Consensus 547 ~ 547 (558)
.
T Consensus 158 ~ 158 (321)
T 1tki_A 158 D 158 (321)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=229.77 Aligned_cols=154 Identities=24% Similarity=0.403 Sum_probs=134.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-----ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
+.|...++||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888899999999999999865 68999999986431 2245789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc---EEEEecCcc
Q 008634 465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLA 540 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DFGla 540 (558)
||||+++|+|.+++.+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988876432 3345899999999999999999999985 999999999999986654 999999999
Q ss_pred eeeCCCC
Q 008634 541 RIFGGNQ 547 (558)
Q Consensus 541 ~~~~~~~ 547 (558)
+.+....
T Consensus 181 ~~~~~~~ 187 (351)
T 3c0i_A 181 IQLGESG 187 (351)
T ss_dssp EECCTTS
T ss_pred eEecCCC
Confidence 9886543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-26 Score=235.76 Aligned_cols=152 Identities=33% Similarity=0.483 Sum_probs=132.1
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
.++|...++||+|+||.||+|+.. +++.||||++... ..+....+.+|+.++.+++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356788899999999999999843 4678999999754 334456789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC---cEEEE
Q 008634 463 LLIYEYMPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS 535 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~ki~ 535 (558)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 2245899999999999999999999985 99999999999999544 59999
Q ss_pred ecCcceeeC
Q 008634 536 DFGLARIFG 544 (558)
Q Consensus 536 DFGla~~~~ 544 (558)
|||+++.+.
T Consensus 227 DFG~a~~~~ 235 (367)
T 3l9p_A 227 DFGMARDIY 235 (367)
T ss_dssp CCHHHHHHH
T ss_pred CCccccccc
Confidence 999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=230.85 Aligned_cols=148 Identities=32% Similarity=0.460 Sum_probs=127.8
Q ss_pred cccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 395 DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++.+++||||+++++++.+.+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3567999999999999864 689999999987666667889999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE--cCCCcEEEEecCcceeeCCCC
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl--~~~~~~ki~DFGla~~~~~~~ 547 (558)
|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99988642 345899999999999999999999985 9999999999999 577899999999999886543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=241.96 Aligned_cols=152 Identities=30% Similarity=0.527 Sum_probs=136.7
Q ss_pred cCCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||+|+... +..||||.++... ...++|.+|+.+|.+++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3467788999999999999999864 8899999997653 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++|+|.+++.+.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....+
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999997533 345899999999999999999999985 999999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=220.56 Aligned_cols=152 Identities=30% Similarity=0.459 Sum_probs=136.6
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.++|...++||+|+||.||++...++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 356788899999999999999998888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....+.
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999653 235899999999999999999999985 9999999999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=223.91 Aligned_cols=150 Identities=28% Similarity=0.397 Sum_probs=134.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
+.|...+.||+|+||.||++... +|+.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45788899999999999999975 589999999875432 13577999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC----cEEEEecCc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGL 539 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DFGl 539 (558)
+||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999953 346999999999999999999999985 99999999999999887 899999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++.+..+
T Consensus 165 a~~~~~~ 171 (326)
T 2y0a_A 165 AHKIDFG 171 (326)
T ss_dssp CEECCTT
T ss_pred CeECCCC
Confidence 9987644
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=227.52 Aligned_cols=155 Identities=28% Similarity=0.499 Sum_probs=122.5
Q ss_pred HcCCCCcccccccCCcccEEEEEecCC----cEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLADG----KAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g----~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
..++|...+.||+|+||.||+|+.... ..||||++... .....+.+.+|++++.+++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 356799999999999999999987543 27999999765 344567899999999999999999999999887655
Q ss_pred ------EEEEEcCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEE
Q 008634 463 ------LLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533 (558)
Q Consensus 463 ------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 533 (558)
++|+||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999986432 2235899999999999999999999985 99999999999999999999
Q ss_pred EEecCcceeeCCC
Q 008634 534 ISDFGLARIFGGN 546 (558)
Q Consensus 534 i~DFGla~~~~~~ 546 (558)
|+|||+++.....
T Consensus 178 l~Dfg~a~~~~~~ 190 (323)
T 3qup_A 178 VADFGLSRKIYSG 190 (323)
T ss_dssp ECCCCC-------
T ss_pred Eeecccccccccc
Confidence 9999999877543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=230.65 Aligned_cols=156 Identities=29% Similarity=0.445 Sum_probs=133.7
Q ss_pred HcCCCCcccccccCCcccEEEEEe------cCCcEEEEEEcccc-CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (558)
..++|...+.||+|+||.||+|+. .++..||||.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788899999999999999985 24568999999754 334467899999999999 8999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRS--------------------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 520 (558)
..++||||+++|+|.+++...... ..++|..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 34899999999999999999999985 9999999
Q ss_pred CCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 521 ASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 521 ~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+|||++.++.+||+|||+++.+..+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCc
Confidence 999999999999999999999875544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=223.21 Aligned_cols=153 Identities=31% Similarity=0.516 Sum_probs=121.1
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999865 58999999987543 2345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|++ |+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69998886432 2245899999999999999999999985 9999999999999999999999999999875
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
..
T Consensus 160 ~~ 161 (317)
T 2pmi_A 160 IP 161 (317)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=231.03 Aligned_cols=153 Identities=24% Similarity=0.392 Sum_probs=136.6
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.+.|...++||+|+||.||+|... +|+.||+|.+..........+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357888999999999999999875 6889999999876655567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC--CCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~--~~~~ki~DFGla~~~~~~ 546 (558)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..+
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999853 2345899999999999999999999985 999999999999974 578999999999988654
Q ss_pred C
Q 008634 547 Q 547 (558)
Q Consensus 547 ~ 547 (558)
.
T Consensus 205 ~ 205 (387)
T 1kob_A 205 E 205 (387)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=239.83 Aligned_cols=155 Identities=32% Similarity=0.477 Sum_probs=137.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56788899999999999999975 68999999997542 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.+... ...+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999975432 346999999999999999999999985 99999999999999999999999999998765
Q ss_pred CCC
Q 008634 546 NQN 548 (558)
Q Consensus 546 ~~~ 548 (558)
+..
T Consensus 342 ~~~ 344 (543)
T 3c4z_A 342 GQT 344 (543)
T ss_dssp TCC
T ss_pred CCc
Confidence 543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=218.29 Aligned_cols=151 Identities=30% Similarity=0.469 Sum_probs=134.0
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
+|.....||+|+||.||+|... +++.|+||.+........+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555668999999999999964 688999999987766667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecCcceeeCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG 545 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGla~~~~~ 545 (558)
+++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+++....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999976555556789999999999999999999985 999999999999987 89999999999998754
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=189.58 Aligned_cols=101 Identities=20% Similarity=0.424 Sum_probs=90.2
Q ss_pred CccccCCCCccCCCChHHHHHHHHHhhHhhhhccC--CCceeeccCC-CCCcEEEEEecCCCCChhchHHHHHHHHHHHH
Q 008634 73 DMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGK--SLYYNASEGE-FPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVL 149 (558)
Q Consensus 73 ~~~~~C~~~~~~~~s~f~~nl~~l~~~~l~~~a~~--~~f~~~~~g~-~~~~vygl~qC~~Dl~~~~C~~Cl~~a~~~~~ 149 (558)
.....|++++|+++++|++||+.||+. |+++++. .+|+++..|. ++++||||+|||||+++++|..||+.|+.+++
T Consensus 5 ~v~~~Cn~~~~t~~s~f~~nl~~ll~~-L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~ 83 (108)
T 3a2e_A 5 FVSSACNTQKIPSGSPFNRNLRAMLAD-LRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIF 83 (108)
T ss_dssp EEEEEECSSBCCTTCTHHHHHHHHHHH-HHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHH
T ss_pred eeeeecCCCccCCCChHHHHHHHHHHH-HHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHH
Confidence 345569999999999999999999998 9888873 3466666654 56899999999999999999999999999999
Q ss_pred hhCCCCccEEEEeecCceEEEEccCCC
Q 008634 150 QKCSGTKEAFIWYQVQECMVRFSDHSS 176 (558)
Q Consensus 150 ~~C~~~~~a~i~~~~~~C~lrY~~~~f 176 (558)
+.||++++|+||++ +|+||||+++|
T Consensus 84 ~~C~~~~g~~i~~~--~C~lRY~~~~F 108 (108)
T 3a2e_A 84 SICNNAIGARVQLV--DCFIQYEQRSF 108 (108)
T ss_dssp HHTTSBSSEEEEET--TEEEEEESSCC
T ss_pred HHCCCCceEEEECC--CEEEEEeCCcC
Confidence 99999999999999 99999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=226.65 Aligned_cols=155 Identities=32% Similarity=0.517 Sum_probs=134.9
Q ss_pred cCCCCcccccccCCcccEEEEEec--------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (558)
.++|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 457888999999999999999863 46789999997653 34467799999999999 899999999999999
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl 526 (558)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975432 234899999999999999999999985 9999999999999
Q ss_pred cCCCcEEEEecCcceeeCCCC
Q 008634 527 DDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 527 ~~~~~~ki~DFGla~~~~~~~ 547 (558)
+.++.+||+|||+++......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~ 211 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNID 211 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTS
T ss_pred cCCCCEEEccccccccccccc
Confidence 999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=224.74 Aligned_cols=150 Identities=21% Similarity=0.263 Sum_probs=132.8
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+|+. .+++.||||.+..... .+.+.+|+.++.++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788899999999999999996 4689999999875432 34688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc-----EEEEecCccee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISDFGLARI 542 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~-----~ki~DFGla~~ 542 (558)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999653 346999999999999999999999985 999999999999998887 99999999998
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=240.15 Aligned_cols=151 Identities=27% Similarity=0.334 Sum_probs=124.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...++||+|+||.||+++.. +|+.||||++... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999865 6899999999754 333456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+ . +|+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999653 358999999999999999999997 6 49999999999999999999999999998754
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
.+
T Consensus 301 ~~ 302 (446)
T 4ejn_A 301 KD 302 (446)
T ss_dssp C-
T ss_pred CC
Confidence 33
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=222.99 Aligned_cols=149 Identities=30% Similarity=0.505 Sum_probs=132.7
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|...++||+|+||.||+++..+|+.||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4678889999999999999999889999999987543 23356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++ +|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 985 888888542 345899999999999999999999985 99999999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=217.98 Aligned_cols=152 Identities=24% Similarity=0.412 Sum_probs=137.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||++... ++..|++|++........+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 346888899999999999999976 4779999999877666778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE---cCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DFGla~~~~~ 545 (558)
+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999988653 34899999999999999999999985 9999999999999 7889999999999998765
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
..
T Consensus 162 ~~ 163 (277)
T 3f3z_A 162 GK 163 (277)
T ss_dssp TS
T ss_pred cc
Confidence 43
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=221.44 Aligned_cols=150 Identities=29% Similarity=0.467 Sum_probs=132.5
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.++|...++||+|+||.||++...++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 456788899999999999999998888999999986543 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999652 235899999999999999999999985 99999999999999999999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=235.45 Aligned_cols=150 Identities=29% Similarity=0.524 Sum_probs=135.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+|+.. +|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888899999999999999975 69999999997542 233567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....+
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999953 345999999999999999999999985 999999999999999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=231.60 Aligned_cols=149 Identities=28% Similarity=0.334 Sum_probs=124.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHH-HhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...++||+|+||.||+++.. +++.||||++.+... .....+..|..+ +..++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999976 588999999976532 234456677776 5678999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++.+. ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999653 35889999999999999999999985 99999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=240.23 Aligned_cols=154 Identities=31% Similarity=0.426 Sum_probs=137.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...++||+|+||.||+++.. +|+.||||++.+.. ......+.+|+.++.+++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999975 68999999997542 23456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999996533 345899999999999999999999985 99999999999999999999999999998865
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
+.
T Consensus 339 ~~ 340 (576)
T 2acx_A 339 GQ 340 (576)
T ss_dssp TC
T ss_pred Cc
Confidence 44
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=239.22 Aligned_cols=151 Identities=32% Similarity=0.497 Sum_probs=134.6
Q ss_pred HcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
..++|...++||+|+||.||+|...++..||||+++... ...+.|.+|+.++.+++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456788889999999999999999888999999998654 34678999999999999999999999986 5678999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++|+|.+++.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999996432 235889999999999999999999985 99999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=227.11 Aligned_cols=152 Identities=32% Similarity=0.562 Sum_probs=127.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCc----EEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...++||+|+||.||+|+.. +++ +|++|.+... .....+.+.+|+.++.+++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46888899999999999999864 343 4688888644 3345678999999999999999999999998765 789
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999753 345899999999999999999999985 9999999999999999999999999999876
Q ss_pred CCCC
Q 008634 545 GNQN 548 (558)
Q Consensus 545 ~~~~ 548 (558)
.+..
T Consensus 169 ~~~~ 172 (327)
T 3poz_A 169 AEEK 172 (327)
T ss_dssp TTCC
T ss_pred CCcc
Confidence 5543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=227.05 Aligned_cols=150 Identities=27% Similarity=0.467 Sum_probs=133.2
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...+.||+|+||.||+|+. .+++.||||++.+.. ......+.+|+.++..++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788899999999999999996 468999999987542 23346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+ +|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78898888653 35899999999999999999999985 99999999999999999999999999997754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
+
T Consensus 161 ~ 161 (336)
T 3h4j_B 161 G 161 (336)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=227.99 Aligned_cols=151 Identities=25% Similarity=0.366 Sum_probs=128.9
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----E
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 461 (558)
.++|...++||+|+||.||+++. .+++.||||++..... .....+.+|+.++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788899999999999999996 4689999999976532 33467899999999999999999999987654 3
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 49999999999999999653 35899999999999999999999985 9999999999999999999999999999
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 87544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=228.08 Aligned_cols=152 Identities=26% Similarity=0.424 Sum_probs=134.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.++|...++||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999875 58999999997543 334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC---CcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~ki~DFGla~~~ 543 (558)
||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999854 345899999999999999999999985 9999999999999865 45999999999987
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
....
T Consensus 182 ~~~~ 185 (362)
T 2bdw_A 182 NDSE 185 (362)
T ss_dssp TTCC
T ss_pred cCCc
Confidence 6443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=225.16 Aligned_cols=156 Identities=35% Similarity=0.487 Sum_probs=136.7
Q ss_pred cCCCCcccccccCCcccEEEEEe------cCCcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (558)
.++|...+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35688889999999999999984 2467899999976543 3457799999999999 99999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE
Q 008634 462 LLLIYEYMPNKSLDVHLFDATR---------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl 526 (558)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976432 124899999999999999999999985 9999999999999
Q ss_pred cCCCcEEEEecCcceeeCCCCC
Q 008634 527 DDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 527 ~~~~~~ki~DFGla~~~~~~~~ 548 (558)
+.++.+||+|||+++....+..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~ 200 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSN 200 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTT
T ss_pred cCCCCEEEcccccccccccccc
Confidence 9999999999999998765543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-25 Score=234.55 Aligned_cols=149 Identities=31% Similarity=0.479 Sum_probs=132.4
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC-EEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 468 (558)
.++|...++||+|+||.||+|... |+.||||+++... ..+.|.+|+.++.+++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356778899999999999999985 7899999998653 4578999999999999999999999988765 79999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++|+|.+++.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999997542 334799999999999999999999985 99999999999999999999999999997643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=227.25 Aligned_cols=152 Identities=32% Similarity=0.525 Sum_probs=130.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCc----EEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...++||+|+||.||+|+.. ++. +|++|.+.... .+..+.+.+|+.++.+++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999864 344 38888876443 344567889999999999999999999986 456899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
|+||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999643 346899999999999999999999985 9999999999999999999999999999886
Q ss_pred CCCC
Q 008634 545 GNQN 548 (558)
Q Consensus 545 ~~~~ 548 (558)
.+..
T Consensus 167 ~~~~ 170 (325)
T 3kex_A 167 PDDK 170 (325)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-25 Score=219.73 Aligned_cols=148 Identities=30% Similarity=0.439 Sum_probs=127.3
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhc--CCCCCeeeeeEEEEeC----CEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCLEG----QELL 463 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~ 463 (558)
.++|...++||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788899999999999999998 6889999998654 23456667777666 7999999999997653 4689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--------EDSRLKIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
+||||+++|+|.+++.. ..+++..++.++.||+.||.||| +. +|+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999942 35899999999999999999999 55 59999999999999999999999
Q ss_pred ecCcceeeCCCCC
Q 008634 536 DFGLARIFGGNQN 548 (558)
Q Consensus 536 DFGla~~~~~~~~ 548 (558)
|||+++.......
T Consensus 156 Dfg~a~~~~~~~~ 168 (301)
T 3q4u_A 156 DLGLAVMHSQSTN 168 (301)
T ss_dssp CCTTCEEEETTTT
T ss_pred eCCCeeecccccc
Confidence 9999998765443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=233.98 Aligned_cols=152 Identities=26% Similarity=0.378 Sum_probs=133.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.++|...++||+|+||.||++... +|+.+|+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456888999999999999999864 68999999987553 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc---CCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DFGla~~~ 543 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999998653 35899999999999999999999985 99999999999998 5678999999999887
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
..+.
T Consensus 164 ~~~~ 167 (444)
T 3soa_A 164 EGEQ 167 (444)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 6554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=221.38 Aligned_cols=152 Identities=31% Similarity=0.556 Sum_probs=131.6
Q ss_pred CCCCcccccccCCcccEEEEEe-----cCCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (558)
+.|...++||+|+||.||++++ .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477889999999999999983 368899999998543 34467899999999999999999999999876 668
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999996432 45899999999999999999999985 99999999999999999999999999998
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
+..+.
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 86554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=229.70 Aligned_cols=151 Identities=28% Similarity=0.393 Sum_probs=134.2
Q ss_pred CCCCcccccccCCcccEEEEEe----cCCcEEEEEEccccC----ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~----~~g~~VaVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (558)
++|...++||+|+||.||+++. .+++.||||++++.. ....+.+.+|++++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999987 368999999997542 23346678899999999 69999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999653 35899999999999999999999985 9999999999999999999999999999
Q ss_pred eeCCCC
Q 008634 542 IFGGNQ 547 (558)
Q Consensus 542 ~~~~~~ 547 (558)
.+..+.
T Consensus 208 ~~~~~~ 213 (355)
T 1vzo_A 208 EFVADE 213 (355)
T ss_dssp ECCGGG
T ss_pred ecccCC
Confidence 875443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=217.46 Aligned_cols=149 Identities=31% Similarity=0.455 Sum_probs=133.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|...+.||+|+||.||+++.. +++.|+||++.... ....+.+.+|+.++.+++||||+++++++.+++..++|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46788899999999999999976 68999999987543 33457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 999999998843 345899999999999999999999985 99999999999999999999999999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-25 Score=223.27 Aligned_cols=150 Identities=29% Similarity=0.342 Sum_probs=128.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|+..++||+|+||.||+|+.. +|+.||||++..... .....+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 689999999865432 3334556666666655 9999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+ +++|.+++... ...++|..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67898888653 345999999999999999999999985 999999999999999999999999999887544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-24 Score=219.24 Aligned_cols=148 Identities=25% Similarity=0.386 Sum_probs=130.5
Q ss_pred CCCCc-ccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSD-ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~-~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 467 (558)
+.|.. ++.||+|+||.||+++.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 468999999999999954 6899999999877666678899999999985 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc---EEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DFGla~~~~ 544 (558)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999653 35899999999999999999999985 999999999999998776 9999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=225.94 Aligned_cols=148 Identities=26% Similarity=0.359 Sum_probs=130.1
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467889999999999999999976 689999999975433 236788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc--EEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~--~ki~DFGla~~~~ 544 (558)
+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999998653 34899999999999999999999985 999999999999987765 9999999998543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=220.07 Aligned_cols=150 Identities=27% Similarity=0.424 Sum_probs=133.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|+||.||+++.. +|+.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888899999999999999976 589999999865533 235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998853 345899999999999999999999985 999999999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-25 Score=225.89 Aligned_cols=151 Identities=25% Similarity=0.393 Sum_probs=130.8
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEcccc--CccchHHHHHHHHHHhcCCC--CCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV 465 (558)
.+.|...++||+|+||.||++...+++.||||++... ..+..+.+.+|+.++.+++| |||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999988999999998754 33445789999999999976 9999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|| +.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5788999999653 35899999999999999999999985 99999999999997 57899999999998865
Q ss_pred CCC
Q 008634 546 NQN 548 (558)
Q Consensus 546 ~~~ 548 (558)
+..
T Consensus 160 ~~~ 162 (343)
T 3dbq_A 160 DTT 162 (343)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-25 Score=230.30 Aligned_cols=154 Identities=28% Similarity=0.417 Sum_probs=135.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--EEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 466 (558)
++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++.+++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888899999999999999976 48999999997643 334577889999999999999999999998765 789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE----cCCCcEEEEecCccee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARI 542 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DFGla~~ 542 (558)
||+++|+|.+++.+......+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976554455999999999999999999999985 9999999999999 7888899999999998
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
...+.
T Consensus 166 ~~~~~ 170 (396)
T 4eut_A 166 LEDDE 170 (396)
T ss_dssp CCCGG
T ss_pred ccCCC
Confidence 76543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=228.42 Aligned_cols=156 Identities=30% Similarity=0.490 Sum_probs=135.8
Q ss_pred HHcCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (558)
...++|...+.||+|+||.||+|+.. +++.|+||.+..... .....+.+|+.++.+++||||+++++++.+++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34567888999999999999999854 367899999976533 34567899999999999999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEE
Q 008634 461 ELLLIYEYMPNKSLDVHLFDAT-------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 533 (558)
..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999986422 1245799999999999999999999985 99999999999999999999
Q ss_pred EEecCcceeeCCC
Q 008634 534 ISDFGLARIFGGN 546 (558)
Q Consensus 534 i~DFGla~~~~~~ 546 (558)
|+|||+++.....
T Consensus 179 l~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 179 IGDFGMTRDIYET 191 (322)
T ss_dssp ECCTTCCCGGGGG
T ss_pred ECcCccccccccc
Confidence 9999999876443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=229.17 Aligned_cols=156 Identities=31% Similarity=0.466 Sum_probs=135.3
Q ss_pred HcCCCCcccccccCCcccEEEEEecC------CcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~------g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (558)
..++|...+.||+|+||.||+|.... ...|++|.+..... ...+.+.+|+.++.++ +||||+++++++.+++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45788899999999999999998642 24799999976533 3456799999999999 8999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC
Q 008634 461 ELLLIYEYMPNKSLDVHLFDAT-----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~ 529 (558)
..++||||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999999986432 1345899999999999999999999985 9999999999999999
Q ss_pred CcEEEEecCcceeeCCCC
Q 008634 530 MNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 530 ~~~ki~DFGla~~~~~~~ 547 (558)
+.+||+|||+++....+.
T Consensus 201 ~~~kl~Dfg~~~~~~~~~ 218 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDS 218 (333)
T ss_dssp GEEEBCCCGGGCCGGGCT
T ss_pred CeEEECcccccccccccc
Confidence 999999999999775443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=216.80 Aligned_cols=150 Identities=31% Similarity=0.510 Sum_probs=134.0
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++. .+|+.|+||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++|+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4688889999999999999996 468999999987542 223567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999642 346899999999999999999999985 99999999999999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=220.74 Aligned_cols=149 Identities=28% Similarity=0.441 Sum_probs=133.6
Q ss_pred CCCCcccccccCCcccEEEEEecC-C-------cEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-G-------KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g-------~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
++|...++||+|+||.||+|+... + ..|++|++........+.+.+|+.++.+++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 467888999999999999998653 3 57999999877666778899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc--------EEE
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--------PKI 534 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~--------~ki 534 (558)
++||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999653 334899999999999999999999985 999999999999998887 999
Q ss_pred EecCcceeeC
Q 008634 535 SDFGLARIFG 544 (558)
Q Consensus 535 ~DFGla~~~~ 544 (558)
+|||+++...
T Consensus 163 ~Dfg~~~~~~ 172 (289)
T 4fvq_A 163 SDPGISITVL 172 (289)
T ss_dssp CCCCSCTTTS
T ss_pred ccCccccccc
Confidence 9999997654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=217.20 Aligned_cols=155 Identities=30% Similarity=0.436 Sum_probs=134.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...++||+|+||.||+++.. +++.||+|++... ......++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456888899999999999999976 6899999998754 233456788999999999 999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC----------------
Q 008634 466 YEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---------------- 528 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---------------- 528 (558)
|||+++++|.+++.+... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975321 245899999999999999999999985 999999999999984
Q ss_pred ---CCcEEEEecCcceeeCCCC
Q 008634 529 ---DMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 529 ---~~~~ki~DFGla~~~~~~~ 547 (558)
...+||+|||+++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC
T ss_pred cCCceEEEEcccccccccCCcc
Confidence 4479999999999876544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=235.36 Aligned_cols=150 Identities=24% Similarity=0.465 Sum_probs=122.6
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (558)
.++|...++||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.+|.+++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999865 6899999999754 233457789999999999999999999999543 57
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++||||+ +|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 99999987 5789888853 345999999999999999999999985 9999999999999999999999999999
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
....+
T Consensus 205 ~~~~~ 209 (458)
T 3rp9_A 205 TVDYP 209 (458)
T ss_dssp CTTSC
T ss_pred hccCc
Confidence 87543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=226.11 Aligned_cols=156 Identities=28% Similarity=0.387 Sum_probs=132.9
Q ss_pred HHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-----CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 008634 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 387 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (558)
....++|...++||+|+||.||++... ++..||+|++... .....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 345667999999999999999999875 5889999998654 3445678999999999999999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 008634 461 ELLLIYEYMPNKSLDVHLFDAT-------------------------------------RSVQLDWKRRQSIINGIARGI 503 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~aL 503 (558)
..++||||+++|+|.+++.... ....+++.....++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999985210 012246777889999999999
Q ss_pred HHHHhCCCCCeeeCCCCCCCEEEcCCC--cEEEEecCcceeeCC
Q 008634 504 LYLHEDSRLKIIHRDLKASNILLDDDM--NPKISDFGLARIFGG 545 (558)
Q Consensus 504 ~yLH~~~~~~ivHrDlk~~NILl~~~~--~~ki~DFGla~~~~~ 545 (558)
.|||+.+ |+||||||+|||++.++ .+||+|||+++.+..
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 9999985 99999999999998776 899999999997643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=227.19 Aligned_cols=151 Identities=18% Similarity=0.261 Sum_probs=135.1
Q ss_pred cCCCCcccccccC--CcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G--~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.++|...++||+| +||.||+++.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578889999999 99999999976 68999999997553 3335678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999996532 345899999999999999999999985 9999999999999999999999999987653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=242.63 Aligned_cols=152 Identities=26% Similarity=0.340 Sum_probs=134.7
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (558)
..++|...++||+|+||.||+++.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467889999999999999999975 5889999999754 234456788999999988 7999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||+++|+|..++.+. ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999753 35899999999999999999999985 999999999999999999999999999975
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
..+
T Consensus 493 ~~~ 495 (674)
T 3pfq_A 493 IWD 495 (674)
T ss_dssp CCT
T ss_pred ccC
Confidence 443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-25 Score=224.64 Aligned_cols=153 Identities=24% Similarity=0.382 Sum_probs=134.6
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 459 (558)
..++|...++||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3467888999999999999999864 688999999876531 1344678899999999999999999999999
Q ss_pred CEEEEEEEcCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 460 QELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 460 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
+..++||||+.+| +|.+++.+. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 999998543 35999999999999999999999985 9999999999999999999999999
Q ss_pred cceeeCCCC
Q 008634 539 LARIFGGNQ 547 (558)
Q Consensus 539 la~~~~~~~ 547 (558)
+++....+.
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-25 Score=222.70 Aligned_cols=156 Identities=30% Similarity=0.501 Sum_probs=125.7
Q ss_pred HHcCCCCcccccccCCcccEEEEEec----CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
...++|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888899999999999999864 24589999987543 3345779999999999999999999999987653
Q ss_pred -----EEEEEEcCCCCCHHHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEE
Q 008634 462 -----LLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533 (558)
Q Consensus 462 -----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 533 (558)
.++|+||+++|+|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 59999999999999998543 23456999999999999999999999985 99999999999999999999
Q ss_pred EEecCcceeeCCC
Q 008634 534 ISDFGLARIFGGN 546 (558)
Q Consensus 534 i~DFGla~~~~~~ 546 (558)
|+|||+++.+...
T Consensus 188 l~Dfg~~~~~~~~ 200 (313)
T 3brb_A 188 VADFGLSKKIYSG 200 (313)
T ss_dssp ECSCSCC------
T ss_pred EeecCcceecccc
Confidence 9999999877543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-26 Score=234.79 Aligned_cols=147 Identities=19% Similarity=0.296 Sum_probs=124.8
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--------ccchHHHHHHHHHHhcCC---------CCCeeeee
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQ---------HKNLVRLL 453 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l~ 453 (558)
++|...++||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577789999999999999998 68999999997553 223477899999998885 88888887
Q ss_pred EEEE------------------------------eCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 008634 454 GCCL------------------------------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503 (558)
Q Consensus 454 g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 503 (558)
+.+. +.+..++||||+++|++.+.+.+ ..+++.....|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 7653 26789999999999977666632 4589999999999999999
Q ss_pred HHHH-hCCCCCeeeCCCCCCCEEEcCCC--------------------cEEEEecCcceeeCC
Q 008634 504 LYLH-EDSRLKIIHRDLKASNILLDDDM--------------------NPKISDFGLARIFGG 545 (558)
Q Consensus 504 ~yLH-~~~~~~ivHrDlk~~NILl~~~~--------------------~~ki~DFGla~~~~~ 545 (558)
.||| +.+ |+||||||+||||+.++ .+||+|||+|+....
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 9999 774 99999999999999887 899999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=237.10 Aligned_cols=151 Identities=33% Similarity=0.526 Sum_probs=131.0
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.++|...++||+|+||.||+|...++..||||+++... ...++|.+|+.++.+++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 45678889999999999999999888889999998654 335789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
++|+|.+++.+. ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....+
T Consensus 261 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 261 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999642 2235899999999999999999999985 999999999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=216.44 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=133.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 46788899999999999999976 47899999987542 234567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988543 35899999999999999999999985 99999999999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=218.16 Aligned_cols=153 Identities=24% Similarity=0.436 Sum_probs=132.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
+.|...++||+|+||.||+++.. ++..|++|++.... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888899999999999999975 58899999987653 33467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE---cCCCcEEEEecCcceeeC
Q 008634 469 MPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG 544 (558)
Q Consensus 469 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DFGla~~~~ 544 (558)
+++|+|.+++.+. .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 22356999999999999999999999985 9999999999999 456889999999998875
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
.+
T Consensus 179 ~~ 180 (285)
T 3is5_A 179 SD 180 (285)
T ss_dssp --
T ss_pred Cc
Confidence 54
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=221.63 Aligned_cols=151 Identities=25% Similarity=0.390 Sum_probs=134.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...+.||+|+||.||+++.. +++.|++|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356888899999999999999976 47899999987542 23456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988643 35899999999999999999999985 99999999999999999999999999998753
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
+
T Consensus 194 ~ 194 (335)
T 2owb_A 194 D 194 (335)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=222.62 Aligned_cols=152 Identities=31% Similarity=0.518 Sum_probs=135.5
Q ss_pred CCCCcccccccCCcccEEEEEe-----cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 463 (558)
++|...++||+|+||.||++++ .+++.|+||++........+.+.+|++++.+++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4678889999999999999984 3588999999987766667789999999999999999999999874 46789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999996532 35899999999999999999999985 999999999999999999999999999987
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
..+.
T Consensus 178 ~~~~ 181 (327)
T 3lxl_A 178 PLDK 181 (327)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 6443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=215.98 Aligned_cols=152 Identities=36% Similarity=0.556 Sum_probs=124.7
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCc----cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...++||+|+||.||++... ++.||||++..... ...+.+.+|++++.+++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888899999999999999974 88999999875432 2356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC--------CCcEEEEec
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--------DMNPKISDF 537 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~--------~~~~ki~DF 537 (558)
|||+++++|.+++. ...+++..+..++.||+.||.|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999984 345899999999999999999999986455999999999999986 778999999
Q ss_pred CcceeeCCC
Q 008634 538 GLARIFGGN 546 (558)
Q Consensus 538 Gla~~~~~~ 546 (558)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999877544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=219.26 Aligned_cols=142 Identities=25% Similarity=0.381 Sum_probs=125.6
Q ss_pred ccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
+++||+|+||.||++... +++.||||++.+. ....+.+|+.++.++. ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 5899999998653 3456789999999997 9999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC---cEEEEecCcceeeCCC
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIFGGN 546 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DFGla~~~~~~ 546 (558)
|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....+
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999653 45999999999999999999999985 99999999999997665 8999999999977544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=215.07 Aligned_cols=151 Identities=29% Similarity=0.508 Sum_probs=135.5
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.+.|...++||+|+||.||+|+.. +++.|+||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 346888899999999999999864 68999999997553 3446789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999843 45899999999999999999999985 9999999999999999999999999999876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=215.45 Aligned_cols=149 Identities=29% Similarity=0.473 Sum_probs=134.8
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...+.||+|+||.||++...+++.|++|++..... ..+.+.+|++++.+++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46778889999999999999998889999999986543 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999999653 345899999999999999999999985 99999999999999999999999999987643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=223.74 Aligned_cols=150 Identities=33% Similarity=0.522 Sum_probs=131.6
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
+.|...++||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477888999999999999996 4789999999975432 23467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 6787777532 345899999999999999999999985 999999999999999999999999999877543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=219.29 Aligned_cols=150 Identities=29% Similarity=0.411 Sum_probs=134.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
+.|...+.||+|+||.||+++.. +|+.||+|.+...... ..+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45888899999999999999975 5899999998754321 3567999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC----cEEEEecCc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGL 539 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DFGl 539 (558)
+||||+++++|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999964 345899999999999999999999985 99999999999999888 799999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++....+
T Consensus 166 ~~~~~~~ 172 (321)
T 2a2a_A 166 AHEIEDG 172 (321)
T ss_dssp CEECCTT
T ss_pred ceecCcc
Confidence 9987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=227.71 Aligned_cols=160 Identities=24% Similarity=0.379 Sum_probs=132.1
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEcccc--CccchHHHHHHHHHHhcCC--CCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 466 (558)
+.|...++||+|+||.||++...+++.||||++... ..+..+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998654 3344678999999999996 599999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
| +.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..+
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 6789999999653 35899999999999999999999985 99999999999995 578999999999988655
Q ss_pred CCccCcccccCC
Q 008634 547 QNQANTNIIAGT 558 (558)
Q Consensus 547 ~~~~~t~~~~Gt 558 (558)
.........+||
T Consensus 208 ~~~~~~~~~~gt 219 (390)
T 2zmd_A 208 TTSVVKDSQVGA 219 (390)
T ss_dssp ------CCSCCC
T ss_pred CccccCCCCCcC
Confidence 433222234444
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-25 Score=222.77 Aligned_cols=160 Identities=29% Similarity=0.403 Sum_probs=136.1
Q ss_pred HHHHHcCCCCcccccccCCcccEEEEEe------cCCcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEE
Q 008634 385 LALEATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCC 456 (558)
Q Consensus 385 ~~~~~t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 456 (558)
......++|...++||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3334567899999999999999999984 3468899999976543 3356789999999999 799999999999
Q ss_pred EeCC-EEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 008634 457 LEGQ-ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 522 (558)
Q Consensus 457 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~ 522 (558)
...+ ..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccc
Confidence 8754 58999999999999999975432 123889999999999999999999985 999999999
Q ss_pred CEEEcCCCcEEEEecCcceeeCCCC
Q 008634 523 NILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 523 NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|||++.++.+||+|||+++.+..+.
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCT
T ss_pred eEEECCCCCEEECCCccccccccCc
Confidence 9999999999999999999875543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=231.05 Aligned_cols=150 Identities=27% Similarity=0.478 Sum_probs=131.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (558)
.++|...++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.+++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467899999999999999999965 5889999999754 233457889999999999999999999999776 57
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++||||++ |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999999987 599999854 345999999999999999999999985 9999999999999999999999999999
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.....
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=223.95 Aligned_cols=149 Identities=28% Similarity=0.462 Sum_probs=121.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.+.|...++||+|+||.||+++.. +++.||||++.... ..+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467888999999999999999976 57899999997543 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla~~~~~ 545 (558)
+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999954 345899999999999999999999985 999999999999975 88999999999997754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 204 ~ 204 (349)
T 2w4o_A 204 Q 204 (349)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=216.78 Aligned_cols=151 Identities=23% Similarity=0.381 Sum_probs=123.5
Q ss_pred cCCCCcccccccCCcccEEEEEecC----CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.++|...+.||+|+||.||+|.... +..|++|++..... ...+.+.+|+.++.+++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3567888999999999999998643 45799999876433 34567999999999999999999999974 567899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999643 345899999999999999999999985 9999999999999999999999999999875
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
..
T Consensus 168 ~~ 169 (281)
T 1mp8_A 168 DS 169 (281)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=220.46 Aligned_cols=152 Identities=33% Similarity=0.597 Sum_probs=134.6
Q ss_pred CCCCcccccccCCcccEEEEEe-----cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC--EEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~ 463 (558)
++|...++||+|+||.||+++. .+++.||||++........+.+.+|++++.+++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577889999999999999984 368899999998776666788999999999999999999999987654 689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 121 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999653 245899999999999999999999985 999999999999999999999999999988
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
..+.
T Consensus 196 ~~~~ 199 (326)
T 2w1i_A 196 PQDK 199 (326)
T ss_dssp CSSC
T ss_pred cccc
Confidence 6543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=222.40 Aligned_cols=162 Identities=27% Similarity=0.329 Sum_probs=138.1
Q ss_pred cccChHHHHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-----CCCeeee
Q 008634 379 PLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----HKNLVRL 452 (558)
Q Consensus 379 ~~~~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l 452 (558)
..+++.......++|...++||+|+||.||+++.. +++.||||++... ....+.+..|+.++.+++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 33444444455688999999999999999999974 6889999998743 233456788999999986 9999999
Q ss_pred eEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC----
Q 008634 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---- 528 (558)
Q Consensus 453 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---- 528 (558)
++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 999999996533 345899999999999999999999985 999999999999975
Q ss_pred ---------------------CCcEEEEecCcceeeCCC
Q 008634 529 ---------------------DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 529 ---------------------~~~~ki~DFGla~~~~~~ 546 (558)
++.+||+|||+++.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~ 215 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY 215 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC
Confidence 789999999999976543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-25 Score=240.51 Aligned_cols=150 Identities=33% Similarity=0.521 Sum_probs=133.3
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.++|...++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|.+++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45678889999999999999999888889999998654 335789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++|+|.++|.+. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999642 1235899999999999999999999985 99999999999999999999999999997753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=218.73 Aligned_cols=152 Identities=29% Similarity=0.411 Sum_probs=133.3
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 464 (558)
.++|...++||+|+||.||+++. .+++.||||++........+.+.+|+.++.+++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45788999999999999999997 4689999999977666667889999999999999999999999973 347899
Q ss_pred EEEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
|+||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999986532 3456999999999999999999999985 999999999999999999999999998865
Q ss_pred C
Q 008634 544 G 544 (558)
Q Consensus 544 ~ 544 (558)
.
T Consensus 185 ~ 185 (317)
T 2buj_A 185 C 185 (317)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=215.63 Aligned_cols=150 Identities=37% Similarity=0.577 Sum_probs=132.5
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...+.||+|+||.||+|...++..|+||++.... ...+.+.+|++++.+++||||+++++++. .+..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4677889999999999999998888899999997543 34578999999999999999999999976 456899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999998532 1225899999999999999999999985 999999999999999999999999999987644
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=216.80 Aligned_cols=153 Identities=30% Similarity=0.528 Sum_probs=136.7
Q ss_pred cCCCCcccccccCCcccEEEEEecC-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||++.... +..|++|.+.... ...+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4567888999999999999999764 8899999987543 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+++++|.+++.+. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....+.
T Consensus 91 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999653 3356899999999999999999999985 9999999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-24 Score=211.96 Aligned_cols=152 Identities=26% Similarity=0.425 Sum_probs=134.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.++|...++||+|+||.||++... +++.|++|++.... ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 58899999987543 334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc---EEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DFGla~~~ 543 (558)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999888653 35899999999999999999999985 999999999999986655 999999999887
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
....
T Consensus 159 ~~~~ 162 (284)
T 3kk8_A 159 NDSE 162 (284)
T ss_dssp CSSC
T ss_pred ccCc
Confidence 6543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-24 Score=216.10 Aligned_cols=148 Identities=34% Similarity=0.557 Sum_probs=131.3
Q ss_pred CCcccccccCCcccEEEEEec-----CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~-----~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (558)
|...++||+|+||.||++.+. +++.||||++.... .+..+.+.+|++++.+++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477889999999999998643 57899999998653 34467799999999999999999999999984 67899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.+. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999542 3899999999999999999999985 9999999999999999999999999999886
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
...
T Consensus 186 ~~~ 188 (318)
T 3lxp_A 186 EGH 188 (318)
T ss_dssp TTC
T ss_pred ccc
Confidence 543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=214.84 Aligned_cols=151 Identities=29% Similarity=0.463 Sum_probs=132.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...+.||+|+||.||++... ++..||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356888899999999999999865 57799999986542 22356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998653 34899999999999999999999874 99999999999999999999999999876544
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 162 ~ 162 (279)
T 3fdn_A 162 S 162 (279)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-24 Score=214.51 Aligned_cols=151 Identities=26% Similarity=0.405 Sum_probs=129.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC----ccchHHHHHHHHHHhcCCCCCeeeeeEEEE--eCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCL--EGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~ 462 (558)
.++|...+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.++.+++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999975 68899999997542 334678999999999999999999999985 44578
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 66666543 3456999999999999999999999985 99999999999999999999999999998
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
...
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=238.78 Aligned_cols=143 Identities=29% Similarity=0.561 Sum_probs=126.7
Q ss_pred ccccCCcccEEEEEec---CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCC
Q 008634 398 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (558)
Q Consensus 398 ~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 473 (558)
+||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|.+++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999998653 3456789999999999999999999999976 56999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|.+++.+ ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..+
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999954 3456999999999999999999999985 999999999999999999999999999987544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=224.03 Aligned_cols=149 Identities=30% Similarity=0.544 Sum_probs=123.4
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCC--EE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQ--EL 462 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~ 462 (558)
..++|...++||+|+||.||+|... +|+.||||++.+. .....+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3568899999999999999999865 6899999998654 2344567889999999997 999999999998654 78
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||++ |+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 689888854 35899999999999999999999985 99999999999999999999999999998
Q ss_pred eCC
Q 008634 543 FGG 545 (558)
Q Consensus 543 ~~~ 545 (558)
+..
T Consensus 159 ~~~ 161 (388)
T 3oz6_A 159 FVN 161 (388)
T ss_dssp SSS
T ss_pred ccc
Confidence 743
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-24 Score=216.17 Aligned_cols=151 Identities=23% Similarity=0.280 Sum_probs=130.6
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
-++|...++||+|+||.||+++.. +++.|++|++..... ...+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467899999999999999999975 688999999976532 2346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
+||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999653 35899999999999999999999985 99999999999999999999999999987754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 187 ~ 187 (309)
T 2h34_A 187 E 187 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-24 Score=217.30 Aligned_cols=155 Identities=28% Similarity=0.427 Sum_probs=129.5
Q ss_pred HHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcC--CCCCeeeeeEEEEeC---
Q 008634 385 LALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL--QHKNLVRLLGCCLEG--- 459 (558)
Q Consensus 385 ~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~--- 459 (558)
......++|...++||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33344568999999999999999999985 8899999986432 23455566666555 999999999999987
Q ss_pred -CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCCEEEcCCCcEE
Q 008634 460 -QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-----RLKIIHRDLKASNILLDDDMNPK 533 (558)
Q Consensus 460 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlk~~NILl~~~~~~k 533 (558)
...++||||+++|+|.+++.+. .+++..++.++.||+.||.|||+.. +.+|+||||||+|||++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7899999999999999999542 4899999999999999999999871 22599999999999999999999
Q ss_pred EEecCcceeeCCCC
Q 008634 534 ISDFGLARIFGGNQ 547 (558)
Q Consensus 534 i~DFGla~~~~~~~ 547 (558)
|+|||+++.+..+.
T Consensus 183 l~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 183 IADLGLAVKFISDT 196 (337)
T ss_dssp ECCCTTCEECC---
T ss_pred EEeCCCceeecccc
Confidence 99999998875543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=227.77 Aligned_cols=152 Identities=24% Similarity=0.408 Sum_probs=128.3
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--------ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 458 (558)
...++|...++||+|+||.||+|... +++.||||++.+.. ......+.+|+.++.+++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999865 58999999987542 122345889999999999999999999975
Q ss_pred CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC---CcEEEE
Q 008634 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKIS 535 (558)
Q Consensus 459 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~ki~ 535 (558)
.+..++||||+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 5568999999999999988843 345999999999999999999999985 9999999999999754 459999
Q ss_pred ecCcceeeCCC
Q 008634 536 DFGLARIFGGN 546 (558)
Q Consensus 536 DFGla~~~~~~ 546 (558)
|||+++.....
T Consensus 285 DFG~a~~~~~~ 295 (419)
T 3i6u_A 285 DFGHSKILGET 295 (419)
T ss_dssp CSSTTTSCC--
T ss_pred ecccceecCCC
Confidence 99999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=220.68 Aligned_cols=151 Identities=32% Similarity=0.568 Sum_probs=128.1
Q ss_pred CCCCcccccccCCcccEEEEEecC-----CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
+.|...++||+|+||.||+|.... +..||||.+.... ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456777899999999999998653 2369999997553 3345678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999653 346899999999999999999999985 9999999999999999999999999999876
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
.+
T Consensus 199 ~~ 200 (333)
T 1mqb_A 199 DD 200 (333)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=219.08 Aligned_cols=149 Identities=30% Similarity=0.512 Sum_probs=129.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc--chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|+||.||+++.. +|+.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46888899999999999999976 4899999998654332 24568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988743 335899999999999999999999985 99999999999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-24 Score=212.74 Aligned_cols=150 Identities=32% Similarity=0.538 Sum_probs=132.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE---------- 458 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 458 (558)
.++|...+.||+|+||.||+++.. +++.|++|++.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 346888899999999999999976 68999999997543 457789999999999999999999865
Q ss_pred ------CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 459 ------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 459 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
....++||||+++|+|.+++.+.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 345899999999999999996532 346899999999999999999999985 9999999999999999999
Q ss_pred EEEecCcceeeCCCC
Q 008634 533 KISDFGLARIFGGNQ 547 (558)
Q Consensus 533 ki~DFGla~~~~~~~ 547 (558)
||+|||+++....+.
T Consensus 162 kl~Dfg~~~~~~~~~ 176 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG 176 (284)
T ss_dssp EECCCTTCEESSCCS
T ss_pred EECcchhheeccccc
Confidence 999999999876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=211.84 Aligned_cols=150 Identities=21% Similarity=0.347 Sum_probs=132.5
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+..+.++ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788899999999999999996 468999999986543 235688999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc-----EEEEecCccee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISDFGLARI 542 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~-----~ki~DFGla~~ 542 (558)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999653 335899999999999999999999885 999999999999987776 99999999998
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
+....
T Consensus 161 ~~~~~ 165 (298)
T 1csn_A 161 YRDPV 165 (298)
T ss_dssp SBCTT
T ss_pred ccccc
Confidence 86543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-24 Score=220.92 Aligned_cols=156 Identities=26% Similarity=0.443 Sum_probs=137.1
Q ss_pred HHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--------cchHHHHHHHHHHhcC-CCCCeeeeeEE
Q 008634 386 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKL-QHKNLVRLLGC 455 (558)
Q Consensus 386 ~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--------~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 455 (558)
.....++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3444567888999999999999999986 699999999875432 1145678999999999 89999999999
Q ss_pred EEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 008634 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 456 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
+...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999643 35899999999999999999999985 9999999999999999999999
Q ss_pred ecCcceeeCCCC
Q 008634 536 DFGLARIFGGNQ 547 (558)
Q Consensus 536 DFGla~~~~~~~ 547 (558)
|||+++.+..+.
T Consensus 243 DfG~~~~~~~~~ 254 (365)
T 2y7j_A 243 DFGFSCHLEPGE 254 (365)
T ss_dssp CCTTCEECCTTC
T ss_pred ecCcccccCCCc
Confidence 999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=213.35 Aligned_cols=154 Identities=32% Similarity=0.540 Sum_probs=128.1
Q ss_pred HcCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCc-----cchHHHHHHHHHHhcC---CCCCeeeeeEEEEeC
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG-----QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEG 459 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~-----~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~ 459 (558)
..++|...++||+|+||.||+++. .+++.||||++..... .....+.+|+.++.++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 4689999999874321 1234667777777766 499999999999886
Q ss_pred C-----EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEE
Q 008634 460 Q-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (558)
Q Consensus 460 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki 534 (558)
. ..++||||+. |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5899999997 59999986533 334999999999999999999999985 999999999999999999999
Q ss_pred EecCcceeeCCCC
Q 008634 535 SDFGLARIFGGNQ 547 (558)
Q Consensus 535 ~DFGla~~~~~~~ 547 (558)
+|||+++.+....
T Consensus 162 ~Dfg~a~~~~~~~ 174 (308)
T 3g33_A 162 ADFGLARIYSYQM 174 (308)
T ss_dssp CSCSCTTTSTTCC
T ss_pred eeCccccccCCCc
Confidence 9999999775443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=215.83 Aligned_cols=153 Identities=22% Similarity=0.429 Sum_probs=127.0
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||++... +|+.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888999999999999999964 68999999997532 334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999986422 3445899999999999999999999985 99999999999999999999999999987754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 189 ~ 189 (310)
T 2wqm_A 189 K 189 (310)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=219.05 Aligned_cols=152 Identities=32% Similarity=0.560 Sum_probs=126.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCc----EEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
.++|...++||+|+||.||+|+.. +++ +|++|.+... .....+.+.+|+.++.+++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357888999999999999999864 344 4688877644 3445678999999999999999999999998765 88
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|+||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999653 345899999999999999999999985 999999999999999999999999999987
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
....
T Consensus 168 ~~~~ 171 (327)
T 3lzb_A 168 GAEE 171 (327)
T ss_dssp ----
T ss_pred cCcc
Confidence 5443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=6.4e-24 Score=211.80 Aligned_cols=150 Identities=29% Similarity=0.427 Sum_probs=132.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
++|...++||+|+||.||+++.. +++.|++|.+..... ...+.+.+|+.++.+++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 35778899999999999999976 689999999875422 23578999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC----cEEEEecCc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGL 539 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DFGl 539 (558)
+||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999643 35899999999999999999999985 99999999999998877 899999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++.....
T Consensus 159 ~~~~~~~ 165 (283)
T 3bhy_A 159 AHKIEAG 165 (283)
T ss_dssp CEECC--
T ss_pred ceeccCC
Confidence 9987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=219.26 Aligned_cols=150 Identities=31% Similarity=0.444 Sum_probs=125.8
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...++||+|+||.||+++.. ++.|+||++... ...+.|.+|++++.+++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 45778889999999999999984 788999998743 345789999999999999999999998763 4799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc-EEEEecCcceeeCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGG 545 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~-~ki~DFGla~~~~~ 545 (558)
+|+|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||+++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999976544445889999999999999999999943346999999999999998886 79999999987643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=216.20 Aligned_cols=149 Identities=28% Similarity=0.506 Sum_probs=131.9
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
..+.|...+.||+|+||.||+++.. +++.|++|++........+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467888999999999999999976 588999999987766677889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
|+++++|.+++.+. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999998653 245899999999999999999999985 99999999999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=212.77 Aligned_cols=150 Identities=29% Similarity=0.550 Sum_probs=130.5
Q ss_pred CCCccc-ccccCCcccEEEEEec---CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 392 HFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 392 ~f~~~~-~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
+|...+ +||+|+||.||+|... ++..||||++.... ....+.+.+|++++.+++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344444 8999999999999853 57789999998653 34467899999999999999999999999 556799999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++++|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999953 3446899999999999999999999985 999999999999999999999999999988644
Q ss_pred C
Q 008634 547 Q 547 (558)
Q Consensus 547 ~ 547 (558)
.
T Consensus 164 ~ 164 (287)
T 1u59_A 164 D 164 (287)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=211.90 Aligned_cols=151 Identities=27% Similarity=0.481 Sum_probs=135.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.++|...+.||+|+||.||+++.. +|+.|+||.+.... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999976 68999999987542 23456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999653 34899999999999999999999985 99999999999999999999999999987754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
+
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=216.06 Aligned_cols=148 Identities=39% Similarity=0.609 Sum_probs=122.9
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+|+..+ .|+||+++... ....+.|.+|+.++.+++||||++++++. ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4578889999999999999998643 59999987543 34457899999999999999999999965 5567899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999954 3356899999999999999999999985 99999999999999999999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=221.35 Aligned_cols=158 Identities=26% Similarity=0.407 Sum_probs=132.2
Q ss_pred hHHHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCcc-----------chHHHHHHHHHHhcCCCCCeee
Q 008634 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-----------GLQEFKNEVNLIAKLQHKNLVR 451 (558)
Q Consensus 383 ~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~ 451 (558)
..++....++|...++||+|+||.||++...+|+.||||++...... ..+.+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45566778999999999999999999999888999999998654221 1367899999999999999999
Q ss_pred eeEEEEeC-----CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE
Q 008634 452 LLGCCLEG-----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (558)
Q Consensus 452 l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl 526 (558)
+++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99999653 36899999998 688888754 3346999999999999999999999985 9999999999999
Q ss_pred cCCCcEEEEecCcceeeCCC
Q 008634 527 DDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 527 ~~~~~~ki~DFGla~~~~~~ 546 (558)
+.++.+||+|||+++....+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~ 187 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD 187 (362)
T ss_dssp CTTCCEEECCTTC-------
T ss_pred cCCCCEEEEecCcccccccc
Confidence 99999999999999865443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=222.32 Aligned_cols=152 Identities=23% Similarity=0.297 Sum_probs=127.1
Q ss_pred HcCCCCcccccccCCcccEEEEEecC------CcEEEEEEccccCccc-----------hHHHHHHHHHHhcCCCCCeee
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQG-----------LQEFKNEVNLIAKLQHKNLVR 451 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~------g~~VaVK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~ 451 (558)
..++|...++||+|+||.||+|...+ ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35678999999999999999998754 4789999987654211 123455667788889999999
Q ss_pred eeEEEEeC----CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 452 LLGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 452 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
+++++... ...++||||+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4589999999 99999999653 346999999999999999999999985 99999999999999
Q ss_pred --CCCcEEEEecCcceeeCCC
Q 008634 528 --DDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 528 --~~~~~ki~DFGla~~~~~~ 546 (558)
.++.+||+|||+++.+..+
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=220.79 Aligned_cols=148 Identities=23% Similarity=0.429 Sum_probs=128.6
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...+.||+|+||.||++... +++.||||++.+... .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456888899999999999999975 588999999976543 245788888887 79999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC----CcEEEEecCcceee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKISDFGLARIF 543 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~----~~~ki~DFGla~~~ 543 (558)
|+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++.+
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999864 345899999999999999999999985 9999999999998543 35999999999987
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
....
T Consensus 171 ~~~~ 174 (342)
T 2qr7_A 171 RAEN 174 (342)
T ss_dssp BCTT
T ss_pred cCCC
Confidence 6543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=216.09 Aligned_cols=157 Identities=26% Similarity=0.388 Sum_probs=136.2
Q ss_pred ccChHHHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhc--CCCCCeeeeeEEEE
Q 008634 380 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCL 457 (558)
Q Consensus 380 ~~~~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~ 457 (558)
..+........++|...+.||+|+||.||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344444555667899999999999999999998 5899999998644 34567888888887 79999999999998
Q ss_pred eCC----EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCEE
Q 008634 458 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--------EDSRLKIIHRDLKASNIL 525 (558)
Q Consensus 458 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ivHrDlk~~NIL 525 (558)
..+ ..++||||+++|+|.+++.+ ..+++..++.++.||+.||.||| +. +|+||||||+|||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 876 79999999999999999964 24899999999999999999999 55 5999999999999
Q ss_pred EcCCCcEEEEecCcceeeCCCC
Q 008634 526 LDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 526 l~~~~~~ki~DFGla~~~~~~~ 547 (558)
++.++.+||+|||+++......
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSAT 201 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTT
T ss_pred ECCCCCEEEEECCCceeccccc
Confidence 9999999999999999876544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=219.68 Aligned_cols=153 Identities=32% Similarity=0.472 Sum_probs=130.2
Q ss_pred cCCCCcccccccCCcccEEEEEe------cCCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
.++|...+.||+|+||.||+|+. .++..||||++.... ......+.+|+.++.+++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45788899999999999999984 246789999997543 34456789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEE
Q 008634 463 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKIS 535 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~ 535 (558)
++||||+++|+|.+++.+... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245899999999999999999999985 999999999999984 4569999
Q ss_pred ecCcceeeCC
Q 008634 536 DFGLARIFGG 545 (558)
Q Consensus 536 DFGla~~~~~ 545 (558)
|||+++....
T Consensus 186 Dfg~~~~~~~ 195 (327)
T 2yfx_A 186 DFGMARDIYR 195 (327)
T ss_dssp CCHHHHHHHC
T ss_pred cccccccccc
Confidence 9999986543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-23 Score=213.01 Aligned_cols=151 Identities=29% Similarity=0.496 Sum_probs=130.3
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
..++|...+.||+|+||.||+|... +|+.|++|.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888999999999999999976 58999999987543 35678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998532 345899999999999999999999985 999999999999999999999999999887644
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=211.69 Aligned_cols=152 Identities=30% Similarity=0.427 Sum_probs=134.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---------cchHHHHHHHHHHhcCC-CCCeeeeeEEEEe
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---------QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLE 458 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---------~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 458 (558)
.++|...++||+|+||.||++... +|+.||||++..... ...+.+.+|+.++.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 588999999875431 22456889999999995 9999999999999
Q ss_pred CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 459 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
++..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999653 35899999999999999999999985 9999999999999999999999999
Q ss_pred cceeeCCCC
Q 008634 539 LARIFGGNQ 547 (558)
Q Consensus 539 la~~~~~~~ 547 (558)
+++.+..+.
T Consensus 170 ~~~~~~~~~ 178 (298)
T 1phk_A 170 FSCQLDPGE 178 (298)
T ss_dssp TCEECCTTC
T ss_pred chhhcCCCc
Confidence 999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=228.49 Aligned_cols=152 Identities=29% Similarity=0.482 Sum_probs=132.1
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-------------cchHHHHHHHHHHhcCCCCCeeeeeEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------------QGLQEFKNEVNLIAKLQHKNLVRLLGC 455 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 455 (558)
.+.|...++||+|+||.||+++.. +++.||||++.+... ...+.+.+|+.++.+++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999975 578999999875421 235678999999999999999999999
Q ss_pred EEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC---cE
Q 008634 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NP 532 (558)
Q Consensus 456 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~ 532 (558)
+.+++..++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999998653 35899999999999999999999985 99999999999998775 69
Q ss_pred EEEecCcceeeCCCC
Q 008634 533 KISDFGLARIFGGNQ 547 (558)
Q Consensus 533 ki~DFGla~~~~~~~ 547 (558)
||+|||+++.+..+.
T Consensus 189 kl~Dfg~a~~~~~~~ 203 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY 203 (504)
T ss_dssp EECCCTTCEECCTTS
T ss_pred EEEECCCCEEcCCCC
Confidence 999999999886553
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=220.81 Aligned_cols=152 Identities=28% Similarity=0.432 Sum_probs=134.8
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccc-----------------hHHHHHHHHHHhcCCCCCeeee
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-----------------LQEFKNEVNLIAKLQHKNLVRL 452 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~-----------------~~~~~~Ei~~l~~l~H~niv~l 452 (558)
.++|...+.||+|+||.||+++. +++.||||.+....... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788999999999999999999 89999999987542211 1789999999999999999999
Q ss_pred eEEEEeCCEEEEEEEcCCCCCHHHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEE
Q 008634 453 LGCCLEGQELLLIYEYMPNKSLDVH------LFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNIL 525 (558)
Q Consensus 453 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlk~~NIL 525 (558)
++++.+.+..++||||+++|+|.++ +.+ .....+++..+..++.||+.||.|||+ . +|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999988 532 224569999999999999999999998 6 4999999999999
Q ss_pred EcCCCcEEEEecCcceeeCCC
Q 008634 526 LDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 526 l~~~~~~ki~DFGla~~~~~~ 546 (558)
++.++.+||+|||+++.....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999987543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=6.7e-24 Score=212.04 Aligned_cols=149 Identities=26% Similarity=0.456 Sum_probs=133.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++.. ++..|++|++.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999976 57889999986542 223467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999653 35899999999999999999999885 99999999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9e-24 Score=211.31 Aligned_cols=151 Identities=34% Similarity=0.608 Sum_probs=130.1
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccc-------hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG-------LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
.++|...++||+|+||.||+++.. +++.||+|++....... .+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999974 68999999987543321 267899999999999999999999987665
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc-----EEEEe
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISD 536 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~-----~ki~D 536 (558)
++||||+++|+|.+++.+ ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999988864 3346999999999999999999999873 23999999999999988776 99999
Q ss_pred cCcceeeCC
Q 008634 537 FGLARIFGG 545 (558)
Q Consensus 537 FGla~~~~~ 545 (558)
||+++....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=217.19 Aligned_cols=154 Identities=25% Similarity=0.419 Sum_probs=120.8
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
..++|...+.||+|+||.||++... +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999864 68899999987543 334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 467 EYMPNKSLDVHLFDA-----TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998641 13456899999999999999999999985 9999999999999999999999999998
Q ss_pred eeCC
Q 008634 542 IFGG 545 (558)
Q Consensus 542 ~~~~ 545 (558)
.+..
T Consensus 170 ~~~~ 173 (303)
T 2vwi_A 170 FLAT 173 (303)
T ss_dssp HCC-
T ss_pred eecc
Confidence 7653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=220.12 Aligned_cols=149 Identities=30% Similarity=0.496 Sum_probs=128.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|...++||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999976 6899999999754322 223566899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++ |+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 98 5888888653 345899999999999999999999985 99999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=220.81 Aligned_cols=152 Identities=30% Similarity=0.509 Sum_probs=127.0
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc-----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (558)
..++|...+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3567999999999999999999975 5899999999754221 134688999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++||||+++ +|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 88888854 3346889999999999999999999985 99999999999999999999999999998
Q ss_pred eCCC
Q 008634 543 FGGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
+...
T Consensus 162 ~~~~ 165 (346)
T 1ua2_A 162 FGSP 165 (346)
T ss_dssp TTSC
T ss_pred ccCC
Confidence 7543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=215.35 Aligned_cols=148 Identities=34% Similarity=0.483 Sum_probs=128.6
Q ss_pred CCcccccccCCcccEEEEEecC----CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE-EEEE
Q 008634 393 FSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL-LLIY 466 (558)
Q Consensus 393 f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV~ 466 (558)
|...++||+|+||.||+|+..+ +..|++|++..... ...+.+.+|+.++.+++||||+++++++.+.+.. ++|+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4556889999999999998532 23799999876443 4467899999999999999999999999877655 9999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||+.+|+|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 103 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999965 3356899999999999999999999985 99999999999999999999999999986643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=216.64 Aligned_cols=149 Identities=28% Similarity=0.536 Sum_probs=129.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--------
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-------- 459 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 459 (558)
++|...++||+|+||.||+++.. +|+.||||++..... .....+.+|+.++.+++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 46888899999999999999974 689999999865432 2356788999999999999999999999873
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
+..++||||+++ +|...+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 676666442 345999999999999999999999985 99999999999999999999999999
Q ss_pred ceeeCC
Q 008634 540 ARIFGG 545 (558)
Q Consensus 540 a~~~~~ 545 (558)
++.+..
T Consensus 171 a~~~~~ 176 (351)
T 3mi9_A 171 ARAFSL 176 (351)
T ss_dssp CEECCC
T ss_pred cccccc
Confidence 998753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=224.85 Aligned_cols=149 Identities=32% Similarity=0.505 Sum_probs=122.4
Q ss_pred CCCcccccccCCcccEEEEEec--CC--cEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA--DG--KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLI 465 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~--~g--~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV 465 (558)
.|...++||+|+||.||+|+.. ++ ..||||.+.... ....+.|.+|+.++.+++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999864 22 468999987543 3456789999999999999999999999765 4578999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999964 3345899999999999999999999985 99999999999999999999999999997643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=219.67 Aligned_cols=151 Identities=30% Similarity=0.499 Sum_probs=127.0
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
..++|...++||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467899999999999999999864 689999999975432 2245678999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE-----cCCCcEEEEecCcc
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-----DDDMNPKISDFGLA 540 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl-----~~~~~~ki~DFGla 540 (558)
|||++ |+|.+++.+. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99998 5999998653 34899999999999999999999985 9999999999999 45566999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.+...
T Consensus 185 ~~~~~~ 190 (329)
T 3gbz_A 185 RAFGIP 190 (329)
T ss_dssp HHHC--
T ss_pred cccCCc
Confidence 877533
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-24 Score=214.93 Aligned_cols=151 Identities=32% Similarity=0.492 Sum_probs=129.9
Q ss_pred CCCCcccccccCCcccEEEEEecC----CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEe-CCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 464 (558)
..|...++||+|+||.||+|+..+ +..+++|.+..... ...+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357778899999999999998643 23689999876433 345779999999999999999999999754 467899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++|+|.+++.+ ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999964 3345899999999999999999999985 9999999999999999999999999998775
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
..
T Consensus 180 ~~ 181 (298)
T 3f66_A 180 DK 181 (298)
T ss_dssp CG
T ss_pred cc
Confidence 43
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-24 Score=214.37 Aligned_cols=148 Identities=30% Similarity=0.508 Sum_probs=125.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEE-----------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL----------- 457 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----------- 457 (558)
.++|...++||+|+||.||+|... +++.||+|++...+....+.+.+|++++.+++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357888999999999999999976 48999999998776666788999999999999999999999873
Q ss_pred ---eCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEE
Q 008634 458 ---EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPK 533 (558)
Q Consensus 458 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~k 533 (558)
+.+..++||||++ |+|.+++.+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3468899999998 699999843 45899999999999999999999985 99999999999997 577999
Q ss_pred EEecCcceeeCC
Q 008634 534 ISDFGLARIFGG 545 (558)
Q Consensus 534 i~DFGla~~~~~ 545 (558)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999998753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=227.50 Aligned_cols=151 Identities=28% Similarity=0.459 Sum_probs=129.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
+.|...++||+|+||.||+++.. ++..||+|++.+.. ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45888899999999999999976 68899999987653 3346788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla~~~~ 544 (558)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+.
T Consensus 117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999888653 35899999999999999999999985 999999999999976 4559999999999886
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
...
T Consensus 191 ~~~ 193 (494)
T 3lij_A 191 NQK 193 (494)
T ss_dssp TTB
T ss_pred CCc
Confidence 543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-24 Score=216.63 Aligned_cols=150 Identities=35% Similarity=0.576 Sum_probs=129.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcE--EEEEEcccc-CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKA--IAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~--VaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...+.||+|+||.||+++.. ++.. |++|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46888999999999999999865 4554 499988754 334456789999999999 999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 466 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
|||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999985 9999999999999999999
Q ss_pred EEEecCcceee
Q 008634 533 KISDFGLARIF 543 (558)
Q Consensus 533 ki~DFGla~~~ 543 (558)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=228.26 Aligned_cols=148 Identities=33% Similarity=0.477 Sum_probs=124.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 460 (558)
.++|...++||+|+||.||++... +++.||||++.+. .....+.+.+|+.++..++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467899999999999999999865 5899999999754 334467789999999999999999999999654 4
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 679999999875 555552 23899999999999999999999985 999999999999999999999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.....
T Consensus 212 ~~~~~~ 217 (464)
T 3ttj_A 212 RTAGTS 217 (464)
T ss_dssp -----C
T ss_pred eecCCC
Confidence 987644
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-25 Score=228.68 Aligned_cols=151 Identities=18% Similarity=0.205 Sum_probs=125.4
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEcccc---CccchHHHHHHH---HHHhcCCCCCeeeee-------EE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEV---NLIAKLQHKNLVRLL-------GC 455 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 455 (558)
.++|...++||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45678889999999999999996 46899999999743 334467889999 566666899999998 66
Q ss_pred EEeCC-----------------EEEEEEEcCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 008634 456 CLEGQ-----------------ELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKI 514 (558)
Q Consensus 456 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 514 (558)
+.+++ ..++||||+ +|+|.+++.+... ...++|..++.|+.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 289999999 6899999975321 123557889999999999999999985 9
Q ss_pred eeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 515 IHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 515 vHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+||||||+|||++.++.+||+|||+++...
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999999643
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=211.81 Aligned_cols=150 Identities=28% Similarity=0.533 Sum_probs=130.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|+||.||+++.. +|+.|+||++.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57888899999999999999976 68999999987543 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 69999986532 345899999999999999999999985 99999999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=222.70 Aligned_cols=146 Identities=25% Similarity=0.342 Sum_probs=123.2
Q ss_pred CCCcc-cccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHh-cCCCCCeeeeeEEEEe----CCEEEE
Q 008634 392 HFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIA-KLQHKNLVRLLGCCLE----GQELLL 464 (558)
Q Consensus 392 ~f~~~-~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~----~~~~~l 464 (558)
+|... ++||+|+||.||++... +++.||||++... ..+.+|++++. ..+||||+++++++.. .+..++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45444 68999999999999875 5889999998642 45778888874 4589999999999876 567899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcce
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLAR 541 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla~ 541 (558)
||||+++|+|.+++.+. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 137 v~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999653 2345999999999999999999999985 999999999999997 7899999999999
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.....
T Consensus 213 ~~~~~ 217 (400)
T 1nxk_A 213 ETTSH 217 (400)
T ss_dssp ECC--
T ss_pred ccCCC
Confidence 77543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=218.52 Aligned_cols=155 Identities=28% Similarity=0.368 Sum_probs=134.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEe--------C
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLE--------G 459 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--------~ 459 (558)
..+|...++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346888899999999999999965 68999999997766666778999999999996 9999999999953 3
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
...++|+||++ |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45899999996 799998876445567999999999999999999999873 2499999999999999999999999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++.+...
T Consensus 185 ~~~~~~~ 191 (337)
T 3ll6_A 185 ATTISHY 191 (337)
T ss_dssp CBCCSSC
T ss_pred ceecccc
Confidence 9987543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=5.9e-24 Score=220.08 Aligned_cols=148 Identities=26% Similarity=0.378 Sum_probs=132.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|...++||+|+||.||++... ++..||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46888899999999999999976 68999999987653 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+++++|.+++.+. ..+++.....++.+|+.||.|||+.. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 113 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 113 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999653 34899999999999999999999851 3999999999999999999999999999765
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-24 Score=214.27 Aligned_cols=149 Identities=26% Similarity=0.429 Sum_probs=130.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|...+.||+|+||.||+++.. +|+.||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46788899999999999999975 68999999998665545567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE---cCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DFGla~~~~~ 545 (558)
++++|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998653 35899999999999999999999985 9999999999999 7889999999999986543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=236.64 Aligned_cols=144 Identities=31% Similarity=0.503 Sum_probs=126.1
Q ss_pred cccccCCcccEEEEEec---CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999998643 2346789999999999999999999999864 568999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+|.+++.+. ..+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..+.
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999643 45899999999999999999999985 9999999999999999999999999999876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.4e-24 Score=212.88 Aligned_cols=149 Identities=34% Similarity=0.533 Sum_probs=131.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE---------- 458 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 458 (558)
.++|...+.||+|+||.||+|+.. +++.|+||++... ....+.+.+|+.++.+++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 346888899999999999999965 6899999998643 3345778999999999999999999999865
Q ss_pred ---CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 008634 459 ---GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 459 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
.+..++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 35789999999999999999652 345788999999999999999999985 9999999999999999999999
Q ss_pred ecCcceeeC
Q 008634 536 DFGLARIFG 544 (558)
Q Consensus 536 DFGla~~~~ 544 (558)
|||+++...
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=218.73 Aligned_cols=150 Identities=20% Similarity=0.264 Sum_probs=124.0
Q ss_pred cCCCCcccccccCCcccEEEEEec----CCcEEEEEEccccCcc-----------chHHHHHHHHHHhcCCCCCeeeeeE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQ-----------GLQEFKNEVNLIAKLQHKNLVRLLG 454 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g 454 (558)
.++|...++||+|+||.||+|... ++..|+||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999975 5678999998765322 1234678889999999999999999
Q ss_pred EEEe----CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC
Q 008634 455 CCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (558)
Q Consensus 455 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~ 530 (558)
++.. ....++||||+ +++|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 77899999999 999999986433 6999999999999999999999985 99999999999999887
Q ss_pred --cEEEEecCcceeeCCC
Q 008634 531 --NPKISDFGLARIFGGN 546 (558)
Q Consensus 531 --~~ki~DFGla~~~~~~ 546 (558)
.+||+|||+++.+..+
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-24 Score=228.38 Aligned_cols=152 Identities=30% Similarity=0.479 Sum_probs=133.9
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.++|...++||+|+||.||+++.. +++.||||++.+. .......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 346888999999999999999975 6899999998643 2344678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc---CCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DFGla~~~ 543 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999988653 35899999999999999999999985 99999999999995 5567999999999977
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
..+.
T Consensus 175 ~~~~ 178 (486)
T 3mwu_A 175 QQNT 178 (486)
T ss_dssp CCC-
T ss_pred CCCC
Confidence 6543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=215.53 Aligned_cols=149 Identities=36% Similarity=0.589 Sum_probs=123.3
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHH--HhcCCCCCeeeeeEEEEe-----CCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL--IAKLQHKNLVRLLGCCLE-----GQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~-----~~~~ 462 (558)
.++|...++||+|+||.||+|+. +++.||||++.... .+.+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788899999999999999987 68899999987543 2344555554 445899999999987653 2367
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCCEEEcCCCcEEEEe
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS------RLKIIHRDLKASNILLDDDMNPKISD 536 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~ivHrDlk~~NILl~~~~~~ki~D 536 (558)
++||||+++|+|.+++... ..+|..+..++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 8999999999999999543 2589999999999999999999871 11499999999999999999999999
Q ss_pred cCcceeeCCC
Q 008634 537 FGLARIFGGN 546 (558)
Q Consensus 537 FGla~~~~~~ 546 (558)
||+++.+..+
T Consensus 164 FG~a~~~~~~ 173 (336)
T 3g2f_A 164 FGLSMRLTGN 173 (336)
T ss_dssp CTTCEECSSS
T ss_pred ccceeecccc
Confidence 9999987643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=211.22 Aligned_cols=150 Identities=31% Similarity=0.506 Sum_probs=129.4
Q ss_pred CCCCccc-ccccCCcccEEEEEec---CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|...+ .||+|+||.||+|... +++.|+||++.... ....+++.+|+.++.+++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 8999999999999642 46789999997653 23357899999999999999999999999 6677899
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999653 35899999999999999999999985 9999999999999999999999999999876
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
.+.
T Consensus 169 ~~~ 171 (291)
T 1xbb_A 169 ADE 171 (291)
T ss_dssp TTC
T ss_pred cCC
Confidence 543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=209.79 Aligned_cols=152 Identities=30% Similarity=0.425 Sum_probs=130.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 463 (558)
+.|...++||+|+||.||+|... ++..|++|++... .....+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34667788999999999999875 5789999998754 33446779999999999999999999999876 35689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEEEEecCccee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 542 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DFGla~~ 542 (558)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999653 35899999999999999999999873 2499999999999998 789999999999986
Q ss_pred eCCC
Q 008634 543 FGGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
....
T Consensus 182 ~~~~ 185 (290)
T 1t4h_A 182 KRAS 185 (290)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=235.84 Aligned_cols=141 Identities=17% Similarity=0.211 Sum_probs=110.7
Q ss_pred cccCCcccEEEEE-ecCCcEEEEEEccccC----------ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEE
Q 008634 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS----------GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 399 LG~G~fG~Vyk~~-~~~g~~VaVK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.+.|++|.+..++ .--|+.+++|.+.+.. ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566666666544 2247889999986542 12356799999999999 7999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||++|++|.+.|.+. ..++.. +|+.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+....+
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999643 346654 58999999999999986 999999999999999999999999999988765
Q ss_pred CC
Q 008634 547 QN 548 (558)
Q Consensus 547 ~~ 548 (558)
.+
T Consensus 393 ~~ 394 (569)
T 4azs_A 393 CS 394 (569)
T ss_dssp -C
T ss_pred Cc
Confidence 44
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-24 Score=217.14 Aligned_cols=154 Identities=28% Similarity=0.498 Sum_probs=133.2
Q ss_pred HHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEe------
Q 008634 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE------ 458 (558)
Q Consensus 387 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~------ 458 (558)
....++|...+.||+|+||.||+|+.. +++.|+||++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 345678999999999999999999974 68999999987543 3357889999999999 89999999999987
Q ss_pred CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 459 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
.+..++||||+++|+|.+++... ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 46899999999999999999653 2346899999999999999999999985 9999999999999999999999999
Q ss_pred cceeeCC
Q 008634 539 LARIFGG 545 (558)
Q Consensus 539 la~~~~~ 545 (558)
+++.+..
T Consensus 175 ~~~~~~~ 181 (326)
T 2x7f_A 175 VSAQLDR 181 (326)
T ss_dssp TTC----
T ss_pred CceecCc
Confidence 9987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=212.67 Aligned_cols=145 Identities=22% Similarity=0.413 Sum_probs=129.4
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEe--CCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLE--GQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 466 (558)
++|...++||+|+||.||+++. .+++.||||++... ..+.+.+|+.++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688889999999999999986 46899999998743 3467899999999997 9999999999998 56789999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~~~ 545 (558)
||+++++|.+++. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+..
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999884 2889999999999999999999985 99999999999999776 899999999998765
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
+.
T Consensus 184 ~~ 185 (330)
T 3nsz_A 184 GQ 185 (330)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-24 Score=209.56 Aligned_cols=151 Identities=25% Similarity=0.391 Sum_probs=132.4
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--CEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 466 (558)
++|...++||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46788899999999999999985 8899999997653 33456799999999999999999999999887 7889999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||+++|+|.+++.+. ....+++..++.++.||+.||.|||+.+ .+++||||||+|||++.++.+||.|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999653 2335899999999999999999999863 349999999999999999999999999876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=214.46 Aligned_cols=150 Identities=25% Similarity=0.400 Sum_probs=127.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (558)
.++|...+.||+|+||.||++... +++.||||.+..... .....+.+|++++.+++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 346888999999999999999875 588999999875421 22346889999999999999999999987655
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc---EEEEec
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDF 537 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DF 537 (558)
.++||||+++++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999999853 346899999999999999999999985 999999999999987654 999999
Q ss_pred CcceeeCCC
Q 008634 538 GLARIFGGN 546 (558)
Q Consensus 538 Gla~~~~~~ 546 (558)
|+++.....
T Consensus 162 g~~~~~~~~ 170 (322)
T 2ycf_A 162 GHSKILGET 170 (322)
T ss_dssp TTCEECCCC
T ss_pred ccceecccc
Confidence 999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=219.18 Aligned_cols=149 Identities=28% Similarity=0.488 Sum_probs=125.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (558)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++.+++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999974 68999999996542 233567899999999999999999999997653
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++||||+ +++|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899999864 34899999999999999999999985 999999999999999999999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.....
T Consensus 176 ~~~~~~ 181 (367)
T 1cm8_A 176 RQADSE 181 (367)
T ss_dssp EECCSS
T ss_pred cccccc
Confidence 987543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.2e-24 Score=228.09 Aligned_cols=151 Identities=29% Similarity=0.479 Sum_probs=134.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888899999999999999976 68999999986542 334678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE---cCCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DFGla~~~ 543 (558)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 106 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 106 EVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp CCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999864 345899999999999999999999985 9999999999999 56789999999999987
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
....
T Consensus 180 ~~~~ 183 (484)
T 3nyv_A 180 EASK 183 (484)
T ss_dssp CCCC
T ss_pred cccc
Confidence 6544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=211.31 Aligned_cols=156 Identities=29% Similarity=0.445 Sum_probs=131.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 465 (558)
++|...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.++.+++||||+++++++.+ ++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 56888899999999999999975 68999999997543 3345679999999999999999999998865 5689999
Q ss_pred EEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 466 YEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
|||+++++|.+++.+.. ....+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999999997532 2345899999999999999999999874 12399999999999999999999999999987
Q ss_pred eCCC
Q 008634 543 FGGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
...+
T Consensus 166 ~~~~ 169 (279)
T 2w5a_A 166 LNHD 169 (279)
T ss_dssp C---
T ss_pred eccc
Confidence 7543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=218.32 Aligned_cols=152 Identities=26% Similarity=0.406 Sum_probs=126.1
Q ss_pred HHcCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-------
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------- 459 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 459 (558)
...++|...++||+|+||.||+++. .+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 4689999999865432 234799999999999999999998543
Q ss_pred -------------------------------CEEEEEEEcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 008634 460 -------------------------------QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507 (558)
Q Consensus 460 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH 507 (558)
...++||||++ |+|.+.+.+. .....+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34889999998 5777776532 23456999999999999999999999
Q ss_pred hCCCCCeeeCCCCCCCEEEc-CCCcEEEEecCcceeeCCCC
Q 008634 508 EDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 508 ~~~~~~ivHrDlk~~NILl~-~~~~~ki~DFGla~~~~~~~ 547 (558)
+.+ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 885 99999999999998 68999999999999875443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-23 Score=208.87 Aligned_cols=142 Identities=11% Similarity=-0.004 Sum_probs=126.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+..+.+++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888999999999999999976 489999999986533 23477999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
||+++++|.+++.+ . .......+|+.||+.||.|||+++ |+||||||+|||++.++.+||+++|..
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999942 1 355568889999999999999985 999999999999999999999987754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-24 Score=210.77 Aligned_cols=151 Identities=26% Similarity=0.393 Sum_probs=129.6
Q ss_pred cCCCCcccccccCCcccEEEEEecC----CcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
.++|...+.||+|+||.||+|+..+ +..|++|.+.... ....+.+.+|+.++.+++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4568888999999999999998643 3469999998653 3446789999999999999999999999765 45689
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+++++|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999999653 345899999999999999999999985 9999999999999999999999999998775
Q ss_pred CC
Q 008634 545 GN 546 (558)
Q Consensus 545 ~~ 546 (558)
..
T Consensus 165 ~~ 166 (281)
T 3cc6_A 165 DE 166 (281)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=216.44 Aligned_cols=149 Identities=25% Similarity=0.433 Sum_probs=131.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 462 (558)
.++|...++||+|+||.||++... +++.||||++..... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999865 688999999975433 3357789999999999999999999999765 368
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||++ |+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 589888854 24899999999999999999999985 99999999999999999999999999998
Q ss_pred eCCC
Q 008634 543 FGGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
....
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7644
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=220.48 Aligned_cols=150 Identities=25% Similarity=0.421 Sum_probs=125.9
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE------EEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE------LLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~l 464 (558)
.+|...++||+|+||.||+++..++..|++|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 45888899999999999999988777799998865432 22369999999999999999999976443 889
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEEEEecCcceee
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIF 543 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DFGla~~~ 543 (558)
||||++++.+............+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999998766554433333456999999999999999999999985 99999999999999 7999999999999987
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
..+.
T Consensus 193 ~~~~ 196 (394)
T 4e7w_A 193 IAGE 196 (394)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 5443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=213.05 Aligned_cols=155 Identities=26% Similarity=0.377 Sum_probs=132.1
Q ss_pred HHcCCCCcc-cccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEE
Q 008634 388 EATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 388 ~~t~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (558)
...+.|... ++||+|+||.||++... +++.||+|++.... ......+.+|+.++.++ +||||+++++++.+.+..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 334456665 78999999999999876 58999999987543 23367899999999999 569999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCc
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGL 539 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGl 539 (558)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 9999999999999988542 3356999999999999999999999985 999999999999987 78999999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++.....
T Consensus 181 a~~~~~~ 187 (327)
T 3lm5_A 181 SRKIGHA 187 (327)
T ss_dssp CEEC---
T ss_pred ccccCCc
Confidence 9987544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=236.34 Aligned_cols=148 Identities=20% Similarity=0.343 Sum_probs=128.3
Q ss_pred cCCCCcccccccCCcccEEEEEec--CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE-----
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~--~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 461 (558)
.++|.+.++||+|+||.||+++.. +|+.|+||++.... ......+.+|++++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 58999999987543 3445678999999999999999999999987655
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++||||+++++|.+++.. .++|..++.|+.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999987732 5899999999999999999999985 9999999999999986 89999999999
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.....
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=214.09 Aligned_cols=159 Identities=26% Similarity=0.337 Sum_probs=120.8
Q ss_pred HHHHHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE--
Q 008634 385 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-- 461 (558)
Q Consensus 385 ~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-- 461 (558)
......++|...++||+|+||.||+|+.. +|+.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566789999999999999999999975 68999999986543 233566788889999999999999999976443
Q ss_pred -----EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCCEEEcC-CCcEE
Q 008634 462 -----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--EDSRLKIIHRDLKASNILLDD-DMNPK 533 (558)
Q Consensus 462 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~ivHrDlk~~NILl~~-~~~~k 533 (558)
.++||||++++.+..+.........+++.....++.||+.||.||| +. +|+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEE
Confidence 8899999987544333322234556899999999999999999999 65 5999999999999996 89999
Q ss_pred EEecCcceeeCCCC
Q 008634 534 ISDFGLARIFGGNQ 547 (558)
Q Consensus 534 i~DFGla~~~~~~~ 547 (558)
|+|||+++.+....
T Consensus 173 l~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE 186 (360)
T ss_dssp ECCCTTCBCCCTTS
T ss_pred EeeCCCceecCCCC
Confidence 99999999876544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=207.86 Aligned_cols=147 Identities=26% Similarity=0.365 Sum_probs=127.1
Q ss_pred CCCCcc-cccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHH-hcCCCCCeeeeeEEEEe----CCEEE
Q 008634 391 NHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLI-AKLQHKNLVRLLGCCLE----GQELL 463 (558)
Q Consensus 391 ~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~ 463 (558)
++|... +.||+|+||.||++... +++.||+|++... ..+.+|+.++ ...+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345555 67999999999999874 6899999998643 4677888887 56699999999999987 67789
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA 540 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla 540 (558)
+||||+++|+|.+++.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999997632 346999999999999999999999985 999999999999998 789999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+...+.
T Consensus 168 ~~~~~~ 173 (299)
T 3m2w_A 168 KETTGE 173 (299)
T ss_dssp EECTTC
T ss_pred cccccc
Confidence 987653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=209.64 Aligned_cols=151 Identities=34% Similarity=0.491 Sum_probs=124.0
Q ss_pred CCCCcccccccCCcccEEEEEec--CCc--EEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA--DGK--AIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~--~g~--~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
++|...++||+|+||.||+|+.. ++. .|+||++... .....+.+.+|+.++.+++||||+++++++.++. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888899999999999999853 233 6899988754 2344678999999999999999999999998765 88
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+|+||+++++|.+++.+. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999999653 245899999999999999999999985 999999999999999999999999999988
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
..+.
T Consensus 172 ~~~~ 175 (291)
T 1u46_A 172 PQND 175 (291)
T ss_dssp CC-C
T ss_pred cccc
Confidence 6543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=218.65 Aligned_cols=148 Identities=31% Similarity=0.475 Sum_probs=115.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------C
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 460 (558)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++.+++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 467889999999999999999854 68999999997542 23456788999999999999999999998754 5
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999998 7899888843 45999999999999999999999985 999999999999999999999999999
Q ss_pred eeeCC
Q 008634 541 RIFGG 545 (558)
Q Consensus 541 ~~~~~ 545 (558)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 97654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.2e-24 Score=210.76 Aligned_cols=149 Identities=31% Similarity=0.476 Sum_probs=124.7
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-CEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 469 (558)
++|...+.||+|+||.||++... |+.|+||.+.... ..+.+.+|+.++.+++||||+++++++.+. +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 56888899999999999999874 8899999997543 457799999999999999999999997655 4789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
++++|.+++.+.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 9999999996432 223789999999999999999999985 999999999999999999999999999876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=213.13 Aligned_cols=149 Identities=28% Similarity=0.454 Sum_probs=130.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 462 (558)
.++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999975 689999999975433 3356788999999999999999999998764 678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
++|+||++ |+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689988854 35899999999999999999999985 99999999999999999999999999998
Q ss_pred eCCC
Q 008634 543 FGGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
+...
T Consensus 162 ~~~~ 165 (353)
T 2b9h_A 162 IDES 165 (353)
T ss_dssp CC--
T ss_pred cccc
Confidence 7543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=209.85 Aligned_cols=154 Identities=23% Similarity=0.327 Sum_probs=120.7
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cc-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.++|...++||+|+||.||+++.. +|+.||||++..... .. .+.+..+...+..++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 356888899999999999999964 689999999976532 22 233455556688889999999999999999999999
Q ss_pred EcCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||++ |+|.+++... .....+++..+..++.||+.||.|||++. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9998 5887777542 23456999999999999999999999861 399999999999999999999999999987754
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
+
T Consensus 163 ~ 163 (290)
T 3fme_A 163 D 163 (290)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=220.21 Aligned_cols=147 Identities=29% Similarity=0.470 Sum_probs=121.3
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC----C--EEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG----Q--ELLL 464 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~--~~~l 464 (558)
.|...++||+|+||.||+|+.. +|+.||||++.... ..+.+|++++.+++|||||++++++... + ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5778899999999999999975 58999999986542 2234799999999999999999998652 2 3679
Q ss_pred EEEcCCCCCHHHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-CcEEEEecCccee
Q 008634 465 IYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARI 542 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DFGla~~ 542 (558)
||||+++ +|...+.. ......+++..+..++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 45544432 123456999999999999999999999885 9999999999999955 6789999999998
Q ss_pred eCCC
Q 008634 543 FGGN 546 (558)
Q Consensus 543 ~~~~ 546 (558)
+..+
T Consensus 207 ~~~~ 210 (420)
T 1j1b_A 207 LVRG 210 (420)
T ss_dssp CCTT
T ss_pred cccC
Confidence 7544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=206.08 Aligned_cols=153 Identities=29% Similarity=0.466 Sum_probs=134.6
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
..++|...++||+|+||.||+++.. +++.|++|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3457888999999999999999976 68999999986543 34467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC---CcEEEEecCccee
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARI 542 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~---~~~ki~DFGla~~ 542 (558)
+||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999988653 35899999999999999999999985 9999999999999754 4799999999987
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
...+.
T Consensus 174 ~~~~~ 178 (287)
T 2wei_A 174 FQQNT 178 (287)
T ss_dssp BCCCS
T ss_pred ecCCC
Confidence 76543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9e-23 Score=204.52 Aligned_cols=152 Identities=26% Similarity=0.401 Sum_probs=126.2
Q ss_pred HHcCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEE-EeCCEEEEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLI 465 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV 465 (558)
...++|...+.||+|+||.||+++. .+++.||||++..... .+.+.+|++++.+++|++++..++.+ ..++..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999996 4688999998664432 24688999999999988877766665 667888999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE---cCCCcEEEEecCccee
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARI 542 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DFGla~~ 542 (558)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 99999998643 335999999999999999999999985 9999999999999 7899999999999998
Q ss_pred eCCCC
Q 008634 543 FGGNQ 547 (558)
Q Consensus 543 ~~~~~ 547 (558)
+....
T Consensus 158 ~~~~~ 162 (296)
T 4hgt_A 158 YRDAR 162 (296)
T ss_dssp CBCTT
T ss_pred ccCcc
Confidence 76543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-23 Score=215.98 Aligned_cols=145 Identities=32% Similarity=0.512 Sum_probs=113.8
Q ss_pred ccccccCCcccEEEEEec---CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCEEEEEEEcCC
Q 008634 396 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 470 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 470 (558)
+++||+|+||.||+|+.. +++.||||++..... ...+.+|+.++.+++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 458999999999999965 478999999975432 3578899999999999999999999965 678999999997
Q ss_pred CCCHHHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE----cCCCcEEEEecCcc
Q 008634 471 NKSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLA 540 (558)
Q Consensus 471 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DFGla 540 (558)
+ +|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4 777766421 12235999999999999999999999985 9999999999999 77889999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.+...
T Consensus 180 ~~~~~~ 185 (405)
T 3rgf_A 180 RLFNSP 185 (405)
T ss_dssp C-----
T ss_pred eecCCC
Confidence 987543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=217.34 Aligned_cols=147 Identities=16% Similarity=0.247 Sum_probs=128.1
Q ss_pred cCCCCcccccccCCcccEEEEEecC---------CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeee---------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR--------- 451 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~---------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~--------- 451 (558)
.++|...+.||+|+||.||+|+... ++.||||.+... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678899999999999999999763 789999998754 46889999999999999987
Q ss_pred ------eeEEEEe-CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 008634 452 ------LLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (558)
Q Consensus 452 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NI 524 (558)
+++++.. ++..++||||+ +++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6788877 67899999999 99999999753 2356999999999999999999999985 99999999999
Q ss_pred EEcCCC--cEEEEecCcceeeCCC
Q 008634 525 LLDDDM--NPKISDFGLARIFGGN 546 (558)
Q Consensus 525 Ll~~~~--~~ki~DFGla~~~~~~ 546 (558)
|++.++ .+||+|||+++.+..+
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999998 9999999999887543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=210.39 Aligned_cols=151 Identities=25% Similarity=0.388 Sum_probs=130.2
Q ss_pred HcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--ccchHHHHHHHHHHhcCC--CCCeeeeeEEEEeCCEEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~l 464 (558)
..++|...+.||+|+||.||++...+++.||||++.... .+..+.+.+|+.++.+++ ||||+++++++.+++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 345688899999999999999998889999999986543 344678999999999997 5999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||| +.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||+++.+.
T Consensus 106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 6789999999653 35899999999999999999999985 999999999999965 889999999999875
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
.+.
T Consensus 178 ~~~ 180 (313)
T 3cek_A 178 PDT 180 (313)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-23 Score=214.46 Aligned_cols=148 Identities=32% Similarity=0.460 Sum_probs=124.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (558)
.++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367888999999999999999865 68899999997542 233567889999999999999999999997664
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6777774 23899999999999999999999985 999999999999999999999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.....
T Consensus 175 ~~~~~~ 180 (371)
T 2xrw_A 175 RTAGTS 180 (371)
T ss_dssp ------
T ss_pred cccccc
Confidence 977543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.3e-23 Score=229.54 Aligned_cols=152 Identities=23% Similarity=0.382 Sum_probs=131.7
Q ss_pred HcCCCCcccccccCCcccEEEEEecC----CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
..++|...+.||+|+||.||+|.... +..||||++..... ...+.|.+|+.++.+++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34668888999999999999998642 46799999876433 33577999999999999999999999984 45689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999643 345899999999999999999999985 999999999999999999999999999987
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
...
T Consensus 542 ~~~ 544 (656)
T 2j0j_A 542 EDS 544 (656)
T ss_dssp CC-
T ss_pred CCC
Confidence 544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=209.49 Aligned_cols=152 Identities=30% Similarity=0.522 Sum_probs=128.4
Q ss_pred HcCCCCcccccccCCcccEEEEEe--cCCcEEEEEEccccCc--cchHHHHHHHHHHhcC---CCCCeeeeeEEEE----
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTL--ADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCL---- 457 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~--~~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~---- 457 (558)
..++|...++||+|+||.||+++. .+|+.||+|++..... .....+.+|+.++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 446788999999999999999997 3688999999875432 2234567777776665 8999999999997
Q ss_pred -eCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 008634 458 -EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536 (558)
Q Consensus 458 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~D 536 (558)
.....++|+||++ |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69999986533 345899999999999999999999985 99999999999999999999999
Q ss_pred cCcceeeCC
Q 008634 537 FGLARIFGG 545 (558)
Q Consensus 537 FGla~~~~~ 545 (558)
||+++....
T Consensus 164 fg~~~~~~~ 172 (326)
T 1blx_A 164 FGLARIYSF 172 (326)
T ss_dssp CCSCCCCCG
T ss_pred CcccccccC
Confidence 999987653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=202.71 Aligned_cols=150 Identities=26% Similarity=0.405 Sum_probs=129.1
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEE-EeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 467 (558)
.++|...+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++.+++|++++..++.+ ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788999999999999999996 5789999999875433 34688999999999988876666655 56778899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE---cCCCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DFGla~~~~ 544 (558)
|+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999999642 345999999999999999999999985 9999999999999 588999999999999876
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-23 Score=210.63 Aligned_cols=153 Identities=25% Similarity=0.389 Sum_probs=125.6
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc------chHHHHHHHHHHhcC----CCCCeeeeeEEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKL----QHKNLVRLLGCC 456 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l~g~~ 456 (558)
...++|...++||+|+||.||+++.. +++.||||++...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 44578999999999999999999864 6889999999765321 233466799999888 899999999999
Q ss_pred EeCCEEEEEEEc-CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEEE
Q 008634 457 LEGQELLLIYEY-MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKI 534 (558)
Q Consensus 457 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~ki 534 (558)
...+..++|+|| +.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 7999999999653 35899999999999999999999985 99999999999999 8999999
Q ss_pred EecCcceeeCCC
Q 008634 535 SDFGLARIFGGN 546 (558)
Q Consensus 535 ~DFGla~~~~~~ 546 (558)
+|||+++.....
T Consensus 182 ~dfg~~~~~~~~ 193 (312)
T 2iwi_A 182 IDFGSGALLHDE 193 (312)
T ss_dssp CCCSSCEECCSS
T ss_pred EEcchhhhcccC
Confidence 999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=216.80 Aligned_cols=150 Identities=25% Similarity=0.378 Sum_probs=129.3
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCCC-CCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+|+. .+++.||||++..... ..++..|++++..++| ++++.+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46788999999999999999996 4689999998765433 2468899999999977 566666677778889999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE---cCCCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DFGla~~~~ 544 (558)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999643 345999999999999999999999985 9999999999999 688999999999999886
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.1e-23 Score=214.88 Aligned_cols=148 Identities=11% Similarity=0.115 Sum_probs=112.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHH---HHHhcCCCCCeeeee-------EEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEV---NLIAKLQHKNLVRLL-------GCC 456 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~~ 456 (558)
..|...++||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+ ..|.+ +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 34788899999999999999965 689999999987543 3355677884 55555 799987755 555
Q ss_pred EeC-----------------CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 008634 457 LEG-----------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR------QSIINGIARGILYLHEDSRLK 513 (558)
Q Consensus 457 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~ 513 (558)
..+ ...++||||++ |+|.+++.... ..+.+..+ +.++.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 443 34899999999 89999997532 23455556 788899999999999985
Q ss_pred eeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 514 ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+||||||+|||++.++.+||+|||+++....
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 99999999999999999999999999997754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-23 Score=208.29 Aligned_cols=153 Identities=25% Similarity=0.374 Sum_probs=133.4
Q ss_pred HHcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc------chHHHHHHHHHHhcCC--CCCeeeeeEEEEe
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQ--HKNLVRLLGCCLE 458 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~ 458 (558)
...++|...++||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++ |+||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34577999999999999999999864 6899999999765322 2345778999999996 5999999999999
Q ss_pred CCEEEEEEEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEEEEe
Q 008634 459 GQELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISD 536 (558)
Q Consensus 459 ~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~ki~D 536 (558)
++..++|+|++.+ ++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 9999999653 35899999999999999999999985 99999999999999 789999999
Q ss_pred cCcceeeCCC
Q 008634 537 FGLARIFGGN 546 (558)
Q Consensus 537 FGla~~~~~~ 546 (558)
||+++.....
T Consensus 194 fg~~~~~~~~ 203 (320)
T 3a99_A 194 FGSGALLKDT 203 (320)
T ss_dssp CTTCEECCSS
T ss_pred Cccccccccc
Confidence 9999987644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.8e-23 Score=212.11 Aligned_cols=148 Identities=27% Similarity=0.490 Sum_probs=125.9
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEE----
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL---- 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 462 (558)
.++|...++||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++.+++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999865 689999999976432 3356789999999999999999999999877654
Q ss_pred --EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 463 --LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 463 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 68887772 23899999999999999999999985 999999999999999999999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.....
T Consensus 192 ~~~~~~ 197 (371)
T 4exu_A 192 RHADAE 197 (371)
T ss_dssp ------
T ss_pred cccccC
Confidence 876543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=206.29 Aligned_cols=153 Identities=25% Similarity=0.379 Sum_probs=126.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHH-HHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
.++|...+.||+|+||.||++... +|+.||||++.... .....++..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 357888899999999999999975 68999999997653 233445666666 777889999999999999999999999
Q ss_pred EcCCCCCHHHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 467 EYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 467 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77777642 12245689999999999999999999986 5 999999999999999999999999999877
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
...
T Consensus 177 ~~~ 179 (327)
T 3aln_A 177 VDS 179 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-22 Score=212.43 Aligned_cols=150 Identities=21% Similarity=0.278 Sum_probs=128.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcC------CCCCeeeeeEEEEeCCEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~ 462 (558)
.++|...++||+|+||.||+|... +++.||||++.... ...+.+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456888999999999999999865 58899999997542 2345677888888776 577999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc--EEEEecCcc
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLA 540 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~--~ki~DFGla 540 (558)
++||||++ ++|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 68988886533 345899999999999999999999985 999999999999999887 999999999
Q ss_pred eeeCC
Q 008634 541 RIFGG 545 (558)
Q Consensus 541 ~~~~~ 545 (558)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 87644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=216.41 Aligned_cols=149 Identities=29% Similarity=0.329 Sum_probs=120.0
Q ss_pred CCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
.|...++||+|+||.||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 445567899999999987766689999999986532 35678999999876 89999999999999999999999996
Q ss_pred CCCHHHHHhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC-------------CcEE
Q 008634 471 NKSLDVHLFDATRSV----QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-------------MNPK 533 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~-------------~~~k 533 (558)
|+|.+++....... ..++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996533211 1133345789999999999999985 9999999999999754 4899
Q ss_pred EEecCcceeeCCCC
Q 008634 534 ISDFGLARIFGGNQ 547 (558)
Q Consensus 534 i~DFGla~~~~~~~ 547 (558)
|+|||+++.+..+.
T Consensus 169 L~DFG~a~~~~~~~ 182 (434)
T 2rio_A 169 ISDFGLCKKLDSGQ 182 (434)
T ss_dssp ECCCTTCEECCC--
T ss_pred EcccccceecCCCC
Confidence 99999999886544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=204.76 Aligned_cols=151 Identities=21% Similarity=0.364 Sum_probs=130.2
Q ss_pred cCCCCcccccccCCcccEEEEEe--cCCcEEEEEEccccCccchHHHHHHHHHHhcCCCC------CeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL--ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK------NLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~--~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~~~~ 461 (558)
.++|...++||+|+||.||++.. .+++.||||++.... ...+.+.+|+.++..++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788899999999999999986 368899999987542 3356788999999988765 49999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-------------
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD------------- 528 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~------------- 528 (558)
.++||||+ +++|.+++.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 899999986532 345899999999999999999999985 999999999999987
Q ss_pred ------CCcEEEEecCcceeeCCC
Q 008634 529 ------DMNPKISDFGLARIFGGN 546 (558)
Q Consensus 529 ------~~~~ki~DFGla~~~~~~ 546 (558)
++.+||+|||+++.....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC
T ss_pred ccccccCCCceEeeCcccccCccc
Confidence 678999999999976543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-23 Score=210.49 Aligned_cols=149 Identities=30% Similarity=0.532 Sum_probs=127.5
Q ss_pred HHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 388 ~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
...++|...+.||+|+||.||+|...+ .+++|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345778899999999999999999754 48999987542 33456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+||+++++|.+++.+ ....+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999954 2346899999999999999999999985 99999999999998 6799999999988753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.7e-23 Score=210.44 Aligned_cols=147 Identities=27% Similarity=0.487 Sum_probs=126.3
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE-----
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 461 (558)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++.+++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888899999999999999975 68999999997543 2335678999999999999999999999987653
Q ss_pred -EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 462 -LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 462 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 68877662 24899999999999999999999985 999999999999999999999999999
Q ss_pred eeeCC
Q 008634 541 RIFGG 545 (558)
Q Consensus 541 ~~~~~ 545 (558)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=209.99 Aligned_cols=136 Identities=24% Similarity=0.377 Sum_probs=113.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC--------CCCeeeeeEEEE---
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--------HKNLVRLLGCCL--- 457 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~--- 457 (558)
.++|...++||+|+||.||+++.. +++.||||++... ....+.+.+|+.++.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467999999999999999999864 6889999999754 234567889999999885 788999999988
Q ss_pred -eCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC
Q 008634 458 -EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (558)
Q Consensus 458 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~ 530 (558)
.....++||||+ +++|.+++.+. ....+++..+..|+.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence 456899999999 55665555442 2345999999999999999999999972 399999999999999775
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-22 Score=203.30 Aligned_cols=149 Identities=25% Similarity=0.325 Sum_probs=120.7
Q ss_pred cCCCCcc-cccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCEEE
Q 008634 390 TNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELL 463 (558)
Q Consensus 390 t~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 463 (558)
.++|... +.||+|+||.||++... +++.||||++.... .........+..++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 46999999999999976 68999999986532 122223334667799999999999976 44589
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA 540 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla 540 (558)
+||||+++|+|.+++.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999996532 346999999999999999999999985 999999999999976 455999999999
Q ss_pred eeeCCC
Q 008634 541 RIFGGN 546 (558)
Q Consensus 541 ~~~~~~ 546 (558)
+.....
T Consensus 179 ~~~~~~ 184 (336)
T 3fhr_A 179 KETTQN 184 (336)
T ss_dssp EEC---
T ss_pred eecccc
Confidence 977543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=213.51 Aligned_cols=148 Identities=25% Similarity=0.338 Sum_probs=121.2
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
..+|...++||+|+||.||.....+++.||||++..... ..+.+|+.++.++ +|||||++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 345788899999999997655556789999999975432 3457899999999 899999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-----CCcEEEEecCcceee
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARIF 543 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-----~~~~ki~DFGla~~~ 543 (558)
++ |+|.+++.... ..+.+.....++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 69999996533 23445556789999999999999985 999999999999943 346889999999987
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
..+
T Consensus 174 ~~~ 176 (432)
T 3p23_A 174 AVG 176 (432)
T ss_dssp ---
T ss_pred cCC
Confidence 644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.9e-23 Score=224.94 Aligned_cols=153 Identities=29% Similarity=0.421 Sum_probs=132.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEe------CCEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~ 462 (558)
++|...++||+|+||.||++... +|+.||||++... .....+.+.+|++++.+++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999874 5899999998754 33446779999999999999999999999765 6678
Q ss_pred EEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCc---EEEEecCc
Q 008634 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGL 539 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DFGl 539 (558)
++||||+++|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999977555556999999999999999999999985 999999999999997664 99999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++.....
T Consensus 171 a~~~~~~ 177 (676)
T 3qa8_A 171 AKELDQG 177 (676)
T ss_dssp CCBTTSC
T ss_pred ccccccc
Confidence 9987544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.5e-22 Score=201.08 Aligned_cols=151 Identities=23% Similarity=0.387 Sum_probs=115.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc-c-hHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-G-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...+.||+|+||.||+++.. +|+.||||++...... . .+.+..+..++..++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 46778889999999999999975 6899999999765332 2 2334455567888899999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+ ++.+..+... ....+++..+..++.||+.||.|||+.. +|+||||||+|||++.++.+||+|||+++.+..+
T Consensus 105 ~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 4555555432 2345899999999999999999999841 3999999999999999999999999999876543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=203.87 Aligned_cols=154 Identities=25% Similarity=0.360 Sum_probs=129.4
Q ss_pred HcCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-CC-----CeeeeeEEEEeCCE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HK-----NLVRLLGCCLEGQE 461 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~ 461 (558)
..++|...++||+|+||.||+|... +++.||||++.... ....++..|+.++..++ |+ +++++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999865 58899999997532 33466788888888875 54 49999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc--CCCcEEEEecCc
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGL 539 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~--~~~~~ki~DFGl 539 (558)
.++||||++ |+|.+++.... ...+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 59999986533 24589999999999999999999963 23699999999999994 578899999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++.....
T Consensus 208 a~~~~~~ 214 (382)
T 2vx3_A 208 SCQLGQR 214 (382)
T ss_dssp CEETTCC
T ss_pred ceecccc
Confidence 9987543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-22 Score=218.94 Aligned_cols=137 Identities=19% Similarity=0.245 Sum_probs=109.5
Q ss_pred CcccccccCCcccEEEEEecCCcEEEEEEccccCcc--------chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
...++||+|+||.||++.. .++.+++|+....... ..+.+.+|++++.+++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999955 5678888876543211 134589999999999999999777777788888999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++++|.+++.+ +..++.||++||.|||+++ |+||||||+|||+++ .+||+|||+++.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999853 4679999999999999985 999999999999999 999999999999866
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
..
T Consensus 482 ~~ 483 (540)
T 3en9_A 482 DE 483 (540)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-21 Score=199.94 Aligned_cols=151 Identities=21% Similarity=0.334 Sum_probs=127.5
Q ss_pred cCCCCcccccccCCcccEEEEEec-CC-cEEEEEEccccCccchHHHHHHHHHHhcCCCCC------eeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g-~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 461 (558)
.++|...++||+|+||.||++... ++ +.||+|++... ....+.+.+|+.++.+++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 367889999999999999999864 34 68999998753 234567888999999987766 9999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE---------------
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL--------------- 526 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl--------------- 526 (558)
.++||||+ +++|.+++.+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66666666543 2345899999999999999999999885 9999999999999
Q ss_pred ----cCCCcEEEEecCcceeeCCC
Q 008634 527 ----DDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 527 ----~~~~~~ki~DFGla~~~~~~ 546 (558)
+.++.+||+|||+++.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~ 195 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH 195 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC
T ss_pred cccccCCCcEEEeecCcccccccc
Confidence 66889999999999976543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=203.78 Aligned_cols=152 Identities=20% Similarity=0.347 Sum_probs=128.5
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcCC-----------CCCeeeeeEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----------HKNLVRLLGCCL 457 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~ 457 (558)
.++|...++||+|+||.||+++. .+++.||||++.... ...+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788899999999999999996 468999999987432 33467889999999886 899999999998
Q ss_pred eCC----EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc------
Q 008634 458 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD------ 527 (558)
Q Consensus 458 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~------ 527 (558)
..+ ..++||||+ +++|.+++.+.. ...+++..+..++.||+.||.|||++. +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 754 789999999 899999986533 345899999999999999999999971 399999999999994
Q ss_pred CCCcEEEEecCcceeeCCC
Q 008634 528 DDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~~~ 546 (558)
..+.+||+|||+++.....
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~ 191 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH 191 (373)
T ss_dssp TEEEEEECCCTTCEETTBC
T ss_pred CcceEEEcccccccccCCC
Confidence 4458999999999987543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=195.45 Aligned_cols=146 Identities=17% Similarity=0.164 Sum_probs=117.0
Q ss_pred hHHHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCc------------------cchHHHHHHHHHHhcC
Q 008634 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLQEFKNEVNLIAKL 444 (558)
Q Consensus 383 ~~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~------------------~~~~~~~~Ei~~l~~l 444 (558)
+.........|...++||+|+||.||+|...+|+.||||.++.... .....+.+|+.++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344455667778899999999999999997799999999964321 1245689999999999
Q ss_pred CCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 008634 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (558)
Q Consensus 445 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NI 524 (558)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.||+.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 4 666665543 45699999999999987 411 123469999999999999985 99999999999
Q ss_pred EEcCCCcEEEEecCcceeeCCC
Q 008634 525 LLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 525 Ll~~~~~~ki~DFGla~~~~~~ 546 (558)
|++ ++.+||+|||+|+.....
T Consensus 225 Ll~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EEE-TTEEEECCCTTCEETTST
T ss_pred EEE-CCcEEEEECCCCeECCCC
Confidence 999 999999999999977543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-20 Score=196.72 Aligned_cols=151 Identities=19% Similarity=0.188 Sum_probs=114.5
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCc---cchHHHHHHHHHHhcCCC-CCee---------------
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQH-KNLV--------------- 450 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H-~niv--------------- 450 (558)
..|...++||+|+||.||+|+. .+|+.||||++..... ...+.|.+|+.++..++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466778999999999999995 4689999999884332 336789999999999987 2211
Q ss_pred e------eeEEEEe-----CCEEEEEEEcCCCCCHHHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 008634 451 R------LLGCCLE-----GQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515 (558)
Q Consensus 451 ~------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 515 (558)
. +..+... ....+++|++ .+++|.+++.. ......++|..++.|+.||+.||.|||+.+ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1 1111111 1235666665 57899988841 123445889999999999999999999985 99
Q ss_pred eCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 516 HRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 516 HrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
||||||+||||+.++.+||+|||+++....
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC
Confidence 999999999999999999999999987543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=177.57 Aligned_cols=140 Identities=19% Similarity=0.193 Sum_probs=107.7
Q ss_pred CCCcccccccCCcccEEEEEe-cCCcE--EEEEEccccCcc------------------------chHHHHHHHHHHhcC
Q 008634 392 HFSDENKLGQGGFGPVYKGTL-ADGKA--IAVKRLSRTSGQ------------------------GLQEFKNEVNLIAKL 444 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~--VaVK~l~~~~~~------------------------~~~~~~~Ei~~l~~l 444 (558)
-|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356678999999999999998 67888 999987543111 013678999999999
Q ss_pred CCCCe--eeeeEEEEeCCEEEEEEEcCCC-C----CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeee
Q 008634 445 QHKNL--VRLLGCCLEGQELLLIYEYMPN-K----SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-EDSRLKIIH 516 (558)
Q Consensus 445 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivH 516 (558)
.|+++ +.+++. +..++||||+.+ | +|.++... .++.....++.||+.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 344432 356899999942 4 67666532 224456789999999999999 774 999
Q ss_pred CCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 517 RDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 517 rDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|||||+|||+++ .+||+|||+|+.....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999998 9999999999877543
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-17 Score=141.62 Aligned_cols=94 Identities=20% Similarity=0.323 Sum_probs=74.6
Q ss_pred eeeccCcccccchhhhHHhhhc-----c---CCCCccccccccccccCcceEEEEEeeeccCChhhHhHHHHHHHHHHhh
Q 008634 188 KIFQNTYNVTKSLAQSFNDVIA-----M---PSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQR 259 (558)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~-----~---a~~~~~~~a~~~~~~~~~~~vy~laQC~~Dls~~dC~~CL~~~~~~~~~ 259 (558)
...||..+++ .... |+..+. | ++.+..+|+++.....+..+||||+||+||+++++|+.||+.+++++++
T Consensus 7 ~~~Cn~~~~t-~~s~-f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~ 84 (108)
T 3a2e_A 7 SSACNTQKIP-SGSP-FNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFS 84 (108)
T ss_dssp EEEECSSBCC-TTCT-HHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHH
T ss_pred eeecCCCccC-CCCh-HHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHH
Confidence 3445665555 2223 443333 2 4455677877766656678999999999999999999999999999999
Q ss_pred hcCCCCCCcceEeccccccccccccc
Q 008634 260 CFDPPGMGFGRILFPSCIMGFELYRY 285 (558)
Q Consensus 260 ~~~~~~~~~g~v~~~~C~~ry~~y~f 285 (558)
+|+ ++.||+|+.++|++||+.|+|
T Consensus 85 ~C~--~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 85 ICN--NAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HTT--SBSSEEEEETTEEEEEESSCC
T ss_pred HCC--CCceEEEECCCEEEEEeCCcC
Confidence 999 899999999999999999986
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=7.6e-17 Score=166.56 Aligned_cols=146 Identities=14% Similarity=0.134 Sum_probs=103.2
Q ss_pred HHHHHHcCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCc-----c---------chHH--------HHHHHHHH
Q 008634 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-----Q---------GLQE--------FKNEVNLI 441 (558)
Q Consensus 384 ~~~~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~-----~---------~~~~--------~~~Ei~~l 441 (558)
..+.....-|.+.++||+|+||.||+|...+|+.||||+++.... + .... ...|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 344444556889999999999999999998999999998753210 0 0111 13456666
Q ss_pred hcCCCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 008634 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 521 (558)
Q Consensus 442 ~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~ 521 (558)
.++.+.++....-+... ..+|||||+++++|..+.. .+ ....++.||+.+|.|||+.+ ||||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-------~~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-------VP--DPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-------CS--CHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc-------cH--HHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 66654443322222222 2379999999988865431 11 23467899999999999985 99999999
Q ss_pred CCEEEcCCC----------cEEEEecCcceee
Q 008634 522 SNILLDDDM----------NPKISDFGLARIF 543 (558)
Q Consensus 522 ~NILl~~~~----------~~ki~DFGla~~~ 543 (558)
.|||+++++ .+.|+||+-+--.
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999998776 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=5.6e-12 Score=123.90 Aligned_cols=145 Identities=17% Similarity=0.090 Sum_probs=114.4
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
-+.|.....++.|+.+.||+.... ++.+++|............+.+|+.+++.+. |.++++++++..+.+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 356777778888888999999864 6789999987533233456889999999884 77888999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED--------------------------------------- 509 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------- 509 (558)
++|.+|.+.+. +......++.+++++|..||+.
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999987641 1122346888999999999982
Q ss_pred -----------------CCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 510 -----------------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 510 -----------------~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
.+..++|+|+++.|||++++..+.|+||+.+...
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 1134899999999999988766789999988654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=3.7e-11 Score=117.26 Aligned_cols=133 Identities=17% Similarity=0.170 Sum_probs=100.5
Q ss_pred ccc-cCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCC--eeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 398 KLG-QGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 398 ~LG-~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
.++ .|..+.||+....+|..+++|..... ....+..|+.++..+.+.+ +++++++...++..++||||+++.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998877888999987643 2356788999998885444 56789988888889999999999888
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 008634 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-------------------------------------------- 510 (558)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------------------------------------------- 510 (558)
. ... .+ ...++.++++.|..||...
T Consensus 103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 211 12 1256777888888888642
Q ss_pred -----------CCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 511 -----------RLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 511 -----------~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
+..++|+|++|.|||++++..++|+|||.+....
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 1229999999999999887777899999987653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=7.6e-10 Score=113.93 Aligned_cols=143 Identities=14% Similarity=0.244 Sum_probs=107.5
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEcc--ccC-ccchHHHHHHHHHHhcCC--CCCeeeeeEEEEeC---CEEEEEE
Q 008634 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLS--RTS-GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEG---QELLLIY 466 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 466 (558)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|..++..+. +..++++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998754 577788765 322 122456888999999886 45688999998776 4589999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS------------------------------------ 510 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------ 510 (558)
||+++..+.+.. ...++...+..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874311 123778888999999999999999731
Q ss_pred -------------------CCCeeeCCCCCCCEEEcCCCc--EEEEecCcceee
Q 008634 511 -------------------RLKIIHRDLKASNILLDDDMN--PKISDFGLARIF 543 (558)
Q Consensus 511 -------------------~~~ivHrDlk~~NILl~~~~~--~ki~DFGla~~~ 543 (558)
+..++|+|+++.|||+++++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997653 699999998854
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.47 E-value=2.2e-07 Score=93.10 Aligned_cols=137 Identities=20% Similarity=0.238 Sum_probs=98.4
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCC--eeeeeEEEEeCC---EEEEEEEcCC
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKN--LVRLLGCCLEGQ---ELLLIYEYMP 470 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~Ey~~ 470 (558)
+.++.|....||+.. ..+++|+.... .....+.+|.+.+..+ .+.. +.+++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458889999998753 45788875432 3346788999999887 3333 445555543333 3488999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED----------------------------------------- 509 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------- 509 (558)
|.+|..... ..++..++..++.++++.|..||..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988865432 1356777778888888888888851
Q ss_pred --------------CCCCeeeCCCCCCCEEEcC--CCcEEEEecCcceeeC
Q 008634 510 --------------SRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFG 544 (558)
Q Consensus 510 --------------~~~~ivHrDlk~~NILl~~--~~~~ki~DFGla~~~~ 544 (558)
.+..++|+|+++.||++++ +..+.|+||+.+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 1245899999999999998 5668999999988653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.4e-06 Score=85.69 Aligned_cols=137 Identities=19% Similarity=0.152 Sum_probs=92.0
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCC---CeeeeeEEEE-eCCEEEEEEEcCCCC
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCL-EGQELLLIYEYMPNK 472 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~g 472 (558)
+.++.|....||+. |..+++|+... ......+..|.++|..+.+. .+.+.+.+.. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45777888889887 45677887432 23346788999999998652 3567777765 345678999999998
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 008634 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED------------------------------------------- 509 (558)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------------- 509 (558)
.+...... .++...+..++.++++.|..||..
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88653211 123334444444444444444432
Q ss_pred --------------CCCCeeeCCCCCCCEEEcC---CCc-EEEEecCcceeeC
Q 008634 510 --------------SRLKIIHRDLKASNILLDD---DMN-PKISDFGLARIFG 544 (558)
Q Consensus 510 --------------~~~~ivHrDlk~~NILl~~---~~~-~ki~DFGla~~~~ 544 (558)
.+..++|+|+++.|||++. ++. +.|+||+.+..-.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2335799999999999987 355 5899999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.3e-06 Score=82.69 Aligned_cols=136 Identities=16% Similarity=0.145 Sum_probs=95.3
Q ss_pred cccCCcc-cEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEcCCCCCHH
Q 008634 399 LGQGGFG-PVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (558)
Q Consensus 399 LG~G~fG-~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 475 (558)
+..|..+ .||+-... ++..+.+|+-... ....+..|...|..+. +-.+.++++++.+++..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445544 58987765 4567888875432 3456788999888773 445788999999999999999999998876
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 008634 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHED---------------------------------------------- 509 (558)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------------------- 509 (558)
+..... ......+..+++..|.-||..
T Consensus 109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 654221 112233455555555555531
Q ss_pred ---------CCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 510 ---------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 510 ---------~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
.+..++|+|+.+.|||+++++.+-|+||+.+....
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 11237899999999999988878899999987643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.9e-06 Score=88.21 Aligned_cols=79 Identities=8% Similarity=0.010 Sum_probs=54.9
Q ss_pred ccc-ccCCcccEEEEEec-------CCcEEEEEEccccC---ccchHHHHHHHHHHhcCC-C--CCeeeeeEEEEeC---
Q 008634 397 NKL-GQGGFGPVYKGTLA-------DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-H--KNLVRLLGCCLEG--- 459 (558)
Q Consensus 397 ~~L-G~G~fG~Vyk~~~~-------~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~--- 459 (558)
+.| +.|....+|+.... +++.+++|+..... ......+..|..++..+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 77888999988764 25678888765432 111246778888888774 2 4577888887655
Q ss_pred CEEEEEEEcCCCCCHH
Q 008634 460 QELLLIYEYMPNKSLD 475 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~ 475 (558)
+..++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.3e-05 Score=77.99 Aligned_cols=141 Identities=17% Similarity=0.248 Sum_probs=81.4
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC--CCCeeeeeE------EEEeCCEEEEEEEc
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--HKNLVRLLG------CCLEGQELLLIYEY 468 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g------~~~~~~~~~lV~Ey 468 (558)
+.|+.|....||+....+| .+++|+.... ..++..|..++..+. .-.+++++. +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4565567889999887655 4888888652 123334455444442 123344443 22356788999999
Q ss_pred CCCCCHH--------------HHHhccCC----C-------CCCCHHHHH------------------------------
Q 008634 469 MPNKSLD--------------VHLFDATR----S-------VQLDWKRRQ------------------------------ 493 (558)
Q Consensus 469 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~~------------------------------ 493 (558)
++|..+. ..+|.... . ..-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11221110 1 112343211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 494 -SIINGIARGILYLHE----------DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 494 -~i~~~ia~aL~yLH~----------~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
.+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011223446677763 1235699999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=3.9e-05 Score=79.67 Aligned_cols=75 Identities=11% Similarity=0.161 Sum_probs=50.0
Q ss_pred ccccccCCcccEEEEEec-CCcEEEEEEccccCc-------cchHHHHHHHHHHhcCCC--C-CeeeeeEEEEeCCEEEE
Q 008634 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------QGLQEFKNEVNLIAKLQH--K-NLVRLLGCCLEGQELLL 464 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~-niv~l~g~~~~~~~~~l 464 (558)
.+.||.|..+.||++... +++.++||....... ...+.+..|.+++..+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 467899997653211 223456788888887732 3 34466654 4555689
Q ss_pred EEEcCCCC
Q 008634 465 IYEYMPNK 472 (558)
Q Consensus 465 V~Ey~~~g 472 (558)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00014 Score=71.94 Aligned_cols=79 Identities=19% Similarity=0.217 Sum_probs=58.5
Q ss_pred CCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC-C--CCeeeeeEEEEeCCEEEEEEEc
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-H--KNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.....+.+|.|..+.||+.++.+|+.+.+|+-..........|..|...|+.+. . -.+++++++ + ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 444567799999999999999999999999876554444456788999888774 2 234555554 2 23789999
Q ss_pred CCCCCH
Q 008634 469 MPNKSL 474 (558)
Q Consensus 469 ~~~gsL 474 (558)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00023 Score=71.37 Aligned_cols=139 Identities=19% Similarity=0.168 Sum_probs=93.5
Q ss_pred cccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC---CCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
..+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+++++++....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999886 4667888876533 2456888988888873 36788999998888899999999998
Q ss_pred CCHH-----------HHHhccCC-C------------------CCCCHHHHH---HHHH----------------HHHHH
Q 008634 472 KSLD-----------VHLFDATR-S------------------VQLDWKRRQ---SIIN----------------GIARG 502 (558)
Q Consensus 472 gsL~-----------~~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~a 502 (558)
..+. --||+... . -.-+|.... ++.. .+...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7652 12333211 0 012565432 1111 11111
Q ss_pred -HHHHHh-CCCCCeeeCCCCCCCEEEcCCCcEEEEecC
Q 008634 503 -ILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (558)
Q Consensus 503 -L~yLH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DFG 538 (558)
...|.. ..++.++|+|+.+.|++++.++ +.|+||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123422 2356799999999999999887 9999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00033 Score=73.26 Aligned_cols=73 Identities=12% Similarity=0.141 Sum_probs=45.0
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEcccc----C---c--cchHHHHHHHHHHh-cCCCCCeeeeeEEEEeCCEEEEE
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT----S---G--QGLQEFKNEVNLIA-KLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~----~---~--~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 465 (558)
.+.||.|....||+... +++.++||..... . . .....+..|+..+. ...+..+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45789999999999965 4678999943211 0 1 12223333433322 22334567777765 5667999
Q ss_pred EEcC-CC
Q 008634 466 YEYM-PN 471 (558)
Q Consensus 466 ~Ey~-~~ 471 (558)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0019 Score=64.53 Aligned_cols=143 Identities=15% Similarity=0.117 Sum_probs=80.9
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCC--CeeeeeEE------EEeCCEEEEEEEc
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGC------CLEGQELLLIYEY 468 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~Ey 468 (558)
+.|+.|....+|+....+| .+++|...... ....+..|..++..+... .+++++.. ....+..++++||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3466787789999887666 57788876521 123455677776665321 23344421 2234678999999
Q ss_pred CCCCCHHH--------------HHhccCC----C--C---CCCHHHHHH------------HHHHHHHHHHHHHhC----
Q 008634 469 MPNKSLDV--------------HLFDATR----S--V---QLDWKRRQS------------IINGIARGILYLHED---- 509 (558)
Q Consensus 469 ~~~gsL~~--------------~l~~~~~----~--~---~l~~~~~~~------------i~~~ia~aL~yLH~~---- 509 (558)
++|..+.. .+|.... . . ...|...+. +...+.+.+.+++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 1221110 0 0 012433111 011244556666532
Q ss_pred CCCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 510 ~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
.+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234689999999999999876668999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0021 Score=64.64 Aligned_cols=142 Identities=15% Similarity=0.137 Sum_probs=73.5
Q ss_pred ccccCCccc-EEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC--CCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 398 KLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 398 ~LG~G~fG~-Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
.|+.|.... +|+....+|..+++|....... ..+..|+.++..+. .-.+++++.+..+.+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455444333 6676654466777775443221 23345666665553 234567777643333 789999987666
Q ss_pred HHHHhc---------------------cCCC--CCCCHHHHH--------------------HHHHHHHHHHHHHH---h
Q 008634 475 DVHLFD---------------------ATRS--VQLDWKRRQ--------------------SIINGIARGILYLH---E 508 (558)
Q Consensus 475 ~~~l~~---------------------~~~~--~~l~~~~~~--------------------~i~~~ia~aL~yLH---~ 508 (558)
.+++.. .... ..++..... .....+...+..+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 543321 1000 112211100 00011122223331 1
Q ss_pred CCCCCeeeCCCCCCCEEEcCC----CcEEEEecCcceeeC
Q 008634 509 DSRLKIIHRDLKASNILLDDD----MNPKISDFGLARIFG 544 (558)
Q Consensus 509 ~~~~~ivHrDlk~~NILl~~~----~~~ki~DFGla~~~~ 544 (558)
..+..++|+|+.+.|||++.+ ..+.|+||+.+..-.
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 124469999999999999875 689999999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0054 Score=61.29 Aligned_cols=143 Identities=15% Similarity=0.141 Sum_probs=82.6
Q ss_pred cccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCC--CCeeeeeEE-----EEeCCEEEEEEEcC
Q 008634 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGC-----CLEGQELLLIYEYM 469 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~Ey~ 469 (558)
..++ |....||+....+|+.+++|...... .....+..|..++..+.. -.+++++.. ....+..++++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77788999887777778999876331 123456677777776632 224445443 23356678999999
Q ss_pred CCCCHH-----HH---------HhccC------CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 008634 470 PNKSLD-----VH---------LFDAT------RSVQLDWKRR----QSI---------------INGIARGILYLHE-- 508 (558)
Q Consensus 470 ~~gsL~-----~~---------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~aL~yLH~-- 508 (558)
++..+. .. +|... .....++... ..+ ...+...+..+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 985432 10 12110 0112233211 001 0111122333322
Q ss_pred --CCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 509 --DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 509 --~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
..+..++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1234588999999999999 4 8999999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0009 Score=70.22 Aligned_cols=72 Identities=15% Similarity=0.265 Sum_probs=48.2
Q ss_pred cccccCCcccEEEEEecC--------CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCEEEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~--------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 467 (558)
+.|+.|-...+|+....+ +..+++|+.... .....+..|..++..+...++ +++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 457778789999998753 478888887432 112456689888888743333 57777643 2 38999
Q ss_pred cCCCCCH
Q 008634 468 YMPNKSL 474 (558)
Q Consensus 468 y~~~gsL 474 (558)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0025 Score=63.21 Aligned_cols=139 Identities=12% Similarity=0.125 Sum_probs=75.1
Q ss_pred ccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCEEEEEEEcC-CCCC
Q 008634 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYM-PNKS 473 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 473 (558)
.+.|+.|....+|+. ..+++|+....... .....+|...+..+...++ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567888888999998 45777876543221 1223567777766632222 466654 344457899999 6544
Q ss_pred HHH------------------HHhccCCC--CCCCHHHHH-HHHH--------------HHHHHHH----HHHh-CCCCC
Q 008634 474 LDV------------------HLFDATRS--VQLDWKRRQ-SIIN--------------GIARGIL----YLHE-DSRLK 513 (558)
Q Consensus 474 L~~------------------~l~~~~~~--~~l~~~~~~-~i~~--------------~ia~aL~----yLH~-~~~~~ 513 (558)
+.. -+|..... ...+...++ .+.. .+.+.+. .|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 01111110 011111111 1100 0111111 1211 22345
Q ss_pred eeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 514 IIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 514 ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56677899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.007 Score=63.89 Aligned_cols=73 Identities=14% Similarity=0.104 Sum_probs=46.6
Q ss_pred cccccCCcccEEEEEecC-CcEEEEEEccccCccchHHHHHHHHHHhcCCCCCe-eeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 397 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
+.|+.|-...+|+....+ +..+++|+....... .-.-..|..++..+...++ +++++.+. + .+|+||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467778789999998765 477888876443221 1122578888888864444 57777762 2 259999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0063 Score=62.59 Aligned_cols=141 Identities=18% Similarity=0.248 Sum_probs=81.5
Q ss_pred cccccCCcccEEEEEecC--------CcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~--------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 467 (558)
+.|..|-...+|+....+ ++.+++|+.-.. ........+|..+++.+. +.-..++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 356667778889988642 468888875332 223456678998888774 3223567766543 29999
Q ss_pred cCCCCCHHH-----------------HHhccC--CCCCCC--HHHHHHHHHHHH-------------------HHHHHH-
Q 008634 468 YMPNKSLDV-----------------HLFDAT--RSVQLD--WKRRQSIINGIA-------------------RGILYL- 506 (558)
Q Consensus 468 y~~~gsL~~-----------------~l~~~~--~~~~l~--~~~~~~i~~~ia-------------------~aL~yL- 506 (558)
|++|..|.. -||... -..... |.+..++..++. ..+.+|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865531 012111 111222 334333433321 123333
Q ss_pred ---HhC-CCCCeeeCCCCCCCEEEcCC----CcEEEEecCccee
Q 008634 507 ---HED-SRLKIIHRDLKASNILLDDD----MNPKISDFGLARI 542 (558)
Q Consensus 507 ---H~~-~~~~ivHrDlk~~NILl~~~----~~~ki~DFGla~~ 542 (558)
... .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 23468899999999999876 7899999998874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.026 Score=56.87 Aligned_cols=33 Identities=21% Similarity=0.387 Sum_probs=28.9
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 511 ~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999887754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.20 E-value=0.007 Score=61.80 Aligned_cols=73 Identities=12% Similarity=0.152 Sum_probs=43.1
Q ss_pred cccccCCcccEEEEEecC---------CcEEEEEEccccCccchHHHHHHHHHHhcCCCCC-eeeeeEEEEeCCEEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~---------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 466 (558)
+.|+.|..-.+|+....+ +..+++|+...... .......|..++..+...+ .+++++.. .+ ++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 456777778899988654 26788887654322 1223457887777774333 44666553 22 6899
Q ss_pred EcCCCCCH
Q 008634 467 EYMPNKSL 474 (558)
Q Consensus 467 Ey~~~gsL 474 (558)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.71 E-value=0.28 Score=50.94 Aligned_cols=73 Identities=12% Similarity=0.179 Sum_probs=46.2
Q ss_pred cccccCCcccEEEEEecC--------CcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~--------g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 467 (558)
+.+..|-...+|+....+ +..+++|+....... .-+-.+|..++..+. +.-..++++.+ .+ ++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 456667778899988753 577888886443221 223357887777774 22245666533 22 78999
Q ss_pred cCCCCCH
Q 008634 468 YMPNKSL 474 (558)
Q Consensus 468 y~~~gsL 474 (558)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.22 E-value=0.13 Score=34.80 Aligned_cols=10 Identities=50% Similarity=0.770 Sum_probs=4.0
Q ss_pred HHHhhheeec
Q 008634 324 FGSFLWYRRR 333 (558)
Q Consensus 324 ~~~~~~~rrr 333 (558)
++.++++|||
T Consensus 29 ~~~~~~~RRr 38 (44)
T 2ks1_B 29 LGIGLFMRRR 38 (44)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHhhhh
Confidence 3333444444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.98 E-value=0.15 Score=34.51 Aligned_cols=11 Identities=18% Similarity=0.380 Sum_probs=4.3
Q ss_pred HHHhhheeecc
Q 008634 324 FGSFLWYRRRR 334 (558)
Q Consensus 324 ~~~~~~~rrrr 334 (558)
++.++++||||
T Consensus 28 ~~~~~~~RRRr 38 (44)
T 2l2t_A 28 LTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHTTC
T ss_pred HHHHHHhhhhh
Confidence 33334444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.57 E-value=0.18 Score=53.00 Aligned_cols=61 Identities=8% Similarity=0.082 Sum_probs=18.3
Q ss_pred cccccccCCcccEEEEEecC-CcEEEE------EEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEe
Q 008634 395 DENKLGQGGFGPVYKGTLAD-GKAIAV------KRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458 (558)
Q Consensus 395 ~~~~LG~G~fG~Vyk~~~~~-g~~VaV------K~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 458 (558)
..++|| ||.||+|.+.. ..+||| |..... +.+....|.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999999864 367888 766543 22334578889999999999999999988654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.18 E-value=2.8 Score=39.00 Aligned_cols=88 Identities=6% Similarity=-0.007 Sum_probs=63.4
Q ss_pred CCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCCC
Q 008634 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL-YLHEDSRLKIIHRDLKASN 523 (558)
Q Consensus 445 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~-yLH~~~~~~ivHrDlk~~N 523 (558)
.||.+ -..+-.+.+.+.+.++.-+++.=..-+. .++...+++++..|+.-.. +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 3344466777777777654443333442 3678889999988876666 5543 5788899999
Q ss_pred EEEcCCCcEEEEecCcceeeCC
Q 008634 524 ILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 524 ILl~~~~~~ki~DFGla~~~~~ 545 (558)
+++|.++.|+|.=.|+-..+++
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSS
T ss_pred EEEeCCCcEEEEEcCCcccCCC
Confidence 9999999999999998666543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.78 E-value=1.9 Score=40.10 Aligned_cols=89 Identities=9% Similarity=0.025 Sum_probs=64.3
Q ss_pred CCCCeeeeeEEEEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 008634 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (558)
Q Consensus 445 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NI 524 (558)
.||+++.. .+-++.+.+.+.++.-+.+.=...+ ..++...+++++..|+.--.+++. -+|--|.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 67888766 4666667666666644322222223 237888999999999888766654 47888999999
Q ss_pred EEcCCCcEEEEecCcceeeCC
Q 008634 525 LLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 525 Ll~~~~~~ki~DFGla~~~~~ 545 (558)
++|.++.|+|.=.|+-..+.+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P 131 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDP 131 (215)
T ss_dssp EECTTSCEEESCCEETTTBSC
T ss_pred EEcCCCCEEEEEccCccCCCC
Confidence 999999999999988665543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 558 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-50
Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 6/168 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ ++G G FG VYKG A+ + ++ + Q LQ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+G Q L ++ ++ SL HL + + + I A+G+ YLH
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK- 123
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
IIHRDLK++NI L +D+ KI DFGLA + ++G+
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-46
Identities = 56/164 (34%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+LG G FG V+ G +AVK L + S F E NL+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL + + +I EYM N SL L ++L + + IA G+ ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
IHRDL+A+NIL+ D ++ KI+DFGLAR+ N+ A
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-46
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 6/166 (3%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ + +LG G FG VYK A K + S + L+++ E++++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+LL L ++ E+ ++D + + R L + Q + + YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
KIIHRDLKA NIL D + K++DFG++ + ++ I
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 2e-46
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 10/167 (5%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQ 445
FSD ++G G FG VY + + + +A+K++S + Q Q+ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H N ++ GC L L+ EY + D+ L ++ +G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
LH +IHRD+KA NILL + K+ DFG A I + T
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 7/161 (4%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL-QEFKNEVNLIAKLQH 446
+ F ++LG G G V+K + G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+V G E+ + E+M SLD L A R + + + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ KI+HRD+K SNIL++ K+ DFG++ +
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 4e-44
Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 6/165 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ ++KLG G +G VY+G +AVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V+LLG C +I E+M +L +L + R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE-- 132
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+ IHRDL A N L+ ++ K++DFGL+R+ G+ A+
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-43
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 6/165 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ +LG G FG V G +A+K + S EF E ++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L G C + + + +I EYM N L +L + + ++ + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
+ +HRDL A N L++D K+SDFGL+R ++ ++
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-43
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ + ++G G FG V+ G + +A+K + R ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L G CLE + L++E+M + L +L + + + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+IHRDL A N L+ ++ K+SDFG+ R +Q ++
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 4e-43
Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 19/184 (10%)
Query: 388 EATNHFSDE---------NKLGQGGFGPVYKGTLA----DGKAIAVKRL-SRTSGQGLQE 433
EA F+ E +G G FG V G L +A+K L S + + ++
Sbjct: 14 EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73
Query: 434 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
F +E +++ + H N++ L G + +++I E+M N SLD L Q +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLV 131
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
++ GIA G+ YL + +HRDL A NIL++ ++ K+SDFGL+R + +
Sbjct: 132 GMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
Query: 554 IIAG 557
G
Sbjct: 189 SALG 192
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 9e-43
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 8/168 (4%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNL 449
+ +G G +G K +DGK + K L S Q +EVNL+ +L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYL 506
VR ++ L ++ EY L + T+ Q LD + ++ + +
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 507 HE--DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H D ++HRDLK +N+ LD N K+ DFGLARI + + A
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-43
Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 10/173 (5%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQG-LQEFKNEVN 439
+L L+ N + +LG G FG V +G +A+K L + + + +E E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
++ +L + +VRL+G C + + L+L+ E L L + ++ +++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ G+ YL +HRDL A N+LL + KISDFGL++ G + +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-42
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L + + ++ EYM SL L T + + IA G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
R+ +HRDL+A+NIL+ +++ K++DFGLAR+ N+ A
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-41
Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 8/170 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKN 448
+ LG+G +G V +A+AVK + E K E+ + L H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+ G EG L EY L + + + Q + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ I HRD+K N+LLD+ N KISDFGLA +F N + N + GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-41
Identities = 54/191 (28%), Positives = 73/191 (38%), Gaps = 26/191 (13%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
N S LG G FG V + T +AVK L ++ + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 444 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---------------ATRSVQL 487
L H N+V LLG C G L+I EY L L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
D + S +A+G+ +L IHRDL A NILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 548 NQANTNIIAGT 558
N
Sbjct: 200 NYVVKGNARLP 210
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-41
Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 8/165 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+LLG +E + L ++ EYM SL +L RSV L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE-- 120
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+HRDL A N+L+ +D K+SDFGL + Q+ +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 4e-41
Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 31/196 (15%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAK 443
N+ +G+G FG V++ +AVK L + +Q +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-------------------- 483
+ N+V+LLG C G+ + L++EYM L+ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 484 -SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L + I +A G+ YL E K +HRDL N L+ ++M KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 543 FGGNQNQANTNIIAGT 558
A
Sbjct: 190 IYSADYYKADGNDAIP 205
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-41
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 395 DENKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNL 449
++ +LG G FG V KG K +AVK L + E E N++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
VR++G C E + +L+ E L+ +L + K +++ ++ G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+HRDL A N+LL KISDFGL++ ++N
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-41
Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 16/171 (9%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
+ ++G+G F VYKG + +A L + + Q FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 453 LGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ ++L+ E M + +L +L R + K +S I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 509 DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ IIHRDLK NI + + KI D GLA + + + GT
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 176
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-40
Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
++ K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V L L G EL ++ EY+ SL + + D + ++ + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
++IHRD+K+ NILL D + K++DFG Q++ +T +
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 42/174 (24%), Positives = 75/174 (43%), Gaps = 17/174 (9%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+ +G+G FG V++G G+ +AVK S + + E+ L+H+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 456 CLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-- 509
+ +L L+ +Y + SL +L + + + A G+ +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 510 ---SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGT 558
+ I HRDLK+ NIL+ + I+D GLA + N GT
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-40
Identities = 46/196 (23%), Positives = 70/196 (35%), Gaps = 31/196 (15%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
+ LG G FG V T +AVK L + + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 444 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--------------------AT 482
L H+N+V LLG C + LI+EY L +L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 483 RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L ++ +A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 543 FGGNQNQANTNIIAGT 558
+ N
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-39
Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 10/161 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH 446
F LG+G FG VY +A+K L + + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
N++RL G + + LI EY P ++ L ++ D +R + I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
H ++IHRD+K N+LL KI+DFG + ++
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (361), Expect = 1e-38
Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 8/170 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+H+ +LG G FG V++ T A G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V L + E+++IYE+M L + D ++ + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 510 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAG 557
+H DLK NI+ + K+ DFGL Q+ T A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 11/168 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTSGQG-LQEFKNEVNLIAKL 444
+ + + +G G FG VYKG L +A+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
H N++RL G + + +++I EYM N +LD L + + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
YL + +HRDL A NIL++ ++ K+SDFGL+R+ + T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 37/169 (21%), Positives = 76/169 (44%), Gaps = 5/169 (2%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKL 444
+ +++ + +G+G +G V + +A+K++S Q Q E+ ++ +
Sbjct: 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 63
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
+H+N++ + + Y+ + L+ ++ L + I RG+
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
Y+H ++HRDLK SN+LL+ + KI DFGLAR+ + +
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-38
Identities = 51/186 (27%), Positives = 82/186 (44%), Gaps = 24/186 (12%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADG---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-Q 445
N ++ +G+G FG V K + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
H N++ LLG C L L EY P+ +L L + + L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ARG+ YL + + IHRDL A NIL+ ++ KI+DFGL+R G +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 553 NIIAGT 558
+
Sbjct: 184 TMGRLP 189
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-38
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
HF +G+G FG VY GTL D AVK L+R + G + +F E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 447 KNLVRLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
N++ LLG CL + L++ YM + L + + T + + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ + K +HRDL A N +LD+ K++DFGLAR + + N
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 12/172 (6%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQH 446
F LG G FG VYKG + +G+ +A+K L TS + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
++ RLLG CL + LI + MP L ++ + + + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+++HRDL A N+L+ + KI+DFGLA++ G + + +
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-37
Identities = 50/169 (29%), Positives = 68/169 (40%), Gaps = 13/169 (7%)
Query: 397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
KLG G FG V +G ++AVK L + + + +F EVN + L H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+RL G L + ++ E P SL L +A G+ YL
Sbjct: 74 IRLYGVVLTP-PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLES- 129
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ IHRDL A N+LL KI DFGL R N +
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 47/170 (27%), Positives = 72/170 (42%), Gaps = 10/170 (5%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHK 447
F LG+G F V LA + A+K L + + E +++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
V+L + ++L Y N L ++ D + I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
IIHRDLK NILL++DM+ +I+DFG A++ QA N G
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-37
Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 17/182 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAK 443
+ +LGQG FG VY+G +A+K ++ S + EF NE +++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRQSII 496
++VRLLG +GQ L+I E M L +L + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
IA G+ YL+ + K +HRDL A N ++ +D KI DFG+ R
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 557 GT 558
Sbjct: 197 LP 198
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (349), Expect = 4e-37
Identities = 38/160 (23%), Positives = 72/160 (45%), Gaps = 8/160 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+++ +LG G FG V++ A G+ K ++ KNE++++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ L + E++LI E++ L + A ++ + + G+ ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 510 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQ 547
I+H D+K NI+ + KI DFGLA ++
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (347), Expect = 9e-37
Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 13/164 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQ- 445
N FS +G+GGFG VY AD GK A+K L + QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 446 --HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+V + +L I + M L HL + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
++H +++RDLK +NILLD+ + +ISD GLA F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-36
Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 11/169 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQ 445
+G+G FG V++G A+A+K + ++E F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H ++V+L+G E + +I E L L S LD ++ + Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
L + +HRD+ A N+L+ + K+ DFGL+R + +
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 169
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 7e-35
Identities = 48/190 (25%), Positives = 75/190 (39%), Gaps = 25/190 (13%)
Query: 391 NHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
+ LG+G FG V + A + +AVK L + + +E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 444 -LQHKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLF-------------DATRSVQLD 488
H N+V LLG C + G L++I E+ +L +L + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ +A+G+ +L K IHRDL A NILL + KI DFGLAR + +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 549 QANTNIIAGT 558
Sbjct: 190 YVRKGDARLP 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 35/154 (22%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
LG+G FG V++ + K K + + G K E++++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
+EL++I+E++ + + T + +L+ + S ++ + + +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 517 RDLKASNILLDDDMNP--KISDFGLARIFGGNQN 548
D++ NI+ + KI +FG AR N
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
++D +G G FG VY+ L D G+ +A+K++ + + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 452 LLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
L E L L+ +Y+P V + L + + + R + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 506 LHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQNQANT 552
+H I HRD+K N+LLD D K+ DFG A+ + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (321), Expect = 6e-34
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 17/167 (10%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------QEFKNEVNLI 441
++ + LG+G V + K AVK + T G + EV+++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 442 AKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
K+ H N+++L L+++ M L +L T V L K + I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
I LH+ L I+HRDLK NILLDDDMN K++DFG + +
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-33
Identities = 53/191 (27%), Positives = 77/191 (40%), Gaps = 26/191 (13%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSR-TSGQGLQEFKNEVNLI 441
+ LG+G FG V +AVK L + + L + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 442 AKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQL 487
+ +HKN++ LLG C + L +I EY +L +L QL
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
K S +ARG+ YL K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 548 NQANTNIIAGT 558
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (321), Expect = 1e-33
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
F LG G FG V+ +G+ A+K L + + ++ +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
++R+ G + Q++ +I +Y+ L L + R K + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
II+RDLK NILLD + + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (315), Expect = 4e-33
Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ K+G+G +G VYK G+ A+K RL + E++++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+L + L+L++E++ + L+ +S + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+++HRDLK N+L++ + KI+DFGLAR FG + I
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 1e-31
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHK 447
+ + + LG G F V K +A+K +++ + +G + +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
N+V L G L LI + + L + + + +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+ I+HRDLK N+L D+D ISDFGL+++ + GT
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGT 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-31
Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 8/166 (4%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+F K+G+G +G VYK G+ +A+K RL + E++L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+LL +L L++E++ DA+ + +S + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+++HRDLK N+L++ + K++DFGLAR FG +
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-31
Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-----FKNEVNLIAKLQHKNLV 450
+ LG+G F VYK + +A+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
LL + L++++M + S+ L ++ + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
I+HRDLK +N+LLD++ K++DFGLA+ FG +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (298), Expect = 9e-31
Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 15/178 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQ 445
++ + LG GG V+ L + +AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 446 HKNLVRLLGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
H +V + G ++ EY+ +L + + KR +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNIIAGT 558
+ + H+ IIHRD+K +NI++ K+ DFG+AR + N T + GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 13/173 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAK-LQ 445
F LG+G FG V+ + A+K L + ++ E +++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H L + + L + EY+ L H+ + D R I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
LH I++RDLK NILLD D + KI+DFG+ + + NT GT
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 7e-30
Identities = 42/174 (24%), Positives = 81/174 (46%), Gaps = 17/174 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHK 447
+ + K+GQG FG V+K G+ +A+K++ + + E+ ++ L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 448 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
N+V L+ C + L++++ + + V+ + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQML 126
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
G L+ R KI+HRD+KA+N+L+ D K++DFGLAR F +N
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-29
Identities = 44/172 (25%), Positives = 67/172 (38%), Gaps = 12/172 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
N F LG+G FG V A G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L L L + EY L HL +R +R + I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
+++RD+K N++LD D + KI+DFGL + G + A GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 168
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-28
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 17/170 (10%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL 444
E + D +G G +G V G +A+K+L R S + E+ L+ +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 445 QHKNLVRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
+H+N++ LL + + L+ +M + + +L R Q ++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQ 129
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ +G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 130 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 2e-28
Identities = 42/174 (24%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKL 444
A + ++G+G +G V+K G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 445 ---QHKNLVRLLGCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRQSIING 498
+H N+VRL C + + + +D D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ RG+ +LH +++HRDLK NIL+ K++DFGLARI+ +
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 175
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-28
Identities = 39/167 (23%), Positives = 64/167 (38%), Gaps = 15/167 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE------FKNEVNLIAK 443
+ + LG GGFG VY G ++D +A+K + + E EV L+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 444 LQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
+ ++RLL +LI E T L + +S +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 502 GILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547
+ + H ++HRD+K NIL+D + K+ DFG +
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (282), Expect = 4e-28
Identities = 40/162 (24%), Positives = 64/162 (39%), Gaps = 10/162 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
+ F LG G FG V G A+K L + + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
LV+L + L ++ EY+ + HL R + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
H L +I+RDLK N+L+D +++DFG A+ G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 9/167 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHK 447
+ K+G+G +G V+K + +A+K RL E+ L+ +L+HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
N+VRL ++L L++E+ + + + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
++HRDLK N+L++ + K+++FGLAR FG + +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAK 443
+++ +LG G F V K + G A K + + G ++ + EV+++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+QH N++ L +++LI E + L L + L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQ 547
++ L+I H DLK NI+L D P KI DFGLA
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 37/163 (22%), Positives = 62/163 (38%), Gaps = 18/163 (11%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLL 453
LG G G V + + A+K L + + EV L + Q ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 454 GCC----LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ LL++ E + L + D + I+ I I YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 510 SRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQ 549
+ I HRD+K N+L K++DFG A+ + +
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (267), Expect = 2e-26
Identities = 29/170 (17%), Positives = 66/170 (38%), Gaps = 15/170 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KN 448
H+ ++G+G FG +++GT L + + +A+K R S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ + EG +L+ + + D+ + K + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 509 DSRLKIIHRDLKASNILLDDDMNP-----KISDFGLARIFGGNQNQANTN 553
+++RD+K N L+ + + DFG+ + + + +
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 2e-26
Identities = 38/168 (22%), Positives = 67/168 (39%), Gaps = 13/168 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
N + K+G G FG +Y GT +A G+ +A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 450 VRLLG-CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ + C EG +++ E + D+ F + + K + + + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 121
Query: 509 DSRLKIIHRDLKASNIL---LDDDMNPKISDFGLARIFGGNQNQANTN 553
IHRD+K N L I DFGLA+ + + +
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 41/168 (24%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIA 442
+F LG G +G V+ GK A+K L + + + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 443 KLQHK-NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
++ LV L +L LI +Y+ L HL R + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+L L +L II+RD+K NILLD + + ++DFGL++ F ++ +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (261), Expect = 2e-25
Identities = 32/162 (19%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKN 448
+ + KLG+G + V++ + + + + VK L ++ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 449 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
++ L + + L++E++ N L + + I + + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 507 HEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547
H + I+HRD+K N+++D + ++ D+GLA + Q
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 7e-25
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHK 447
+ + +G G G V + +A+K+LSR + + E+ L+ + HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 448 NLVRLLGCCL------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
N++ LL E Q++ L+ E M V +LD +R ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
GI +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 9e-24
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 7/165 (4%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL 444
E + + + +G G +G V G +AVK+LSR S + E+ L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 445 QHKNLVRLLGCCLEGQELLLI-YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+H+N++ LL + L Y+ + L + + +L Q +I I RG+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.8 bits (235), Expect = 4e-23
Identities = 28/155 (18%), Positives = 56/155 (36%), Gaps = 20/155 (12%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQ--------GLQEFKNEVNLIAKLQH 446
+G+G V+ VK ++ TS + G F A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+ L +L G + Y + N ++ + L DA ++ + +++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I+H DL N+L+ + I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.9 bits (206), Expect = 4e-18
Identities = 27/177 (15%), Positives = 57/177 (32%), Gaps = 18/177 (10%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG G F V+ + + +A+K + + ++E+ L+ ++ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76
Query: 455 CCLEGQELLLIYEYMPNKSLDV-------------HLFDATRSVQLDWKRRQSIINGIAR 501
LL + + L + + I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 502 GILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAG 557
G+ Y+H R IIH D+K N+L++ D + +A + +
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.98 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.98 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.94 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.93 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.93 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.93 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.93 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.93 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.82 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.36 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.26 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.9e-33 Score=274.90 Aligned_cols=162 Identities=31% Similarity=0.450 Sum_probs=139.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..++||+|+||.||+|+.. +|+.||||++.... .+..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999999999999975 68999999997543 33456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
+++|+|.+++.+ ...+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+..+..
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999843 346999999999999999999999985 99999999999999999999999999998865544
Q ss_pred ccCcccccCC
Q 008634 549 QANTNIIAGT 558 (558)
Q Consensus 549 ~~~t~~~~Gt 558 (558)
......++||
T Consensus 159 ~~~~~~~~GT 168 (271)
T d1nvra_ 159 ERLLNKMCGT 168 (271)
T ss_dssp ECCBCCCCSC
T ss_pred cccccceeeC
Confidence 3334446776
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.7e-32 Score=269.64 Aligned_cols=151 Identities=26% Similarity=0.462 Sum_probs=137.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|...++||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46888999999999999999964 69999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
++|+|.+++.+ ..+++.....++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+.+..+..
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998854 24899999999999999999999985 99999999999999999999999999998865543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-32 Score=270.60 Aligned_cols=151 Identities=29% Similarity=0.502 Sum_probs=130.5
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|+..++||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999888999999997643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+|+|.+++.. ....++|..++.|+.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999864 3356899999999999999999999985 9999999999999999999999999999876544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=8.8e-33 Score=275.57 Aligned_cols=154 Identities=30% Similarity=0.515 Sum_probs=138.0
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
.++|...++||+|+||.||+|+.. +++.||||+++... ...++|.+|+.+|++++|||||+++|++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 346778889999999999999976 58899999997543 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
+++|+|.+++.+. ....++|..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+....+..
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999999653 3456999999999999999999999985 99999999999999999999999999998866543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-32 Score=270.41 Aligned_cols=161 Identities=35% Similarity=0.564 Sum_probs=131.7
Q ss_pred cCCCCcccccccCCcccEEEEEecCCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|...++||+|+||.||+|+.+ ..||||+++.. +.+..+.|.+|+.++.+++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 457888999999999999999875 36999999754 34557889999999999999999999998754 56899999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+++|+|.+++... ...++|..++.|+.||++||.|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999643 345999999999999999999999984 9999999999999999999999999999886554
Q ss_pred CccCcccccCC
Q 008634 548 NQANTNIIAGT 558 (558)
Q Consensus 548 ~~~~t~~~~Gt 558 (558)
.......+.||
T Consensus 159 ~~~~~~~~~gt 169 (276)
T d1uwha_ 159 GSHQFEQLSGS 169 (276)
T ss_dssp -------CCCC
T ss_pred CcccccccccC
Confidence 43333445555
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-32 Score=269.35 Aligned_cols=151 Identities=36% Similarity=0.583 Sum_probs=133.7
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...++||+|+||.||+|++++++.||||+++... ...+.|.+|++++.+++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4677788999999999999999888999999997543 345789999999999999999999998754 56799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+|+|.+++... ....++|..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+....+.
T Consensus 91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999987542 2235999999999999999999999984 9999999999999999999999999999886554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-32 Score=271.74 Aligned_cols=150 Identities=29% Similarity=0.476 Sum_probs=137.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
+.|+..++||+|+||.||+|+.. +|+.||||++.....+..+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46788899999999999999975 68999999998777777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
++|+|.+++.+. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+....
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 999999998653 345999999999999999999999985 99999999999999999999999999987643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=7.2e-32 Score=270.50 Aligned_cols=153 Identities=31% Similarity=0.542 Sum_probs=125.9
Q ss_pred CCCCcccccccCCcccEEEEEecC-C---cEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g---~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...++||+|+||.||+|+... + ..||||++... ..+..++|.+|+++|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 346677899999999999998752 3 36899998754 334567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++.. ....++|..++.|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998864 3346999999999999999999999984 99999999999999999999999999998865
Q ss_pred CCC
Q 008634 546 NQN 548 (558)
Q Consensus 546 ~~~ 548 (558)
+..
T Consensus 181 ~~~ 183 (299)
T d1jpaa_ 181 DTS 183 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=266.46 Aligned_cols=162 Identities=28% Similarity=0.417 Sum_probs=137.3
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|+..+.||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888999999999999999975 6899999998753 2334577999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999998643 35999999999999999999999985 999999999999999999999999999998765
Q ss_pred CCccCcccccCC
Q 008634 547 QNQANTNIIAGT 558 (558)
Q Consensus 547 ~~~~~t~~~~Gt 558 (558)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 544444445666
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-31 Score=259.75 Aligned_cols=151 Identities=29% Similarity=0.472 Sum_probs=137.4
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|+..++||+|+||.||+|+.+++++||||++++... ..++|.+|+.++.+++|||||+++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998889999999986543 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+|+|..++... ...++|..+.+++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999997543 346899999999999999999999985 9999999999999999999999999999876544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-31 Score=261.85 Aligned_cols=151 Identities=29% Similarity=0.469 Sum_probs=135.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+|+.+ +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999975 6899999998753 2334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....+
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999643 35999999999999999999999985 999999999999999999999999999877654
Q ss_pred C
Q 008634 547 Q 547 (558)
Q Consensus 547 ~ 547 (558)
.
T Consensus 160 ~ 160 (263)
T d2j4za1 160 R 160 (263)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.4e-32 Score=265.82 Aligned_cols=158 Identities=29% Similarity=0.441 Sum_probs=126.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe--CCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 465 (558)
++|+..+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++.+++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999865 68999999987653 3345678999999999999999999999975 4568999
Q ss_pred EEcCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 466 YEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
|||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 3456999999999999999999999864 23599999999999999999999999999998
Q ss_pred eCCCCC
Q 008634 543 FGGNQN 548 (558)
Q Consensus 543 ~~~~~~ 548 (558)
+..+..
T Consensus 164 ~~~~~~ 169 (269)
T d2java1 164 LNHDTS 169 (269)
T ss_dssp C-----
T ss_pred cccCCC
Confidence 865443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=271.76 Aligned_cols=151 Identities=26% Similarity=0.365 Sum_probs=135.4
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|+..++||+|+||.||+|+.. +|+.||+|+++.. +....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467888999999999999999965 6899999999754 33445679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+.. +|+||||||+||||++++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999653 35999999999999999999999741 499999999999999999999999999997753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-30 Score=260.02 Aligned_cols=151 Identities=28% Similarity=0.543 Sum_probs=130.6
Q ss_pred CCCCccc-ccccCCcccEEEEEec---CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...+ +||+|+||.||+|..+ ++..||||+++... ....++|.+|+++|.+++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455555 5999999999999864 35579999997653 3446789999999999999999999999865 568999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++.. ....++|..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999853 3346999999999999999999999984 99999999999999999999999999998865
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
..
T Consensus 162 ~~ 163 (285)
T d1u59a_ 162 DD 163 (285)
T ss_dssp CS
T ss_pred cc
Confidence 54
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-31 Score=263.53 Aligned_cols=151 Identities=33% Similarity=0.527 Sum_probs=130.7
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 470 (558)
++|...++||+|+||.||+|+++++..||||+++... ...+.|.+|+.++.+++|||||+++|++. .++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 4688899999999999999999888899999997543 44578999999999999999999999985 456899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+|+|..++.... ...++|..++.|+.||+.||.|||+++ |+||||||+|||||.++++||+|||+|+.+..+.
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999886532 235999999999999999999999985 9999999999999999999999999999876544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.8e-31 Score=267.71 Aligned_cols=165 Identities=28% Similarity=0.400 Sum_probs=136.1
Q ss_pred CCCCcccccccCCcccEEEEEecC-C-----cEEEEEEcccc-CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-G-----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g-----~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (558)
++|...++||+|+||.||+|+... + ..||||++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568888999999999999998643 2 36999998654 344567899999999998 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 008634 463 LLIYEYMPNKSLDVHLFDATR--------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 522 (558)
Q Consensus 463 ~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~ 522 (558)
++||||+++|+|.++|++... ...++|..++.|+.||+.||.|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999975432 235899999999999999999999984 999999999
Q ss_pred CEEEcCCCcEEEEecCcceeeCCCCCccCcccccCC
Q 008634 523 NILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 523 NILl~~~~~~ki~DFGla~~~~~~~~~~~t~~~~Gt 558 (558)
|||++.++.+||+|||+|+...............||
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 999999999999999999987665544333334443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.2e-31 Score=260.76 Aligned_cols=152 Identities=32% Similarity=0.567 Sum_probs=128.3
Q ss_pred CCCCcccccccCCcccEEEEEecCC-----cEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g-----~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
+.|+..++||+|+||.||+|.+++. ..||||++.... .....+|.+|+.++.+++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987642 479999997543 3345679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
||||+.+|++.+++.+. ...++|..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999888643 346999999999999999999999984 9999999999999999999999999999876
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
.+.
T Consensus 162 ~~~ 164 (283)
T d1mqba_ 162 DDP 164 (283)
T ss_dssp ---
T ss_pred CCC
Confidence 554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-30 Score=257.70 Aligned_cols=145 Identities=32% Similarity=0.507 Sum_probs=126.2
Q ss_pred cccccCCcccEEEEEecC---CcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcCCC
Q 008634 397 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~---g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 471 (558)
++||+|+||.||+|.+.+ ++.||||+++.. +....++|.+|+++|++++|||||+++|++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 468999999754 23345789999999999999999999999865 467899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCCC
Q 008634 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (558)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 548 (558)
|+|.+++.+. ..++|..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+....+
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 9999999653 35999999999999999999999984 99999999999999999999999999998866544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=2.3e-30 Score=264.91 Aligned_cols=152 Identities=26% Similarity=0.451 Sum_probs=137.5
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|.+.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47889999999999999999965 68999999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc--CCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~--~~~~~ki~DFGla~~~~~~~ 547 (558)
++|+|.+++.+ ....+++.....|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999854 3346999999999999999999999985 99999999999996 46789999999999886554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-30 Score=255.86 Aligned_cols=149 Identities=30% Similarity=0.429 Sum_probs=129.0
Q ss_pred CcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEe----CCEEEEEE
Q 008634 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIY 466 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 466 (558)
..+++||+|+||.||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++++ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999975 5889999998754 33445679999999999999999999999976 35689999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc-CCCcEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DFGla~~~~~ 545 (558)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999653 35899999999999999999999873 3599999999999996 578999999999987654
Q ss_pred C
Q 008634 546 N 546 (558)
Q Consensus 546 ~ 546 (558)
.
T Consensus 168 ~ 168 (270)
T d1t4ha_ 168 S 168 (270)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=2e-30 Score=260.88 Aligned_cols=149 Identities=32% Similarity=0.547 Sum_probs=133.0
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.|+..++||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4788899999999999999864 688999999976543 335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
|+++|+|..++.. ...++|..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999877643 245999999999999999999999985 999999999999999999999999999976543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=3.1e-30 Score=264.15 Aligned_cols=152 Identities=24% Similarity=0.400 Sum_probs=137.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|...++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46889999999999999999964 69999999998766556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc--CCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~--~~~~~ki~DFGla~~~~~~~ 547 (558)
++|+|.+++.+ ....+++.....|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+.+..+.
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999988743 3346999999999999999999999985 99999999999998 67899999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-30 Score=263.26 Aligned_cols=160 Identities=26% Similarity=0.341 Sum_probs=139.7
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...+.||+|+||.||+++.. +|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56888999999999999999964 6999999999754 2334677899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998653 35899999999999999999999985 999999999999999999999999999987554
Q ss_pred CCccCcccccCC
Q 008634 547 QNQANTNIIAGT 558 (558)
Q Consensus 547 ~~~~~t~~~~Gt 558 (558)
.... ..++||
T Consensus 159 ~~~~--~~~~GT 168 (337)
T d1o6la_ 159 GATM--KTFCGT 168 (337)
T ss_dssp TCCB--CCCEEC
T ss_pred Cccc--ccceeC
Confidence 3322 235565
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=7.7e-31 Score=263.34 Aligned_cols=166 Identities=30% Similarity=0.483 Sum_probs=139.3
Q ss_pred HcCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCcc-chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCE
Q 008634 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 389 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (558)
..++|+..++||+|+||.||+|+.. +++.||||+++....+ ..++|.+|++++++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4568999999999999999999864 3578999999765433 45679999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 008634 462 LLLIYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk 520 (558)
.++||||+++|+|.++++... ....++|..++.|+.||+.||.|||+++ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999996432 1234899999999999999999999984 9999999
Q ss_pred CCCEEEcCCCcEEEEecCcceeeCCCCCccCcccccC
Q 008634 521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557 (558)
Q Consensus 521 ~~NILl~~~~~~ki~DFGla~~~~~~~~~~~t~~~~G 557 (558)
|+|||||.++.+||+|||+|+....+.....+....|
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~ 204 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 204 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCc
Confidence 9999999999999999999998755443333333344
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=7.5e-30 Score=252.74 Aligned_cols=151 Identities=30% Similarity=0.428 Sum_probs=135.2
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCcc---------chHHHHHHHHHHhcCC-CCCeeeeeEEEEeC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---------GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG 459 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 459 (558)
++|+..++||+|+||.||+++.. +|+.||||++.+.... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999864 6899999998765321 1346889999999997 99999999999999
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
+..++||||+++|+|.+++... ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999653 35999999999999999999999985 99999999999999999999999999
Q ss_pred ceeeCCCC
Q 008634 540 ARIFGGNQ 547 (558)
Q Consensus 540 a~~~~~~~ 547 (558)
++.+..+.
T Consensus 157 a~~~~~~~ 164 (277)
T d1phka_ 157 SCQLDPGE 164 (277)
T ss_dssp CEECCTTC
T ss_pred eeEccCCC
Confidence 99886543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=8.1e-30 Score=257.34 Aligned_cols=150 Identities=27% Similarity=0.404 Sum_probs=134.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+|+.+ +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888899999999999999974 6899999999754 2344678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+++|+|..++... ..+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999988643 35788999999999999999999885 999999999999999999999999999987543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=4.2e-30 Score=258.39 Aligned_cols=152 Identities=26% Similarity=0.386 Sum_probs=122.8
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
.+.|...++||+|+||.||+|+.. +|+.||||++.+... ...+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888899999999999999975 689999999975532 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc---CCCcEEEEecCcceeeC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFG 544 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DFGla~~~~ 544 (558)
|+++|+|.+++.+ ...+++.....++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999964 346999999999999999999999985 99999999999994 57899999999999876
Q ss_pred CCC
Q 008634 545 GNQ 547 (558)
Q Consensus 545 ~~~ 547 (558)
.+.
T Consensus 162 ~~~ 164 (307)
T d1a06a_ 162 PGS 164 (307)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=251.08 Aligned_cols=151 Identities=28% Similarity=0.395 Sum_probs=134.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc------cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
+.|...++||+|+||.||+|+.. +|+.||||++++... ...+.+.+|+.+|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56888999999999999999974 689999999875421 23577999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC----cEEEEecCc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGL 539 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DFGl 539 (558)
+||||+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999653 35999999999999999999999985 99999999999998776 499999999
Q ss_pred ceeeCCCC
Q 008634 540 ARIFGGNQ 547 (558)
Q Consensus 540 a~~~~~~~ 547 (558)
|+....+.
T Consensus 164 a~~~~~~~ 171 (293)
T d1jksa_ 164 AHKIDFGN 171 (293)
T ss_dssp CEECTTSC
T ss_pred hhhcCCCc
Confidence 99886543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=256.51 Aligned_cols=162 Identities=30% Similarity=0.509 Sum_probs=131.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCc----EEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (558)
++|+..++||+|+||.||+|+.. +|+ +||+|+++.. +.+..++|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888999999999999999864 343 6899998754 445577899999999999999999999999875 5678
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeC
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~ 544 (558)
++||+.+|+|.+++.. ....++|..+++++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998865 3456999999999999999999999984 9999999999999999999999999999887
Q ss_pred CCCCccCcccccCC
Q 008634 545 GNQNQANTNIIAGT 558 (558)
Q Consensus 545 ~~~~~~~t~~~~Gt 558 (558)
.+.....+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 65554444444454
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-29 Score=254.89 Aligned_cols=156 Identities=30% Similarity=0.483 Sum_probs=135.7
Q ss_pred CCCCcccccccCCcccEEEEEec------CCcEEEEEEccccC-ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
++|...++||+|+||.||+|.+. ++..||||++++.. .+....|.+|+.++.+++|||||+++|++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56778899999999999999863 25789999997553 334567999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 008634 464 LIYEYMPNKSLDVHLFDA-------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~D 536 (558)
+||||+++|+|.+++... .....++|..+.+|+.||++||.|||++ +|+||||||+||||+.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999998642 2234579999999999999999999998 499999999999999999999999
Q ss_pred cCcceeeCCCCCc
Q 008634 537 FGLARIFGGNQNQ 549 (558)
Q Consensus 537 FGla~~~~~~~~~ 549 (558)
||+|+........
T Consensus 177 FGla~~~~~~~~~ 189 (308)
T d1p4oa_ 177 FGMTRDIYETDYY 189 (308)
T ss_dssp TTCCCGGGGGGCE
T ss_pred cccceeccCCcce
Confidence 9999987655443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.2e-30 Score=255.13 Aligned_cols=166 Identities=27% Similarity=0.386 Sum_probs=129.4
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccC-ccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeC-C
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 460 (558)
.++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|...+.++ +|+||+++++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357888999999999999999853 34689999997543 33456788888888877 689999999998765 4
Q ss_pred EEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
..++||||+++|+|.+++..... ...++|..++.++.||++||.|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999975321 235899999999999999999999984 99999999999999
Q ss_pred CCCcEEEEecCcceeeCCCCCccCcccccCC
Q 008634 528 DDMNPKISDFGLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~~~~~~~~t~~~~Gt 558 (558)
+++.+||+|||+|+..........+....||
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred CCCcEEEccCcchhhccccccccccCceeeC
Confidence 9999999999999988766554444445665
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.9e-29 Score=250.65 Aligned_cols=151 Identities=21% Similarity=0.361 Sum_probs=133.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
++|.+.++||+|+||.||+|... +|+.||||.++... .....+.+|+++|++++|||||++++++++++..|+||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 57888999999999999999975 68899999997653 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCC--CcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~--~~~ki~DFGla~~~~~~~ 547 (558)
++|+|.+++.+ ....+++.+...|+.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999954 2346899999999999999999999985 9999999999999854 589999999999876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=4.5e-29 Score=255.31 Aligned_cols=150 Identities=25% Similarity=0.372 Sum_probs=135.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (558)
++|...++||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+..++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46888999999999999999975 6999999998753 2344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
||+.+|+|..++.+. ..+++.....++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+.+.
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999999653 35899999999999999999999985 999999999999999999999999999988643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=5.2e-29 Score=256.23 Aligned_cols=151 Identities=30% Similarity=0.378 Sum_probs=131.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHH---HHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEF---KNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~---~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
++|...++||+|+||.||+|+.. +|+.||||++.+.. ......+ ..|+.++..++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999975 69999999986432 1222333 34577888889999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||+++|+|.+++.+. ..+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999653 35889999999999999999999985 999999999999999999999999999988
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
....
T Consensus 158 ~~~~ 161 (364)
T d1omwa3 158 SKKK 161 (364)
T ss_dssp SSSC
T ss_pred CCCc
Confidence 6543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-29 Score=248.78 Aligned_cols=151 Identities=24% Similarity=0.393 Sum_probs=123.2
Q ss_pred CCCCcccccccCCcccEEEEEecC----CcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~----g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...++||+|+||.||+|+... +..||||+++.... ...+.|.+|+.++++++|||||+++|++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 468888999999999999998642 35789999875543 33567999999999999999999999985 4678999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999998754 3346899999999999999999999985 99999999999999999999999999998765
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
..
T Consensus 161 ~~ 162 (273)
T d1mp8a_ 161 ST 162 (273)
T ss_dssp --
T ss_pred Cc
Confidence 44
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.7e-29 Score=251.89 Aligned_cols=152 Identities=34% Similarity=0.555 Sum_probs=131.7
Q ss_pred CCCCcccccccCCcccEEEEEecC-Cc--EEEEEEcccc-CccchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~--~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (558)
++|+..++||+|+||.||+|++.+ |. .||||+++.. ..+..+.|.+|+++|.++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999998753 43 5788888654 344567899999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcE
Q 008634 466 YEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 532 (558)
|||+++|+|.++|++. .....++|..+++++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 23456999999999999999999999984 9999999999999999999
Q ss_pred EEEecCcceeeCC
Q 008634 533 KISDFGLARIFGG 545 (558)
Q Consensus 533 ki~DFGla~~~~~ 545 (558)
||+|||+|+....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.6e-29 Score=250.59 Aligned_cols=151 Identities=26% Similarity=0.425 Sum_probs=132.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC---ccchHHHHHHHHHHh-cCCCCCeeeeeEEEEeCCEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIA-KLQHKNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~---~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 465 (558)
++|...++||+|+||+||+|+.. +|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999975 68999999997542 334556777777765 68999999999999999999999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCC
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 545 (558)
|||+++|+|.+++... ..+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999653 34899999999999999999999985 99999999999999999999999999997765
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
..
T Consensus 156 ~~ 157 (320)
T d1xjda_ 156 GD 157 (320)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.1e-29 Score=249.55 Aligned_cols=152 Identities=27% Similarity=0.501 Sum_probs=130.4
Q ss_pred CCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|...++||+|+||.||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788899999999999999996 468999999996543 2346789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
|+.++.+. ++.. .....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99865554 3322 23456999999999999999999999985 9999999999999999999999999999876543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=248.46 Aligned_cols=152 Identities=34% Similarity=0.485 Sum_probs=124.2
Q ss_pred CCCCcccccccCCcccEEEEEec--CC--cEEEEEEcccc---CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA--DG--KAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~--~g--~~VaVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (558)
++|+..+.||+|+||.||+|+.. ++ .+||||++++. ..+..++|.+|+.+|++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45788899999999999999864 22 37899998754 23445789999999999999999999999976 4678
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+||||+++|++.+++... ...++|..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999888643 345999999999999999999999984 999999999999999999999999999998
Q ss_pred CCCCC
Q 008634 544 GGNQN 548 (558)
Q Consensus 544 ~~~~~ 548 (558)
..+..
T Consensus 162 ~~~~~ 166 (273)
T d1u46a_ 162 PQNDD 166 (273)
T ss_dssp CC-CC
T ss_pred ccCCC
Confidence 66544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.3e-29 Score=249.40 Aligned_cols=159 Identities=26% Similarity=0.382 Sum_probs=128.5
Q ss_pred CCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHH--HHHHHhcCCCCCeeeeeEEEEeCC----EEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRLLGCCLEGQ----ELLLI 465 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~--Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV 465 (558)
+|...++||+|+||.||+|++ +|+.||||+++... .+++.. |+..+.+++|||||+++|++.+.+ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 456778999999999999997 58899999986543 233444 455556789999999999998753 68999
Q ss_pred EEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 466 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
|||+++|+|.++|++. .++|..+++++.|++.||.|||+. ...+|+||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999653 489999999999999999999974 2347999999999999999999999999999
Q ss_pred eeeCCCCCcc--CcccccCC
Q 008634 541 RIFGGNQNQA--NTNIIAGT 558 (558)
Q Consensus 541 ~~~~~~~~~~--~t~~~~Gt 558 (558)
+.+....... .....+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt 175 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEEETTTTEECC----CCSC
T ss_pred ccccCCCcceeccccceecc
Confidence 9886544322 22335555
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.3e-28 Score=247.97 Aligned_cols=147 Identities=32% Similarity=0.519 Sum_probs=128.5
Q ss_pred ccccccCCcccEEEEEecCC----cEEEEEEcccc-CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-CEEEEEEEcC
Q 008634 396 ENKLGQGGFGPVYKGTLADG----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEYM 469 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~~g----~~VaVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 469 (558)
.++||+|+||+||+|++.++ ..||||++++. +....++|.+|+++|.+++|||||+++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 36899999754 444567899999999999999999999998874 5899999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
++|+|.+++.. ....++|..+++++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999864 3445789999999999999999999984 9999999999999999999999999999876543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.5e-29 Score=252.29 Aligned_cols=166 Identities=33% Similarity=0.431 Sum_probs=140.8
Q ss_pred cCCCCcccccccCCcccEEEEEec------CCcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCCE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (558)
.++|+..++||+|+||.||+|++. +++.||||+++.... ....+|.+|+.++.++ +|||||+++|++.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 357788899999999999999852 457899999976543 3456799999999999 79999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEE
Q 008634 462 LLLIYEYMPNKSLDVHLFDAT---------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl 526 (558)
.++||||+++|+|.+++++.. ....+++..+..++.||+.||.|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997543 2235899999999999999999999985 9999999999999
Q ss_pred cCCCcEEEEecCcceeeCCCCCccCcccccCC
Q 008634 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558 (558)
Q Consensus 527 ~~~~~~ki~DFGla~~~~~~~~~~~t~~~~Gt 558 (558)
+.++.+||+|||+++...............||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccCcccccccchheeccCCCcceEeeecccC
Confidence 99999999999999988765554444344444
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.6e-29 Score=246.85 Aligned_cols=150 Identities=31% Similarity=0.476 Sum_probs=125.0
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-CEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 469 (558)
++|...++||+|+||.||+|+++ |.+||||++++. ...+.|.+|++++++++|||||+++|++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677889999999999999984 789999999754 3457899999999999999999999998654 5689999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
++|+|.++|.+.. ...++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999996532 23589999999999999999999998 49999999999999999999999999999865443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.6e-29 Score=248.00 Aligned_cols=164 Identities=32% Similarity=0.432 Sum_probs=134.2
Q ss_pred CCCCcccccccCCcccEEEEEecC--------CcEEEEEEccccCc-cchHHHHHHHHHHhcC-CCCCeeeeeEEEEeCC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~--------g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (558)
++|...++||+|+||.||+|+... +..||||++++... ....++.+|...+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467788999999999999998532 24799999976543 4467889999999988 8999999999999999
Q ss_pred EEEEEEEcCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~ 527 (558)
..++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999975432 245899999999999999999999985 99999999999999
Q ss_pred CCCcEEEEecCcceeeCCCCCccCcccccC
Q 008634 528 DDMNPKISDFGLARIFGGNQNQANTNIIAG 557 (558)
Q Consensus 528 ~~~~~ki~DFGla~~~~~~~~~~~t~~~~G 557 (558)
.++.+||+|||+++..........+....|
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred CCCCeEeccchhhccccccccccccccCCC
Confidence 999999999999998866554433333444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=9.4e-29 Score=246.05 Aligned_cols=150 Identities=28% Similarity=0.482 Sum_probs=134.4
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 468 (558)
++|...++||+|+||.||+|+.++|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999899999999997543 23367899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 546 (558)
+.++.+..+.. ....+++.....|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 99887777763 3456999999999999999999999984 999999999999999999999999999987543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9e-29 Score=247.84 Aligned_cols=146 Identities=29% Similarity=0.456 Sum_probs=125.3
Q ss_pred ccccccCCcccEEEEEec-CCcEEEEEEccccCcc-----chHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 396 ~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
.++||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 6899999999754321 1356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
+++++..+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9988776653 3456888999999999999999999985 9999999999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=2.8e-28 Score=241.51 Aligned_cols=151 Identities=24% Similarity=0.346 Sum_probs=132.3
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCc---cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----E
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 461 (558)
.++|...+.||+|+||.||+|+. .+|+.||||++++... ...+.|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36788999999999999999996 4799999999976533 33567999999999999999999999998653 4
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.|+||||+++|+|.+++... ..++|.....++.||+.||.|||+++ |+||||||+|||++.++..||+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 89999999999999988653 35999999999999999999999985 9999999999999999999999999998
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.....
T Consensus 160 ~~~~~ 164 (277)
T d1o6ya_ 160 AIADS 164 (277)
T ss_dssp ECC--
T ss_pred hhccc
Confidence 76543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-27 Score=243.25 Aligned_cols=148 Identities=25% Similarity=0.352 Sum_probs=126.3
Q ss_pred CCCCcc-cccccCCcccEEEEEe-cCCcEEEEEEccccCccchHHHHHHHHHHhcC-CCCCeeeeeEEEEe----CCEEE
Q 008634 391 NHFSDE-NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQELL 463 (558)
Q Consensus 391 ~~f~~~-~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~ 463 (558)
++|.+. +.||+|+||.||+|+. .+++.||||++++. ..+.+|+.++.++ +|||||++++++.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467665 4599999999999986 46899999998643 4678899987655 89999999999876 35689
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC---CCcEEEEecCcc
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA 540 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DFGla 540 (558)
+||||+++|+|.+++.+. ....+++.....|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999999653 2346999999999999999999999985 999999999999985 567999999999
Q ss_pred eeeCCCC
Q 008634 541 RIFGGNQ 547 (558)
Q Consensus 541 ~~~~~~~ 547 (558)
+....+.
T Consensus 162 ~~~~~~~ 168 (335)
T d2ozaa1 162 KETTSHN 168 (335)
T ss_dssp EECCCCC
T ss_pred eeccCCC
Confidence 9876544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.4e-28 Score=237.95 Aligned_cols=150 Identities=25% Similarity=0.371 Sum_probs=129.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCc------cchHHHHHHHHHHhcCC--CCCeeeeeEEEEeCCE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQE 461 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 461 (558)
++|.+.++||+|+||.||+|+.. +|+.||||++.+... .....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 56889999999999999999964 689999999875421 11244678999999986 8999999999999999
Q ss_pred EEEEEEcCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-CCcEEEEecCc
Q 008634 462 LLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGL 539 (558)
Q Consensus 462 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DFGl 539 (558)
.++||||+.+ +++.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 6777777542 35899999999999999999999985 999999999999985 57999999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
|+.....
T Consensus 158 a~~~~~~ 164 (273)
T d1xwsa_ 158 GALLKDT 164 (273)
T ss_dssp CEECCSS
T ss_pred ceecccc
Confidence 9986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.2e-27 Score=241.80 Aligned_cols=149 Identities=29% Similarity=0.466 Sum_probs=125.4
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC------CEEEE
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELLL 464 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 464 (558)
.|...++||+|+||+||+|+.. +|+.||||++.+... .+.+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4777889999999999999975 689999999976532 234799999999999999999998653 24799
Q ss_pred EEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceee
Q 008634 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 543 (558)
Q Consensus 465 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~ 543 (558)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999998765555443344557999999999999999999999885 99999999999999765 8999999999987
Q ss_pred CCCC
Q 008634 544 GGNQ 547 (558)
Q Consensus 544 ~~~~ 547 (558)
..+.
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.3e-27 Score=232.24 Aligned_cols=151 Identities=27% Similarity=0.452 Sum_probs=134.9
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCCEEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|+..++||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888999999999999999964 68999999986543 2346789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceeeCCCC
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 547 (558)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....+.
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999888753 345889999999999999999999985 9999999999999999999999999999886543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.8e-27 Score=239.96 Aligned_cols=150 Identities=24% Similarity=0.391 Sum_probs=126.5
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCc-cchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC----EEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELL 463 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 463 (558)
+++|...++||+|+||.||+|+. .+|+.||||++.+... ...+.+.+|+++|.+++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999986 4799999999976543 34567899999999999999999999997643 334
Q ss_pred EEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 464 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
+++||+.+|+|.+++.. ..+++.....++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55567789999999954 24899999999999999999999985 999999999999999999999999999987
Q ss_pred CCC
Q 008634 544 GGN 546 (558)
Q Consensus 544 ~~~ 546 (558)
...
T Consensus 160 ~~~ 162 (345)
T d1pmea_ 160 DPD 162 (345)
T ss_dssp CGG
T ss_pred cCC
Confidence 544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.93 E-value=1.4e-26 Score=234.69 Aligned_cols=145 Identities=22% Similarity=0.411 Sum_probs=127.1
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeC--CEEEEEE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIY 466 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 466 (558)
++|.+.++||+|+||.||+|+.. +|+.||||+++... .+.+.+|+.+|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 47889999999999999999974 68999999987543 467889999999995 99999999999854 4689999
Q ss_pred EcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC-cEEEEecCcceeeCC
Q 008634 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGG 545 (558)
Q Consensus 467 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DFGla~~~~~ 545 (558)
||+++++|..+. ..+++.....++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 24899999999999999999999985 99999999999998654 699999999998865
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
+.
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 54
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1e-26 Score=235.15 Aligned_cols=151 Identities=27% Similarity=0.396 Sum_probs=132.5
Q ss_pred CCCCcccccccCCcccEEEEEec----CCcEEEEEEccccC----ccchHHHHHHHHHHhcCCC-CCeeeeeEEEEeCCE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQE 461 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~VaVK~l~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 461 (558)
++|...++||+|+||.||+|+.. +|+.||||.+++.. ....+.+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 46888999999999999999842 47899999987542 2335678899999999976 899999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++|+||+.+|+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 4678888999999999999999984 9999999999999999999999999999
Q ss_pred eeCCCC
Q 008634 542 IFGGNQ 547 (558)
Q Consensus 542 ~~~~~~ 547 (558)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 875443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.8e-26 Score=234.37 Aligned_cols=150 Identities=28% Similarity=0.482 Sum_probs=124.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEeCC------
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (558)
.++|...++||+|+||.||+|+.. +|+.||||++++.. ....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357888999999999999999964 69999999997542 233567899999999999999999999997654
Q ss_pred EEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcc
Q 008634 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (558)
Q Consensus 461 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla 540 (558)
..++||||+ +.+|..+... ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 5677776643 34999999999999999999999985 999999999999999999999999999
Q ss_pred eeeCCCC
Q 008634 541 RIFGGNQ 547 (558)
Q Consensus 541 ~~~~~~~ 547 (558)
+......
T Consensus 169 ~~~~~~~ 175 (346)
T d1cm8a_ 169 RQADSEM 175 (346)
T ss_dssp EECCSSC
T ss_pred eccCCcc
Confidence 9876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.8e-26 Score=230.53 Aligned_cols=150 Identities=27% Similarity=0.503 Sum_probs=126.8
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEcccc--CccchHHHHHHHHHHhcCCCCCeeeeeEEEEeC--------
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-------- 459 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 459 (558)
++|+..++||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+|++++|||++++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 57888899999999999999964 7999999998654 233456789999999999999999999998653
Q ss_pred CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCc
Q 008634 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (558)
Q Consensus 460 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGl 539 (558)
...++||||++++.+..+.. ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45899999999887775542 3445888999999999999999999985 99999999999999999999999999
Q ss_pred ceeeCCC
Q 008634 540 ARIFGGN 546 (558)
Q Consensus 540 a~~~~~~ 546 (558)
++.+...
T Consensus 164 ~~~~~~~ 170 (318)
T d3blha1 164 ARAFSLA 170 (318)
T ss_dssp CEECCC-
T ss_pred eeecccc
Confidence 9987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.93 E-value=9.3e-26 Score=225.05 Aligned_cols=161 Identities=20% Similarity=0.347 Sum_probs=134.2
Q ss_pred cCCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCC-CCeeeeeEEEEeCCEEEEEEE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 467 (558)
.++|.+.++||+|+||.||+|+.. +|+.||||++..... ...+.+|++.+..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357889999999999999999965 689999998865432 3457889999999965 899999999999999999999
Q ss_pred cCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcC-----CCcEEEEecCccee
Q 008634 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARI 542 (558)
Q Consensus 468 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~-----~~~~ki~DFGla~~ 542 (558)
|+ +++|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 68999888643 345899999999999999999999985 999999999999974 57899999999999
Q ss_pred eCCCCCc-----cCcccccCC
Q 008634 543 FGGNQNQ-----ANTNIIAGT 558 (558)
Q Consensus 543 ~~~~~~~-----~~t~~~~Gt 558 (558)
+...... ..+..++||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT 176 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGT 176 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSC
T ss_pred cccCccccceeecccCceEEc
Confidence 8644321 223346676
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.1e-26 Score=227.05 Aligned_cols=152 Identities=28% Similarity=0.480 Sum_probs=124.9
Q ss_pred cCCCCcccccccCCcccEEEEEec-C-CcEEEEEEccccCc--cchHHHHHHHHHHhcC---CCCCeeeeeEEEEeC---
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTLA-D-GKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEG--- 459 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~~-~-g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~--- 459 (558)
.++|+..++||+|+||.||+|+.. + ++.||||+++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 367889999999999999999863 4 66799999865422 2234566777776655 899999999998642
Q ss_pred --CEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 008634 460 --QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (558)
Q Consensus 460 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DF 537 (558)
...++++||++++++..... .....+++.....++.||+.||.|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 46899999999988765543 34456899999999999999999999985 999999999999999999999999
Q ss_pred CcceeeCCC
Q 008634 538 GLARIFGGN 546 (558)
Q Consensus 538 Gla~~~~~~ 546 (558)
|+++....+
T Consensus 161 g~~~~~~~~ 169 (305)
T d1blxa_ 161 GLARIYSFQ 169 (305)
T ss_dssp CSCCCCCGG
T ss_pred hhhhhhccc
Confidence 999876543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=3.5e-25 Score=221.38 Aligned_cols=149 Identities=26% Similarity=0.382 Sum_probs=122.4
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCee-eeeEEEEeCCEEEEEEEc
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEY 468 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey 468 (558)
++|+..++||+|+||.||+|+.. +|+.||||.+..... .+++..|++++++++|+|++ .+.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 56889999999999999999864 689999998875433 34688999999999877655 455556778899999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEc---CCCcEEEEecCcceeeCC
Q 008634 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGG 545 (558)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DFGla~~~~~ 545 (558)
+. ++|...+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 85 555555533 2346899999999999999999999985 99999999999985 456799999999999865
Q ss_pred CC
Q 008634 546 NQ 547 (558)
Q Consensus 546 ~~ 547 (558)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1e-25 Score=230.10 Aligned_cols=148 Identities=30% Similarity=0.436 Sum_probs=125.5
Q ss_pred cCCCCcccccccCCcccEEEEEe-cCCcEEEEEEccccCc--cchHHHHHHHHHHhcCCCCCeeeeeEEEEeC-----CE
Q 008634 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (558)
Q Consensus 390 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~VaVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (558)
.++|...++||+|+||.||+|+. .+|+.||||++.+... ...+.+.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46788999999999999999996 4799999999976532 3356789999999999999999999998643 34
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++++||+.+|+|.+++.. ..+++.....++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5677788899999999843 35999999999999999999999985 9999999999999999999999999998
Q ss_pred eeC
Q 008634 542 IFG 544 (558)
Q Consensus 542 ~~~ 544 (558)
...
T Consensus 170 ~~~ 172 (348)
T d2gfsa1 170 HTD 172 (348)
T ss_dssp CCT
T ss_pred ccC
Confidence 664
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=8.4e-25 Score=224.05 Aligned_cols=147 Identities=33% Similarity=0.473 Sum_probs=120.6
Q ss_pred CCCCcccccccCCcccEEEEEec-CCcEEEEEEccccC--ccchHHHHHHHHHHhcCCCCCeeeeeEEEEe------CCE
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE 461 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 461 (558)
++|...++||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999965 69999999997543 3345678999999999999999999999964 368
Q ss_pred EEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEEecCcce
Q 008634 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (558)
Q Consensus 462 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~ 541 (558)
.++||||+.++.+.. +. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 899999997765543 32 24899999999999999999999985 9999999999999999999999999998
Q ss_pred eeCCC
Q 008634 542 IFGGN 546 (558)
Q Consensus 542 ~~~~~ 546 (558)
.....
T Consensus 168 ~~~~~ 172 (355)
T d2b1pa1 168 TAGTS 172 (355)
T ss_dssp -----
T ss_pred ccccc
Confidence 77544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=8.3e-22 Score=183.46 Aligned_cols=135 Identities=19% Similarity=0.215 Sum_probs=106.5
Q ss_pred CcccccccCCcccEEEEEecCCcEEEEEEccccCc------------------cchHHHHHHHHHHhcCCCCCeeeeeEE
Q 008634 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLQEFKNEVNLIAKLQHKNLVRLLGC 455 (558)
Q Consensus 394 ~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 455 (558)
.++++||+|+||.||+|+..+|++||||+++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999988999999998753210 001234568889999999999988765
Q ss_pred EEeCCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 008634 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (558)
Q Consensus 456 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 535 (558)
. . .+++|||++++.+.. +++.....++.|++.+|.|||+++ |+||||||+|||+++++ ++|+
T Consensus 83 ~--~--~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c--C--CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 2 379999999866532 333445678999999999999985 99999999999998654 8999
Q ss_pred ecCcceeeCCC
Q 008634 536 DFGLARIFGGN 546 (558)
Q Consensus 536 DFGla~~~~~~ 546 (558)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999877543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.82 E-value=1.3e-20 Score=192.66 Aligned_cols=152 Identities=19% Similarity=0.274 Sum_probs=122.5
Q ss_pred CCCcccccccCCcccEEEEEec-CCcEEEEEEccccCccchHHHHHHHHHHhcCC-----------CCCeeeeeEEEEe-
Q 008634 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----------HKNLVRLLGCCLE- 458 (558)
Q Consensus 392 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~- 458 (558)
+|.+.++||+|+||.||+|+.. +|+.||||++++... ..+.+.+|+.++.+++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4888999999999999999964 799999999975432 2456788998888775 5789999998864
Q ss_pred -CCEEEEEEEcCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEEcCCC------c
Q 008634 459 -GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM------N 531 (558)
Q Consensus 459 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk~~NILl~~~~------~ 531 (558)
....+++++++..+..............+++.....++.||+.||.|||+.. +|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 4567778887776655444444455667899999999999999999999832 699999999999998655 3
Q ss_pred EEEEecCcceeeCCC
Q 008634 532 PKISDFGLARIFGGN 546 (558)
Q Consensus 532 ~ki~DFGla~~~~~~ 546 (558)
+|++|||.++.....
T Consensus 171 ~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH 185 (362)
T ss_dssp EEECCCTTCEETTBC
T ss_pred eeEeecccccccccc
Confidence 999999999876543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=5.8e-07 Score=85.31 Aligned_cols=144 Identities=17% Similarity=0.102 Sum_probs=97.1
Q ss_pred CCCCcccccccCCcccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEEcC
Q 008634 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYM 469 (558)
Q Consensus 391 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 469 (558)
..|...+..+-++...||+... ++..+.+|+...........+..|...+..+. +--+.+++.+..+++..++|||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 4454444333333468998875 45567788877665545556778888877663 445678899888899999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 008634 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED---------------------------------------- 509 (558)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------------- 509 (558)
++.++.+..... .. ...++.++++.|..||+.
T Consensus 93 ~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 93 DGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred cccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 998876543210 11 122344455555555531
Q ss_pred ----------------CCCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 510 ----------------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 510 ----------------~~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
.+..++|+|+.|.|||++++..+-|+||+.+..-
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 0123789999999999998777789999988754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=2.3e-05 Score=73.45 Aligned_cols=143 Identities=17% Similarity=0.146 Sum_probs=86.5
Q ss_pred ccccCCc-ccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCC--CCCeeeeeEEEEeCCEEEEEEEcCCCCCH
Q 008634 398 KLGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (558)
Q Consensus 398 ~LG~G~f-G~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 474 (558)
.+..|.. ..||+....++..+.+|.-.... ...+..|...++.+. .-.+.+++++..+++..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 67899988778888888765443 234667777777663 34467888888888899999999987665
Q ss_pred HHH-----------------HhccC-CCCCC--CHHHHHHH--------------------HHHHHHHHHHHHhC----C
Q 008634 475 DVH-----------------LFDAT-RSVQL--DWKRRQSI--------------------INGIARGILYLHED----S 510 (558)
Q Consensus 475 ~~~-----------------l~~~~-~~~~l--~~~~~~~i--------------------~~~ia~aL~yLH~~----~ 510 (558)
.+. ||... ....+ .+.....- .......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 321 11000 00000 11100000 00011222333322 1
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 511 ~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
++.++|+|+.|.|||++++..+-|+||+.+..-
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 223899999999999998877889999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.36 E-value=0.00043 Score=69.24 Aligned_cols=75 Identities=12% Similarity=0.205 Sum_probs=48.5
Q ss_pred cccccCCcccEEEEEecC-CcEEEEEEcccc-------CccchHHHHHHHHHHhcC-CC--CCeeeeeEEEEeCCEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-------SGQGLQEFKNEVNLIAKL-QH--KNLVRLLGCCLEGQELLLI 465 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~-g~~VaVK~l~~~-------~~~~~~~~~~Ei~~l~~l-~H--~niv~l~g~~~~~~~~~lV 465 (558)
+.||.|..-.||+....+ ++.|+||.-... -+...++...|.+.|..+ .+ ..+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998754 678999964321 112234456688777665 22 345666655 55566899
Q ss_pred EEcCCCCC
Q 008634 466 YEYMPNKS 473 (558)
Q Consensus 466 ~Ey~~~gs 473 (558)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.66 E-value=0.0038 Score=60.30 Aligned_cols=136 Identities=15% Similarity=0.157 Sum_probs=78.5
Q ss_pred ccEEEEEecCCcEEEEEEccccCccchHHHHHHHHHHhcCCCCCe--eeee-----EEEEeCCEEEEEEEcCCCCCHH--
Q 008634 405 GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL--VRLL-----GCCLEGQELLLIYEYMPNKSLD-- 475 (558)
Q Consensus 405 G~Vyk~~~~~g~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~-- 475 (558)
-.||+.+..+|..+++|..... ....+++..|...+..|...++ +..+ ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999987643 2234667788888877642222 1111 1234567789999999864431
Q ss_pred ---HH---------Hhc------cCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCCCe
Q 008634 476 ---VH---------LFD------ATRSVQLDWKR-------------------RQSIINGIARGILYLHE----DSRLKI 514 (558)
Q Consensus 476 ---~~---------l~~------~~~~~~l~~~~-------------------~~~i~~~ia~aL~yLH~----~~~~~i 514 (558)
.+ +|. ......+++.. +-.+...+...+..+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 111 01111222211 11122222223333322 223468
Q ss_pred eeCCCCCCCEEEcCCCcEEEEecCcceee
Q 008634 515 IHRDLKASNILLDDDMNPKISDFGLARIF 543 (558)
Q Consensus 515 vHrDlk~~NILl~~~~~~ki~DFGla~~~ 543 (558)
||+|+.+.|||++++ ..++||+-+..-
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred ecCCCCcccEEEeCC--ceEEechhcccC
Confidence 999999999999754 458999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.71 E-value=0.0086 Score=59.35 Aligned_cols=72 Identities=14% Similarity=0.193 Sum_probs=46.4
Q ss_pred cccccCCcccEEEEEecCC--------cEEEEEEccccCccchHHHHHHHHHHhcCC-CCCeeeeeEEEEeCCEEEEEEE
Q 008634 397 NKLGQGGFGPVYKGTLADG--------KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 467 (558)
Q Consensus 397 ~~LG~G~fG~Vyk~~~~~g--------~~VaVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 467 (558)
++|+-|-.=.+|+...+++ ..|.+++.- .. .......+|..+++.+. +.-.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4576677788999886543 456666554 22 22344567888888774 4334577877642 68999
Q ss_pred cCCCCCH
Q 008634 468 YMPNKSL 474 (558)
Q Consensus 468 y~~~gsL 474 (558)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.26 E-value=0.34 Score=45.37 Aligned_cols=32 Identities=28% Similarity=0.305 Sum_probs=28.1
Q ss_pred CCCeeeCCCCCCCEEEcCCCcEEEEecCccee
Q 008634 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (558)
Q Consensus 511 ~~~ivHrDlk~~NILl~~~~~~ki~DFGla~~ 542 (558)
+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 34699999999999999988789999998864
|